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Abstract 
Background and aim: In Nigeria, only medical doctors, dentists and some nurses in 
primary care facilities have the legal right to prescribe medicines. Patients’ access to 
prescriptions can be seriously affected by the shortage of prescribers and waiting times 
in hospitals. This research was carried out to investigate the facilitators and barriers to 
extending pharmacists’ clinical roles to include prescribing in Nigeria. 
Methods: The research employed an exploratory sequential mixed methods design 
consisting of three studies: The first involved semi-structured interviews with 32 UK 
pharmacy staff to investigate the changes in the structure of pharmacy practice in order 
to identify lessons for the Nigerian context. The second was semi-structured interviews 
with 49 Nigerian stakeholders including policymakers, pharmacists, doctors and patient 
group representatives to explore their views on pharmacist prescribing in Nigeria. The 
third was a cross-sectional survey involving 775 Nigerian pharmacists.  
Results: The UK study suggests that changes in the traditional structure of pharmacy 
including a shift in the focus of pharmacy training to a patient orientated one, 
specialisation in practice, the development of a clinical career route, enhanced working 
relationship with doctors and the utilisation of pharmacy technicians could benefit the 
development of pharmacists’ clinical roles including prescribing. The two Nigerian 
studies showed a strong support for pharmacist prescribing especially by pharmacists 
and patient group representatives. The facilitators to pharmacist prescribing identified 
included pharmacists’ expert medicine knowledge, the positive attitude of pharmacists 
towards extended clinical roles, a positive relationship between doctors and 
pharmacists in some teaching hospitals and the potential benefits associated with 
pharmacist prescribing including increasing patients’ access to medicines. Barriers 
identified included lack of government support, medical opposition, pharmacists’ lack of 
confidence to do clinical roles, inadequate pharmacists’ skills in diagnosis and shortage 
of pharmacists. 
Conclusion:  This research concludes that a change in the traditional structure of 
pharmacy would be necessary for the development of pharmacist prescribing in 
Nigeria. The key areas for change are enumerated in the recommendations of this 
thesis.  
 
5 
 
Table of contents 
Acknowledgement ........................................................................................................ 3 
Abstract ........................................................................................................................ 4 
Table of contents .......................................................................................................... 5 
List of tables ............................................................................................................... 13 
List of figures .............................................................................................................. 14 
List of abbreviations .................................................................................................... 15 
CHAPTER 1: INTRODUCTION .................................................................................. 17 
1.1 How it all started ........................................................................................... 17 
1.2 Research background and rationale ............................................................. 19 
1.3 Aim and objectives ....................................................................................... 21 
1.4 Structure of this thesis .................................................................................. 22 
1.5 Chapter summary ......................................................................................... 23 
CHAPTER 2: PHARMACIST PRESCRIBING: A REVIEW .......................................... 24 
2.1 Introduction ................................................................................................... 24 
2.2 Adoption of pharmacist prescribing across the world .................................... 24 
2.2.1 United States of America ....................................................................... 24 
2.2.2 United Kingdom ..................................................................................... 26 
2.2.3 Canada .................................................................................................. 28 
2.2.4 New Zealand ......................................................................................... 30 
2.2.5 Australia ................................................................................................ 31 
2.2.6 South Africa ........................................................................................... 32 
2.3 Impact of Pharmacist Prescribing ................................................................. 34 
2.4 Scoping review of the facilitators and barriers to implementing pharmacist 
prescribing in the UK ............................................................................................... 37 
2.4.1 Review methods .................................................................................... 38 
2.4.1.1 Identifying research question .......................................................... 39 
2.4.1.2 Identifying relevant studies ............................................................. 40 
2.4.1.3 Study selection ............................................................................... 41 
6 
 
2.4.1.4 Charting of data .............................................................................. 42 
2.4.1.5 Collating, summarizing and reporting results .................................. 42 
2.4.2 Results .................................................................................................. 43 
2.4.2.1 Studies included ............................................................................. 43 
2.4.2.2 Characteristics of included studies .................................................. 44 
2.4.2.3 Barriers and facilitators to pharmacist prescribing ........................... 45 
2.4.3 Legislation/policy ................................................................................... 46 
2.4.4 Pharmacy factors ................................................................................... 47 
2.4.5 Awareness of pharmacist prescribing .................................................... 50 
2.4.6 Patient Factors ...................................................................................... 52 
2.4.7 Medical factors....................................................................................... 53 
2.4.8 Organisational factors ............................................................................ 55 
2.5 Chapter summary ......................................................................................... 56 
CHAPTER 3: RESEARCH METHODOLOGY ............................................................. 60 
3.1 Introduction ................................................................................................... 60 
3.2 Nature of qualitative research ....................................................................... 60 
3.3 Nature of quantitative research ..................................................................... 64 
3.4 Why take a mixed methods approach? ......................................................... 65 
3.5 Typologies of mixed methods designs .......................................................... 68 
3.6 Interpretive Paradigm .................................................................................... 73 
3.7 Chapter summary ......................................................................................... 74 
CHAPTER 4: INVESTIGATING CHANGES IN THE STRUCTURE OF PHARMACY 
PRACTICE IN THE UNITED KINGDOM ..................................................................... 76 
4.1 Introduction ................................................................................................... 76 
4.2 Objectives ..................................................................................................... 77 
4.3 Methods ........................................................................................................ 77 
4.3.1 Ethics ..................................................................................................... 77 
4.3.1.1 Autonomy and informed consent .................................................... 78 
4.3.1.2 Confidentiality and anonymity ......................................................... 78 
7 
 
4.3.1.3 Data protection ............................................................................... 79 
4.3.1.4 Risks to participants or researcher ................................................. 79 
4.3.2 Study setting .......................................................................................... 79 
4.3.3 Recruitment and sampling strategy........................................................ 80 
4.3.4 Sample size ........................................................................................... 81 
4.3.5 Data collection method .......................................................................... 81 
4.3.6 Interview guide ...................................................................................... 83 
4.3.7 Pilot interviews....................................................................................... 85 
4.3.8 Interview process ................................................................................... 86 
4.3.9 Data analysis ......................................................................................... 87 
4.3.9.1 Stage 1: Data familiarisation ........................................................... 88 
4.3.9.2 Stage 2: Generating initial codes .................................................... 88 
4.3.9.3 Stage 3: Searching for themes ....................................................... 89 
4.3.9.4 Stage 4: Reviewing themes ............................................................ 90 
4.3.9.5 Stage 5: Defining and naming themes ............................................ 91 
4.3.9.6 Stage 6: Producing the report ......................................................... 91 
4.3.10 Demonstrating rigour ............................................................................. 92 
4.4 Results ......................................................................................................... 94 
4.4.1 Demographics ....................................................................................... 94 
4.4.2 Redefining the pharmacists’ professional role ........................................ 97 
4.4.3 Drivers for change ................................................................................. 98 
4.4.3.1 Safe use of medicines .................................................................... 99 
4.4.3.2 Government policies and legislations ............................................ 103 
4.4.3.3 Pharmacists’ education and training ............................................. 108 
4.4.3.4 Specialisation ............................................................................... 111 
4.4.3.5 The role of pharmacy technicians ................................................. 112 
4.4.3.6 Economic driver ............................................................................ 114 
4.4.3.7 Professional relationship with doctors ........................................... 116 
4.4.3.8 Shortage of medical doctors ......................................................... 118 
8 
 
4.4.3.9 The role of leading individuals and professional associations ....... 119 
4.4.4 Barriers to pharmacy practice change .................................................. 121 
4.4.4.1 The Medical Profession ................................................................ 121 
4.4.4.2 Professional attitude of pharmacy staff ......................................... 122 
4.4.4.3 Legislative and policy constraints .................................................. 124 
4.4.4.4 Professional Isolation .................................................................... 125 
4.4.4.5 Organisational barriers.................................................................. 127 
4.4.5 Benefits of clinical role extension ......................................................... 128 
4.4.5.1 Benefits to the patients ................................................................. 128 
4.4.5.2 Benefits to pharmacy staff ............................................................ 129 
4.4.5.3 Economic benefits ........................................................................ 131 
4.4.6 Strategies for achieving pharmacy practice change ............................. 132 
4.4.6.1 Developing a credible pharmacy practitioner ................................ 132 
4.4.6.2 Freeing-up pharmacists to do extended role ................................. 133 
4.4.6.3 Seizing the opportunity ................................................................. 134 
4.4.6.4 Developing a relationship with the medical profession .................. 135 
4.4.6.5 Leading individuals and professional associations ........................ 135 
4.5 Study strengths and limitations ................................................................... 136 
4.6 Chapter summary ....................................................................................... 137 
CHAPTER 5: EXPLORING THE FACILITATORS AND BARRIERS TO EXTENDING 
PHARMACISTS’ CLINICAL ROLES TO INCLUDE PRESCRIBING IN NIGERIA ...... 140 
5.1 Introduction ................................................................................................. 140 
5.2 Objectives ................................................................................................... 141 
5.3 Methods ...................................................................................................... 141 
5.3.1 Ethics ................................................................................................... 141 
5.3.2 Study setting ........................................................................................ 142 
5.3.3 Recruitment and sampling strategy ...................................................... 143 
5.3.4 Interview guide .................................................................................... 144 
5.3.5 Pilot interviews ..................................................................................... 144 
9 
 
5.3.6 Interview process ................................................................................. 145 
5.3.7 Data analysis ....................................................................................... 146 
5.4 Results ....................................................................................................... 147 
5.4.1 Demographics ..................................................................................... 147 
5.4.2 Pharmacists’ professional identity ........................................................ 149 
5.4.2.1 Pharmacists as underutilised professionals .................................. 149 
5.4.2.2 Pharmacists as custodians of medicines ...................................... 150 
5.4.2.3 Pharmacists’ as dispensers of medicines ..................................... 150 
5.4.2.4 Pharmacists as medicines advisers .............................................. 152 
5.4.2.5 Pharmacists as clinical practitioners ............................................. 153 
5.4.2.6 The business image of pharmacy ................................................. 155 
5.4.3 Pharmacy professional structure ......................................................... 156 
5.4.3.1 Confidence ................................................................................... 156 
5.4.3.2 Specialisation and career structure ............................................... 158 
5.4.3.3 Shortage of pharmacy staff ........................................................... 159 
5.4.3.4 Utilisation of pharmacy technicians ............................................... 162 
5.4.3.5 Medical dominance and opposition ............................................... 165 
5.4.3.6 Collaboration with doctors ............................................................ 168 
5.4.3.7 Lack of policies to support clinical pharmacy practice ................... 171 
5.4.3.8 Regulation .................................................................................... 172 
5.4.4 Views on prescribing ........................................................................... 174 
5.4.4.1 Prescribing a logical role for pharmacists ..................................... 174 
5.4.4.2 Pharmacist prescribing: a threat to doctors’ role ........................... 177 
5.4.4.3 Pharmacists’ competence in prescribing ....................................... 178 
5.4.4.4 Collaborative prescribing as an appropriate model ....................... 180 
5.4.4.5 Potential benefits of pharmacist prescribing .................................. 181 
5.4.4.6 Potential facilitators and barriers to pharmacist prescribing .......... 184 
5.5 Ensuring rigour in this study ........................................................................ 190 
5.6 Strengths and limitations of the study ......................................................... 191 
10 
 
5.7 Chapter summary ....................................................................................... 191 
CHAPTER 6: A CROSS-SECTIONAL SURVEY OF PHARMACISTS’ VIEWS ON THE 
FACILITATORS AND BARRIERS TO EXTENDING THEIR CLINICAL ROLES TO 
INCLUDE PRESCRIBING IN NIGERIA ..................................................................... 195 
6.1 Introduction ................................................................................................. 195 
6.2 Key qualitative findings informing the present study .................................... 195 
6.3 Objectives ................................................................................................... 196 
6.4 Methods ...................................................................................................... 196 
6.4.1 Ethics ................................................................................................... 196 
6.4.2 Recruitment of participants .................................................................. 197 
6.4.3 Sample size ......................................................................................... 197 
6.4.4 Sampling.............................................................................................. 198 
6.4.5 Questionnaire development ................................................................. 199 
6.4.6 Validity and reliability ........................................................................... 202 
6.4.7 Pilot survey .......................................................................................... 203 
6.4.7.1 Pilot sample .................................................................................. 204 
6.4.7.2 Pilot data collection ....................................................................... 204 
6.4.7.3 Pilot results ................................................................................... 204 
6.4.7.4 Modifications based on pilot findings............................................. 206 
6.4.8 Main study ........................................................................................... 206 
6.4.9 Data Analysis ....................................................................................... 207 
6.4.9.1 Descriptive analysis ...................................................................... 207 
6.4.9.2 Bivariate relationships ................................................................... 207 
6.4.9.3 Logistic regression ........................................................................ 208 
6.4.9.4 Analysis of textual data ................................................................. 208 
6.5 Results ....................................................................................................... 208 
6.5.1 Response rate ..................................................................................... 208 
6.5.2 Demographic details of respondents .................................................... 209 
6.5.3 Views on clinical pharmacy practice in Nigeria ..................................... 211 
6.5.4 Views on pharmacist prescribing ......................................................... 214 
11 
 
6.5.5 Independent predictors of support for pharmacist prescribing .............. 217 
6.5.6 Potential facilitators and barriers to pharmacist prescribing ................. 217 
6.5.7 Analysis of textual data ........................................................................ 219 
6.6 Study strengths and limitations ................................................................... 221 
6.7 Chapter summary ....................................................................................... 222 
CHAPTER 7: DISCUSSION AND CONCLUSION ..................................................... 225 
7.1 Introduction ................................................................................................. 225 
7.2 Overview of thesis aim, objectives and key findings ................................... 225 
7.3 Development of clinical pharmacy practice ................................................. 229 
7.3.1 Government support ............................................................................ 229 
7.3.2 Education and training ......................................................................... 230 
7.3.3 Pharmacy workforce shortages and utilisation of pharmacy technicians
 233 
7.3.4 Career structure and specialisation...................................................... 236 
7.3.5 Medical dominance and professional relationship with doctors ............ 238 
7.4 The potential for pharmacist prescribing in Nigeria ..................................... 240 
7.4.1 Views on pharmacist prescribing ......................................................... 240 
7.4.2 Potential facilitators and barriers to pharmacist prescribing ................. 244 
7.5 Strengths and limitations of the exploratory sequential mixed methods design
 249 
7.6 Research dissemination ............................................................................. 250 
7.7 Conclusion .................................................................................................. 251 
7.8 Recommendations ...................................................................................... 252 
7.8.1 Recommendations for policy ................................................................ 252 
7.8.2 Recommendations for practice ............................................................ 253 
7.8.3 Recommendations for education ......................................................... 254 
7.8.4 Recommendations for research ........................................................... 255 
References ............................................................................................................... 256 
Appendices ............................................................................................................... 277 
Appendix 1: Literature Search Strategy ............................................................. 277 
12 
 
Appendix 2: Included studies ............................................................................. 279 
Appendix 3: Comparisons of common paradigms used in social and behavioural 
sciences ............................................................................................................. 288 
Appendix 4: Ethical approval letter for the UK study ........................................... 289 
Appendix 5: Participant Information Sheet (UK study) ........................................ 291 
Appendix 6: Consent form (UK study) ................................................................ 293 
Appendix 7:  Final interview guide used in the UK study .................................... 294 
Appendix 8: Mind mapping of potential ideas during thematic analysis .............. 296 
Appendix 9: SHREC’s Ethics approval letter for the Nigerian study ................... 297 
Appendix 10: Nigerian ethics approval letter ...................................................... 298 
Appendix 11: Participant Information Sheet (Nigerian study) ............................. 299 
Appendix 12: Consent form (Nigerian study) ...................................................... 301 
Appendix 13: Draft interview guides for the Nigerian study ................................ 302 
Appendix 14: Final interview guide used in interviewing Nigerian pharmacists and 
pharmacy technicians ........................................................................................ 306 
Appendix 15: Online Survey Questionnaire ........................................................ 308 
Appendix 16: Online survey recruitment letter .................................................... 320 
13 
 
List of tables 
Table 2-1: Summary of prescribing status in countries across the world ..................... 33 
Table 2-2: Comparison of systematic and scoping reviews* ....................................... 37 
Table 2-3: A summary of the Arksey and O’Malley framework .................................... 39 
Table 2-4: Perceived facilitators and barriers to pharmacist prescribing ...................... 46 
Table 4-1: Draft interview guide used for the pilot interviews conducted with UK 
pharmacy staff ............................................................................................................ 83 
Table 4-2: Potential themes and subthemes identified during analysis ....................... 90 
Table 4-3: Demographic details of participants interviewed ........................................ 95 
Table 4-4: Themes and sub-themes from analysis ...................................................... 96 
Table 5-1: Themes and sub-themes identified from analysis .................................... 148 
Table 6-1: How survey items were generated from qualitative data .......................... 200 
Table 6-2: Demographic characteristics of respondents............................................ 210 
Table 6-3: Views of respondents on clinical pharmacy practice in Nigeria................. 212 
Table 6-4: Relationship between respondents’ area of practice and preferred 
prescribing model ..................................................................................................... 215 
Table 6-5: Perceived facilitators and barriers to pharmacist prescribing .................... 218 
Table 6-6: Themes and supporting quotes identified from the analysis of textual data
 ................................................................................................................................. 220 
14 
 
List of figures 
Figure 2-1: Flow chart of the articles selection process. .............................................. 44 
Figure 3-1: Overview of the exploratory sequential mixed methods research design .. 72 
Figure 4-1: Screen shot showing categories generated............................................... 90 
Figure 4-2: Relationship of identified themes with the Input-Process-Outcome model 98 
Figure 4-3: Timeline of some key events in the UK ..................................................... 99 
Figure 4-4: Medicine related events that led to the development of pharmacists’ roles 99 
Figure 4-5: Some government documents linked to the development of clinical 
pharmacy practice in the UK ..................................................................................... 103 
Figure 4-6: Developments in pharmacy training programme in the UK ...................... 108 
Figure 6-1: Relationship between target population and study participants ............... 199 
Figure 6-2 : Relationship between postgraduate clinical qualification and respondents’ 
agreement on further training of pharmacy technicians to do some pharmacists’ 
traditional medicine supply roles ............................................................................... 213 
Figure 6-3: Respondents’ preferred model of prescribing .......................................... 214 
Figure 6-4: Areas of training need identified by respondents ..................................... 216 
Figure 7-1: Key issues that emerged from empirical research ................................... 227 
15 
 
List of abbreviations 
AIDS  Acquired Immune Deficiency Syndrome 
APTUK Association of Pharmacy Technicians, United Kingdom 
B. Pharm Bachelor of Pharmacy 
CDTM  Collaborative Drug Therapy Management 
CINAHL Cumulative Index to Nursing and Allied Health Literature  
CMP  Clinical Management Plan 
CPD  Continuing Professional Development 
EU  European Union     
FMoH  Federal Ministry of Health 
GOPD  General Out-Patient Department 
GP  General Practitioner 
GPhC  General Pharmaceutical Council 
GT  Grounded Theory 
HIV  Human Immunodeficiency Virus 
IPA  International Pharmaceutical Abstracts     
NHREC National Health Research Ethics Committee of Nigeria 
NHS  National Health Service     
NMP  Non-Medical Prescribing     
PCN  Pharmacists’ Council of Nigeria 
PCNZ  Pharmacy Council of New Zealand 
PCT  Primary Care Trust 
Pharm D Doctor of Pharmacy 
PLP  Period of Learning in Practice 
16 
 
PSN  Pharmaceutical Society of Nigeria 
RCT  Randomised Controlled Trial  
SCT  Secondary Care Trust  
SHREC School of Healthcare Research Ethics Committee  
SP  Supplementary Prescribing     
UK  United Kingdom 
UKCPA United Kingdom Clinical Pharmacy Association    
USA  United States of America     
WAPCP West African Postgraduate College of Pharmacists  
WHO  World Health Organisation 
17 
 
CHAPTER 1: INTRODUCTION 
1.1 How it all started 
My interest in pharmacy practice research stems from my experience as a hospital 
pharmacist in the first year after qualification as a pharmacist in Nigeria. As a hospital 
pharmacist, my roles were limited. I was seen by patients and doctors as someone who 
had no contribution in patients’ hospital journey other than to dispense medications 
according to the doctors’ instructions. This left me dissatisfied as a pharmacist knowing 
that my skills were highly underutilised in the hospital environment. After a year of 
hospital practice, I moved to the University of Jos to take up a teaching and research 
post. My hospital experience influenced my research direction at the University as I 
became much more interested in researching into how pharmacists’ roles can be 
enhanced in practice settings.  
My journey to this thesis began in 2011 during the design of the cross-sectional survey 
that I and other researchers at the University of Jos conducted among 330 hospital and 
community pharmacists in north-central Nigeria. This survey explored their views on 
generic medicines substitution and potential generic medicine substitution authority for 
pharmacists in Nigeria (Auta et al., 2014a). The questionnaire used for the 2011 survey 
was designed based on the review of the literature. As the research team reviewed the 
literature the concept of pharmacist prescribing came to the fore. The research team 
explored this further by designing and conducting a pilot survey that sought patients’ 
opinions on pharmacist prescribing in Nigeria. The pilot survey which included 432 
clients of community pharmacists showed a high support (92.5%) for an extended 
clinical role for pharmacists in prescribing (Auta et al., 2014b). Therefore, my 
experience during the design of these two studies and the potential benefits associated 
with pharmacist prescribing in Nigeria informed my decision to pursue doctoral 
research that considered the facilitators and barriers to extending prescribing authority 
to pharmacists in Nigeria.  
Prior to starting my PhD, I had little understanding of pharmacist prescribing and how it 
worked within the United Kingdom (UK) healthcare system. Hence, the design of this 
research including its methodology and objectives was predominantly informed by the 
review of the literature. The details of how the literature informed key aspects of this 
research are reported in subsequent chapters. For example, the objectives of the first 
empirical study conducted “to investigate the changes in the structure of pharmacy 
practice in the UK prior to the introduction of pharmacist prescribing in order to identify 
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lessons that might assist in the potential changes needed in Nigeria” was based on the 
research gap identified in the literature review conducted in the first year of my PhD.  
My background in pharmacy and previous research experience has mainly emphasised 
the quantitative paradigm. Therefore, I would describe my belief and research 
orientation prior to starting my PhD as positivism. I was introduced to other research 
paradigms including qualitative methodology during my Masters degree in Public 
Health at the University of Leeds and the research methods module (HECS5237M) I 
undertook in the first year of my PhD. During these periods, I increasingly became 
aware of the different approaches to research. These exposures challenged my initial 
positivist view point and provided the foundation to develop my understanding of 
research methodologies. From this, I was able to match research questions with 
appropriate methodologies. Therefore, my choice of a mixed methods design and the 
generic approach in the qualitative component of the mixed methods research 
conducted was mainly based on their appropriateness in meeting my research 
objectives (as discussed in chapter 3) and not on my previous research experience.  
I employed a pragmatic world view in the research process to enable me to use 
elements of qualitative and quantitative research to meet my research objectives. 
Therefore, I employed a constructivist viewpoint in the qualitative component of my 
research to value multiple (subjective) perspectives of my research participants in order 
to gain a deeper understanding of the facilitators and barriers to extending pharmacists’ 
clinical roles to include prescribing (Creswell, 2013, Tashakkori and Teddlie, 1998). In 
the quantitative component of the research, I worked from a post-positivist perspective 
in order to pursue objectivity, measure variables and evaluate trends in my data 
(Creswell and Plano-Clark, 2011).  
My interaction with the qualitative interviews conducted with UK participants (reported 
in chapter 4) was minimal because prior to this research, my experience of pharmacy 
practice in the UK was limited. It was mainly based on the knowledge gained during the 
literature review in the first year of my PhD. Therefore, data interpretation in the UK 
study was mainly supported by the literature. On the other hand, being a Nigerian 
pharmacist, I am, to a large extent, experienced with pharmacy practice in Nigeria. 
Therefore, this experience might have influenced key decisions made regarding the 
Nigerian qualitative study including study objectives and data interpretations reported in 
chapter 5. However, deliberate efforts were made as outlined in section 5.5 of chapter 
5 to ensure the ‘trustworthiness’ of the research. In addition, my knowledge and 
experience of pharmacy practice in Nigeria enabled me to collect rich data and 
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produced better in-depth interpretations of the data obtained.  For example, as a 
pharmacy lecturer in Nigeria, I was able to better understand and interpret (while 
cautious of my personal bias) issues raised by participants regarding the inadequacy of 
the Nigerian undergraduate programme to prepare pharmacists who are confident in 
clinical settings. The rich interpretations given concerning this issue in the research 
would have otherwise not have been provided if the study was undertaken by someone 
who is inexperienced of pharmacy education in Nigeria.   
1.2 Research background and rationale  
To prescribe is to “authorize by means of a written prescription the supply of a 
medicine” (Department of Health, 1999 p.11). Prescribing to patients has traditionally 
been under the professional domain of doctors and dentists, until the introduction of 
non-medical prescribing (NMP) in some countries which allowed non-medical 
professionals including nurses, pharmacists, optometrists, radiographers and 
physiotherapists to prescribe medicines (Stewart et al., 2012, Kroezen et al., 2011). A 
number of countries have made legislation for NMP including the United States of 
America (USA), UK, Australia, New Zealand, Canada, Sweden, the Republic of Ireland, 
South Africa, Botswana, Kenya and Uganda (Bhanbhro et al., 2011). Nurse prescribing 
is the most popular form of NMP.  Available data shows that Nurses have been 
authorised to prescribe in 22 countries (Bhanbhro et al., 2011). Pharmacists currently 
have legal authority to prescribe medicines in  the USA, UK, Canada and New Zealand 
(PCNZ, 2013, Tonna et al., 2008). However, a 2009 global survey of hospital pharmacy 
practice revealed that hospital pharmacists in 20 countries are involved in the 
prescribing of medicines under certain local arrangements in emergency situations 
(Doloresco and Vermeulen, 2009). For instance in Ghana, Tanzania, Anguilla and 
Argentina, designated pharmacists are allowed to prescribe narcotic analgesics to 
cancer patients in an emergency (Cleary et al., 2013a, Cleary et al., 2013b).  
There are different models of pharmacist prescribing including collaborative and 
independent models (Tonna et al., 2008, Emmerton et al., 2005). These models are 
discussed in chapter 2. Furthermore, the type of medicines pharmacists are allowed to 
prescribe differs across countries. For example, in the UK, pharmacists can prescribe 
any medicine within their area of competence except cocaine, dipipanone and 
diamorphine for treating addiction (Statutory Instrument, 2012), while in the US 
restrictions still exist in some states on pharmacist prescribing of narcotics (Hammond 
et al., 2003). Also in Canada, pharmacists are not legally allowed to prescribe 
controlled medicines including narcotics (Law et al., 2012, Steed, 2012).  
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Despite the challenges associated with the implementation of pharmacist prescribing 
including opposition from doctors and lack of evidence on its effectiveness (Nissen, 
2014), it is gradually being accepted and implemented internationally. For example, 
pharmacist prescribing started in Canada in 2007 in the Alberta province and by 2012 
all the provinces except Quebec had granted prescribing authority to pharmacists 
(Bacovsky, 2012). Furthermore, in 1997, the American College of Clinical Pharmacy 
reported that United States pharmacists were able to prescribe under the collaborative 
agreement in 16 states (Carmichael et al., 1997). In less than 10 years following this 
report, pharmacists were legally allowed to prescribe in 42 states (Barclay, 2005). The 
increase in the international recognition of pharmacist prescribing has been facilitated 
by the desire to ensure prompt patients’ access to prescription medicines and better 
utilisation of pharmacists’ skills (Nissen, 2014). Nevertheless, in many developing 
countries including Nigeria, where access to medicines has remained a public health 
challenge due to shortage of medical prescribers, pharmacist prescribing is yet to be 
recognised as an important strategy that would enhance access to medicines.   
The legislation concerning prescribing of medicines in Nigeria states that: 
“In tertiary and secondary health care institutions, only duly qualified 
and licensed medical practitioners shall have the authority to prescribe 
drugs. At the primary health care level, government shall designate 
appropriate health care personnel to prescribe drugs; only qualified 
and licensed medical practitioners shall have the authority to prescribe 
drugs in the private sector” (FMoH and WHO, 2005 p.25). 
Hence, only medical doctors and dentists have the legal right to prescribe medicines to 
patients in Nigeria, except in primary health centres (PHCs). Since most PHCs lack 
doctors, prescribing is mostly done by nurses and community health workers using 
standing orders or protocols (Ehiri et al., 2005, FMoH, 2010a). However, prescribing by 
nurses and community health workers has been reported to be inappropriate for a 
number of reasons including lack of adherence to treatment guidelines and their 
inadequate knowledge of medicines (Babalola et al., 2011, Ehiri et al., 2005, Fagbule 
and Kalu, 1995). For example, prescription of antibiotics for the treatment of viral 
respiratory infections have been reported to be common among them (Ehiri et al., 
2005, Fagbule and Kalu, 1995). 
The general out-patient department (GOPD) of hospitals in Nigeria serve as the entry 
points for most patients seeking medical help because of the lack of doctors in PHCs 
(FMoH, 2007). These GOPDs function more or less like the general practitioner (GP) 
practices in the UK. Typically, a doctor in a GOPD in Nigeria has approximately 40 – 50 
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patient consultations per day because of the shortage of doctors (Umar et al., 2011, 
Ajayi, 2002).  In addition, more than 50% of patients visiting GOPDs wait for between 
one to three hours to see a doctor (Oche and Adamu, 2014, Umar et al., 2011, Ajayi, 
2002).  As a result, access to medicines in Nigeria can be seriously affected by the 
shortage of medical prescribers (40 doctors per 100,000 people compared with 280 
doctors per 100,000 people in the UK) including general practitioners and specialist 
physicians (World Bank, 2013) and long waiting times in hospitals (Ehiri et al., 2005, 
Ajayi, 2002). Thus, it is beyond doubt that the current prescribing arrangements in 
Nigeria do not sufficiently meet the needs of patients in terms of timely and convenient 
access to prescriptions. In addition, concerns exist in terms of the safety of prescribing 
by nurses and community health workers in Nigeria. 
Pharmacists in Nigeria are highly educated professionals with expertise in medicines 
management. Their mode of training follows similar models in advanced countries 
including the UK (Alo, 2006). It consists of a five-year undergraduate professional 
programme followed by a one-year pre-registration work-based supervised training 
(Alo, 2006). In addition, many pharmacists in Nigeria are specialising as clinical 
pharmacists at various universities and the West African Postgraduate College of 
Pharmacists (WAPCP, 2012a). About two-thirds of the 482 Nigerian pharmacists who 
successfully completed the WAPCP fellowship programme as of 2011 were in the 
specialty of clinical pharmacy (WAPCP, 2012a). Despite the cost and high level of 
training of pharmacists in Nigeria, their expertise is not used effectively as their roles 
have not been expanded to a more clinical one. They mainly perform the traditional role 
of dispensing, which could be handled by suitably trained pharmacy technicians as in 
other countries such as the UK (Anto et al., 2013, Mullen, 2004).   
Pharmacists in Nigeria have shown a willingness for expanded clinical roles including 
prescribing (Erhun et al., 2013, Oparah and Eferakeya, 2005). Therefore, extending 
prescribing roles to them would potentially increase patients’ access to prescription 
medicines, reduce doctors’ workload, promote efficient use of pharmacists’ clinical 
skills and rational use of medicines. It would also enhance pharmacists’ job 
satisfaction, improve recruitment and retention and increase their contribution to 
healthcare delivery in Nigeria.   
1.3 Aim and objectives 
The aim of this research is to investigate the facilitators and barriers to extending 
pharmacists’ clinical roles to include prescribing in Nigeria.  
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The objectives are: 
 To review pharmacist prescribing in the UK including facilitators and barriers.  
 To investigate the changes in the structure of pharmacy practice in the UK prior 
to the introduction of pharmacist prescribing in order to identify lessons that 
might assist in the potential changes needed in Nigeria.  
 To explore the views of stakeholders involved in prescribing and pharmacy 
practice about the barriers and facilitators to the extension of a prescribing role 
to pharmacists in Nigeria. 
 To identify the potential changes that would be required in the structure of 
pharmacy practice for the development of pharmacist prescribing in Nigeria.  
 To make practice and policy recommendations for pharmacist prescribing in 
Nigeria. 
1.4 Structure of this thesis 
There are seven chapters in this thesis. Chapter 1 is this introduction. In Chapter 2, a 
review of pharmacist prescribing is presented. Chapter 2 is organised into three 
sections: an overview of international experience of pharmacist prescribing; a review of 
the current evidence in relation to the impact of pharmacist prescribing and a scoping 
review of the facilitators and barriers to pharmacist prescribing in the UK. Chapter 3 of 
this thesis presents the research design. It describes the nature of qualitative and 
quantitative research and justifies the choice of a mixed methods design for the 
empirical investigations conducted.  
Chapter 4 presents the first empirical study conducted, which was a qualitative study 
involving semi-structured interviews with pharmacists and pharmacy technicians in the 
UK. This study was aimed at investigating the changes in the structure of pharmacy 
practice in the UK prior to the introduction of pharmacist prescribing in order to identify 
lessons that might assist in the potential changes needed in Nigeria. The findings of the 
study reported in Chapter 4 were used to inform the qualitative study reported in 
Chapter 5. The study in Chapter 5, which involves semi-structured interviews with 
Nigerian stakeholders including pharmacists, doctors and patients was aimed at 
investigating the current structure of pharmacy practice in Nigeria in order to identify 
the potential changes needed for the development of pharmacist prescribing. The study 
also explored stakeholders’ views on the extension of pharmacists’ traditional role in 
Nigeria to include prescribing. The findings in chapter 5 were used to inform the design 
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of the cross sectional survey conducted with Nigerian pharmacists. This survey is 
reported in Chapter 6.  
This thesis concludes with Chapter 7 by presenting an integrated discussion of all the 
research findings in this thesis. The discussion was followed with practice and policy 
recommendations for the development of pharmacists’ clinical roles to include 
prescribing in Nigeria.  
1.5 Chapter summary 
This chapter provided the background, aim and objectives of the entire research work 
contained in this thesis. It clearly demonstrates that the present arrangements for 
prescribing of medicines do not sufficiently meet the needs of patients in terms of 
timely and convenient access to prescriptions. In addition, it recognised the potential 
for a prescribing role for pharmacists in Nigeria.  These premises provided the basis for 
the investigations contained in subsequent chapters, in order to identify the facilitators 
and barriers to extending pharmacists’ clinical roles to include prescribing in Nigeria.
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CHAPTER 2: PHARMACIST PRESCRIBING: A REVIEW 
2.1 Introduction 
This chapter presents a review of pharmacist prescribing. The chapter is structured into 
three sections. The first section discusses the adoption of pharmacist prescribing in 
some countries across the world including the USA and UK and highlights the model 
and level of prescribing authority accorded to pharmacists in these countries. Section 
2.3 then discusses the evidence relating to the impact of pharmacist prescribing in 
terms of its effectiveness in improving clinical outcomes, benefits, clinical 
appropriateness and safety. 
The third section of this chapter presents a scoping review of the facilitators and 
barriers to pharmacist prescribing in the UK in order to identify the nature of evidence 
available in empirical literature. The section describes the scoping review methodology 
including the process of identifying the research question, identifying relevant studies, 
study selection, charting of data, collating, summarising and reporting of evidence. The 
scoping review section then concludes with a summary of the nature of evidence 
identified and highlights key gaps in the existing literature. 
2.2 Adoption of pharmacist prescribing across the world 
2.2.1 United States of America 
Pharmacists in the United States of America (USA) were the first to gain prescribing 
authority. In 1972, a Health Manpower Pilot Project was introduced in California. This 
was to prepare non-medical students to be able to perform certain non-traditional roles 
including prescribing (Carmichael et al., 1997). This pilot project produced pharmacists, 
nurses and physician assistants who were competent to prescribe. As a result of the 
success of this project, the California Assembly Bill 717 was introduced in California in 
1977 to grant prescribing authority to these non-medical professionals (Carmichael et 
al., 1997).  Pharmacists’ prescribing activity in the USA was first reported in 1977 
among pharmacists working with the Indian Health Service who were prescribing for 
acute and chronic disease conditions in ambulatory care settings (Koch, 2000, 
Carmichael et al., 1997).  The state of Washington became the second state (1979) to 
grant pharmacists limited prescribing authority in the USA and this was followed by 
Mississippi in 1980 (Koch, 2000, Carmichael et al., 1997). Presently, pharmacists are 
prescribing in 46 (out of 50) states of the USA (CDC, 2012, Roberts and Gainsbrugh, 
2010). In addition, there are federal laws granting prescribing authority to pharmacists 
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working in federal institutions including armed forces and veterans’ affairs (Koch, 
2000). 
Overall, two forms of prescribing exist in the USA, dependent and independent 
prescribing (Tonna et al., 2008, Emmerton et al., 2005). In the dependent model, a 
pharmacist works in collaboration with a physician (independent prescriber) who 
delegates prescribing roles to the pharmacist based on agreed guidelines or protocols 
(Emmerton et al., 2005). This form of prescribing is seen in Collaborative Drug Therapy 
Management (CDTM) agreements. In CDTM, the delegating physician and the 
pharmacist make decisions and share responsibility for the treatment of the patient 
based on agreed protocols, policies or procedures (Roberts and Gainsbrugh, 2010, 
Tonna et al., 2008).  The physician diagnoses and makes initial treatment decisions 
while the pharmacist may select, initiate, monitor or adjust treatment within the limits of 
the agreement (Roberts and Gainsbrugh, 2010, Emmerton et al., 2005).   
CDTM agreements are governed by individual state laws and therefore vary from one 
state to another in terms of their scope (CDC, 2012, Hammond et al., 2003). 
Pharmacists are allowed to initiate therapy in at least 21 states (CDC, 2012). In more 
than 36 states, CDTM can be practised in all patient care settings: hospitals, clinics and 
community pharmacies. However, in some states, it is restricted to hospitals and 
ambulatory care clinics (CDC, 2012). Furthermore, variations exist across states in the 
drugs included in CDTM. Legislation in most states allows the pharmacist in CDTM 
agreement to prescribe all medicines. However,  restrictions exist in some states 
including Florida, Indiana, North and South Dakota regarding the prescribing of 
narcotics in CDTM (Hammond et al., 2003).  
Similarly the educational/training requirement to engage in CDTM varies across the 
states. While some states require additional post-registration training and advanced 
certification, in others, no additional educational requirement is necessary (Hammond 
et al., 2003).  For example, pharmacists in New Mexico must undergo additional 
training in diagnosis and physical assessment and pass a board approved competency 
test before they are certified to prescribe (Dole, 2012, Hammond et al., 2003). 
However, no additional training is required for Nebraska and Nevada (Hammond et al., 
2003).  
Independent prescribing authority is limited in the US.  Pharmacists with independent 
prescribing authority in the US prescribe medicines without the supervision of a 
physician. Independent prescribing is mainly seen in federal institutions including the 
United States Army and the Indian Health Service (Tonna et al., 2008, Barclay, 2005). 
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However, state laws in Florida have now granted legal rights to pharmacist to prescribe 
independently from a limited formulary including anti-emetics and antidiarrhoeals 
(Tonna et al., 2008).   
Limited data are available on the extent and scope of pharmacist prescribing in the US 
(CDC, 2012, Thomas et al., 2006). Data are not available on the number of 
pharmacists currently prescribing in the US. However, pharmacist prescribing has been 
reported in various areas. These areas included pain, anticoagulation, hypertension, 
lipid management, parenteral nutrition, asthma and smoking cessation (Dole, 2012, 
Ragan, 2012, Thomas et al., 2006). A 2003 survey of pharmacist collaborative drug 
therapy management in 327 US hospitals revealed that the common prescribing 
activities carried out by pharmacists were adjusting strength of medicines (86.7%), 
ordering laboratory investigations (84.2%) and modifying  the frequency of medicine 
administration (81.6%) (Thomas et al., 2006).  
2.2.2 United Kingdom 
The Health and Social Care Act, 2001 provided the legal framework for NMP in the UK. 
This was aimed at improving patients care while ensuring patient safety, promoting 
patients access to and choice of treatment/medicines and better use of the clinical 
skills of non-medical professionals including pharmacists (Department of Health, 
2006b). It was also intended to promote better team working among National Health 
Service (NHS) staff (Department of Health, 2006b).   
Two forms of pharmacist prescribing exist in the UK: supplementary prescribing 
introduced in 2003 and independent prescribing introduced in 2006 (Tonna et al., 
2008). Supplementary prescribing involves a 
 “voluntary partnership between an independent prescriber (a doctor or 
dentist) and a supplementary prescriber to implement an agreed 
patient-specific clinical management plan (CMP)” (Department of 
Health, 2005b p.8).  
In the independent prescribing model, the prescriber is 
“responsible and accountable for the assessment of patients with 
undiagnosed or diagnosed conditions and for decisions about the 
clinical management required, including prescribing” (Department of 
Health, 2006b p.2). 
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Therefore, in the independent prescribing model, pharmacists are solely responsible for 
every prescribing decision made even though they work in collaboration with other 
members of the healthcare team (Nissen, 2011).  
To qualify as a pharmacist independent prescriber (which now includes a qualification 
as a supplementary prescriber), a pharmacist must have at least 2 years post-
registration experience in a patient-orientated environment, undergo study at university 
level equivalent to 26 days of full-time education and at least a 12-day period of 
learning in practice with a designated medical practitioner (Stewart et al., 2012).  
Studies investigating the training of supplementary and independent prescribers in the 
UK have reported positive views in terms of the appropriateness of knowledge and 
skills gained. The period of learning in practice was highly appreciated among 
pharmacists (Latter et al., 2010, Cooper et al., 2008d). New Zealand has adopted this 
model of training for its pharmacist prescribers (PCNZ, 2013).  Also, an Australian 
qualitative study involving semi-structured interviews with 25 pharmacy stakeholders 
showed a strong support for adopting the UK training model in Australia when 
pharmacist prescribing is implemented (Kamarudin et al., 2013).  Despite these 
positive reports on the UK training model, some pharmacists in the UK had reported 
that additional training on physical assessment and diagnosis are needed (Latter et al., 
2010, Cooper et al., 2008d). This would be essential considering that pharmacist 
prescribers are increasingly adopting an independent prescribing role.  
There are approximately 3200 registered pharmacist supplementary/independent 
prescribers in the UK (Phelps et al., 2014, Pharmaceutical Society of Northern Ireland, 
2014). This represents about 6.5% of the approximately 49,000 practicing pharmacists 
in the UK (OECD, 2013). As mentioned in chapter 1, these prescribers are able to 
prescribe medicines for any condition within their clinical competence with the 
exception of some controlled drugs which include cocaine, dipipanone and 
diamorphine for treating addiction (Statutory Instrument, 2012). However, pharmacist 
prescribers usually prescribe in one specialised clinical area (Latter et al., 2010, Lloyd 
et al., 2010). As in the US, prescribing by pharmacists in the UK has been reported in 
many disease areas including critical care, pain, mental health, oncology, hypertension 
and anticoagulation (Mulholland, 2013, NPC, 2010, Guillaume et al., 2008). A recent 
survey of 1914 pharmacist prescribers in Great Britain revealed that the three most 
common areas of pharmacist prescribing were in antibiotics, pain management and 
cardiovascular diseases (Phelps et al., 2014).  However, this survey revealed that the 
majority (64%) of pharmacist prescribers in Great Britain prescribe to 10 or fewer 
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patients in a typical week. This suggests that the degree of pharmacists’ prescribing in 
the UK is still low.   
2.2.3 Canada 
In Canada, pharmacy practice is regulated by provincial pharmacy regulatory bodies. 
Therefore variation in governance structure, legislation and scope of practice exists 
across provinces (Bacovsky, 2012, Law et al., 2012). Alberta became the first 
Canadian province to grant pharmacists prescribing authority as outlined in the Health 
Professions Act for Pharmacist Practice of 1 April, 2007 (Makowsky et al., 2013, 
Alberta College of Pharmacists, 2007b).  This Act permitted pharmacists to prescribe 
schedule 1 drugs (which are prescription medicines) with the exception of narcotics 
and controlled drugs (MacLeod-Glover, 2011, Alberta College of Pharmacists, 2007b).   
Prior to this time, various arrangements existed across some provinces and hospital 
facilities that enabled pharmacists to perform some prescribing functions. For example, 
a national survey of 620 hospitals in Canada revealed that a significant number of 
hospitals reported that pharmacists were involved in prescribing functions under a 
collaborative drug therapy programme. Pharmacists prescribing functions included 
performing therapeutic substitutions (7.4%), adjusting dosages or dosage form of 
medicines (55.0%), initiating (3.5%) and modifying (39.4%) treatment with a non-
prescription medicine (Pearson et al., 2002).  Furthermore, in 2006, an arrangement 
was made for pharmacists in Nova Scotia and Manitoba provinces to offer continued 
care prescriptions to patients. This enabled pharmacists in these provinces to extend 
the prescriptions of patients with long-term conditions (with the exception of narcotics 
and control substances) to ensure continuity of care. However, these pharmacists were 
also obliged to report such services offered to patients to the original prescriber by the 
next business day (Law et al., 2012).  
Presently, pharmacists in 9 out of the 10 provinces and 1 out of the 3 territories of 
Canada have been granted prescribing rights (Canadian Pharmacists Association, 
2014). Quebec is the only province awaiting legislative approval for pharmacist 
prescribing. However, pharmacists in this province can initiate or modify patient therapy 
based on a collaborative agreement with a doctor (Canadian Pharmacists Association, 
2014). As in the USA,  the level of prescribing authority varies across provinces 
(Canadian Pharmacists Association, 2014, Bacovsky, 2012).  For instance, in Alberta, 
pharmacists can independently initiate a prescription drug therapy, while those in New 
Brunswick are only allowed to do that within a collaborative practice (Canadian 
Pharmacists Association, 2014). 
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Various forms of dependent (delegated) and independent prescribing exist in Canada. 
These are manifested through three different models: ‘Initial access prescribing’, 
‘prescription modification’ and ‘comprehensive medication management’ (Pharmacist 
Prescribing Task Force, 2010).  Initial access prescribing involves prescribing for minor 
illnesses and providing health promotion information for patients who choose to visit 
the pharmacist for prescription and advice. It also includes prescribing in emergency 
situations such as the provision of emergency contraception or extending prescription 
stop date for patients with chronic conditions (Alberta College of Pharmacist, 2012, 
Pharmacist Prescribing Task Force, 2010). Community pharmacists can independently 
perform initial access prescribing in 7 of the 10 provinces in Canada (Law et al., 2012).  
Prescription modification is also referred to as adapting prescriptions. This is a 
dependent form of prescribing where pharmacists are allowed to perform therapeutic 
substitution or alter the dose, regimen, duration of therapy or formulation of a 
prescription written by another prescriber. This is done with the aim of improving 
therapeutic outcome or ensuring continuity of therapy (Guirguis et al., 2014, 
Pharmacist Prescribing Task Force, 2010). Comprehensive Medication Management is 
a collaborative form of prescribing and requires the pharmacist to be a member of a 
collaborative health team. In this model, the pharmacist prescriber initiates, monitors or 
modifies patient treatment after initial diagnosis has been made by a member of the 
collaborative team. Referral of the patients to the pharmacist is undertaken by a 
member of the collaborative team who made the initial diagnosis or upon request by 
the patient (Alberta College of Pharmacist, 2012).  
Like the USA, the requirements to become a pharmacist prescriber differ across 
provinces. Generally, all registered pharmacists are allowed to prescribe in many 
provinces. However, a few provinces have some additional requirements. For example, 
all registered pharmacists in New Brunswick can initiate a therapy. However, in Alberta, 
this function is performed by pharmacists on the clinical register of the Alberta College 
of Pharmacy who have been approved to prescribe after application to the college 
(Pharmacist Prescribing Task Force, 2010).  
There is paucity of data concerning the adoption of prescribing role by pharmacists in 
Canada. Available information showed that the prescribing role has not been 
adequately taken up by pharmacists. For example, as mentioned earlier, all 
pharmacists in Alberta are permitted to adapt prescriptions and prescribe in 
emergencies. However, additional prescribing authorization is needed to initiate 
therapy independently (Hughes et al., 2013, Bacovsky, 2012). This authorisation can 
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be obtained on application to the Alberta College of Pharmacists and following the 
successful evaluation of the applicant including the applicant’s educational qualification 
and practice experience (Guirguis et al., 2014). As at February 2011 only 155  out of 
the 4300 practising pharmacists in Alberta have obtained additional prescribing 
authorisation (Bacovsky, 2012). A survey conducted among 500 hospital pharmacists 
in Alberta to explore their perspectives on taking on additional prescribing authorisation 
revealed the cumbersome nature of the  application process and the concern about 
increased responsibilities and risks as barriers to adoption of additional prescribing 
authorisation (Hutchison et al., 2012). However, a recent report from the Alberta 
College of Pharmacist suggests that the trend in the uptake of additional prescribing 
authorisation is changing. Applications for additional prescribing authorisation have 
been increasing. The college received 257 applications in 2013 compared to 95 in 
2005. The majority of these applicants were community (66%) and hospital (16%) 
pharmacists. As of February 2014, 435 pharmacists have received additional 
prescribing authorisation and this represent a 98% increase from the 2012 data of 220 
(Alberta College of Pharmacist, 2014).  
2.2.4 New Zealand 
Prior to the introduction of pharmacist prescribing in New Zealand, other non-medical 
practitioners including nurses and optometrists were legally allowed to prescribe 
medicines (Wheeler et al., 2010). In 2007, the Pharmacy Council of New Zealand 
(PCNZ) made a proposal for designated prescribing authorisation for pharmacists. 
They sought feedback from various stakeholders on the appropriate prescribing model 
for New Zealand. Collaborative practice was identified by stakeholders (Wheeler et al., 
2012). In this model, the pharmacist prescriber works in a multidisciplinary health team 
to initiate, alter or monitor a patient’s prescription (Wheeler et al., 2012). Pharmacists in 
a collaborative practice model will be able to prescribe prescription medicines within 
their area of competence (Hoti et al., 2011).    
The PCNZ made an application to the Health Workforce New Zealand, Ministry of 
Health in 2010 and by 2011,  it was agreed in principle to approve prescribing 
authorisation for pharmacists (PCNZ, 2012). Hence, a pilot project was established and 
funded by the Health Workforce New Zealand. This project recruited 14 pharmacists (7 
pharmacists each from primary and secondary care) to undertake  a university based 
postgraduate course in pharmacist prescribing accredited by the PCNZ  (Kamarudin et 
al., 2013, PCNZ, 2012). The course entails 600 hours (two semesters) of study and a 
practical component of 300 hours. In the practical component, pharmacists spent not 
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less than 150 hours (compared to the 90 hours in the UK)  of supervised practice under 
a Designated Medical Practitioner as in the UK (PCNZ, 2011).  
Following successful completion of the pilot project, the Medicines (Designated 
Pharmacist Prescriber) Regulation was introduced in July 2013 in New Zealand to 
enable pharmacists to act as prescribers (Legislative Instrument, 2013). This Act 
granted pharmacist prescribers  the authority to prescribe prescription medicines with 
the exceptions of  controlled drugs (Legislative Instrument, 2013). This act require the 
PCNZ to set competence and registration requirement for prescribers (PCNZ, 2013, 
Legislative Instrument, 2013). According to PCNZ, pharmacist prescribers must 
practice in a collaborative healthcare team and are able to adjust dosages of 
medicines, prescribe new ones and discontinue medicines if necessary in a defined 
practice area of the collaborative team in which they work (HWNZ, 2013, PCNZ, 2013).   
In order to become a pharmacist prescriber in New Zealand, a pharmacist must 
possess a postgraduate diploma in clinical pharmacy (or equivalent) to enable them to 
meet the requirement to be admitted to the university based post-graduate certificate in 
prescribing. The  pharmacists must also complete the prescribing course and work in a 
collaborative healthcare team to prescribe (HWNZ, 2013, PCNZ, 2013). As at August 
2014, there were 16 pharmacist prescribers in New Zealand. About half of these 
prescribers work in primary care (Ministry of Health, 2014a). There is currently little 
information concerning these prescribers. Available data indicates that they are now 
prescribing in different clinical areas including pain management, infection, 
cardiovascular and paediatrics (Ministry of Health, 2014b).   
2.2.5 Australia 
Pharmacy practice in Australia has undergone significant changes in recent years. 
Australian pharmacists now take on a number of advanced roles including medication 
reviews (Tan et al., 2012). They also work within collaborative healthcare teams to 
provide clinical pharmacy services to patients and participate in treatment decisions. 
Currently, there are provisions within the Australian laws for pharmacists to supply 
prescription-only medicines based on emergency supply or medication continuance 
(Hoti et al., 2011). In addition, many prescription medicines including Chloramphenicol 
eye drop and some proton-pump inhibitors have been re-scheduled to ‘Pharmacist 
Only Medicine’ (Pharmacy Guild of Australia, 2014). Despite these developments, 
Australian pharmacists are yet to be given prescribing authority over prescription only 
medicines. Australia has therefore been viewed by many authors to be lagging behind 
in the aspect of pharmacists prescribing (Kamarudin et al., 2013, Tonna et al., 2008).  
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There has been strong advocacy and support by stakeholders and professional groups 
including the Society of Hospital Pharmacists of Australia for expanded roles in 
prescribing (Kamarudin et al., 2013, Tonna et al., 2008).  These stakeholders have 
argued that prescribing would utilise pharmacists’ clinical skills and improve patients’ 
access to medicines. Research has shown that the collaborative prescribing model was 
highly favoured among many stakeholders including Australian pharmacists and 
doctors. They viewed this model as a natural progression for hospital pharmacists 
since hospital pharmacists are already working within a collaborative healthcare team 
and contributing to prescribing decisions (Kamarudin et al., 2013, Hoti et al., 2010).  
However, these stakeholders have expressed the need for further training of 
pharmacists in the aspect of clinical examination, diagnosis and consultations.  The UK 
training model for non-medical prescribers consisting of a university based learning and 
period of leaning in practice with a medical doctor was preferred (Kamarudin et al., 
2013). 
2.2.6 South Africa 
In South Africa, pharmacists who obtained the Primary Care Drug Therapy 
Qualification were previously permitted to prescribe some medicines under schedule 3 
and 4 of the Medicines and Related Substance Act. These medicines included those 
used in hypertension, diabetes and infectious diseases which were, at the time, only 
prescribed by medical doctors (Department of Health, 2012, SAPC, 2011). The 
permission came as a result of the application made by these pharmacists with the 
support of the South African Pharmacy Council in 1992 to grant prescribing role to 
them in order to fill the skill gap and meet patient needs in rural areas  (SAPC, 2011, 
Gilbert, 1998).   
This permission was granted under the Section 22A (15) of the Medicines and Related 
Substances Act 101 of 1965 of South Africa (Ward et al., 2014).  However, it was 
suspended in 1998 (Gilbert, 1998). As of 1998, 66 pharmacists who had completed the 
Primary Care Drug Therapy Course had been issued the permit (Gilbert, 1998). A 
survey carried out among these pharmacists showed that about 70% of them had more 
than 100 patients per day. Beside their traditional pharmacy roles, the majority of them  
were involved in prescribing for acute illness, prescribing contraceptives and monitoring 
drug therapy for chronic conditions including hypertension and diabetes (Gilbert, 1998).  
A recent document by the South African Pharmacy Council revealed that plans are on-
going to review the scope of practice of pharmacists in South Africa (SAPC, 2011). 
This document proposes the ‘Authorised Pharmacist Prescribers’.  These prescribers 
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are expected to work within primary care to diagnose and prescribe for disease 
conditions listed in the South Africa’s Primary Health Care Essential Medicine List and 
Standard Treatment Guidelines (SAPC, 2011). The Department of Health of South 
Africa is currently reviewing the proposed authorised pharmacist prescriber 
qualification and the re-instatement of the Section 22A (15) permit of the Medicines and 
Related Substances Act (Ward et al., 2014).  
Table 2-1: Summary of prescribing status in countries across the world 
Country Legal framework Prescribing model Current 
status 
USA Varies across states. 
Pharmacist prescribing 
began in California 
following  the California 
Assembly Bill 717 of 1977 
Dependent and 
Independent 
prescribing 
Ongoing in 46 
(out of 50) 
states 
UK Health and Social Care 
Act, 2001.  
Supplementary and 
Independent 
prescribing 
Ongoing 
South Africa The Medicines and 
Related Substances Act 
101 of 1965 
Limited formulary 
prescribing 
Suspended 
and under 
review 
Canada Varies across provinces. 
Pharmacist prescribing 
started in Alberta following 
the Health Professions Act 
for Pharmacist Practice of 
1 April, 2007 
Dependent and 
Independent 
prescribing 
Ongoing in 9 
(out of 10) 
provinces 
New Zealand The Medicines 
(Designated Pharmacist 
Prescriber) Regulation 
2013 
Collaborative 
prescribing 
Ongoing 
Australia Under development Collaborative 
prescribing proposed  
Not yet 
legislated  
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2.3 Impact of Pharmacist Prescribing 
Research evidence on aspects of pharmacist prescribing is still emerging. Therefore, 
those demonstrating any improvement in the outcome to patient therapy due to 
pharmacist prescribing are very few (Bruhn et al., 2013, Charrois et al., 2011). In 
addition, these studies are limited in their methodologies and strength of evidence as 
they are usually single site studies with limited sample size and non-randomised 
controlled trials. For example, Bowron et al. (2011) conducted a retrospective non-
randomised controlled study to compare the health outcomes of patients with type-2 
diabetes managed by a pharmacist independent prescriber and  a medical prescriber 
(serving as control) in a diabetic clinic in the UK. They looked at retrospective data of 
50 patients for each type of prescriber and evaluated the patients’ weight and 
metabolic parameters including their cholesterol level over a 2-year period.  Even 
though these researchers concluded that there was no difference in the clinical 
outcomes achieved by patients managed by the pharmacist independent prescriber 
and the medical doctor based on their findings, their study was limited by its small 
sample size.  In addition, research evidence based on a retrospective case control 
design is weak compared to those of a randomised controlled trial (Petticrew and 
Roberts, 2003, Hawker et al., 2002), as they may be subject to a number of 
confounding factors including those associated with the demographics of patients 
which were not controlled in the study.   
However, Bruhn et al. (2013) conducted an exploratory randomised controlled trial 
(RCT) in the UK to compare the effectiveness of pharmacist medication review, with or 
without pharmacist prescribing, with standard care, for patients with chronic pain. The 
RCT involved 196 chronic pain patients (from six general practices) randomised into 
three study groups: pharmacist medication review with pharmacist prescribing (n=70); 
pharmacist medication review with feedback to the General Practitioner (GP) and no 
planned patient contact (n=63); and treatment as usual group (n=63). Patients in the 
pharmacist prescribing group and the pharmacist review group showed significant 
improvement in some clinical outcomes after six months of follow-up.  For example, in 
comparison to baseline data, 47.7% of patients in the pharmacist prescribing group and 
38.6% of patients in the review group showed a significant improvement in chronic pain 
grade than those in the treatment as usual group (31.3%) (Bruhn et al., 2013). 
However, the contribution of pharmacist prescribing alone remains unclear since 
patients in the pharmacist prescribing group had both pharmacist prescribing and 
medication review. But the findings suggest that pharmacist prescribers could be as 
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effective as GPs in prescribing for chronic non-cancer pain. Nevertheless, a larger trial 
that would result in more robust evidence is needed.  
The predominant evidence on the impact of pharmacist prescribing is mainly 
qualitative. This relates to the experience of pharmacist prescribing reported by various 
stakeholders including patients, doctors and pharmacists. Findings from the literature 
were consistent across various stakeholders including doctors, pharmacists, patients, 
and policymakers in reporting an increase in patients’ access to treatment as a result of 
NMP, and a perceived reduction in delays to appointments (Hacking and Taylor, 2010, 
Stewart et al., 2009a, Cooper et al., 2008a). Several qualitative and quantitative studies 
exploring patients’ experience of pharmacist prescribing in the US and UK have 
reported positive benefits including pharmacists’ approachability, better patient 
education and extended consultation time (McCann et al., 2015, Gonzalvo et al., 2012, 
Stewart et al., 2011, Stewart et al., 2009a). Despite these benefits, patients in some 
studies reported that they would prefer to consult a doctor for a prescription, especially 
for initial diagnosis or when their illness is considered serious (McCann et al., 2015, 
Stewart et al., 2009b).  
Doctors have reported positive benefits of pharmacist prescribing in many qualitative 
studies in the UK. These benefits included comprehensive medication review, keeping 
doctors’ medicine knowledge updated, and freeing doctors’ time to allow for other 
specialised responsibilities (McCann et al., 2012, Weiss and Sutton, 2009, Blenkinsopp 
et al., 2008). However, some doctors have reported that pharmacist prescribing is likely 
to result in the deskilling of junior doctors (Lloyd and Hughes, 2007). There are 
assertions that NMP reduces doctors’ workload; however, no research has clearly 
demonstrated this claim (Lloyd et al., 2010, Poonawala et al., 2007). What is usually 
reported in most studies is a shift or reorganisation of tasks and it is uncertain whether 
this shift has resulted in an overall reduction in doctors’ workload. Furthermore, 
doctors’ workload may be unaffected because nonmedical prescribing may be taking 
care of  previously unmet need or has generated demand for care that was not 
previously there (Laurant et al., 2005). 
Pharmacists in many empirical studies have also reported a positive impact on their 
role to include: enhanced job satisfaction; better use of their clinical skills; recognition 
of the pharmacists’ role in patient care by other healthcare professionals; integration of 
pharmacists into the patient management team and more autonomy and responsibility 
in patient management (McCann et al., 2011, Lloyd et al., 2010, Stewart et al., 2009a, 
George et al., 2007b). A survey conducted among 105 qualified pharmacist prescribers 
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in Northern Ireland found that those who were prescribing, were more likely to report 
enhanced job satisfaction than those who had never prescribed (McCann et al., 2011). 
Studies investigating the clinical appropriateness of prescribing decisions and safety of 
NMP are lacking. Many authors have argued that supplementary prescribing is likely to 
improve safe prescribing because it involves collaborative prescribing decisions 
between an independent and a supplementary prescriber (Blenkinsopp et al., 2008, 
Cooper et al., 2008a). In addition, the ability of non-medical prescribers to adhere 
strictly to guidelines or protocols was viewed positively in terms of promoting 
prescribing safety (Blenkinsopp et al., 2008). A randomised controlled trial was 
conducted in Australia to compare collaborative pharmacist prescribing with usual care 
in a surgical pre-admission clinic (Hale et al., 2013). The trial randomised 400 patients 
into intervention (n=200) and control (n=200) group. In the intervention arm, the 
pharmacist prescriber prepared a medication chart, made a plan for medication 
preoperatively and prescribed venous thromboembolism (VTE) prophylaxis while in the 
control arm, medication charts were generated by resident medical officers. The trial 
reported that there was statistically significant less unintended omissions of 
medications in the intervention arm (1.2%) compared to the control arm (31.5%). Also, 
prescribing errors were less in the intervention group (0.2%) compared with the control 
group (6.3%). VTE prophylaxes were considered to be appropriate in 93% of 
intervention patients and 90% of control patient. Although this was a single site study 
that involves only one pharmacist prescriber, the evidence suggests that 
collaborative/supplementary pharmacist prescribing could be clinically safe and 
appropriate.   
Similarly, very little research has investigated the clinical appropriateness and safety of 
pharmacist independent prescribing. Latter et al. (2012) conducted a study to evaluate 
the appropriateness of prescribing decisions of nurse and pharmacist independent 
prescribers.  They utilised 20 independent healthcare professionals including 10 
medical doctors, 7 pharmacists and 3 nurses experienced in prescribing to rate 100 
audio-recorded pharmacists’ and nurses’ consultations (in which a  medication was 
prescribed) using a modified version of the Medication Appropriateness Index (MAI). 
The MAI was based on a number of criteria including indication, effectiveness, dosage, 
directions, practicality, drug-drug interaction, drug-disease interaction, duplication, 
duration and cost. The results showed that the highest average inappropriate ratings 
were in the aspects of correct directions (nurses 12%; pharmacists 11%) and cost of 
prescribed medicines (nurses 16%; pharmacists 22%). The authors concluded that the 
prescribing decisions of nurse and pharmacist independent prescribers were clinically 
37 
 
appropriate. However, this conclusion cannot be generalised as the consultations 
evaluated were purposefully sampled by the researchers. This sampling procedure can 
be prone to researchers’ bias and lacks representativeness. In addition, the number of 
nurse and pharmacist prescribers’ practice sites (n=9) evaluated was small. Therefore, 
more robust evidence is needed to demonstrate the appropriateness and safety of 
pharmacist independent prescribing.  
2.4 Scoping review of the facilitators and barriers to implementing pharmacist 
prescribing in the UK 
The aim of a scoping review is to map rapidly the key concepts underpinning a specific 
subject of interest based on the existing literature (Arksey and O'Malley, 2005, Mays et 
al., 2001).  This involves summarising a range of data to identify the nature and depth 
of evidence in a research area (Levac et al., 2010).  Just like systematic reviews, 
scoping reviews can be conducted as a standalone project in their own right (Mays et 
al., 2001). However, they differ considerably from systematic reviews in many ways as 
enumerated in Table 2-2. Nevertheless, they both employ a rigorous and transparent 
procedure to fully identify and analyse research evidence (Pham et al., 2014). 
Table 2-2: Comparison of systematic and scoping reviews* 
Systematic  review Scoping review 
Focussed research question with narrow 
parameters 
Research question(s) often broad 
Inclusion and exclusion criteria usually 
defined at outset 
Inclusion and exclusion criteria can be 
developed post hoc 
Quality filters often applied Quality not an initial priority 
Detailed data extraction May or may not involve data extraction 
Quantitative synthesis often performed Synthesis more qualitative and typically 
not quantitative 
Formally assesses the quality of studies 
and generates a conclusion relating to the 
focussed research question 
Used to identify parameters and gaps in 
the literature 
*Adopted from Brien et al. (2010) 
Scoping reviews are becoming more popular in healthcare including pharmacy practice 
(Grindrod et al., 2014, Brien et al., 2010). They are usually employed to: examine the 
extent, range and nature of research activity in a particular field of study; determine the 
value and potential cost of conducting a full systematic review; summarise and 
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disseminate research findings to policymakers, practitioners and other consumers; and 
identify research gaps in the existing literature (Arksey and O'Malley, 2005). Scoping 
reviews are particularly useful when a research area has not been extensively 
reviewed (Pham et al., 2014). Levac et al. (2010) added that they are useful in fields 
where research evidence is emerging and randomised controlled trials are lacking. This 
makes scoping reviews suitable for investigations in the area of pharmacist prescribing 
as research evidence is developing in this field and randomised controlled trials are 
limited (Bruhn et al., 2013, Cooper et al., 2008c).  Furthermore, a literature search in 
Medline and Embase databases identified very few published reviews on pharmacist 
prescribing globally. The ones identified included those of Cooper et al. (2008c), Tonna 
et al. (2007), Emmerton et al. (2005) and Kay and Brien (2004). Only Cooper et al. 
(2008c), who thematically reviewed nurse and pharmacist supplementary prescribing in 
the UK, focussed on the barriers and facilitators associated with implementing 
supplementary prescribing.  However, their review did not consider barriers associated 
with independent prescribing as it was just introduced in the UK when the review was 
done. In addition, the review included personal opinions and commentaries because at 
that time, empirical studies investigating non-medical prescribing were lacking. 
Therefore, the current scoping review is necessary to map the existing evidence on the 
barriers and facilitators to pharmacist prescribing including independent pharmacist 
prescribing in the UK.  
2.4.1 Review methods 
Methods of conducting scoping reviews vary across the literature (Pham et al., 2014). 
However, the methodological framework developed by Arksey and O'Malley (2005) is  
popular (Pham et al., 2014). A recent scoping review of 174 scoping reviews revealed 
that Arksey and O’Malley framework was used in about two-thirds of the reviews 
evaluated (Pham et al., 2014). The Arksey and O’Malley framework was employed to 
conduct the present scoping review because of its rigour and transparency (Levac et 
al., 2010). The Arksey and O’Malley framework consists of 5 main stages and an 
additional optional stage (see Table 2-3). The five main stages include: identifying the 
research question; identifying relevant studies; study selection; charting the data; and 
collating, summarising and reporting the results. These stages are briefly represented 
in the table below as described by Levac et al. (2010). 
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Table 2-3: A summary of the Arksey and O’Malley framework  
Stage Description 
1. Identifying the research 
question 
The research questions are broad in nature as they seek to 
provide breadth of coverage. Also, relevant aspects of the 
research question must be clearly defined as they have 
implications for search strategies.   
2. Identifying relevant 
studies 
This stage involves identifying the relevant studies and 
developing a decision plan for where to search, which term to 
use, which sources are to be searched, time span and 
language. Comprehensiveness and breadth is important in the 
search. Sources include electronic databases, reference lists, 
hand searching of key journals, and organisations and 
conferences. Breadth is important; however, practicalities of the 
search as well. Time, budget and personnel resources are 
potential limiting factors and decisions need to be made upfront 
about how these will impact the search. 
3. Study selection Study selection involves post hoc inclusion and exclusion 
criteria. These criteria are based on the specifics of the research 
question and on familiarity with the subject matter through 
reading the studies. 
4. Charting the data A data-charting form is developed and used to extract data from 
each study. A ‘narrative review’ or ‘descriptive analytical’ 
method is used to extract contextual or process oriented 
information from each study. 
5. Collating, summarising 
and reporting results 
An analytical framework or thematic construction is used to 
provide an overview of the breadth of the literature but not a 
synthesis. A numerical analysis of the extent and nature of 
studies using tables and charts is presented. A thematic 
analysis is then presented. Clarity and consistency are required 
when reporting results. 
6. Consultation (optional) Provides opportunities for consumer and stakeholder 
involvement to suggest additional references and provide 
insights beyond those in the literature. 
*Adopted from Arksey and O'Malley (2005) 
2.4.1.1  Identifying research question 
As earlier highlighted in Table 2-3, research questions for scoping reviews are usually 
broad. Hence, drawing on the literature review initially conducted in the first year of my 
PhD, the research question for this review was defined as follows: what are the 
facilitators and barriers to pharmacist prescribing in the UK? This question will identify 
the range, extent and nature of facilitators and barriers to pharmacist prescribing in the 
UK. Facilitators in this review were defined as those factors that enable the 
development of pharmacist prescribing while barriers were considered as factors that 
hinder the development of pharmacist prescribing. 
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The rationale for the choice of this research question is explained as follows. Globally, 
pharmacy practice is changing. Pharmacists in many countries are seeking to 
undertake advanced roles including prescribing. The UK pharmacist prescribing 
training and practice model is increasingly becoming popular among countries 
considering pharmacist prescribing including Australia (Kamarudin et al., 2013). 
Therefore, an understanding of the factors that could facilitate pharmacist prescribing 
and the barriers that exist in developing such a role in the UK would be valuable for 
both policymakers and healthcare practitioners including pharmacists in many 
countries considering pharmacist prescribing including Nigeria.   
Furthermore, despite legislative changes granting prescribing rights to pharmacists in 
the UK, the implementation and adoption of pharmacist prescribing is lagging behind 
(Courtenay et al., 2011a).  As mentioned earlier, only about 6.5% of the practising 
pharmacists in the UK are prescribers (Phelps et al., 2014, Pharmaceutical Society of 
Northern Ireland, 2014). In addition, research has shown that not all pharmacists who 
qualified as prescribers in the UK are fully utilising their prescribing qualification 
(Phelps et al., 2014, Courtenay et al., 2011a). A quarter of all qualified prescribers in 
Great Britain have never prescribed (Phelps et al., 2014). Therefore, if pharmacist 
prescribing is to be widely adopted in the UK, an understanding of the factors that 
facilitate or hinder its implementation in clinical practice is necessary. This would help 
in developing strategies to enhance the implementation of pharmacist prescribing in the 
UK, as well as the wider world.  
2.4.1.2 Identifying relevant studies 
The essence of conducting a scoping review in a particular area is to be as 
comprehensive as possible in identifying primary studies that  would answer the review 
question (Arksey and O'Malley, 2005). In this review, this was achieved through the 
following: 
 Electronic database literature search 
 Electronic search of key journals  
 Electronic search of key organisations  
 Electronic search of UK theses 
 Science Citation Index and searching of literature from the reference lists of 
articles 
A comprehensive list of search terms including pharmacist prescribing, supplementary 
prescribing, independent prescribing and non-medical prescribing (see Appendix 1) 
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was developed and discussed with my supervisors.  Since the aim was to obtain a 
comprehensive coverage of the literature in the research area, search terms were kept 
broad. The electronic databases searched were Medline, Embase, International 
Pharmaceutical Abstracts (IPA), PsycINFO and Cumulative Index to Nursing and Allied 
Health Literature (CINAHL). The search strategies employed vary across databases. 
However, different search strategies including the use of truncation; AND/OR in 
combining searches; and adjacency operator were employed. An example of the 
literature search conducted in the Embase database is represented in Appendix 1. 
Electronic searches were also conducted in key pharmacy practice journals including 
the International Journal of Pharmacy Practice and Pharmaceutical Journal. The 
website of the Department of Health UK and the United Kingdom Clinical Pharmacy 
Association were also searched for relevant grey literature. In addition, an electronic 
search of UK theses was conducted through the British Library Electronic Theses 
Online Service. Finally, a Science Citation Index search was carried out in Google 
Scholar. This was done by looking up articles that have cited the articles selected for 
this review. In addition, the bibliographies of selected studies were also checked for 
any relevant study.  
2.4.1.3 Study selection 
The inclusion/exclusion criteria used for this review were determined before the 
literature search was conducted. These criteria were informed by the previous literature 
review conducted in the first year of my PhD study. A study was considered eligible if it 
included: 
 A primary collection of data in the UK whether published or unpublished, and 
 The findings of the study related to the barriers and/or facilitators to extending 
prescribing authority to pharmacists, OR 
 The barriers and/or facilitators to implementing pharmacists’ prescribing 
practice. 
Research investigating both nurse and pharmacist prescribing that met the above 
criteria were included. Overall, all studies included in the review were conducted 
between 1990 and 2015 and reported in the English language. 
The criteria employed to exclude studies from the review were:  
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 Empirical research considering facilitators and barriers to delivering pharmacy 
clinical services other than pharmacist prescribing. For example, medication 
reviews.   
 Empirical research considering Nurse or other allied healthcare professionals 
prescribing.  
 Review articles, case reports, personal opinions and commentaries 
These inclusion and exclusion criteria were applied to all the citations retrieved during 
the literature search by reading the titles and abstracts of all citations. In instances 
where the relevance of the study was unclear on reading the abstract, the full article 
was read to determine its eligibility. Where more than one publication presented the 
same data for example a conference report and a peer-reviewed journal publication of 
a single study, the most recent publication or the one with a detailed description of the 
methods and findings was considered. However, if the findings were complementary, 
both reports were included. Furthermore, all studies that met the inclusion criteria were 
included in the review irrespective of their study design. The included and excluded 
articles including the rationale for inclusion/exclusion were discussed with my 
supervisors.  
2.4.1.4 Charting of data 
Using a descriptive analytical procedure, all key relevant data from individual articles 
selected were extracted and entered into a table created in Microsoft Word. The data 
extracted include authors, year of publication, research setting, aim of the study, study 
population, study methods, prescribing model considered, and main outcome of 
interest (barriers and facilitators to pharmacist prescribing).  
2.4.1.5 Collating, summarizing and reporting results 
This stage of the review began by importing charted data into Nvivo 10 qualitative 
software for data management and coding. The data on main outcome of interest were 
thematically coded to generate a list of themes relating to the facilitators and barriers to 
pharmacist prescribing. Coding was carried out using both a priori (codes generated 
based on initial review carried out in the first year of my PhD) and inductive codes 
(developed as data coding progressed). The themes generated were defined and 
organised into categories (see Table 2-4). Furthermore, basic numerical analyses were 
conducted to assess the nature and distribution of the studies included and the themes 
generated from the review.  
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2.4.2 Results 
2.4.2.1 Studies included 
A total of 663 articles were initially identified from the database searches: Embase (332 
hits), Medline (162 hits), IPA (80 hits), PsychInfo (22 hits) and CINAHL (67 hits) (see 
Figure 2-1). Following this, 184 duplicates were removed. Titles and abstracts of the 
remaining 479 articles were screened and 266 articles not considering non-medical 
prescribing were excluded. From the remaining 213 articles that reported on non-
medical prescribing, 125 were removed because they did not meet the inclusion 
criteria. These included commentaries, personal opinions, editorials and reviews, as 
well as articles on pharmacist prescribing in other countries. Finally, 88 full-text articles 
were retrieved including published (71) and grey literature (17). Among these, 42 met 
the inclusion criteria but 3 were excluded because they were presented in more than 
one publication. Therefore, 39 articles including 35 published and 4 grey articles were 
retained from the electronic databases search. 
Furthermore, the search on the British Library Electronic Theses Online Service gave 
47 records, 7 of which met the inclusion criteria but only 3 were included because the 
remaining 4 had published their key findings in peer-reviewed journals and had already 
been considered. Two (2) research reports on the Department of Health website were 
included. Also, additional 8 conference articles were included from the International 
Journal of Pharmacy Practice (6) and the United Kingdom Clinical Pharmacy 
Association (2) website. Two (2) articles were identified through the Science citation 
index while 5 were identified through checking of the reference lists of articles. 
Therefore, the search from sources outside the databases yielded additional 20 articles 
including 1 published and 19 grey literature articles.  
Overall, 59 articles: 36 published (see reference number 1-35 and 56 in Appendix 2) 
and 23 grey articles (reference number 36-55 and 57-59 in Appendix 2) were included. 
A summary of the article selection process is represented in Figure 2-1.      
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Figure 2-1: Flow chart of the articles selection process. 
2.4.2.2 Characteristics of included studies 
Most articles included in this review reported original studies conducted primarily in 
England (n=23; 39.0%), this was followed by Scotland (n=11; 18.6%), then Northern 
Ireland (n=8; 13.6%) and Wales (n=3; 5.1%). The remaining 14 (23.7%) studies were 
conducted in more than one country, either in countries within Great Britain or the UK. 
About half of the articles included primarily reported quantitative findings (n=29; 49.1%) 
while 44.1% (n=26) reported qualitative findings. Mixed methods studies account for 
6.8% (n=4) of the included studies. All the quantitative studies were cross-sectional 
studies using questionnaires as the data collection tool. Sample sizes in these surveys 
Total databases hits: 663 
Remaining: 479 
Removed duplicates: 184 
1054 
Remaining: 213 
266 articles not considering non-
medical prescribing were 
removed after reading of titles 
and abstracts. 
125 commentaries, personal 
opinions and reviews on 
nonmedical prescribing 
including pharmacist 
prescribing were removed after 
reading titles and abstracts. 
 
 Removed 123 commentaries, personal 
opinions and reviews on nonmedical 
prescribing including pharmacist 
prescribing after reading of titles and 
abstracts. 
Remaining: 88 
Removed 49 articles not meeting 
the inclusion criteria after looking 
at their full-text.  
Added 20 articles meeting 
inclusion criteria from other 
sources.  
Included in this review: 59 
Remaining: 39 
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ranged from 19 to 5000 while the response rates ranged from 22.3% to 82.2% (see 
Appendix 2). The qualitative studies predominantly employed a generic qualitative 
approach to their enquiry with the exception of a few that employed either a case study 
(n=4) or grounded theory (n=1) approach. The sample sizes for the qualitative studies 
ranged from 7 to 117.  
About three-quarters of the included studies (n=43, 72.9%) reported on the perception 
of pharmacists including pharmacist prescribers. Fifteen (25.4%) studies reported on 
the perceptions of doctors including GPs and mentors of pharmacist prescribers, 8 
(13.6%) included nurses’ perceptions, 15 (25.4%) included patients’ perceptions and 9 
(15.3%) included the perception of other stakeholders including service commissioners.  
Three (5.1%) of the included studies investigated pharmacist prescribing prior to the 
extension of prescribing rights to UK pharmacists in 2003. Of the remaining 56 studies 
investigating pharmacist prescribing following the extension of prescribing rights to UK 
pharmacists, 7 solely investigated independent pharmacist prescribing. 
2.4.2.3 Barriers and facilitators to pharmacist prescribing 
Table 2-4 presents the facilitators and barriers to pharmacist prescribing identified in 
this review. For each theme presented in the table, the reference number of the article 
(rather than its citation) where the theme was identified is reported. This is because of 
the large number of reference associated with many of the themes identified as citing 
the references using the reference style of this thesis would require more space. In 
addition, presenting the themes in this manner would facilitate ease of reading.  
In order of frequency, the most commonly reported facilitators to pharmacist 
prescribing were pharmacists’ willingness/motivation to be prescribers (n=10), 
pharmacists’ clinical experience prior to prescribing (n=9), pharmacists’ education and 
training (n=9), relationship with the medical doctors (n=9), patients’ acceptance (n=8), 
access to support from peers and mentors (n=8), and team approach to prescribing 
(n=7). On the other hand, the barriers commonly cited were lack of organisational 
strategy and support (n=21), lack of funding (n=16), lack of time (n=16), pharmacists’ 
inadequate skills in diagnosis (n=12), access to patients’ medical records (n=12), lack 
of awareness of pharmacist prescribing among other healthcare professionals (n=12) 
and patients (n=9), inadequate infrastructure including IT systems (n=11), shortage of 
pharmacists (n=10)  and lack of medical support (n=10).  
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Table 2-4: Perceived facilitators and barriers to pharmacist prescribing 
Theme Facilitators (number of studies 
in which factor was identified) 
[reference number] 
Barriers (number of studies in 
which factor was identified) 
[reference number] 
Legislation/policy   
Legislation 4 [1, 2, 46, 57] 0 
Legislative restrictions 0 3 [6, 7, 35] 
   
Pharmacy factors   
Pharmacists’ willingness/motivation to 
be prescribers 
10 [ 3, 7, 9,  29, 30, 34,  39, 42, 
53, 56] 
2 [2, 56] 
Pharmacists’ confidence to prescribe 
medicines 
2 [9, 53] 0 
Professional isolation 0 1 [38] 
Community pharmacists’ commercial 
image 
0 5 [1, 13, 15, 19, 42] 
Community pharmacies accessibility 3 [14, 15, 27] 0 
Pharmacists’ education/training 9 [2, 3, 14, 24, 30, 36, 40, 54, 57] 0 
Pharmacists’ clinical skills in diagnosis 1 [9] 12 [2, 3, 17-20, 22, 26, 30, 40, 53, 56] 
Pharmacists’ clinical experience prior to 
prescribing 
9 [2, 7, 17, 26, 31, 33, 38, 44, 49] 0 
Specialisation in practice 4 [7, 13, 17, 57] 0 
Pharmacists’ competence  in managing 
comorbidity 
0 1 [22] 
Team approach to prescribing 7 [2, 15, 18, 20-22, 33] 0 
   
Awareness of pharmacist prescribing   
Public/Patient awareness 0 8 [3, 4, 14, 19, 22, 26, 27, 50] 
Healthcare professionals awareness 3 [9, 24, 34] 12 [1, 3, 4, 11, 15, 18, 20, 38-41, 43]   
   
Patient factors   
Patient acceptance 8 [19, 23, 25, 27-29, 39, 50] 0 
Patient preference for medical 
prescribing 
0 7[4, 19, 22, 23, 25, 28, 50] 
   
Medical factors   
Medical support 2 [ 4, 16] 10 [1, 2, 9, 15, 18, 21, 26, 30, 35, 38] 
Relationship with medical doctors 9 [5, 13, 17, 29, 35, 38, 41. 42, 54] 6 [3, 5, 12, 13, 15, 17] 
Medical control over pharmacist 
prescribing 
0 4 [1, 4, 29, 33] 
Shortage of medical doctors 1 [31] 0 
   
Organisational factors   
Infrastructure 1 [3] 11 [3, 7, 8, 11, 14, 18, 20, 29, 37, 38, 
45] 
Challenges with Clinical Management 
Plan 
0 9 [3, 7, 8, 11, 18, 20, 30-32] 
Funding 3 [38, 42, 49] 16 [7, 8, 11, 13, 18, 20, 26, 32, 35, 37, 
42, 44-46, 49, 52] 
Access to patients’ medical records 0 12 [3, 6, 7, 14, 19, 20, 32, 34, 38, 52, 
54, 59] 
Time 2 [16, 49] 16 [5, 10, 12, 13, 16, 18, 32, 37, 38, 
46, 48, 49, 52-54, 56] 
Organisational strategies/support 4 [3, 5, 16, 38] 21 [3, 5-8, 10, 16, 18, 24, 29, 32, 35, 
37-39, 42, 44, 45, 47, 51, 59] 
Administrative delays 0 6 [3, 5, 7, 8, 31, 37] 
Support network for prescribers 8 [3, 16, 24, 35, 36, 39, 44, 49] 7 [5, 10, 12, 26, 45-47]  
Access to CPD 0 6 [3, 6, 26, 36, 38, 58] 
Remuneration  0 4 [5, 10, 12, 32] 
Change of role/job 0 6 [6, 8, 11, 35, 37, 51] 
Availability/Shortage of pharmacy staff 1 [13] 10 [7, 8, 11, 13, 18, 31, 36, 38, 46, 56] 
 
2.4.3 Legislation/policy  
In many countries including the UK, there is legislation governing the prescribing of 
medicines including the healthcare professionals that are legally allowed to prescribe 
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medicines (Department of Health, 1999). The legislative change (Health and Social 
Care Act, 2001) following the recommendations of the Crown reports (Department of 
Health, 1999, Department of Health, 1998) enabled non-medical professionals 
including pharmacists to prescribe first as supplementary prescribers then as 
independent prescribers (Cooper et al., 2008b). Prior to the legislative change 
contained in the Health and Social Care Act, 2001, district nurses and health visitors 
were permitted to prescribe a limited range of medicines following the amendment of 
the Medicines Act in 1992 (Act of Parliament, 1992). The legislative change extending 
prescribing authority to healthcare professionals other than doctors and dentists was 
driven by the need to increase patients’ access to medicines and to promote the 
utilisation of the skills of these professionals (Department of Health, 2005b). However, 
some general practitioners in focus groups conducted by Blenkinsopp et al. (2008) 
perceived NMP as politically motivated. They reported that it was part of government’s 
agenda to weaken the power that medical doctors have over healthcare delivery in the 
UK (Blenkinsopp et al., 2008).    
Although legislative change was a major facilitator of pharmacist prescribing in the UK, 
it was rarely recognised in the empirical literature examined. This was because the 
majority of the included studies were conducted after NMP was authorised and the 
studies were mainly focussed on the implementation of pharmacist prescribing. 
However, one study reported on the impact of legislation in expanding the scope of 
practice of a pharmacist prescriber (Mulholland, 2013).  The study which was a cross-
sectional survey conducted among 45 members of the Neonatal and Paediatric 
Pharmacists Group found that two pharmacist prescribers were prescribing controlled 
medicines (Mulholland, 2013). This was as a result of the legislative change in 2012 
that allowed non-medical prescribers to prescribe controlled medicines (Statutory 
Instrument, 2012).  Prior to this legislative change, the findings of three different studies 
in England revealed that legislative restriction on the prescribing of controlled drugs 
was a barrier to pharmacist prescribing of narcotics (Courtenay et al., 2012, Dawoud et 
al., 2011, Baqir et al., 2010).  
2.4.4 Pharmacy factors 
Despite concerns that pharmacists’ reluctance to take on new roles could be a barrier 
to pharmacist prescribing as expressed by  participants including pharmacists in some 
early studies (Buckley et al., 2006, Child et al., 1998), analysis of data obtained from 
the included studies in this review revealed that pharmacists’ willingness and 
motivation to take on a prescribing role was a major facilitator to pharmacist 
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prescribing. Research evidence on the implementation of both supplementary and 
independent pharmacist prescribing in practice settings has shown that it has been 
largely driven by individual pharmacists’ enthusiasm rather than organisational drive 
(Dawoud et al., 2011, Latter et al., 2010, Cooper et al., 2008a, Tann et al., 2008).  For 
example, a qualitative study involving focus groups with pharmacist supplementary 
prescribers and general practitioners in two Primary Care Trusts (PCTs) in England 
revealed that pharmacist prescribing in these PCTs was mostly implemented as a 
result of pharmacists’ initiatives rather than a strategic plan and development of the 
trusts (Tann et al., 2008).     
A cross-sectional survey of the views of 418 newly qualified pharmacists in Great 
Britain revealed that 86.4% of them were willing to become prescribers (McIntosh et al., 
2012a). Other previous surveys showed similar findings among non-prescribing 
pharmacists including Shrestha et al. (2011), George et al. (2006b), and Child et al. 
(1998) where 64.3% (9/14), 80.2% (174/217) and 95.5% (64/67), respectively were 
happy to be prescribers. In addition, the majority of these pharmacists were confident 
in their ability to take on a prescribing role including independent prescribing (Shrestha 
et al., 2011, George et al., 2006b). However, these non-prescribing pharmacists 
showed concerns for additional training particularly in the area of clinical diagnosis prior 
to prescribing.  
Furthermore, there is evidence to suggest that non-prescribing pharmacists in acute 
care settings are more willing to take on independent than supplementary prescribing 
roles because of the difficulty associated with implementing supplementary prescribing 
including the development of individual CMP in acute care settings (Tonna et al., 
2010). However, further research evidence is needed to establish this claim.  
Facilitators and barriers related to community pharmacy practice including accessibility 
of community pharmacies, community pharmacists’ isolation and business image were 
also identified. Three studies made reference to community pharmacies accessibility 
(Hobson et al., 2010, Stewart et al., 2009b, Hughes and McCann, 2003). Of these 
three studies, two explored public/patients’ opinion on pharmacist prescribing in 
England and Scotland (Hobson et al., 2010, Stewart et al., 2009b). Participants in 
these studies acknowledged the convenience and accessibility of community 
pharmacies in terms of its location and opening hours. They saw these as potential 
factors that could enhance the acceptance of community pharmacist prescribing. This 
view was earlier on expressed by community pharmacists in Northern Ireland in a 
qualitative study (Hughes and McCann, 2003). However, concerns were expressed on 
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community pharmacies lack of privacy and facilities including space to provide 
prescribing services. In addition, the relative isolation of community pharmacists affects 
their relationship with GPs and access to patients’ medical records which are essential 
in pharmacist prescribing (Dapar, 2012). These are further discussed in section 2.4.7 
and 2.4.8.  Furthermore, GPs and patients in many studies have reported that the 
commercial nature of community pharmacies could lead to a conflict of interest in 
prescribing by community pharmacists (MacLure et al., 2013, Blenkinsopp et al., 2008, 
Hughes and McCann, 2003). Nevertheless, no research evidence has established this 
claim.  
Advances in pharmacy education and training with increasing integration of clinical 
pharmacy practice at both the undergraduate and postgraduate levels was also an 
important facilitator to pharmacist prescribing in the UK (Department of Health, 1999). 
In many of the studies reviewed, pharmacists’ expert knowledge of medicines was 
acknowledged as a potential facilitator to pharmacist prescribing by various 
stakeholders including patients, pharmacists, nurses and doctors (Adigwe, 2012, 
Hobson et al., 2010, Tonna et al., 2010, Jones and Western, 2009, Cooper et al., 
2008a, Buckley et al., 2006). Furthermore, two studies revealed that pharmacists’ with 
postgraduate qualifications were more likely to take on a prescribing role than those 
without postgraduate qualifications (Stewart et al., 2007, While et al., 2004). Thus, 
confirming the claim that advancement in clinical pharmacy education is a potential 
facilitator to prescribing. 
Similarly, pharmacists’ prior clinical experience was also viewed as a key facilitator to 
pharmacist prescribing. In many of the studies conducted to explore pharmacists’ views 
on supplementary prescribing, hospital and community pharmacists viewed 
supplementary prescribing as a logical progression of their existing role because of 
their involvement in patient care (Dapar, 2012, Dawoud et al., 2011, Weiss and Sutton, 
2009, Lloyd and Hughes, 2007, Tully et al., 2007, Buckley et al., 2006). Some doctors 
also held similar views because of pharmacists’ influences on their prescribing (Lloyd 
and Hughes, 2007). Studies exploring the transition of pharmacist supplementary 
prescribers to independent prescribers revealed pharmacists’ prior supplementary 
prescribing experience as a facilitator to independent prescribing (Rees, 2013, 
MacLure et al., 2011, Stewart et al., 2009a).  
Pharmacists’ long-term experience and specialisation in a clinical area emerged as a 
facilitator to pharmacist supplementary prescribing (Dawoud et al., 2011, Lloyd and 
Hughes, 2007, Hobson and Sewell, 2006, Department of Health, 1999). The cross-
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sectional survey conducted among 414 pharmacists to explore the implementation of 
supplementary prescribing in primary and secondary care trusts in England revealed 
that pharmacists within Secondary Care Trusts (SCTs) were intending to be 
supplementary prescribers in their areas of specialty (Hobson and Sewell, 2006). 
Similarly, a Northern Irish study that involved focus groups with 47 intending 
pharmacist supplementary prescribers and semi-structured interviews with 35 medical 
mentors indicated that supplementary prescribing would be easier to implement in 
hospital pharmacy settings because of pharmacists’ specialisation (Lloyd and Hughes, 
2007).  
Despite the aforementioned facilitators relating to pharmacists’ clinical knowledge and 
experience, pharmacists’ inadequate skills in diagnosis and inability to manage patients 
with co-morbidities were commonly cited as barriers to pharmacist prescribing (Latter 
et al., 2010, Tonna et al., 2010, Lloyd and Hughes, 2007). Pharmacists’ inadequate 
skills in diagnosis was particularly identified as a barrier to independent prescribing 
since in supplementary prescribing, diagnostic decisions rest on the independent 
prescriber which is usually a doctor (Tonna et al., 2010, Lloyd and Hughes, 2007).  
Similarly, the review has shown that pharmacist independent prescribers were usually 
reluctant to prescribe without a diagnosis (McCann et al., 2011, Tonna et al., 2010). 
According to Tonna et al. (2010), they are usually confident to prescribe when a 
diagnosis has been established by a medical prescriber. This lack of confidence in 
prescribing for undiagnosed conditions could be due to pharmacists’ limited training 
and experience in diagnosis. Therefore, on many occasions, a team approach to 
pharmacist prescribing including independent pharmacist prescribing has been 
advocated (McCann et al., 2012, McCann et al., 2011, Tonna et al., 2010, Weiss and 
Sutton, 2009). This enables other members of the healthcare team to provide 
prescribing support including diagnosis to the pharmacist prescriber. However, the lack 
of confidence of independent prescribers in prescribing for undiagnosed conditions still 
represents an unmet training need for these prescribers. Thus, since prescribing is now 
a part of pharmacists’ domain, introducing the principles of diagnosis including 
differential diagnosis at the undergraduate level would be helpful.  
2.4.5 Awareness of pharmacist prescribing 
This review revealed a general lack of awareness and understanding of pharmacist 
prescribing among patients. Of the 15 studies that explored patients’ opinions on 
pharmacist prescribing, 8 investigated patients’ awareness of pharmacist prescribing 
including McCann et al. (2015), MacLure et al. (2013), Park et al. (2013), Cooper et al. 
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(2012), Hobson et al. (2010), Stewart et al. (2009a), Stewart et al. (2009b) and Cooper 
et al. (2008a). In all of these 8 studies, the authors identified patients’ lack of 
awareness as a barrier to pharmacist prescribing implementation. For example, Cooper 
et al. (2008a) explored the views of various stakeholders including patient group 
representatives on the implementation of nurse and pharmacist supplementary 
prescribing in the UK, using semi-structured interviews. These researchers found that 
patients were largely unaware of supplementary prescribing and the findings of their 
study suggest that it was introduced without adequate patient awareness. Other 
qualitative studies appear to confirm this finding. Cooper et al. (2012) found that 
patients lacked understanding of who supplementary prescribers were, often assuming 
they were doctors. Also, McCann et al. (2015) reported that patients lacked awareness 
that pharmacists could prescribe prior to attending a pharmacist prescriber’s clinic. 
However, a cross-sectional survey of 1728 members of the public in Scotland found 
that 56.6% were aware that trained non-medical professionals could prescribe 
medicines (Stewart et al., 2009b). Respondents’ awareness was found to be 
associated with increasing age, having a health professional in their immediate family, 
self-rated general health and a higher education level. Nevertheless, these authors 
emphasised the need for public engagement prior to the development of any new 
service.   
Similarly, a widespread lack of awareness and understanding of pharmacist prescribing 
was reported among doctors particularly non-mentors of supplementary prescribers. 
Some doctors including GPs showed a lack of: awareness of  the pharmacists’ role as 
a prescriber (Cooper et al., 2008a, George et al., 2007b, Lloyd et al., 2005a); and 
understanding between the different models of pharmacist prescribing (Blenkinsopp et 
al., 2008). For example, in the survey of 115 Junior and Senior House Officers of nine 
hospitals in Northern Ireland, to explore their opinion on the introduction of 
supplementary prescribing, 68.1% were unaware of the role of a supplementary 
prescribing pharmacist (Lloyd et al., 2005a). However, most of the studies reporting 
doctors’ unawareness of pharmacist prescribing were conducted shortly after the 
introduction of pharmacist prescribing. Furthermore, mentors of pharmacist 
supplementary prescribers have argued that this unawareness seen among doctors not 
directly linked to pharmacist prescribing could be due to the low level of the 
implementation of pharmacist prescribing (Lloyd et al., 2010). This explanation could 
be justifiable as an early survey conducted among 205 nurses in Northern Ireland also 
revealed a high level of unawareness (80%) of pharmacist prescribing among 
respondents (Lloyd et al., 2005b).  Therefore, given the importance of doctors in the 
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development of pharmacist prescribing, there is a need for current research that would 
investigate the awareness of pharmacist prescribing among doctors and ways to 
improve it. 
On the other hand, studies investigating pharmacist prescribing among pharmacists 
have commonly reported a high level of awareness. In the cross-sectional survey 
conducted by Stewart et al. (2007) among 2371 pharmacists in Great Britain, nearly all 
(97.7%) the respondents who were practising in patient care settings were aware of 
pharmacist supplementary prescribing. In a more recent cross-sectional survey 
involving 418 newly registered pharmacists in Great Britain, 79.5% of respondents 
reported that they were aware of non-medical prescribing (McIntosh et al., 2012a). 
However, the majority of them lacked knowledge regarding the legal aspect and scope 
of non-medical prescribing (McIntosh et al., 2012a). According to the authors, these 
findings highlight the need for the incorporation of the teaching of non-medical 
prescribing including its legal aspects and scope in the undergraduate curriculum.  
2.4.6 Patient Factors 
One of the policy objectives of non-medical prescribing is to ‘increase patient choice in 
accessing medicines’ (Department of Health, 2006b p.35).  All the studies reviewed 
that explored patients’ views and experiences of pharmacist prescribing showed 
positive findings in terms of patients’ acceptance and satisfaction (Stewart et al., 
2009b, Stewart et al., 2008). About two-thirds of the 1728 members of the Scottish 
general public who participated in a survey that explored their views on non-medical 
prescribing, agreed that pharmacists should have a prescribing role (Stewart et al., 
2009b). Also, Stewart et al. (2008) surveyed 103 patients of pharmacist supplementary 
prescribers in primary and secondary care settings to explore their experience of 
prescribing by pharmacists. The results revealed that more than three quarters of the 
patients were satisfied with their consultation experience and about 70% would 
recommend seeing a pharmacist prescriber to others (Stewart et al., 2008).  Other 
similar studies including Stewart et al. (2011) and  Latter et al. (2010) also indicated a 
high level of patient satisfaction with pharmacist prescribing.  
However, patients demonstrated certain reservations in many studies and these could 
be barriers to pharmacist prescribing. In some cases, patients preferred a limited form 
of prescribing for pharmacists (MacLure et al., 2013). Some patients have also 
reported that they would prefer to consult a doctor over pharmacists when they 
considered their illness to be serious (Cooper et al., 2012, Stewart et al., 2011, Hobson 
et al., 2010). However, patients’ preferences for medical prescribing could have been 
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influenced by their perceptions of doctors’ clinical training and experience (Cooper et 
al., 2012, Hobson et al., 2010). Many patients considered pharmacists to be less well-
trained and experienced than doctors in terms of clinical assessment and diagnosis 
which they considered as important elements of prescribing (Hobson et al., 2010).  In 
addition, MacLure et al. (2013) reported patient preference for a medical prescriber 
could also be as a result of the positive influence medical prescribing has had over the 
years (MacLure et al., 2013). Hence, this notion is likely to change overtime as more 
patients become exposed to pharmacist prescribing. This is because the majority of 
patients (55%) who had experienced pharmacist independent prescribing reported in a 
survey in England that there was no difference in terms of safety and quality of care 
provided by independent pharmacist prescribers and their doctors (Latter et al., 2010).  
2.4.7 Medical factors 
The opposition from the medical profession was a recurrent theme from the literature 
as a barrier to allowing pharmacists to be supplementary and independent prescribers 
in the UK (Buckley et al., 2006, Hughes and McCann, 2003). However, research 
evidence has shown that medical practitioners’ support especially from mentors of 
supplementary prescribers played a significant role in developing and legitimising 
supplementary prescribing in practice settings (Lim et al., 2013, Cooper et al., 2012). 
For example, Lim et al. (2013) reported that medical doctors who acted as initial 
Designated Medical Practitioners (DMPs) were strong advocates for the 
implementation of non-medical prescribing including pharmacist prescribing in some 
hospitals. Cooper et al. (2012) also reported that in addition to referring patients to 
supplementary prescribers, medical mentors were essential in underwriting 
supplementary prescribers’ credentials and clinical competence.  
Furthermore, many studies have demonstrated that an excellent working relationship 
between doctors and pharmacists is a facilitator to implementing pharmacist 
prescribing (Courtenay et al., 2011a, George et al., 2008, Lloyd and Hughes, 2007, 
Hobson and Sewell, 2006). For instance, pharmacists who had an existing working 
relationship with the medical team identified a medical mentor more easily than those 
without a close working relationship with doctors (George et al., 2008, Lloyd and 
Hughes, 2007, Hobson and Sewell, 2006).  Therefore, many reports indicated that it 
was easier for hospital pharmacists who work within medical teams to identify medical 
mentors than for community pharmacists who practise in isolation (Lloyd and Hughes, 
2007, Hobson and Sewell, 2006).  
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Medical control of pharmacist prescribing was an important theme that emerged from 
this review (Cooper et al., 2012, Weiss and Sutton, 2009, Blenkinsopp et al., 2008, 
Tann et al., 2008).  As mentioned earlier, a supplementary prescriber works in 
partnership with an independent prescriber (a doctor or dentist) to implement an 
agreed patient-specific Clinical Management Plan (CMP). A widespread view held by 
many pharmacists including supplementary pharmacist prescribers is that this model of 
prescribing is limited and restrictive (Cooper et al., 2008a, Lloyd and Hughes, 2007). 
However, many doctors view this in good light as it helps them to maintain control over 
the prescribing process (Lloyd and Hughes, 2007). Furthermore, research has shown 
that supplementary prescribing does not pose a threat to medical control (Cooper et al., 
2012, Blenkinsopp et al., 2008).  Cooper et al. (2012) conducted a qualitative case 
study to explore whether supplementary nurse and pharmacist prescribing represented 
a challenge to medical authority. The case study involved 77 observations of 
supplementary prescribing consultations and interviews with 11 doctors and 28 patients 
at ten case study sites in primary and secondary settings in England. The study 
revealed that continued medical authority was maintained in 5 key areas including 
patients’ and supplementary prescribers’ perception of doctors as being hierarchically 
superior; delegation of routine prescribing tasks to supplementary prescribers and 
doctors’ knowledge claim over diagnosis. Therefore, this continued medical authority 
supported by supplementary prescribing could account for why it is usually favoured by 
medical doctors more than independent prescribing which is likely to constitute a 
significant threat to medical authority (Lloyd et al., 2010, Blenkinsopp et al., 2008). 
However, other reasons have been cited for doctors lack of support for independent 
prescribing including professional boundary encroachment, and inadequate skills of 
pharmacists in clinical examination and diagnosis as previously discussed (Lloyd et al., 
2010, Stewart et al., 2009a, Blenkinsopp et al., 2008, Lloyd and Hughes, 2007).  
One study reported on the shortage of medical doctors as a facilitator to pharmacist 
prescribing (Tully et al., 2007). This facilitator was mentioned by a pharmacist who 
participated in the qualitative interview aimed to investigate pharmacists’ views and 
experience before and after registration as supplementary prescribers in England. The 
pharmacist reported that changes in junior doctors working hours was responsible for 
the organisational support he gained to be a prescriber (Tully et al., 2007). This could 
be linked to the European Union Working Time Directives which limits doctors’ weekly 
working hours, initially to 58 hours (in August, 2004), and then to 48 hours by 2009 
(Coucil of the European Commission, 1993). This could have necessitated role 
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extension including prescribing to non-medical professionals in the UK in order to 
maintain service delivery. 
2.4.8 Organisational factors 
Barriers to the implementation of pharmacist prescribing reported in many studies were 
mainly organisational. Some early barriers included: (i) inadequate funding for training 
and setting up prescribing services; (ii)  lack of organisational recognition and policies 
to support NMP in some trusts; (iii) administrative delays including delays in registering 
as a supplementary prescriber and in getting prescription pads; (iv) inadequate 
infrastructure including access to appropriate  information technology; (v) lack of 
access to patient records; (vi) lack of remuneration for mentors; (vii) lack of time; (viii) 
shortage of pharmacy staff; (ix) inadequate support from colleagues; (x) lack of access 
to appropriate continuing professional development (CPD) and (xi) paperwork and 
restriction due to the creation of the patient-specific CMP  (Lloyd et al., 2010, George et 
al., 2008, George et al., 2007b, George et al., 2006a).  
Very few studies have reported on the prescribing experience of pharmacist 
independent prescribers. The recent General Pharmaceutical Council (GPhC) 
registrant survey revealed that a quarter of pharmacist independent prescribers had 
never prescribed since their annotation (Phelps et al., 2014). The barriers to 
independent prescribing identified in this review were largely organisational. Latter et 
al. (2010) conducted a national survey to evaluate nurse and pharmacist independent 
prescribing in England. Common reasons given by respondents of the survey for 
delays in initiating independent prescribing after qualification were mainly 
organisational including absence of policies within trusts for NMP, IT issues, and 
delays in getting prescription pads. A similar study in Wales involving 128 pharmacist 
independent prescribers reported lack of time and funding as barriers to independent 
prescribing (Rees, 2013). Furthermore, other studies investigating pharmacists’ 
transition from supplementary to independent prescribing have identified a number of 
barriers. These barriers were again largely organisational including lack of 
organisational strategy and support, lack of time, funding constraints and lack of 
support from colleagues (MacLure et al., 2011, Sutton et al., 2010).  
Generally, recent research evidence suggests that many of the early barriers to 
pharmacist prescribing still persist despite many years since the introduction of 
pharmacist prescribing in the UK (McIntosh et al., 2015, Phelps et al., 2014, Adigwe, 
2012). For example, Adigwe (2012) investigated non-medical prescribing in non-
malignant chronic pain using a grounded theory approach and found that issues 
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around access to appropriate CPD that meet the needs of pharmacist prescribers and 
‘second checking’ were limiting pharmacist prescribing. Also, Phelps et al. (2014) 
identified a number of barriers including change in job specification and lack of 
organisational recognition and strategy.  
The literature also revealed that the implementation of pharmacist prescribing in 
community pharmacies is poor in comparison to other pharmacy practice settings. For 
example, a questionnaire survey conducted in Great Britain among 401 pharmacists to 
explore their early experience as supplementary prescribers revealed that respondents 
in other practice settings including hospital and primary care medical practice were 
three times more likely to prescribe than those in community pharmacy settings 
(George et al., 2006a). Other studies also showed similar findings. For example, the 
survey conducted by Winstanley (2009) among 293 pharmacists who qualified as 
prescribers found that almost 60% of GP practice-based pharmacists as against  25% 
of community pharmacists were using their prescribing qualification. Barriers identified 
in this review that were predominantly associated with prescribing in community 
pharmacy settings included difficulty in accessing patients’ medical records, lack of 
privacy, lack of funding and poor working relationships with GPs (Dapar, 2012, Hobson 
et al., 2010, George et al., 2006a, Hughes and McCann, 2003).   
The organisational facilitators of pharmacist prescribing identified were often the 
opposite of the barriers mentioned earlier. For example, Adigwe (2012) and Cooper et 
al. (2008a) identified support from networks of fellow prescribers as a facilitator to 
pharmacist prescribing. Also, some studies have shown that pharmacist prescribing 
thrives in Trusts where strategic policies exist for the development of non-medical 
prescribing (Courtenay et al., 2011a, Latter et al., 2010).  Courtenay et al. (2011a) 
reported that in Trusts where such policies exist, careful considerations are given to the 
process of the development of NMP including workforce planning, training, clinical and 
professional support.  
2.5 Chapter summary  
This chapter has provided an international overview of pharmacist prescribing. It 
reveals that pharmacist prescribing is increasingly being adopted in countries across 
the world irrespective of the challenges associated with developing such role. This 
chapter also shows that several potential benefits are associated with pharmacist 
prescribing including promoting patients’ access to care and improving treatment 
outcomes, freeing doctors’ time to enable them to deal with complex cases, promoting 
efficient use of pharmacists’ clinical skills and enhancing pharmacists’ job satisfaction. 
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However, more robust evidence is needed to demonstrate: the effectiveness of 
pharmacist prescribing in improving clinical outcomes in patients; and the clinical 
appropriateness and safety of pharmacist prescribing.  
Using the scoping methodology, this chapter has uncovered the nature of evidence 
relating to the facilitators and barriers to pharmacist prescribing in the UK. The review 
showed that the available evidence is predominantly based on stakeholders’ 
perceptions which are primarily self-reported data. These forms of data are prone to 
respondents’ bias. However, the consistency across many studies in identifying several 
of the facilitators and barriers further substantiate the evidence.   
Many of the barriers to the implementation of pharmacist prescribing in the UK were 
organisational including inadequate funding, inadequate infrastructure, lack of 
dedicated time for prescribing, lack of access to patients’ medical records by 
community pharmacists, lack of organisational strategy and support. Other non-
organisational barriers were also common including pharmacists’ inadequate skills in 
diagnosis, lack of medical support for independent prescribing and lack of public 
awareness of pharmacist prescribing. Therefore, targeted interventions designed to 
overcome the barriers identified in this review would be needed in order to enhance the 
implementation of pharmacist prescribing in the UK.  
This review has identified a number of gaps in the literature which would require further 
investigation. The review showed that there is paucity of data concerning what 
stakeholders including pharmacist prescribers are doing to resolve many of the barriers 
associated with the implementation of pharmacist prescribing in practice settings. 
Therefore, qualitative studies employing grounded theory approaches would be needed 
to provide insightful data into what stakeholders are constantly doing to overcome 
barriers associated with pharmacist prescribing in practice settings. In addition, not 
many studies investigated the barriers associated with pharmacist independent 
prescribing. More research evidence is needed in this area. The review also shows that 
a team approach to pharmacist independent prescribing appears to be a successful 
approach to it in practice. This claim would need to be further explored in research.   
Furthermore, the literature shows that the implementation of pharmacist prescribing in 
the UK was aided by the changes that occurred in the structure of pharmacy practice 
(especially within the hospital setting) prior to the introduction of pharmacy prescribing 
(Cooper et al., 2008b, Lloyd and Hughes, 2007, Mullen, 2004, Andalo, 2002). This is 
because on many occasions, references were made to the clinical knowledge and 
experience of pharmacists prior to the introduction of pharmacist prescribing as 
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facilitators. For example, as mentioned earlier, early pharmacist supplementary 
prescribers in the qualitative study reported by Lloyd and Hughes (2007), argued that 
supplementary prescribing would be well supported within hospital pharmacy because 
of the existing pharmacists’ specialisation in different clinical areas within hospitals. 
This  specialisation was as a result of the development in clinical pharmacy training 
and practice which began in the 1970s and 1980s following the introduction of ward 
pharmacy (Child and Cooke, 2003). Therefore, as part of this PhD project, the changes 
that occurred in the structure of pharmacy practice prior to prescribing would be 
investigated in order to identify lessons that can be learned for the Nigerian context.   
Finally, this review has some limitations. Unlike a systematic review, the 
methodological quality of the primary research articles included in this review was not 
assessed. Hence, it is possible that some research papers with low methodological 
quality were included. Also, grey literature was included which is likely to impact on the 
quality of evidence presented. However, research evidence in the field of pharmacist 
prescribing is still emerging and the inclusion of grey literature provided more 
comprehensive information for the review. Furthermore, being able to establish that 
some facilitators and barriers to pharmacist prescribing were consistent across many 
studies enhanced the validity of this review (Gravel et al., 2006). Finally, the literature 
search was largely conducted using electronic databases. Therefore, it is possible that 
some eligible articles that were not indexed on the databases searched were excluded. 
The next chapter of this thesis will discuss the methodology and research design 
employed in the empirical studies conducted.  
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CHAPTER 3:  RESEARCH METHODOLOGY 
3.1 Introduction 
This chapter presents the theoretical framework underpinning the research contained 
in this thesis and justifies the chosen research design. It begins by presenting an 
overview of qualitative and quantitative research and states the elements that define 
these research methodologies. It also justifies the choice of a generic approach (not 
underpinned by any theoretical perspectives) in the qualitative component of the mixed 
methods research employed in this project. Chapter 3 goes on to discuss mixed 
methods research including the rationale for the choice of an exploratory sequential 
mixed methods design. The chapter concludes by presenting the interpretive position 
assumed by the researcher.  
3.2 Nature of qualitative research 
Qualitative research is a process of enquiry that traditionally emanates from the social 
sciences including anthropology, sociology and psychology but in recent times, it has 
been used increasingly in other disciplines including health sciences (Tonna and 
Edwards, 2013, Merriam, 1998).  Various descriptions of what constitute qualitative 
research exist in the literature. For example, Merriam (2009 p.13) stated that: 
“qualitative researchers are interested in understanding the meaning 
people have constructed, that is how people make sense of their world 
and the experiences they have in the world” 
This definition focussed mainly on the purpose of qualitative research. However,  
Denzin and Lincoln (2011) definition concentrated on the context of data collection. 
They define qualitative research as an: 
 “interpretive, material practice designed to transform the world into a 
series of representations, including fieldnotes, interviews, 
conversations, photographs, recordings, and memos in order to make 
the world visible” (Denzin and Lincoln, 2011 p.3).  
Despite these variable definitions, qualitative researchers often seek to understand a 
phenomenon from the perspective of the participants and the meaning and 
interpretations participants give to their experience (Creswell, 2013, Denzin and 
Lincoln, 2011, Hennink et al., 2011, Holloway and Wheeler, 2010). This form of inquiry 
is conducted in the natural setting of the study participants to enable researchers to 
understand how participants’ behaviour and experience have been influenced by the 
context in which they live which could be social, economic, cultural or physical 
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(Hennink et al., 2011, Lincoln and Guba, 1985). Therefore, this research approach is 
focussed on understanding people’s subjective experience.   
As a result of the importance of  qualitative research in exploring people’s experience, 
behaviour and emotions, and in understanding a phenomenon from the participants’ 
perspectives (Holloway and Wheeler, 2010), pharmacy practice researchers are 
increasingly employing qualitative research to understand complex social problems 
(Smith, 2002, Smith, 1998). For example, Hughes and McCann (2003) employed focus 
groups to explore the barriers to the inter-professional relationship between community 
pharmacists and general practitioners, and the extension of prescribing authority to 
pharmacists in the UK.  
Qualitative research involves a wide range of philosophies and approaches and has 
been variously classified and described in the literature (Creswell, 2013, Hennink et al., 
2011, Merriam, 2002). Creswell (2013) identified five approaches to qualitative inquiry 
namely the narrative, phenomenology, grounded theory, ethnography and case study. 
However, a number of other approaches exist including autoethnography, participatory 
action research and conversational analysis (Creswell, 2013, Denzin and Lincoln, 
2008). This section will present a brief overview of the five qualitative approaches 
identified by Creswell (2013) and justify the choice of a generic approach in the present 
study. 
In Narrative research, stories of lived and told experience of individuals are collected 
and linked chronologically by the researcher. Data are mainly collected through 
interviews and other forms of data collection including observations, documents, and 
pictures (Creswell, 2013). Narrative approaches are increasingly being employed in 
medicine and health to understand the patients’ illness journey (Stenhouse, 2014, 
Hurwitz et al., 2004). However, they are still uncommon in pharmacy practice research 
(Bissell et al., 2006). The recent commentary by Dowse (2015) on patient-centred care 
in pharmacy using an illness narrative, demonstrates the importance of using a 
narrative approach to understand patients’ medication journey in chronic conditions.     
Ethnography involves studying a culture-sharing group to enable an understanding of 
their patterns of values, beliefs, behaviours and language (Creswell, 2013). Data are 
usually collected in ethnography through interviews, observations, symbols, artefacts, 
and other sources (Creswell, 2013). For example, De Oliveira and Shoemaker (2006) 
conducted an ethnographic study in six clinics and one community pharmacy in 
Minnesota for 8 months. The study which included 14 participants including 
pharmacists, employed participant observation, in-depth interviews, focus groups and 
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analysis of documents as techniques of data collection. An ethnographic approach was 
taken by these researchers in order to understand the culture of pharmaceutical care 
provision by pharmacists.  
On the other hand, qualitative researchers generally employed a phenomenological 
approach to understand the essence of a ‘lived experience’ of a phenomenon for 
several individuals (Creswell, 2013).  Therefore, some authors have argued that 
phenomenology is a philosophical approach that underpins all qualitative research 
because all qualitative research is conducted to uncover how people make sense of 
their experience (Hourigan and Edgar, 2014, Merriam, 2009). Participants in 
phenomenological studies are individuals who have experienced the phenomenon 
being investigated. In phenomenological studies, data are primarily collected through 
interviews. However, other sources of data including observations, poems, and 
documents have been used (Hourigan and Edgar, 2014, Creswell, 2013).   
A number of pharmacy practice researchers including Makwosky et al. (2009) and De 
Oliveira and Shoemaker (2006) have employed a phenomenological approach in their 
qualitative inquiry.  A good research question for a phenomenological study would have 
been: “what does it mean to be a pharmacist prescriber?” Or “what is the nature of the 
experience of pharmacist prescribing?” However, Nigerian participants have no 
experience of pharmacist prescribing. Furthermore, phenomenology mostly employs 
unstructured interviews to allow the study participants to describe the meaning of their 
experience with a phenomenon. This form of interview is usually driven by the 
interviewee (Holloway and Wheeler, 2010, Smith et al., 2011). Hence, the specific 
objectives of this study are not likely to be achieved by this approach. 
Grounded theory employs an iterative process of data collection and analysis to 
inductively generate theory for a process or an action through the data collected from 
participants who have experienced the process (Creswell, 2013, Strauss and Corbin, 
1998). There are at least three different approaches in grounded theory including the 
Glaser’s approach, Strauss and Corbin’s approach and constructivist grounded theory 
(Mills et al., 2008, Charmaz, 2006, Strauss and Corbin, 1998, Glaser and Strauss, 
1967). Details of these approaches are beyond the scope of this section of the thesis. 
However, despite these different approaches, a key defining feature of grounded theory 
is the development or discovery of a theory or theories that are grounded in the data 
(Creswell, 2013). Hence, a grounded theory design is particularly useful where no 
theory exists to explain an action or process in a topic area (Creswell, 2013, Cooper 
and Endacott, 2007). A number of pharmacy practice researchers including Adigwe et 
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al. (2013) and Benson et al. (2009) have employed the principles of grounded theory in 
their qualitative investigations. A grounded theory (GT) approach would have been 
appropriate for the qualitative component of this research if the aim was to generate a 
theory. However, generating a theory was not the explicit aim of this research as a 
number of theories or models of role expansion and practice change exist  and have 
been used to explain human behaviour towards role expansion in pharmacy (Roberts 
et al., 2008, Guirguis and Chewning, 2005, Roberts et al., 2003, Adamcik et al., 1986). 
Although  a GT approach would help in identifying barriers to pharmacist prescribing by 
looking at the concerns of stakeholders as they view allowing pharmacists to prescribe, 
this approach would however, fail to identify potential changes needed (i.e. what can 
be done?) for the development of pharmacist prescribing in Nigeria. This is because 
GT is one of sociological action and looks at documented behaviour of study 
participants; for example, what people do to resolve their concerns rather than what 
can be done (Strauss and Corbin, 1998, Glaser and Strauss, 1967). Since prescribing 
is not currently implemented in Nigeria, applying a grounded theory approach to 
answer this research question was considered inappropriate. 
In case study research, the researcher conducts a real life in-depth study of a case (an 
individual, small group of persons, or organisation) or multiple cases through 
observations, interviews, documents, reports and other data sources (Creswell, 2013). 
The unit of analysis in this type of study is the case(s) being investigated. Case studies 
therefore result in an in-depth understanding of  the case(s) being studied in their 
natural settings (Creswell, 2013, Yin, 2009). Many pharmacy practice researchers 
including Cooper et al. (2012) and Stewart et al. (2009a) have used the case study 
approach in their qualitative inquiry. However, the present research was not intended to 
study pharmacists in practice settings as this could not sufficiently address the 
research aim. 
In view of the limitations associated with the approaches described above, a generic 
approach to inquiry in the qualitative component of the present research was 
considered appropriate. A generic qualitative research approach seeks to “discover 
and understand a phenomenon, a process, or the perspectives and world views of the 
people involved”  (Merriam, 1998 p.11) rather than lay emphasis on philosophical 
underpinnings (Caelli et al., 2003). Generic approaches have also been referred to as 
qualitative description and interpretative description in the literature (Cooper and 
Endacott, 2007, Sandelowski, 2000b, Thorne et al., 1997). Many qualitative research 
studies in pharmacy practice including Kamarudin et al. (2013), Lloyd et al. (2010) and 
Blenkinsopp et al. (2008) were not underpinned by any of the established strategies of 
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inquiry. Researchers employ a generic approach in their studies for practical reasons 
such as an inability to find a specific approach that fits the study, making the research 
aim a priority over a philosophical stance, and a desire to accurately represent 
participants’ views (Smith et al., 2011, Cooper and Endacott, 2007). These practical 
reasons lie behind the choice of a generic approach in the qualitative component of the 
present research.    
3.3 Nature of quantitative research 
Quantitative research involves the collection of numerical data which are usually 
analysed statistically in order to explain a phenomenon (Muijs, 2010). Quantitative 
research is employed to test theories/hypotheses and to study relationships between 
variables (Creswell, 2009). Quantitative research designs are generally classified into 
experimental, quasi-experimental and non-experimental research designs (Muijs, 2010, 
Miller and Salkind, 2002).  The difference between these quantitative research designs 
is in the degree of control the researcher has over the study (McBurney and White, 
2007).  
In an experimental study, the researcher has major control over the conditions of the 
study. This includes the manipulation of a set of independent variables to produce 
systematic changes in the outcome or dependent variables (Polgar and Thomas, 2008, 
McBurney and White, 2007). Within experimental designs, all variables, other than the 
independent variables, are controlled in order to prevent bias or any influence on the 
research outcome. In addition, study units are assigned into treatment groups in a 
random design (Polgar and Thomas, 2008). Experimental designs are regarded to 
produce a higher levels of research evidence than quasi-experimental and non-
experimental designs (Petticrew and Roberts, 2003, Hawker et al., 2002). An example 
of an experimental design is the randomised controlled trial (Polgar and Thomas, 
2008).  
On the other hand, quasi-experimental design differs from experimental design in that 
treatments are not assigned randomly into groups. An example of a quasi-experimental 
design is the time series design (Polgar and Thomas, 2008). In non-experimental 
design, the researcher does not have complete control over the conditions of the study 
(McBurney and White, 2007). Non-experimental research studies are necessary 
because not all variables (for example gender, and age) are subject to experimental 
manipulation (Polgar and Thomas, 2008). Examples of non-experimental research 
designs are surveys and observational research (McBurney and White, 2007).  
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Surveys are employed to “provide a quantitative description of trends, attitudes, or 
opinions of a population by studying a sample of the population and making 
generalisations or claims about the population” (Creswell, 2009 p.153). Surveys can be 
cross-sectional, in which data are collected at one point in time (Creswell, 2009), or 
longitudinal, in which data are collected over time on multiple occasions from the same 
sample of the population (Lynn, 2009).  Four types of data collection methods are 
identifiable in surveys including self-administered questionnaires, interviews, structured 
record reviews and structured observations (Creswell, 2009). Surveys are widely used 
in pharmacy practice research to evaluate people’s attitude or opinion regarding a 
phenomenon.  For example, Stewart et al. (2008) conducted a survey among 180 
patients to explore their opinion on pharmacist supplementary prescribing in Scotland. 
One of the studies contained in this thesis employed a cross-sectional survey to 
explore the views of pharmacists on the barriers and facilitators to pharmacist 
prescribing in Nigeria. 
3.4 Why take a mixed methods approach? 
Mixed methods research is becoming increasingly popular as a third research 
approach in addition to the existing qualitative and quantitative research approaches 
(Johnson et al., 2007).  Mixed methods research has been used by researchers in 
various fields including social sciences, education and medicine (Morse and Niehaus, 
2009). However, a number of controversies have been raised regarding mixed 
methods and what constitutes mixed methods research. These controversies include 
the evolving definitions of mixed methods, the paradigm debate (can paradigms be 
mixed?), advantages of mixed methods over mono-methods and the choice of 
appropriate designs from an array of designs available in the literature (Creswell, 
2011). 
Existing definitions of mixed methods research emphasise different aspects of the 
research process including methods, philosophy and research design (Creswell and 
Plano-Clark, 2011, Creswell and Tashakkori, 2007). For example, the definition of 
Greene et al. (1989) focussed on the ‘research method’ by defining mixed methods 
research  as “those that include at least one quantitative method (designed to collect 
numbers) and one qualitative method (designed to collect words), where neither type of 
method is inherently linked to any particular inquiry paradigm” (Greene et al., 1989 
p.256). However, Johnson et al. (2007) reviewed 19 different definitions of mixed 
methods research and concluded that it is a  
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“type of research in which a researcher or team of researchers 
combine elements of qualitative and quantitative research approaches 
(e.g., use of qualitative and quantitative viewpoints, data collection, 
analysis and inference techniques) for the broad purposes of breadth 
and depth of understanding and corroboration” (Johnson et al., 2007 
p.123).  
Despite these evolving definitions, the major defining characteristics of a mixed 
methods study is that it involves qualitative and quantitative research and data are 
derived from combinations of qualitative and quantitative methods. However, some 
researchers including Morse and Niehaus (2009) and Christ (2010) have advanced the 
view that mixed methods study may contain multiple qualitative approaches. This 
thesis will work with the definition of Johnson et al. (2007) as it intends to combine 
elements of qualitative and quantitative research including viewpoints, methods and 
analysis to develop an in-depth understanding of the facilitators and barriers to 
extending pharmacists’ clinical roles to include prescribing in Nigeria. 
There are many reasons why researchers employ mixed methods. Greene et al. (1989) 
classified these reasons into five: triangulation, complementarity, development, 
initiation and expansion. However, Bryman (2006) expanded on this list when he 
reviewed 232 social science articles in order to investigate how quantitative and 
qualitative research are combined in practice. Bryman (2006) advanced a number of 
reasons for employing mixed method research including to obtain a comprehensive 
picture of the enquiry, enhance validity of findings, offset the weaknesses and draw on 
the strengths associated with each method, generate and test hypotheses. Other 
authors including Collins et al. (2006) have also outlined a number of reasons for 
conducting mixed methods research including to enhance interpretation of findings and 
facilitate thickness and richness of data. 
Historically, triangulation has been employed in qualitative social research. In 
qualitative research it involves the use of multiple forms of qualitative research 
methods to investigate a phenomenon in order to have an in-depth understanding of 
the issues being investigated (Denzin, 2012). The concept of triangulation has been 
extended beyond multiple methods to also include multiple data sets collected at 
different times or from different sources (data triangulation), using multiple theoretical 
approaches to study a phenomenon (theoretical triangulation) and the use of multiple 
investigators with different theoretical or methodological orientation (investigator 
triangulation) to investigate a phenomenon in a single study   (Brannen, 2003, Flick et 
al., 2012). In mixed methods research, triangulation “seeks convergence, 
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corroboration, correspondence of results from the different methods” (Greene et al., 
1989). The different methods used in mixed methods triangulation to investigate a 
phenomenon usually have offsetting biases which help in enhancing the credibility and 
validity of the research findings (Greene, 2007). This involves the combination of 
different research methods for instance qualitative interviews and questionnaire 
surveys to answer the research questions. Therefore the combination of different 
methods in a single study is a strategy that adds to rigor, richness of data and depth of 
inquiry (Denzin, 2012). The use of triangulation in mixed methods research was 
illustrated in a Mexican study to investigate the barriers to over-the-counter syringe 
purchase among injecting drug users. The research which employed a sequential 
mixed methods design nested within a longitudinal study consisting of initial in-depth 
interviews  with 20 injecting drug users (Strathdee et al., 2005) followed by a cross-
sectional quantitative survey of 627 injecting drug users in order to validate the findings 
of the qualitative study through triangulation (Pollini et al., 2010). The authors reported 
that the quantitative findings support the findings of their qualitative study and provided 
detailed evidence of the barriers to syringe access by injecting drug users. In the 
present study, qualitative interviews and questionnaire surveys with Nigerian 
participants would be employed to triangulate their perceptions on the facilitators and 
barriers to pharmacist prescribing in Nigeria. 
Mixed methods design was also employed in this research for the purpose of 
development. Development ‘seeks to use the results from one method to help develop 
or inform the other method, where development is broadly construed to include 
sampling and implementation, as well as measurement decisions’ (Greene et al., 1989 
p.259). These forms of mixed methods research are usually implemented sequentially 
in order for the preceding method to inform the next one. It also enables the researcher 
to increase the validity of their findings by capitalising on the inherent method’s 
strength (Greene et al., 1989). For example, Smith et al. (2013) conducted a national 
study in Australia using a mixed methods design to explore the current rural and 
remote pharmacist workforce, to identify the barriers and drivers influencing rural and 
remote pharmacy practice. The study conducted involved two phases. The first was a 
qualitative phase which included semi-structured interviews (n = 83) and focus group 
discussions (n = 143) with stakeholders including pharmacists and pharmacy 
educators with interest in rural and remote pharmacy. The second was a quantitative 
phase which was a survey conducted among 3300 registered Australian pharmacists 
practicing in non-urban locations. In the study, findings of the qualitative phase were 
used to develop a 45-item questionnaire for the quantitative phase (survey). This 
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provided data that were generalizable to the study population thereby increasing the 
validity of the study.  Similarly, in the current research, development was achieved by 
using the results of previous findings to inform the development of subsequent studies 
including their objectives and data gathering methods. For example, the findings of the 
qualitative interviews conducted with Nigerian stakeholders were used to develop the 
questionnaire used for the cross-sectional survey conducted as illustrated in Figure 
3-1. 
Furthermore, the use of multiple methods enable researchers to ‘attack a research 
problem with an arsenal of methods that have non-overlapping weaknesses in addition 
to their complementary strengths’ (Brewer and Hunter, 1989 p.17). Therefore, the 
combination of the qualitative and quantitative methods in the present research will  
enable the researcher to capitalise on the inherent strengths of each method included 
in the research design (Morse and Niehaus, 2009, Greene et al., 1989), provide  
comprehensive understanding and capture nuances of the facilitators and barriers to 
extending pharmacists’ clinical role to include prescribing (De-Lisle, 2011). In addition, 
the combination of qualitative and quantitative methods will make the findings 
transferable and generalizable. The sequential nature of the mixed methods design (as 
seen in section 3.5) will increase the validity of the results by verifying the findings from 
previous study using a different perspective. 
3.5 Typologies of mixed methods designs 
Various classifications of mixed methods designs exist in the literature (Creswell and 
Plano-Clark, 2011, Morse and Niehaus, 2009). Many mixed methods researchers 
including Tashakkori and Teddlie (1998), Leech and Onwuegbuzie (2009),  Morse and 
Niehaus (2009) and (Creswell and Plano-Clark, 2011) have advanced a number of 
classifications of mixed methods designs based on certain criteria. These include the 
number of strands or phases,  degrees of mixing, timing, relative importance of mixed 
methods strands and theoretical perspectives (Teddlie and Tashakkori, 2008).  While 
some researchers argued that a specific number of designs should be identified for 
mixed methods research, others are of the view that designs cannot be prescriptive 
and predetermined (as in quantitative research). This is because changes are likely to 
be made to the design and/or data collection methods during the study (Teddlie and 
Tashakkori, 2011).  Therefore, mixed methods design can be fixed, in which the 
researcher predetermines the quantitative and qualitative methods to be included 
during the research design or emergent, in which a second method is added to the 
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design as the research progresses because the research question couldn’t be 
sufficiently answered by the initial method (Creswell and Plano-Clark, 2011). 
Creswell and Plano-Clark (2011) identified six major mixed methods designs including 
convergent parallel, explanatory sequential, exploratory sequential, embedded, 
transformative and multiphase design. A detailed discussion on these designs is 
beyond the scope of this thesis. However, the design of the research contained in this 
thesis matches Creswell and Plano-Clark (2011)  description of the exploratory 
sequential mixed methods design. 
Exploratory sequential mixed methods design involves two distinct phases, a 
qualitative and quantitative phase which are implemented sequentially. In this design, 
the researcher implements the qualitative phase of the study initially by collecting and 
analysing qualitative data and using the findings to inform the quantitative phase of the 
research (Creswell and Plano-Clark, 2011). The initial qualitative phase is employed to 
explore the phenomenon being investigated before building this into the quantitative 
phase (Creswell and Plano-Clark, 2011).  Usually, precedence is given to the 
qualitative phase (exploratory phase) as this phase of the research will predominantly 
answer the research question(s) (Creswell and Plano-Clark, 2011, Morgan, 1998). The 
quantitative strand plays a supplementary role and may function to test or generalise 
the findings obtained in the qualitative phase of the research (Creswell and Plano-
Clark, 2011). 
Exploratory sequential mixed methods design was exemplified in the research protocol 
reported by Mbuagbaw et al. (2013) to investigate community ownership of a text 
message programme to improve adherence to antiretroviral therapy and provider-client 
communication. The study consists of a qualitative phase which will involve focus 
group discussions with people living with HIV at the Yaounde Central Hospital in 
Cameroon; and a quantitative phase which will involve a cross-sectional survey 
conducted among HIV patients attending the hospital to enable generalisation of 
findings. The two strands will be implemented successively and priority will be given to 
the qualitative component of the study. Findings from the qualitative aspect of the study 
are expected to be used to develop the survey instrument. 
Similarly, the research contained in this thesis has two distinct phases, a qualitative 
phase (exploratory phase) and a quantitative phase (see Figure 3-1). The exploratory 
phase consists of two qualitative studies while the quantitative phase consists of a 
single quantitative study.  All the studies were conducted sequentially.  The first study 
(qualitative study 1) was conducted in the UK to investigate the changes in the 
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professional structure of pharmacy practice in the UK prior to the introduction of 
pharmacist prescribing. The study involved semi-structured interviews with pharmacy 
staff and findings from this study were used to inform the next study (qualitative study 
2) conducted with Nigerian participants. Qualitative study 2, investigated the 
professional structure of pharmacy practice in Nigeria and the facilitators and barriers 
to extending pharmacists’ clinical roles to include prescribing. This study also involved 
semi-structured interviews with various stakeholders including doctors, pharmacists, 
policymakers and patient group representatives in Nigeria. The findings from qualitative 
study 2 was used to inform (develop an instrument) the quantitative study which was 
an online cross-sectional survey conducted among Nigerian pharmacists.   
A key consideration in mixed methods research is the relative importance or weighting 
of the quantitative or qualitative methods in answering the research questions  
(Creswell and Plano-Clark, 2011). Three comparative weightings are possible in mixed 
methods research. First, where both strands are equally weighted (equal priority) in 
terms of answering the research question. Second, where the quantitative strand 
primarily address the research questions (quantitative priority) and third where the 
qualitative strand primarily address the research objectives (qualitative priority) 
(Creswell and Plano-Clark, 2011).  
In a quantitative priority mixed methods research, the qualitative strand plays a 
supplementary role and the possible role of the qualitative strand may include 
generation of theories or hypotheses that may be tested with the quantitative strand, 
development of the quantitative research instrument and enhancement including 
interpretation and clarification of the quantitative data (Brannen, 2003). On the other 
hand in studies with qualitative priority (quantitative strand play a supplementary role), 
the quantitative strands are likely to function to: provide contextual data for in-depth 
qualitative study; to test theories or hypotheses generated by qualitative work; and 
point to the nature of participants (sampling) to be involved in the primary qualitative 
work (Brannen, 2003). In the mixed methods design of this research, priority was given 
to the qualitative phase because the two qualitative studies conducted, primarily 
answered the research questions and provided an in-depth understanding to the 
barriers and facilitators to extending pharmacists’ clinical roles to include prescribing in 
Nigeria. The quantitative study conducted played a supplementary role and was used 
to test and generalise the views of pharmacists on the barriers and facilitators to 
extending their clinical roles to include prescribing. 
71 
 
Furthermore, the degree to which the qualitative and quantitative components of the 
study interact is important in mixed methods design. The interaction could be 
independent or interactive (Creswell and Plano-Clark, 2011). In independent 
interaction,   the qualitative and quantitative components including research questions, 
data collection method and analysis are kept separate. In independent strands, 
interactions only occur at the point of the general interpretation of findings and 
conclusion (Creswell and Plano-Clark, 2011). In interactive strands, the qualitative and 
quantitative components of the study interact at various points prior to the final 
interpretation of the findings.  The interaction could be at the point of development 
where the data from one component is used to inform and develop the other 
component, or at the point of data analysis where the data set from one strand is 
transformed into data type of the second strand then analysed together (Creswell and 
Plano-Clark, 2011, Morse and Niehaus, 2009).  
In the present research design, the qualitative and the quantitative components were 
interactive as illustrated in Figure 3-1. The research questions and design of the 
quantitative method (cross-sectional survey) depended on the findings of the qualitative 
phase. The qualitative and quantitative strands were connected by using the results of 
the qualitative interviews with Nigerian stakeholders to shape data collection in the 
survey by determining the research question and data collection instrument 
(questionnaire). In addition, the integration of the overall qualitative and quantitative 
findings occurred during the integrated discussion presented in chapter 7 of this thesis.   
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3.6 Interpretive Paradigm 
Researchers bring into their research certain principles that inform their ontological, 
epistemological and methodological positions (Creswell, 2013).  Such sets of basic 
beliefs that guide researchers’ actions are referred to as paradigms or interpretive 
frameworks (Creswell, 2013, Denzin and Lincoln, 2011). Several interpretive 
frameworks exist including positivism, postpositivism, interpretivism, constructivism, 
feminism, hermeneutics and pragmatism (Creswell, 2013, Denzin and Lincoln, 2011).  
A comparison of the four commonly used paradigms in social and behavioural sciences 
as outlined by Tashakkori and Teddlie (1998) is presented in Appendix 3. 
However, Creswell and Plano-Clark (2011) argued that four different paradigms are 
likely to guide mixed methods research: postpositivism, constructivism, pragmatism 
and the participatory paradigm. A postpositivist world view is usually associated with 
quantitative research while the constructivist view is aligned to qualitative research 
(Creswell and Plano-Clark, 2011, Doyle et al., 2009). Creswell and Plano-Clark (2011) 
suggested that a combination of paradigms can be used in mixed methods research. 
However, there are still debates in the literature as to whether two paradigms can be 
mixed in a study (Creswell, 2011, Sandelowski, 2000a). Critics have argued that 
qualitative and quantitative research are linked with different paradigms which are not 
compatible (Creswell and Tashakkori, 2007, Sandelowski, 2000a). For example, a 
constructivist view of multiple and co-constructed reality is incompatible with the 
positivist view of singular and objective reality (Sandelowski, 2000a)   
Many mixed methods researchers including Tashakkori and Teddlie (1998) and 
Johnson and Onwuegbuzie (2004) have suggested that pragmatism should be the 
philosophical partner of mixed methods research. Pragmatism philosophy “advanced 
the notion that the consequences are more important than the process and therefore 
the end justifies the means” (Doyle et al., 2009 p.176). Hence, a pragmatic researcher 
is concerned with ‘what works’ to answer the research question rather than aligning to 
a methodological position (Creswell, 2009, Teddlie and Tashakkori, 2008). Tashakkori 
and Teddlie (1998) argued that researchers should be more interested in rigorous 
investigation of the research problem rather than the methodologies or paradigms that 
underpin the research. Therefore, pragmatism represents a flexible world view in terms 
of its methods, logic and epistemology when compared with the extreme and opposing 
views held by the positivists (including postpositivists) and the constructivists (Creswell, 
2009, Teddlie and Tashakkori, 2008, Tashakkori and Teddlie, 1998). For example, a 
pragmatist may be both objective and subjective in epistemological orientation in 
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answering a research question during a study (Tashakkori and Teddlie, 1998). Hence 
the pragmatists are able to employ both qualitative and quantitative methodologies in 
their approach to inquiry depending on the research questions. This research will 
therefore adopt the pragmatic world view because this will allow different research 
methods that can answer the research question to be used and also fit well with the 
generic qualitative approach to inquiry of this study. 
3.7 Chapter summary 
This chapter discussed the mixed methods design upon which the studies presented in 
the next three chapters are based. It provided the rationale for the choice of a mixed 
methods design and justified its appropriateness in meeting the overall objectives of 
this research. Chapter 4 will discuss the first qualitative study conducted in the UK 
including its methods and findings. 
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Chapter 4: UK qualitative study 
Phase Method Product 
 
Qualitative 
Phase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quantitative 
Phase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 semi-structured 
interviews with UK 
pharmacy staff 
 
 
 
 Thematic analysis 
 
 
 
 
 
 Developing interview 
questions 
 
 
 
 
49 semi-structured 
interviews with 
purposively sampled 
stakeholders  
 
 
 Thematic analysis 
 
 
 
 
 
 
 Developing research 
objective 
 Developing survey 
items 
 
 
 
 Cross-sectional web 
survey 
 
 
 
 Univariate and 
multivariate analysis 
 
  
 
 Interpretation and 
explanations of 
qualitative and 
quantitative results 
 
 
 
 
 Textual data 
(interview 
transcripts) 
 
 
 
 Themes related to 
UK’s pharmacy 
structure 
 
 
 
 Interview guide for 
qualitative study 2 
 
 
 
 
 Textual data 
(interview 
transcripts) 
 
 
 
 Themes related to 
barriers & facilitator 
to clinical role 
extension 
 
 
 
 Research 
objectives 
 Questionnaire 
 
 
 
 
 
 
 Numeric data 
 
 
 
 
 Descriptive and 
inferential statistics 
 
 
 
 
 Discussions 
 Implications for 
practice & policy 
 Future research 
 
 
Qualitative Data 
collection 1 
 
Qualitative data 
analysis 1 
Qualitative Data 
collection 2 
 
Qualitative data 
analysis 2 
Quantitative 
data analysis  
Quantitative 
Data collection  
 
Connecting 
qualitative 
study 1 &2 
Connecting 
qualitative & 
quantitative 
phases 
Integrating 
qualitative & 
quantitative 
results 
76 
 
CHAPTER 4: INVESTIGATING CHANGES IN THE STRUCTURE OF 
PHARMACY PRACTICE IN THE UNITED KINGDOM 
4.1 Introduction 
As stated in the previous chapter, this research uses an exploratory sequential mixed 
methods design consisting of three studies: two qualitative and one quantitative study. 
This chapter describes the first qualitative study which was conducted in the UK. The 
chapter begins with a brief background on why this study is necessary, followed by the 
study objectives. The next aspect of the chapter outlines the specific methods used to 
address the objectives. This is then followed by the presentation of the study findings 
and a concluding summary.   
Traditionally, pharmacists’ roles have been associated with stock control, dispensing of 
medicines prescribed by doctors and offering advice about medicines to patients and 
other healthcare professionals. However, in some countries including the UK, USA, 
Canada, Australia and New Zealand, their roles have been expanded significantly. 
Pharmacists in these countries now take on roles such as medication reviews, 
collaborative drug therapy management and prescribing in order to optimise patients’ 
therapy and improve therapeutic outcomes (Doloresco and Vermeulen, 2009, Tonna et 
al., 2008).   
Globally, pharmacists are highly educated professionals with expertise in medicines 
management (Doloresco and Vermeulen, 2009, Anderson, 2002). In most European 
countries, pharmacists’ basic education consists of a 4-year masters level 
undergraduate education with a significant clinical component (Van Mil and Schulz, 
2006). Even though there are diversities in pharmacy education in Africa and Asia, 
many institutions in these continents run Bachelor of Pharmacy programmes which are 
similar to the training model in Europe. A number of institutions also run the Doctor of 
Pharmacy programme (Pharm D.) which has extended clinical components (Basak and 
Sathyanarayana, 2010, Alo, 2006). Despite pharmacists’ high level of training, their 
expertise is often not utilised effectively in many settings including Nigeria as indicated 
earlier in chapter 1 (Erah, 2003). Their roles are still limited to dispensing which could 
be handled by suitably trained pharmacy technicians as in for example, the UK 
(Doloresco and Vermeulen, 2009).  Therefore, advances in pharmacy education and 
medical practice require that pharmacists who are experts in medicines management 
take an active role in patient care.  
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In the UK, hospital pharmacists have expanded their roles beyond the dispensary, 
initially with the introduction of ward pharmacy and medicines information, which were 
followed by the provision of clinical pharmacy services including reviewing patients’ 
medications, monitoring patients’ therapy and contributing to doctors’ prescribing (Child 
and Cooke, 2003). Today, hospital pharmacists are directly involved in patient care 
working as specialists among healthcare teams in different clinical areas with some 
acting as prescribers of medicines either as independent (autonomous) or 
supplementary prescribers (Stewart et al., 2012). There is evidence from the literature 
that the current roles of pharmacists in the UK, including prescribing, are supported by 
the changes that occurred in the professional structure of pharmacy including changes 
in education and training (Hudson et al., 2007, Lloyd and Hughes, 2007, Mullen, 2004, 
Andalo, 2002).   
However, empirical research primarily exploring pharmacy staff views on changes in 
the structure of pharmacy practice that have enabled and supported pharmacists’ 
clinical roles including prescribing is lacking. This study therefore investigated the 
changes in the structure of pharmacy practice in the UK in order to identify lessons that 
might assist in the potential changes needed in Nigeria. 
4.2 Objectives 
The aim of the study was to investigate the changes in the structure of pharmacy 
practice in the UK prior to the introduction of pharmacist prescribing in order to identify 
lessons that might assist in the potential changes needed in Nigeria.  
The specific objectives were: 
 To investigate the changes in the structure of pharmacy practice in the UK prior 
to the introduction of pharmacist prescribing. 
 To identify the barriers and facilitators to the changes in pharmacy practice in 
the UK. 
4.3 Methods 
4.3.1 Ethics 
Ethical approval for this study was obtained from the School of Healthcare Research 
Ethics Committee (SHREC) (Ref no: SHREC/RP/344) (see Appendix 4). The main 
ethical issues associated with this research were those of autonomy and informed 
consent, anonymity of participants and confidentiality in handling of data and data 
protection.  
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4.3.1.1 Autonomy and informed consent 
One of the basic principles that underpin social research ethics is that of obtaining 
informed consent from participants and respecting their autonomy by giving them the 
opportunity to freely and independently decide if they wish to participate in the study. In 
addition, they can withdraw their consent at any point without any consequence to 
them (Hammersley and Traianou, 2012). In this study, a participant information sheet 
(see Appendix 5) containing information on the purpose of the research, the 
participant’s involvement, and how the information obtained from participants would be 
handled and managed, was emailed to each prospective participant. They were given 
the opportunity to make further enquiries about the research and were allowed to make 
a free, independent and voluntary informed choice to participate in the study.  
All participants who agreed to participate in this study signed a written consent form 
(see Appendix 6). Consent forms were either sent in advance for participants to sign 
and return (for those whose interviews were conducted over the telephone) or it was 
signed at the beginning of the interviews in case of participants who had their 
interviews face-to-face. No participant objected to the content of the consent form or 
withdrew his/her consent.  
4.3.1.2 Confidentiality and anonymity 
Ways of protecting participants’ confidentiality were explicitly stated in the information 
sheet and discussed with participants prior to their participation in this research. 
Information collected from participants were treated and handled in strict confidence. 
Anonymity was maintained by assigning codes to all participants and referring to them 
by their profession for example P11, Pharmacist. All personal identifiable data were 
excluded from interview transcripts and from this report even when detailed data was 
being reported. For example, to protect the identity of participants, I used ‘XXX’ to 
substitute for names of hospital or places when direct quotations were used.   
Electronic data including audio–records of interviews and transcripts were kept in a 
password protected M-drive of the University and hard copies of documents of the 
research were kept under lock and key in filling cabinets in the post-graduate suite of 
the School of Healthcare, University of Leeds. Only my supervisors had access to the 
transcripts (all personal identifiable data were excluded) for the purpose of analysis and 
participants were informed about this prior to their participation in the study. 
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4.3.1.3 Data protection 
Information obtained from participants were handled in line with the principles of the 
UK’s Data Protection Act of 1998 including keeping data safe and secure, processed 
fairly and for the purpose of which it was collected, and not be kept for longer than 
necessary (British Parliament, 1998).  
All interviews, recorded with the digital voice recorder, were uploaded and stored 
immediately in a password protected M-drive of the University of Leeds. Each recorded 
interview was erased immediately after each upload.  All transcripts were digitised 
using the University computer.  Digitised records of transcripts will be held in the 
password protected university secure network for a period of five years. All other 
research documents including consent forms were kept under lock and key in a cabinet 
in the postgraduate suite (access to the suite is password protected) in the University 
at all times.  
4.3.1.4 Risks to participants or researcher 
A risk assessment in line with the University of Leeds policy was carried out prior to the 
start of this study. There were no known significant risks including physical, emotional 
and financial risks to participants except for the time involved as a result of participating 
in the study. Risks to participants associated with breach of anonymity, confidentiality 
and data security were prevented as outlined above. 
The risk to the researcher was minimised by conducting all interviews except one at the 
University of Leeds or at the place of practice of participants which were NHS facilities. 
All interviews were conducted during the day time and on working days. One interview 
was conducted at a participant’s home and all control measures as outlined in the lone 
working risk assessment form completed were taken including providing my supervisor 
with the itinerary of my visit for the interview.  
4.3.2 Study setting 
This study was conducted in the United Kingdom and participants were recruited from 
England and Scotland. Healthcare in England and Scotland is mainly provided by the 
National Health Service (NHS). Pharmacy practice in Great Britain is regulated by the 
General Pharmaceutical Council while the Royal Pharmaceutical Society serves as the 
professional body. There are currently about 49,000 practising pharmacists (78 per 
100,000 people) in the UK (OECD, 2013). There are approximately 22,000 pharmacy 
technicians in Great Britain (Phelps et al., 2014). Pharmacists and pharmacy 
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technicians work in various settings including hospitals, primary care trusts, community 
pharmacies, pharmaceutical industries and academia. In Great Britain, 64% of 
pharmacists and 52% of pharmacy technicians primarily work in community 
pharmacies while 22% of pharmacists and 38% of pharmacy technicians work in 
hospitals (Phelps et al., 2014). 
4.3.3 Recruitment and sampling strategy  
This research recruited pharmacists and pharmacy technicians who qualified between 
the 1970s and 1990s as participants. The rationale for the choice of pharmacy staff 
who qualified within this period was because significant changes in pharmacy practice 
in the UK occurred during this period. Therefore, these pharmacy staff would be able to 
report their experiences of pharmacy practice and the changes they have seen since 
they qualified. Those excluded from the study were: 
 Pharmacy staff who qualified after the 1990s.  
 Pharmacists who qualified prior to the 2000s but never practiced in the UK until 
the 2000s 
 Pharmacy staff who had no experience of community or hospital pharmacy 
practice in the UK even if they qualified before the 2000s. 
All pharmacists (n=312) who were part of the Royal Pharmaceutical Society Virtual 
network of Prescribing and Medicines Management (which is moderated by one of my 
supervisors) and pharmacists (n=30) who attended the prescribing course at the 
University of Leeds were sent a generic email by my supervisor in October 2013. This 
email asked them if they were interested in participating in a research that was looking 
at ‘role development’ in pharmacy. The contact details of those that indicated that they 
qualified between the 1970s and 1990s and were interested in the research were 
forwarded to me. I then emailed them the participant information sheet to assist them in 
their decision to participate in the study. Those that replied to say they wished to 
participate in the study were contacted and an arrangement was made for an interview 
at a location and time that was convenient to the participants.  
Eight (8) participants were recruited from the initial contact made. A snowball sampling 
strategy was employed to recruit other participants. In this strategy, participants who 
had been interviewed were asked if they knew other pharmacy colleagues who may be 
relevant to this research and if they were willing to forward the general email they 
received to these colleagues. Those who were contacted through this means replied to 
indicate their interest. This referral system continued until data saturation was 
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achieved; that is no new themes emerged from the data (further explained in section 
4.3.4).  The snowball strategy was effective as a further 24 participants were recruited. 
4.3.4 Sample size 
There are no simple rules for sample size determination in qualitative research (Patton, 
1990).  Sample size is usually dependent on data or theoretical saturation (Holloway 
and Wheeler, 2010, Strauss and Corbin, 1998). Data saturation is reached when no 
new information is emerging from newly sampled participants while for theoretical 
saturation to be achieved, sampling is continued until no new concepts or theoretical 
insights can be obtained from the data (Holloway and Wheeler, 2010, Lincoln and 
Guba, 1985). Usually, sample sizes are between 4 and 40 participants. However, a 
sample size of 6 - 8 and 14 - 20 participants may be adequate for homogenous and 
heterogeneous groups, respectively (Holloway and Wheeler, 2010). In the present 
study, recruitment of participants continued until data saturation was reached. At this 
point, interview data did not yield any new code. Therefore, no new concept relevant to 
the development of new themes emerged from the data. A total of 32 participants were 
recruited in this qualitative study.  
4.3.5 Data collection method 
There are various methods of data collection in qualitative research including 
interviews, focus groups, observations, documents and audio-visual materials 
(Creswell, 2009). Interviews are the most common form of data collection technique in 
qualitative research including those in the area of pharmacy practice (Smith, 1998). 
The use of interviews in this research would enable me to gather data from 
participants’ subjective experiences and views on the changes in the structure of 
pharmacy practice in the UK that would otherwise have been inaccessible through 
review of historical accounts contained in published documents.  
Interviews involve skilful questioning by the researcher to obtain information from the 
respondent on his experience, perception and feelings (Holloway and Wheeler, 2010). 
Interviews are either conducted one-on-one or in a group.  Three types of interviews 
are identifiable in the literature including the unstructured interview, the semi-structured 
interview and the structured interview  (Bryman, 2012, Holloway and Wheeler, 2010). 
Structured interviews are conducted using an interview schedule containing list of 
questions in a pre-defined order which is strictly followed (Hardon et al., 2004). In this 
type of interview, the respondent has minimal control over the interview and the 
researcher is unable to collect information which are not covered in the interview 
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schedule (Hardon et al., 2004). Therefore, data collected using this form of interview is 
usually limited (Britten, 1995). Hence, they are less commonly employed in qualitative 
studies because most qualitative studies are intended to gain in-depth understanding of 
the phenomenon. On the other hand, unstructured interview starts with a general 
question on the topic area and subsequent questioning is dependent on the 
interviewee’s response (Holloway and Wheeler, 2010, Britten, 1995). This form of 
interview is usually driven by the interviewee as the researcher’s control over the 
interview is minimal (Holloway and Wheeler, 2010, Corbin and Morse, 2003). The 
interviewee therefore determines what would be included in the interview; the order 
and amount of information gathered during the interview (Corbin and Morse, 2003). 
Hence, this form of interview would be unsuitable for researchers who want to meet 
specific objectives in their study. Therefore, using this form of interview was considered 
inappropriate for this study because it intends to investigate specific aspects of the 
structure of pharmacy in the UK including education, career structure and the roles of 
pharmacy technicians. However, unstructured interviews are commonly employed in 
grounded theory to uncover hidden perspectives of a phenomenon as they represent a 
valuable ‘methods of discovery’ (Duffy et al., 2004, Glaus et al., 1996). 
Semi-structured interviews are based on a list of questions or defined topics to be 
covered usually referred to as an interview guide (Bryman, 2012, Hardon et al., 2004). 
They are flexible as the order in which questions are asked may not be the same for all 
participants. However,  the use of an interview guide ensures that core issues are 
covered during the interview (Holloway and Wheeler, 2010, Hardon et al., 2004). 
Therefore, this form of interviewing technique is commonly used by qualitative 
researchers as the researcher has significant control over the interview process and 
allows the researcher to address specific areas of the study. Hence, this research 
employed semi-structured interviews to explore the phenomena under investigation. 
This form of interview will allow the specific objectives of this study to be investigated 
using an interview guide. A common pitfall associated with semi-structured interview is 
that it is difficult to obtain valuable data from participants if appropriate questions are 
not asked by the interviewer (Corbin and Morse, 2003). This was taken care of in this 
study by designing a suitable interview guide containing list of questions and prompts 
which was reviewed by my supervisors (see section 4.3.6 for details on the interview 
guide). In addition, the findings of the pilot study conducted (reported in section 4.3.7) 
were suggestive of the ability of the interview guide to generate relevant data.  
Interviews are conducted either face-to face, via the telephone or the internet involving 
the use of emails, chat boxes, and Skype (Hanna, 2012, Opdenakker, 2006). In 
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telephone interviews, communication between the researcher and the interviewee is 
occurring in real time as with face-to-face interviews. However, telephone interviews 
differ from face-to-face interviews in that the researcher is unable to observe any non-
verbal communication (since the researcher and the interviewee are not present in the 
same place). Also, rapport between the researcher and interviewee is less compared to 
face-to-face interview (Cooper et al., 2008a, Opdenakker, 2006). In research where 
non-verbal response and rapport are less important, telephone interviews are as 
effective as face-to-face-interviews (Holt, 2010, Opdenakker, 2006). The current 
research combined both face-to-face and telephone interviews to enable the 
interviewing of participant across many locations in the UK. Semi-structured, in-depth 
interviews were conducted from October, 2013 to February, 2014. 
4.3.6 Interview guide 
An interview guide (Table 4-1) was developed based on the review of the literature.  
The initial section of the interview guide contained questions about participants’ 
practice experience including how long they have been practising as 
pharmacists/pharmacy technicians and their current and previous roles. This section of 
the interview guide was to: enable me develop rapport with the participants; understand 
the changes they may have seen over time and how their roles have evolved over time; 
and their involvement in the development of clinical pharmacy services within their 
practice settings. Other aspects covered in the interview guide were participants’ 
perception of: the changes they have seen introduced in pharmacy practice in the UK; 
facilitators and barriers to implementing these changes; advantages and disadvantages 
associated with these changes; and how pharmacist prescribing can be introduced in 
other countries. 
This interview guide was pilot tested. Details of the pilot test including its findings are 
reported in section 4.3.7 
Table 4-1: Draft interview guide used for the pilot interviews conducted with UK 
pharmacy staff 
Areas covered by the interview 
Preamble 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the changes in the professional structure of pharmacy in the UK prior to the 
introduction of pharmacist prescribing. This interview is expected to last about an hour, and 
you are free to stop from participating in the interview at any point in time. All information 
obtained from you will be kept confidential.  
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Are you happy for me to record the interview? 
Key interview questions 
1. May I ask how long you have been a practising pharmacist/pharmacy technician? 
o This will help me decide which changes they may have seen introduced 
2. Can you tell me something about the roles you have had in your career? 
o If in senior management they may have been responsible for change and 
know what it was like prior to the change 
3. In your opinion, what changes have occurred in the structure of pharmacy in the UK 
since you registered?  
o If prompting is needed, mention changes in the roles of technicians, salary 
changes following Noel Hall report (only useful if they have been registered 
for some years.  May want to mention some of the extended roles such as 
prescribing at this stage. 
4. What advantages and disadvantages do you think are associated with these 
changes?  
o This should help consider barriers and facilitators and if the interviewee is in 
favour of change or not. 
5. In your opinion, how have these changes affected pharmacy staff roles (expansion 
or erosion)? 
o Need to ensure the word roles is stressed but may also want to consider 
activities of the different staff groups 
6. What do you think were the facilitators for change?  
o May need to explain what facilitators mean at this stage and keep this 
definition the same for all interviews. May need some examples as prompts 
such as influential individuals, need for change, need to keep professionals 
interested 
7. Were there any barriers to the change process? If they were, how were they 
overcome? 
o May need to have some examples ready such as money, other professional 
groups, other pharmacists or pharmacy technicians. 
8. If you were considering introducing pharmacist prescribing in another country, how 
would you go about it. 
o If they talk about countries such as the US then guide onto Africa and 
Nigeria if possible although accept they may have no experience. 
Thank you for taking part in this interview 
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4.3.7 Pilot interviews 
Pilot interviews were conducted to: test and refine the draft interview guide; evaluate 
the researcher’s ability to engage in a qualitative interview; and the practicability of 
using a telephone interview.  Two pilot interviews were conducted with a pharmacist 
and a pharmacy technician.  The interviews entailed one telephone interview and a 
face to face interview. The pilot interviews were recorded using an audio digital 
recording device (Roland R-05 Portable MP3 Recorder). In the case of the telephone 
interview, an Olympus (TP-8) telephone pick-up microphone was used in conjunction 
with the audio digital recording device to record the interview. The pilot interviews were 
transcribed verbatim 
The pilot interviews were considered during a supervision meeting and that provided 
both the researcher and the supervisors the opportunity to reflect on the interview 
process. The following observations were made on the pilot interviews conducted:  
 The interview guide adequately covered the relevant topic area and desired 
responses were obtained from the participants. Participants’ responses to the 
questions asked showed they had a clear understanding of the questions.  
 The participants had little or no experience of pharmacy practice in developing 
countries including Nigeria. Hence they were unable to give an appropriate 
response when asked to comment on how they would go about introducing 
pharmacist prescribing in a country like Nigeria. This question was substituted 
with “what lessons are there for other countries to learn from the UK 
experience”.  
 Less exploratory prompts were used by the researcher. Therefore, additional 
prompts were introduced into the interview guide to elicit further details from 
participants and ensure that participants were asked to comment on all relevant 
areas.  
 The telephone interview conducted was as effective as the face-to-face 
interview and the inability of the telephone interview to capture non-verbal 
communication did not affect the study. 
 The duration of the interviews were acceptable as both types of interview lasted 
about an hour  
Overall, there were no major changes to the structure and content of the interview 
guide except for those highlighted above. Hence, the pilot interviews were also 
included in the study. The final interview guide used for this study is included as an 
appendix in this report (see Appendix 7). 
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4.3.8 Interview process 
Once a prospective participant agreed to participate in the study, arrangements were 
made for an interview, which was either a face-to-face interview for those participants 
in West Yorkshire or a telephone interview for participants outside of the West 
Yorkshire region.  As mentioned earlier, telephone interviews were employed to enable 
the interviewing of participants across many locations in the UK. For face-to-face 
interviews, a convenient location and time was agreed by the researcher and 
participant. Face to face interviews were largely conducted at either the participant’s 
place of work or the University of Leeds to minimise risk to the researcher. For 
interviews done over the telephone, participants gave the researcher a convenient 
telephone number (either work or home), a date and a time to call them for the 
interview.  
At the design stage of this research, it was anticipated that about 30 interviews would 
be sufficient to reach data saturation based on the review of the literature (Holloway 
and Wheeler, 2010, Glaser, 1978). Therefore, semi-structured interviews were 
conducted in this research until data saturation was achieved, when further interviews 
did not yield any new theme. Thirty two (32) interviews were conducted in all.  This 
therefore confirms other accounts suggesting that about 20-50 interviews are needed 
to achieve data saturation (Holloway and Wheeler, 2010, Glaser, 1978).  
At the beginning of each interview, the researcher created a relaxed atmosphere for 
the interview by engaging with the participants in a brief informal discussion. 
Participants were told the purpose of the interview, how long the interview was 
expected to last and assured of confidential handling of any information obtained from 
them. Permission was also sought from participants to record the interviews conducted. 
No participants objected to the record of his/her interview. Interviews were recorded 
using an audio digital recording device as described in section 4.3.7. 
An attempt was made by the researcher to complete all interviews within the duration 
of an hour. In situation where an hour was exceeded, permission was sought from 
participants to continue the interview if possible. These participants were allowed to 
freely accept to continue the interview or not. In addition, apologies were offered for 
exceeding the agreed duration of the interview. Only three interviews exceeded an 
hour.  
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4.3.9 Data analysis 
There are many methods of analysing qualitative data. Smith and Firth (2011) 
categorised these methods into three: methods that consider the use and meaning of 
language such as discourse and conversational analysis; methods used in developing 
theory such as the constant comparative method employed in grounded theory; and 
methods used to describe and interpret participants’ views such as content and 
thematic analysis. 
A variety of methods of data analysis can be used in generic qualitative research 
(Cooper and Endacott, 2007). Sandelowski (2000b) suggested that qualitative content 
or thematic analysis are the preferred methods for a generic qualitative study. On the 
other hand, she also suggested that since generic qualitative studies may have some 
tones of the traditional qualitative methodological approach, data analysis methods that 
are specific to the traditional approaches may be employed. For example, the constant 
comparative method of analysis may be employed in generic qualitative studies without 
generating a theory (Sandelowski, 2000b). However, for this research, thematic 
analysis was used to analyse the data and the rationale for the choice of this analytical 
method is explained below. 
 All analytical methods in qualitative research involve the generation of themes (Miles 
et al., 2014, Smith and Firth, 2011). Thematic analysis is a “data reduction and analysis 
strategy by which data are segmented, categorised, summarised, and reconstructed in 
a way that captures the important concepts within a data set” (Ayres, 2008 p.867). 
Therefore, thematic analysis is a versatile technique of data analysis and this makes it 
fit for a variety of data including that of this research. Other authors have identified 
other applications of thematic analysis which are relevant to this study including: (i) it 
produce a detail description of the data sets (ii) It is appropriate for large data sets and  
(ii) interpretation within the context of thematic analysis is usually grounded in the data 
(Guest et al., 2012, Braun and Clarke, 2006). In addition, thematic analysis is relatively 
easy to learn and do. Therefore, it is suitable for a novice qualitative researcher (Braun 
and Clarke, 2006). Hence, thematic analysis was considered appropriate for analysing 
the data collected. However, thematic analysis has been criticized for its lack of depth, 
and the fragmentation of the data. This can lead to the loss of context in which the data 
was taken and misconstruction of meanings (Smith and Firth, 2011).  But a number of 
measures were taken to build rigour into the analysis conducted and these are 
discussed in section 4.3.10.  
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The thematic analysis conducted in this study progressed  in six different stages as 
described by  Braun and Clarke (2006).  These stages are discussed below.  
4.3.9.1 Stage 1: Data familiarisation 
Familiarisation with the data in this study began at the point of data collection 
(interview). All interviews were conducted by me and during each interview notes were 
taken of potential ideas which were brought into the analysis.  Immersion into the data 
was achieved by repeated listening to the individual recordings of the interviews, 
transcribing and re-reading of individual transcripts.  
Transcription involves transforming the verbal research data into written data and this 
has been described as a crucial step in qualitative data analysis (Kowal and O'Connell, 
2014). I transcribed all the interviews myself and after each transcription, the transcript 
was cross-checked against the audio recording for accuracy. All interviews were 
transcribed verbatim. Transcription was aided by the DSS Player Transcription Module 
software. The transcribing of the interviews together with re-reading of the transcripts 
prior to coding helped me to develop more depth and breadth in the understanding of 
the data collected. During the reading of the transcripts, potential ideas and themes 
were noted.  
4.3.9.2 Stage 2: Generating initial codes  
Data management in this research was assisted by the use of NVivo 10 software. This 
software was used to facilitate the coding of portions of the interview transcripts. A 
code in this context is “a word or short phrase that symbolically assigns a summative, 
salient, essence-capturing, and/or evocative attribute for a portion of the interview 
transcripts” ( Saldana, 2012 p.3). Coding results in labelling of statements under one or 
more  concepts thereby reducing the entire data set (Flick, 2014).  
The coding process began while data collection was ongoing as suggested by many 
qualitative researchers including Miles et al. (2014). Coding was done in this study by 
selecting a portion of the interview transcript and assigning a word or phrase to capture 
the meaning of the text selected. The portion of text selected and coded could be a 
phrase or sentence(s) as seen in the excerpt below from one of the interviews 
conducted, in which the participant was discussing on the advantages of the changes 
in UK pharmacy structure. 
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1
Well, at least the advantages are that in a sense they are 
bringing us closer to the other healthcare professionals like 
doctors and nurses for instance. So, we are working more closely 
with the other healthcare professions in a way we didn’t before 
and 
2
in special care as well. So, as pharmacists become more 
specialised, 
3
we are making more use of technicians now. So, 
4
it 
has resulted in the change of the skill mix really. I mean, 
5
pharmacists are becoming less involved in dispensing now and 
supply and are more involved in advice and areas like prescribing. 
I think that’s far one of the big advantages, 
6
then a more satisfying 
career is one of course. 
1
CLOSE WORKING 
WITH OTHER 
PRACTITIONERS  
 
 
 
2
SPECIALISATION 
 
3
UTILISING 
TECHNICIANS 
4
CHANGE IN SKILL 
MIX 
5
TASKS SHIFT 
 
6
“SATISFYING 
CAREER” 
 
Coding was carried out both deductively (using codes derived from the literature, 
research objectives and interview guide) and inductively (data driven) as the 
researcher worked systematically through the data. In-vivo codes (coding with terms 
used by participants) were also assigned to the data in some cases. For instance in the 
excerpt above, a portion of the transcript was labelled “satisfying career” and placed in 
quotation marks to indicate in-vivo coding.  
Initially, eight interview transcripts were coded and a list of codes were generated 
which form the coding structure. The coding structure generated was discussed with 
my supervisors at a supervision meeting. This coding structure was applied to 
subsequent transcripts; additional codes were generated and the coding structure was 
also refined as the analysis progressed.  
4.3.9.3 Stage 3: Searching for themes 
Stage 3 began with searching for patterns within the data and combining codes into 
related categories. During this stage, references on individual codes were examined 
and comparisons of data across cases were carried out. In addition, relationships 
between codes were examined and similar codes were brought together to form 
categories. For examples, codes labelled pharmacists’ pre-registration training and 
post-registration training were brought together to form a category called pharmacists’ 
training. This category later became a subcategory under education and training of 
pharmacy staff as seen in the screenshot below.  The development of categories was 
iterative and the viability of each item under a category was constantly reviewed 
against the category.  The use of memos in Nvivo to note ideas was valuable in the 
development of categories. Mind mapping (see Appendix 8) was carried out at this 
stage to help show relationships and organise codes into categories and potential 
themes. Some categories identified such as barriers to pharmacy practice change 
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emerged as themes while others were combined to form potential themes. At the end 
of this stage, references associated with each potential theme and subthemes were 
gathered together and further examined. 
 
Figure 4-1: Screen shot showing categories generated 
4.3.9.4 Stage 4: Reviewing themes 
Stage 4 of the analysis began with the examination of potential themes and 
subthemes. According to Braun and Clarke (2006) reviewing potential themes involves 
two levels: examining each theme in relation to its fit to the coded data (level 1) and to 
the entire data set (level 2) to ensure that the themes identified accurately represent 
the data set as a whole. In this research, reviewing themes took place on two 
occasions. In the first, I reviewed the identified themes for appropriateness with the 
data set during the analysis as suggested above. In addition, each theme and sub-
theme identified was reviewed with respect to its importance to the research question. 
The first review yielded six potential themes and their subthemes as shown below. 
Table 4-2: Potential themes and subthemes identified during analysis 
Theme 1: Development of Clinical Pharmacy Practice 
 Hospital versus community pharmacy practice 
 Changes in hospital pharmacists’ roles 
 Changes in pharmacists’ education and training 
 Changes in hospital pharmacists’ career structure 
Theme 2: Development of the technician workforce 
 Shift in technicians roles 
 Training of Pharmacy Technicians 
 Professionalization of Technicians 
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Theme 3: Drivers for change 
 Safety in the use of medicines 
 Complexity of medicines 
 Pharmacists’ education and training 
 Agents of change 
 Acceptance by Doctors 
 Government policies and legislation 
 Growing demand for healthcare 
Theme 4: Barriers to change 
 The medical profession 
 Professional attitude 
 Regulatory and legal constraints 
 Organisational barriers 
Theme 5: Benefits of clinical role extension 
 Benefits to the patients 
 Benefits to the health system 
Theme 6: Lessons for other contexts 
 Developing a credible practitioner 
 Development of the technician workforce 
 Developing a relationship with the medical profession 
 Engaging the legislators 
 Change leaders 
 
 A second review of the identified themes was carried out with my supervisors. As a 
result of this review, some subthemes and themes were merged. For example, theme 1 
and 2 which were mainly descriptive accounts of the changes that occurred in 
pharmacy practice in the UK were merged with theme 3 which centred on drivers for 
change. In addition, some subthemes were refined which involved renaming, splitting 
or combining them. For example, the sub-theme ‘benefits to the health system’ under 
theme 5 was divided into ‘benefits to pharmacy staff’ and ‘economic benefits’ to make it 
more specific.  
4.3.9.5 Stage 5: Defining and naming themes 
Following the review of the identified themes, a descriptive name for each theme was 
decided upon.  An operational definition that captured and explained the meaning of 
each theme was developed and analysis of the data was presented within the scope of 
each theme.  
4.3.9.6 Stage 6: Producing the report 
This involved producing a report of the analysis of the research data and linking the 
analysis with the research objectives and the literature to produce a coherent report. 
The analysis of the interview data is presented in the result section of this report 
(section 4.4). 
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4.3.10 Demonstrating rigour 
Qualitative research is usually criticized for lacking rigour especially by those of a   
quantitative background (Mays and Pope, 1995). This is because the concepts of 
validity and reliability as viewed by qualitative researchers differ greatly from the 
opinion held by quantitative researchers (Seale and Silverman, 1997).  Quantitative 
researchers view validity in terms of the ability of an instrument to measure what it is 
supposed to measure and reliability in terms of the ability of the study to produce the 
same findings when it is repeated under similar conditions  (Holloway and Wheeler, 
2010, Merriam, 1998). This perception of validity and reliability is held by quantitative 
researchers because they view research as a process of objective discovery of a single 
reality known as ‘the truth’ (Leitch et al., 2009). However, qualitative researchers 
believe that there are multiple and changing realities and human behaviour is never 
static (Merriam, 1998). Therefore, the quality of qualitative research cannot be 
determined by following set formulae as in quantitative research (Mays and Pope, 
1995, Buchanan, 1992).  Hence, the concepts of trustworthiness and authenticity are 
usually used in qualitative research rather than validity and reliability (Holloway and 
Wheeler, 2010, Merriam, 1998, Seale and Silverman, 1997, Lincoln and Guba, 1985).  
Even though many qualitative researchers argued that it is difficult to achieve a 
comprehensive approach for assessing the quality of a qualitative research (Leitch et 
al., 2009, Morse et al., 2008), the quality criteria described by Lincoln and Guba (1985) 
are commonly employed by qualitative researchers. Lincoln and Guba (1985) use four 
criteria to demonstrate trustworthiness in qualitative research: credibility, transferability, 
dependability and confirmability and these terms are similar to the traditional terms of 
internal validity, external validity, reliability and objectivity respectively, used in 
quantitative research.   
Credibility considers how congruent research findings are with reality (Merriam, 1998). 
This can be achieved through prolonged engagement in research, persistent 
observation, triangulation, negative case analysis, peer review and member checking 
(Merriam, 1998, Lincoln and Guba, 1985).  A number of strategies including member 
checking; reviewing of the research including its findings by my supervisors, and 
triangulation were employed in this research to establish credibility.  Firstly, this study 
used a digital voice recorder whose output is of high audio quality to record all 
interviews; and the researcher carried out the transcription and also checked 
transcripts against their recordings to ensure that information obtained from 
participants are accurately converted into textual data. These activities in themselves 
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add to the credibility of the study. Secondly, member checking was carried out. The 
analysed data and its interpretation were taken back to two (a pharmacist and a 
pharmacy technician selected by convenience) study participants. Feedback was 
sought from them on how well the data and interpretations represented the changes 
that occurred in pharmacy practice in the UK and any other comments they may have 
concerning the findings of the study. These participants agreed with the findings and 
its’ interpretation. However, one of the participants noted a strategy for practice change 
that was omitted in the report; that is, identifying gaps where pharmacists’ could fill to 
enhance doctors’ role in patient care. This comment was considered in relation to the 
entire data set and that resulted in the development of a sub-theme ‘seizing the 
opportunity’ under the ‘strategy for change’ theme reported in section 4.4.6. Thirdly, 
peer-reviewing of the research process including the development of themes and 
interpretations by my supervisors (discussed in section 4.3.9.4) and the discussions 
with a pharmacy practice researcher (who was in hospital practice when these changes 
were occurring) outside my supervisory team also adds to the credibility of this study. 
Fourthly, triangulation which involve the use of multiple sources to confirm emerging 
findings (Merriam, 1998), was employed in this study. As reported in chapter 3, 
triangulation can be by data sources which can include persons, time and places; by 
data collection methods; by researchers or by theory (Miles et al., 2014, Merriam, 
1998). Triangulation by data sources was used. The study recruited both pharmacists 
and pharmacy technicians (triangulation by persons) and participants across many 
regions in the UK (triangulation by place) in order to gain understanding on the 
changes that occurred in pharmacy practice in the UK from different sources. 
Convergent views were obtained from participants (irrespective of their profession or 
location) on many of the issues explored in this study including changes in pharmacy 
staff roles in the UK.   
Transferability deals with the extent to which the findings in a study can be applied to 
other settings. This entails a detailed description of the research process and context to 
enable others to understand the similarity of their context to the research context. This 
enables them to see if the research is transferable to their context (Holloway and 
Wheeler, 2010, Merriam, 1998). Therefore, a detailed account of how this study was 
conducted including research setting, methods, what informed the choice of a particular 
method, process of interviews and data analysis was maintained in this report. This is 
to enable other readers to ascertain whether the findings of this study can be 
transferable to their context. 
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Dependability involves demonstrating that the research findings are consistent and 
could be repeated. This can be achieved through an audit trail by reporting in detail the 
research methods, procedures and all decisions made by the researcher(s) during the 
study (Holloway and Wheeler, 2010, Merriam, 1998). Similarly, detailed accounts of the 
research method including procedures involved and decisions made were maintained 
in this report. 
In confirmability, the researcher ensures that the findings of the research are a 
representation of the participants’ experiences and views and not the researcher’s prior 
assumptions and preconception (Holloway and Wheeler, 2010, Shenton, 2004). This 
can be achieved through an audit trail to enable readers to follow up how themes and 
interpretations were generated and be able to link these with data sources (Holloway 
and Wheeler, 2010). Other means of achieving confirmability are triangulation and 
reflexivity (Lincoln and Guba, 1985).  The findings in this study were described in detail 
and supporting quotes from participants were used to enable the readers of this report 
to ascertain whether the account presented reflected the participants’ views. In 
addition, a reflexive account of my interaction with this study was given in the 
introductory chapter of this thesis. 
4.4 Results 
4.4.1 Demographics 
Thirty two (32) participants (consisting of 26 pharmacists and 6 pharmacy technicians) 
were interviewed. Thirteen (13) interviews were conducted face-to-face while the 
remaining nineteen (19) were via the telephone. The interviews conducted lasted 
between 30 - 80 minutes, with an average interview time of 45 minutes. All those who 
participated in the study had worked in hospital pharmacy at one point in their career 
throughout the 1970s – 1990s, while 8 participants had worked in a community 
pharmacy either in a full-time or part time position. Three (3) of the pharmacists who 
participated in this study were retired, two of them were chief pharmacists of district 
hospitals and the third participant was a district pharmaceutical officer under the old 
hospital pharmacy structure. Table 4-3 shows details of the characteristics of 
participants interviewed. 
Among the 26 pharmacists interviewed, 13 were primarily in clinical service areas 
either as managers or clinical pharmacists. Seven (7) of these pharmacists had 
prescribing as a part of their roles. 
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Table 4-3: Demographic details of participants interviewed 
Characteristics Number of participants 
Gender   
Male 14 
Female 18 
Profession  
Pharmacy Technician 6 
Pharmacist 26 
Period of qualification  
1970s 16 
1980s 12 
1990s 4 
Participants’ location  
East of England 4 
East Midlands 3 
London 1 
North East 1 
North West 2 
South East 1 
West Midlands 1 
Yorkshire and Humber 15 
Scotland 4 
Participants’ practice setting  
Hospital 15 
Primary care 7 
Education/Training 6 
Leadership 1 
Retired 3 
Participants’ current role  
Director of pharmacy/Chief pharmacist  5 
Consultant pharmacist 1 
Service manager 5 
Lead pharmacy staff 5 
Senior clinical pharmacist 1 
Senior technician 1 
Practice pharmacist 5 
Pharmacy lecturer 5 
Leadership 1 
Retired 3 
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Table 4-4: Themes and sub-themes from analysis 
Theme Subtheme 
4.4.2   Redefining the pharmacists’ professional role  
4.4.3   Drivers for pharmacy practice change 4.4.3.1 Safe use of medicines  
4.4.3.2 Government policies and legislations 
4.4.3.3 Pharmacists’ education and training  
4.4.3.4 Specialisation  
4.4.3.5 The role of pharmacy technicians  
4.4.3.6 Economic driver 
4.4.3.7 Professional relationship with doctors  
4.4.3.8 Shortage of medical doctors  
4.4.3.9 The role of leading individuals and professional associations 
4.4.4   Barriers to pharmacy practice change 4.4.4.1 The Medical Profession 
4.4.4.2 Professional attitude of pharmacy staff 
4.4.4.3 Legislative and policy constraints 
4.4.4.4 Professional Isolation 
4.4.4.5 Organisational barriers 
4.4.5 Benefits of clinical role extension 4.4.5.1 Benefits to the patients 
4.4.5.2 Benefits to pharmacy staff  
4.4.5.3 Economic benefits 
4.4.6 Strategies for achieving pharmacy practice 
change 
4.4.6.1 Developing a credible pharmacy practitioner 
4.4.6.2 Freeing-up pharmacists to do extended role 
4.4.6.3 Seizing the opportunity 
4.4.6.4 Developing a relationship with the medical profession 
4.4.6.5 Leading individuals and professional associations 
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4.4.2 Redefining the pharmacists’ professional role 
Redefining pharmacists’ professional role emerged as an overarching theme in this 
research. It revealed that hospital pharmacists in the UK have succeeded in assuming 
roles which are significantly different from those carried out by pharmacists in the past, 
which were mainly supply functions. They have expanded their roles significantly over 
the years and are now working at a highly specialised and advanced level clinically. In 
addition, many hospital pharmacists interviewed viewed themselves as clinicians 
contributing to patient care. 
Pharmacists and pharmacy technicians interviewed in this study described how they 
saw the roles of the hospital pharmacists evolve from a purely supply function to a 
clinical one from the 1970s. This change in hospital pharmacists’ roles initially began 
with the introduction of ward pharmacy which was followed by the development of 
clinical pharmacy services as pharmacists’ knowledge and skills advanced.  
“In the 1970s we started getting more clinically involved, we started 
working on the wards alongside nurses and doctors and other 
specialists.” (P01, Pharmacist) 
Participants’ commonly observed that although hospital pharmacists in the UK 
developed their clinical roles as early as the 1970s, the clinical roles of community 
pharmacists are just evolving.  
“Starting from the hospital side, it changed fairly quickly in the 1970s; 
we got much more clinically involved in hospital and of course that has 
now started to happen in the community pharmacy as well now but 
that has taken obviously longer, and it is happening at a later stage 
really.” (P01, Pharmacist) 
“… it has taken much longer and clinical pharmacy is still in it’s infancy 
in community pharmacy.”(P04, Pharmacist) 
Analysis of the interview data identified a number of drivers and barriers to the 
development of pharmacists’ clinical roles in both hospital and community pharmacy 
settings which are discussed in subsequent sections of these results. Overall, four 
major themes (see Table 4-4 above) including drivers, barriers, benefits and strategies 
for developing clinical pharmacy practice were identified.  These themes fit into the 
input (drivers and barriers), process (strategies) and outcome (benefits) model (Ilgen et 
al., 2005). This is illustrated in Figure 4-2.  
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Figure 4-2: Relationship of identified themes with the Input-Process-Outcome 
model   
4.4.3 Drivers for change  
This category considered the factors that enabled hospital pharmacists in the UK to 
develop their clinical roles. Nine factors were identified which facilitated the 
development of clinical pharmacy practice: concern for safe use of medicines; 
government policies and legislation; economic drivers; pharmacists’ education and 
training; specialisation; professional relationships with doctors; shortage of medical 
doctors; the influence of leading individuals and professional bodies; and the 
development of pharmacy technicians’ roles. These factors are discussed in relation to 
the timeline of events (outlined in Figure 4-3) that had influenced pharmacy practice in 
the UK. 
 
 
 
 
 
 
 
Input  
(Drivers and barriers) 
•Policies and 
legislation 
•Education/training 
•Specialisation of 
pharmacists 
•Career structure 
•Pharmacy 
technician 
•Medical profession 
•Pharmacy related 
factors including 
staff attitude 
•Professional 
leadership 
 
Process  
(How change was 
achieved) 
•Developing credible 
practitioners 
•Freeing up 
pharmacists' time 
•Seizing opportunity 
•Relationship with 
medical colleagues 
•Leadership influence 
 
Outcome  
(Benefits) 
•Patient benefits 
•Pharmacy staff 
benefits including 
enhanced roles 
•Benefits to the 
medical profession 
•Economic benefits 
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AfC- Agenda for Change, SP- Supplementary Prescribing, IP- Independent Prescribing 
Figure 4-3: Timeline of some key events in the UK 
4.4.3.1 Safe use of medicines 
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Figure 4-4: Medicine related events that led to the development of pharmacists’ 
roles 
At the establishment of the NHS in 1948, there were few potent medicines available in 
clinical practice. The National Formulary of 1949 following the establishment of the 
NHS contained about 400 entries and many of these were formulae for the preparation 
of medicines (Bond and Clarke, 2007). The period between 1940 and 1975 was 
described by Le Fanu (1999) as the golden age of drug discovery. This author reported 
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that over 100 new medicines were being registered each year in the pharmacopoeia in 
the 1960s.  
Therefore, many participants in the current research observed that over time, 
medicines became the mainstay in the treatment of many conditions. In addition, many 
new potent and complex medicines that demanded detailed monitoring were 
introduced into clinical practice.  
“When I first started one of the most common surgical procedures was 
for stomach ulcers because there were no medicines for stomach 
ulcers, then cimetidine came and then other drugs.” (P07, Pharmacist) 
“I think probably the other driver was the sort of pharmaceutical 
explosion, the therapeutic explosion, the range of drugs that became 
available from the 60s onwards.” (P11, Pharmacist) 
Participants also noted that the tragedy associated with the use of thalidomide in 1961 
brought to light the dangers associated with the use of the increasing numbers of new 
and potent medicines within the NHS. As a result, the Medicine Act was enacted in 
1968 to regulate the sale, supply and production of medicines. Within the same period, 
there were reports of medication prescribing and administration errors on the hospital 
wards because of the increasing numbers of medicines available and the complexity of 
treatments (Crooks et al., 1965, Vere, 1965).  
It was a usual practice in the UK for hospital pharmacies to supply commonly used 
medicines to wards as ward stocks which are managed and administered to patients by 
nurses. These ward stocks were potential sources of medication errors (Taxis et al., 
1999). Other reports have indicated that not all prescriptions for medicine items 
included in the ward stock at that time were reviewed by pharmacists prior to 
administration because of pharmacists’ absence on the wards (Stone and Curtis, 2002, 
Calder and Barnett, 1967). In addition, some pharmacists interviewed in the current 
study, reported that even when they dispensed prescribed medicines themselves, in 
many cases they were unable to make informed decisions on the appropriateness of 
the prescribed medicines because they lacked access to patients’ clinical data at that 
time. 
“…you are all trying to second guess the right medicines, the right 
dose for the patient....” (P24, Pharmacist) 
Although several distribution systems were developed in the 1960s to prevent 
prescribing and administration errors including the unit dose dispensing system and 
ward pharmacy which originated from the United States and the UK respectively 
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(Leckie and Clansey, 1968, Barker and Heller, 1964); ward pharmacy was perceived  
to be the most effective method within hospitals in the UK. This was acknowledged in 
the Noel Hall report.  
“We are aware that several schemes are being developed which seek 
to eliminate errors in the prescribing and administration of drugs and it 
is not yet clear which system will prove to be the most efficient and 
economical. But we consider that the development of ward pharmacy 
and of systems based on the principles of ward pharmacy is to be 
commended and will be a major factor in the future development of the 
service.” (DHSS, 1970 p.9) 
Therefore, many participants perceived that the need to ensure a safe supply of 
medicines in the wards was the drive for the development of ward pharmacy.  
“…there was a recognition that medicine use on wards wasn’t perfect 
and pharmacists being the expert in medicines could contribute to 
something around that.” (P18, Pharmacist) 
However, participants’ description of ward pharmacy indicated that it largely included 
coordinating the supply of medicines to inpatients and stock control.  
“…we started to develop work outside of the dispensary and we took a 
group of services to the ward and that was called ward pharmacy 
initially.” (P24, Pharmacist) 
“I remember when I was newly qualified in XXX, I remember going to a 
ward and my job was really almost like top-up the amount of drugs that 
were on the ward. It wasn’t really directed at patient any way.” (P32, 
Pharmacist) 
Ward pharmacy services were initially reported on hospital wards in Aberdeen and 
London in the 1960s (Calder and Barnett, 1967). However, many participants in the 
current study noted that it was not popular in many hospitals until the 1970s and the 
early 1980s because its introduction was locally driven. Their reports indicated that 
ward pharmacy services were easily adopted in larger hospitals like the teaching 
hospitals with more resources including staffing. Furthermore, in the early days of ward 
pharmacy only a few pharmacists were able to visit hospital wards. These pharmacists 
were usually on the wards for a limited time because there weren’t enough pharmacists 
to free them up to spend more time on the wards. 
“The structure was such that the amount of time you can spend on the 
ward was limited because there was still quite an important as you said 
a dispensing role or a supply role in the pharmacy.” (P07, Pharmacist)     
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However, as the number of hospital pharmacists increased and pharmacy technicians  
were developed to take up some traditional roles of pharmacists (discussed in section 
4.4.3.5), that freed pharmacists up to be more involved in ward activities including 
participating in ward rounds with doctors.  
Participants reported that ward-based prescription charts were also introduced in the 
early days of ward pharmacy as a measure to minimise medication errors and 
pharmacists took advantage of this opportunity to enhance their contribution to patient 
care. 
“…we were going and looking at the inpatient charts and annotating 
them with, ‘with food’, ‘take before meal’, putting extra instructions, 
clarifying dosages and writing on the prescription chart at that point.” 
(P17, Pharmacist) 
Some participants also perceived that because these charts were usually kept on the 
wards it made pharmacists, including those who did not have a positive attitude 
towards ward pharmacy, to regularly visit the wards in order to monitor the charts.  
“We designed our medication prescribing administration chart, which 
means that they never left the ward. So, in order for the pharmacists to 
exercise their professional responsibility to the issue of medication 
patients were receiving, we had to go on the ward.” (P26, Pharmacist) 
However, a few pharmacists pointed out that at that time, pharmacists had less 
influence on doctors prescribing. These pharmacists associated it with pharmacists’ 
inadequate clinical knowledge at that time. This is because, the undergraduate 
pharmacy course had less clinical component and many hospital pharmacists had no 
postgraduate training in clinical pharmacy.   
“I think my opinion is that at that point, pharmacists generally weren’t 
sufficiently clinically qualified to be able to really do that.” (P04, 
Pharmacist) 
Despite the perceived inadequate clinical knowledge, some pharmacists reported that 
their presence on the wards enabled them to identify inappropriate use of medicines.  
  “Once we got unto the wards, we picked up so many potential errors 
in the prescribing…” (P17, Pharmacist) 
In addition, pharmacist expert knowledge of medicines was utilised especially by junior 
doctors who became dependent on them for prescribing advice and to minimise risks 
associated with their prescriptions.  
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“I think it’s kind of a natural progression from dosing advice about 
medicines, to the doctors come and say I got a patient with A, B, C and 
so and so is wrong with them, can you advise what we could 
prescribe?” (P14, Pharmacist) 
“We eventually got more pharmacists and we were able to spend more 
time on the wards advising doctors and talking to patients about their 
medicines.” (P17, Pharmacist) 
The increasing number of new and potent medicines and the concern for medication 
safety also led to the establishment of drug information services within local hospitals 
which later became an area of specialisation in pharmacy  
“…drug information started back in the 70s. We had the drug 
information centre back in the 70s.” (P14, Pharmacist) 
Overall, pharmacists observed that their role in minimising risks associated with 
medicines on the wards was a major factor contributing to their acceptance and 
integration into the ward team. In addition, the pharmacists interviewed believed that 
doctors appreciated their role because it was difficult for them to keep up to date with 
all the developments regarding medicines given the increasing number of new and 
potent medicines introduced into the clinical practice.  
4.4.3.2 Government policies and legislations 
Since the inception of the NHS, there were several government reports and policy 
documents that were published. These included the Linstead reports (1955 and 1958), 
Noel Hall report (1970), the Nuffield report (1986) and the Department of Health’s 1998 
circular on the way forward for hospital pharmaceutical services.  
 
Figure 4-5: Some government documents linked to the development of clinical 
pharmacy practice in the UK 
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Many participants in this study perceived that some of these reports had a significant 
impact on the development of clinical pharmacy practice in the UK.  
Although, the Linstead reports of 1955 and 1958 were the initial reports that considered 
the hospital pharmaceutical services, the recommendations of these reports were not 
implemented by government (Anderson, 2005a). The Noel Hall committee was set up 
in 1968 to advise the government on how best the hospital pharmaceutical services 
were to be organised to make efficient use of pharmacy staff and recommend a 
suitable career structure for staff including pharmacists and pharmacy technicians 
(DHSS, 1970).   
The Noel Hall report recommended the organisation of hospital pharmaceutical 
services into area and regional units in order to provide a better career structure for 
hospital pharmacists and promote the use of pharmacists’ skills. The report also 
recommended that pharmacists should perform roles that were appropriate to their 
professional training and suggested that hospital pharmacists have an important 
advisory role and should work alongside other clinical staff to ensure safe and cost 
effective use of medicines (DHSS, 1970).  
Many participants in this study saw the Noel Hall report as the initial government 
document that led to a significant change in hospital pharmacy practice. 
“The Noel Hall report was sort of a kick off to getting the things going.” 
(P17, Pharmacist) 
The pharmacists interviewed in the current study reported that prior to the 
recommendations and implementation of the Noel Hall report in the 1970s, hospital 
pharmacy practice was not attractive to newly qualified pharmacists. This was because 
the career structure was flat and did not provide the opportunity for young pharmacists 
to move up the career scale so easily. In addition, remuneration was poor compared to 
community pharmacy practice or the industry. Therefore, many participants perceived 
that this had an effect on staff recruitment and retention.  
“As at the time I joined hospital pharmacy there were certainly 
difficulties with recruitment and the career structure was very limited. 
So, people looking for long term career were not necessarily looking to 
hospital pharmacy.” (P11, Pharmacist) 
The findings of this study indicate that those pharmacists who joined and remained in 
the hospital service in the 1970s did so because they wanted to work in an 
environment where they perceived their professional skills would be utilised. 
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“I moved into hospital pharmacy [from community pharmacy] because I 
wanted to do a more clinical job. I wanted to do some work that was 
more clinically related to the care of patients with medicines.” (P15, 
Pharmacist)  
“I saw that as being more professional than going into retail. The 
hospital was more where you could sort of practise your profession 
more.” (P28, Pharmacist) 
However, with the reorganisation of the hospital pharmacy services and improved 
grading structure for pharmacy staff following the Noel Hall’s recommendations, the 
career structure of hospital pharmacists became better and that made hospital 
pharmacists’ jobs more attractive. Participants reported that regional and area 
pharmaceutical service posts were established and chief pharmacists of some 
hospitals became regional and area pharmacists thereby creating an opportunity for 
those in lower grades of the career structure to move upward.   
“…because Noel Hall came in and a number of senior people were 
promoted to a regional and area posts which created vacancies for 
principal pharmacists, you were able to get promotion to staff 
pharmacist very early on and on top of that remuneration started to 
improve as well and so it became much more attractive.” (P11, 
Pharmacist) 
“…a lot of relatively young pharmacists were made staff pharmacists. 
So, I see that as a big boost to their career.” (P28, Pharmacist) 
Some participants perceived that these developments had positive effect on 
recruitment and retention of experienced pharmacists. 
“…there was a change, the salaries of hospital pharmacists went up 
quite significantly and mine did as a result of that re-grading and I think 
that probably had an impact on the development of clinical pharmacy 
because pharmacists who had a significant clinical role could earn a 
salary which was more aligned to their expertise.” (P07, Pharmacist) 
The Nuffield report of 1986 which considered the structure of pharmacy in the UK was 
also another major government initiative that moved clinical pharmacy practice forward. 
The Nuffield report was the first government document to officially recognise clinical 
pharmacy and made recommendations that pharmacists have a role in patient care 
and that clinical pharmacy should be practiced by hospital pharmacists (Nuffield 
Foundation, 1986). The recommendations of the Nuffield report resulted in a circular 
published by the Department of Health in 1988 entitled the ‘Way Forward for Hospital 
Pharmaceutical Services’ (Department of Health, 1988). Many clinical pharmacists 
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interviewed saw this document as a major driver for clinical pharmacy development in 
the UK.  
“And also there have been a lot of national things, there was a report 
of.., I think it was in 1988, before I qualified which talked about why we 
should have clinical pharmacy.” (P31, Pharmacist) 
There was a landmark event in 1988, the government issued a health 
circular to all hospitals, it was called the way forward. (P32, 
Pharmacist) 
According to these pharmacists, the government through this circular spelt out certain 
functions that hospital pharmacists could do to contribute to patient care including 
contributing to prescribing decisions. In addition, the government urged every hospital 
to develop clinical pharmacy services.  These pharmacists reported that as a result of 
this document the post of clinical service managers was created in some hospitals to 
manage clinical pharmacy services.  
Furthermore, the recommendations of the Nuffield report provided clinical pharmacists 
with the opportunity to grow into senior positions while maintaining their specialist 
functions, though they couldn’t get to the top of the grade without moving into 
managerial roles (Nuffield Foundation, 1986). However, pharmacists reported that the 
implementation of the Agenda for Change grading structure in the 2000s (about 30 
years after Noel Hall) which recognised advanced level practitioners and the 
subsequent introduction of the consultant pharmacist post in 2005 (Department of 
Health, 2005a), provided a clinical career pathway for hospital pharmacists. Therefore, 
specialist clinical pharmacists now move to the top of their career grade within their 
specialty.  
 “….the career structure now reflects a very clear opportunity to 
specialise and sub-specialise at the unit here, whereas at one time, 
you know you are in a position where it sort of led into the 
management route really as opposed to specialised into clinical level” 
(P04, Pharmacist) 
However, some pharmacists interviewed expressed concern over the present 
consultant pharmacist model as it does not provide as many specialist clinical 
pharmacists the opportunity to get to the post. This is because only a few posts are 
currently available.  
“If you want to go to the top, you have to go down one of the other 
routes. You won’t get to the top as a clinical pharmacist. There is a 
new post called consultant pharmacists… that is where we are all 
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trying to get now but there are not very many of that post yet.” (P27, 
Pharmacist) 
 “I think in my own hospital I have a large number of pharmacists who 
would be capable of practising as pharmacist consultants but we don’t 
have the post available for them to go into.” (P15, Pharmacist) 
This study revealed that major obstacle to increasing the current number of consultant 
pharmacist posts were around funding. Not many hospitals especially the smaller ones 
would be able to sponsor the consultant pharmacist post. Since the posts are 
developed locally, some participants believed that up to now, some chief pharmacists 
don’t really know where consultant pharmacists fit in within their context. In addition, a 
participant noted that even when the posts are created, they are usually created in 
specialties where the hospital management perceived it would be of a great impact in 
service delivery. 
“If I want to move up to the next grading in my job, there is just two 
ways of going really. One is to become managerial and the other one 
is to go into the role of consultant grade but in this organisation that is 
not an easy partway to take. Because, the posts are tend to be 
appointed on a sort of… to do with the bigger service. So, we have the 
microbiology, haematology, elderly care type role and most of these 
posts are created because there is a strategic demand in the service.” 
(P30, Pharmacist) 
Participants also noted that there have been other recent drivers from the government 
that have impacted on clinical pharmacy practice. For example they mentioned that the 
recommendations of the ‘A Spoonful of Sugar’ publication in 2001 (The Audit 
Commission, 2001), enabled chief pharmacists to be elevated as clinical directors and 
be part of hospitals’ board of directors advising the board on the development of clinical 
pharmacy services.  Participants also talked about the legislative change outlined in the 
Health and Social Care Act of 2001 that enabled pharmacists to become prescribers, 
initially as supplementary prescribers in 2003, then as independent prescribers in 2006. 
However, some participants felt that the success of the initial extension of prescribing 
rights to nurses was a major driver to extending such rights to pharmacists and other 
allied health professionals.  
“Nurses had already got a foot in the door in 1992 and that was a 
facilitator. You mustn’t forget that, nurse prescribing, was a facilitator to 
pharmacist prescribing because it was seen to be acceptable.” (P08, 
Pharmacist) 
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4.4.3.3 Pharmacists’ education and training 
 
Figure 4-6: Developments in pharmacy training programme in the UK 
Prior to the 1970s individuals with the druggist or pharmaceutical chemist certificates 
who studied at a diploma level were allowed to register and practice as pharmacists. 
However, these certifications were gradually phased out. By 1967, all pharmacy 
programmes available in the country were awarded a degree status and as a result all 
individuals seeking registration as pharmacists in the UK after December 1970 were 
graduates (DHSS, 1970). Pharmacists’ training therefore consisted of a 3-year 
undergraduate degree followed by a year of pre-registration training in practice. 
Despite this development in pharmacists’ training, the participants I interviewed who 
qualified in the 1970s and 1980s reported that their undergraduate degree was 
predominantly science based and does not prepare them for clinical practice.  
“I got into my day one in pharmacy in the dispensary at XXX hospital 
and I thought, ‘I don’t know’. I felt completely at sea because my 
training had been very scientific, a little bit of application to practice.” 
(P17, Pharmacist) 
“My first job was here in XXX and I found it challenging, my 
undergraduate course hadn’t prepared me clinically for working in the 
clinical role. It was an old fashion course, quite theoretical and at that 
time, there was no placement or exposure to patients at all.” (P07, 
Pharmacist) 
Several factors were likely to have contributed to the strong scientific or theoretical bias 
of the pharmacy programme. First, pharmacists were still viewed as manufacturers or 
compounders of medicines; hence pharmacists’ training was tailored toward making it 
more relevant to drug manufacturing and possibly research. In addition, many 
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individuals who trained the initial cohorts of pharmacists were either not pharmacists or 
were academic pharmacists who were not practising and unlike now, practitioners were 
not usually involved in teaching. Therefore, it was difficult to link learning and practice.  
However, with increasing developments in hospital pharmacy practice as a result of the 
introduction of ward pharmacy and subsequently clinical pharmacy, more clinical 
contents were increasingly added to the undergraduate course and some participants 
reported that teacher practitioners and clinical rotations in practice settings were 
introduced in order to bridge the gap between training and practice.  
“I became the first teacher practitioner at XXX University. At the 
University I had to put in place a number of clinical modules within the 
undergraduate curriculum.” (P32, Pharmacist) 
Participants also noted that postgraduate programmes in clinical pharmacy were 
established to address many of the shortcomings of pharmacists’ clinical knowledge 
and skills. The initial masters’ programme in clinical pharmacy was established in 
Manchester in 1978, other universities including London and Bradford also developed 
their programmes subsequently (Calvert, 1999). The initial cohort of pharmacists who 
undertook the course were taught mainly by medical consultants because there were 
no clinical pharmacists at that time to do so. 
“I undertook a masters’ in clinical pharmacy and this was brand new… 
Initially we were taught by medical staff.” (P24, Pharmacist) 
“I got the opportunity to do one of the first master’s degree in clinical 
pharmacy. At that time that course was taught mainly by consultant 
medical staff with a little bit of pharmacy staff for the pharmacokinetics 
and pharmacology but a lot of input from consultant medical staff.” 
(P32, Pharmacist) 
These initial cohorts of hospital pharmacists were instrumental in the training of other 
pharmacists as many of them served as teacher practitioners teaching other 
pharmacists enrolled in the masters programme, thereby resulting in the training of 
more pharmacists. 
Although the postgraduate programme in clinical pharmacy was introduced, 
participants reported that not many hospital pharmacists did the course at that time 
because it wasn’t a requirement for clinical pharmacy practice or career progression 
within the hospital. 
“When I first started, not everybody had the diploma,… some people 
went on to do a masters of what was called clinical pharmacy but there 
weren’t many people taken on to do that.” (P17, Pharmacist) 
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In spite of these developments in training, pharmacists were still performing roles that 
were below their level of training. Pharmacists interviewed in this study acknowledged 
that their skills were underutilised and that resulted in dissatisfaction among 
pharmacists regarding their job roles.  
“I do think it was about the pharmacists realising that putting tablets in 
bottles and checking prescriptions is not the role of the pharmacist. 
You don’t need a degree to do that.”  (P17, Pharmacist) 
This perception of underutilisation of pharmacists’ skills was put forward strongly by the 
younger pharmacists I interviewed because they perceived they were more highly 
trained than their older colleagues and could not continue with the traditional roles their 
older colleagues were performing. In an interview with a pharmacist who graduated in 
the 1990s, he exclaimed:       
“I didn’t do a pharmacy degree to do the counting tablet role! I did it 
because I wanted to do clinical pharmacy, I wanted to be on the ward, 
I wanted to be influencing doctors prescribing, I wanted to be 
counselling patients on their medicines, I wanted to make sure that the 
medicines were being used in a safe way providing my expertise” 
(P18, Pharmacist) 
Participants noted that pharmacists’ perception of their professional role beyond 
dispensing came as a result of a change in the orientation of pharmacy education. This 
was a significant driver for the adoption of new clinical roles by younger pharmacists.  
In 1997, the undergraduate programme was converted to a four-year Master of 
Pharmacy course (Anderson, 2005b). Even though the undergraduate degree has 
changed to a four-year first degree-masters level with more clinical contents added to 
the course, many pharmacists were of the opinion that the undergraduate pharmacy 
degree was still not sufficient for clinical pharmacy practice in the hospital.    
 “I think the undergraduate course has changed in some places and 
they are out in practice more. But still, when they come out of the 
university, they are still clueless; they still don’t really know what to 
do…” (P27, Pharmacist) 
Currently, every pharmacist who goes into hospital pharmacy practice is expected to 
do a clinical diploma as part of his or her training. The clinical diploma is in principle a 
pre-requisite to attaining a senior clinical pharmacist role in the hospital. 
“Now, every hospital pharmacist who goes into the junior level will do a 
clinical diploma, otherwise all the job specifications high up will say, 
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you need to have a clinical diploma or masters before you can get 
those jobs.” (P17, Pharmacist) 
Pharmacists acknowledged that the postgraduate clinical pharmacy programmes have 
enabled hospital pharmacists to develop more breadth and depth in their clinical 
knowledge and skills. They added that this has helped to push clinical pharmacy 
significantly as many hospital pharmacists can now communicate at the same level 
with doctors and other clinical staff.  
“…those diplomas have been an important part of arming pharmacists 
with the clinical abilities…” (P07, Pharmacist)  
“I think doing that masters gave me a lot of confidence to take on that 
clinical role really.” (P16, Pharmacist) 
“I listen to the younger clinical pharmacists now they are almost like 
doctors with their understanding of various conditions and the 
treatment of those conditions.” (P28, Pharmacist) 
On the other hand, participants observed that community pharmacists had not been 
able to develop their clinical practice because not many of them had done the clinical 
diploma which they perceived would have enabled community pharmacists to enhance 
their clinical competence.  
“The practitioners [community pharmacists] themselves don’t have the 
necessary knowledge of therapeutics so they can’t relate to GPs in the 
same way that hospital practitioners can. Because there is no 
requirement for any postgraduate qualification, their knowledge base is 
often lacking in terms of the ability to influence practice…” (P04, 
Pharmacist) 
Overall, the changes that have occurred within the educational structure of pharmacists 
in the UK have resulted in producing competent practitioners who now work in 
advanced level clinically and are specialists within different clinical areas. 
4.4.3.4 Specialisation 
As hospital pharmacists developed more depth in their clinical knowledge and skills 
through postgraduate training, more services were developed on the wards Therefore, 
pharmacists became much more involved in patient facing roles including participating 
in consultant ward rounds and prescribing decision making; and providing medicine 
advice to doctors, nurses and patients. Participants saw this as the beginning of clinical 
pharmacy. Further developments in clinical pharmacy practice and training resulted in 
specialisation and sub-specialisation in different clinical areas.  
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“Obviously, as pharmacists have become more confident and 
developed more breadth and depth in their knowledge, you started to 
see more specialisation and sub-specialisation within clinical 
pharmacy.” (P04, Pharmacist)  
 “There was one area that we started to have a much stronger role in, 
in that we had the aseptic lead for pharmacists, we use to go on the 
consultant ward rounds with the surgical team and she will do the 
advising for the prescribing of total parenteral nutrition.” (P17, 
Pharmacist) 
Pharmacists reported that they began to organise their practice and the training of 
basic grade pharmacists around specialist clinical areas including oncology, surgery, 
clinical nutrition, nephrology, gastroenterology, endocrinology, neurology and 
respiratory medicine.  
“So, my two training years when I was newly qualified involved moving 
round lots of specialties such as paediatric, surgery, general 
medicines, respiratory, care of the elderly and doing those probably for 
3-6 months depending on the specialty. After that, I then specialised in 
care of the elderly.” (P18, Pharmacist) 
Pharmacists acknowledged that being able to specialise in an area enabled them to 
develop more depth in their clinical practice and influence clinical decision making in 
that specialty which helped to push clinical pharmacy practice forward. Participants 
who were pharmacist prescribers noted that because they were specialist in an area, it 
was easier for them to develop prescribing role in that area.  
4.4.3.5 The role of pharmacy technicians 
Participants observed that pharmacy technicians played an important role in the 
development of clinical pharmacy especially within hospital pharmacy practice. They 
acknowledged that the development of pharmacy technicians to take on roles 
previously undertaken by pharmacists freed up pharmacists to develop more clinical 
roles.  
 “In the hospital, the technicians freed up pharmacists time to actually 
be more visible on the ward and have more impact in terms of 
prescribing advice especially with the junior doctors.” (P06, 
Pharmacist) 
“You can’t do clinical role at the bench checking prescriptions. So I 
think, the emergence of pharmacy technicians as a profession in this 
country was a huge step for pharmacists to get out there and do this 
role.” (P18, Pharmacist) 
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The creation of the senior pharmacy technician posts which began to happen in the 
1970s following the recommendations of Noel Hall report was seen by technicians as 
the initial major shift in technicians’ roles. This enabled technicians in senior post to 
take over some supervisory roles from pharmacists.  Participants in this study who 
were senior technicians reported taking over the day to day running of the dispensary 
and management of staff to free their pharmacists up for other roles. 
“I can remember my first job as a senior technician, I can remember 
going to the pharmacist and saying to her, “is it all right if I authorise 
people’s annual leave?” because it seems a bit silly you doing it” and 
then it was like… all right then.” (P03, Pharmacy Technician) 
Because there were shortages of hospital pharmacists even after the implementation of 
the Noel Hall report (Nuffield Foundation, 1986), senior technicians sometimes 
performed roles that were not formally recognised as technicians’ roles to free-up the 
pharmacists for other roles.  
“I became a senior technician in 1977 and at that time I was doing the 
checking of prescriptions.” (P10, Pharmacy Technician) 
 “…my senior technician was an accuracy checker when I first started 
but she didn’t do a qualification for it. She just did it...” (P02, Pharmacy 
Technician) 
Although pharmacy technicians in the UK work under the supervision of pharmacists, 
those in senior roles have increasingly taken over staff supervision and some 
managerial roles as pharmacists continue to develop their roles clinically. Participants 
reported that presently technicians are involved in senior management posts in some 
trusts which gives them enhanced status and some degree of autonomy.  
“From my lead role in acute services, I have a senior management 
team of 4 individuals, two of these individuals are pharmacy 
technicians, and they are at that top level. One of them looks after the 
purchasing and distribution of medicines across hospitals and clinics. 
The other one looks after medicines management and operations. 
They are at the top of their profession, both are managerial.” (P26, 
Pharmacist) 
Also, pharmacy technicians in the UK, who undergo an accredited checking pharmacy 
technician course, now perform final accuracy check of dispensed medicines of 
prescriptions that have been clinically validated by pharmacists. Many participants saw 
this as a major step in the development of the role of the technicians and freeing up of 
pharmacists’ time for other advanced clinical roles. 
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“The next biggest change that I saw was the change to technicians 
starting to do accuracy check and I think that was a huge step…” (P03, 
Pharmacy Technician) 
“One of the key things that enabled the pharmacists to spend more 
time on the ward was the technician checking policy.” (P17, 
Pharmacist) 
Pharmacists and pharmacy technicians reported that the current career structure has 
enabled technicians to specialise in clinical areas including medicine management and 
clinical trials. Clinical pharmacists observed that their roles in the wards were 
supported by medicine management technicians working in the wards. Technicians in 
medicines management roles perform medication history taking, medicine 
reconciliation and work in specialist clinics.  
“…the pharmacy technician will do medicine reconciliation, they will 
look at patients own drugs to see if they are fit for purpose, fit for use 
and take medication histories and counsel patients on taking 
medicines.” (P22, Pharmacy Technician) 
“They [pharmacy technicians] are now spending a lot more time based 
in the clinical area with patients and teaching patients how to use their 
medicines and making sure that prescribing is correct on admission by 
taking drug histories.”  (P15, Pharmacist) 
Although participants noted that the training of trainee pharmacy technicians has now 
been standardised following technicians’ mandatory registration with the General 
Pharmaceutical Council, variation in post-registration training of pharmacy technicians 
still exists nationally. Many participants expressed concern on the absence of a 
national framework for technicians’ post-registration training. 
“…there isn’t anything formally in the country, everybody does it 
locally.” (P29, Pharmacist) 
“Post registration training is done locally. I think we probably need to 
get some standardisation into that…” (P15, Pharmacist) 
Pharmacists observed that the post-registration training of technicians need to be well 
coordinated and a national framework is needed giving technicians’  increasing level of 
involvement in medicines management roles and the reliance of pharmacists on them. 
4.4.3.6 Economic driver 
This study revealed that a major factor driving policy change and recommendations 
made by for example the Noel Hall and Nuffield inquiry reports was the drive for cost-
effective use of healthcare budgets. 
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“…cost-efficiency in the NHS could be seen as the bottom line to all of 
these [government policies]. The cost driver is a huge motivation 
behind those initiatives.” (P02, Pharmacy Technician) 
Participants observed that as many new and expensive medicines were introduced into 
clinical practice, spending on medicines became increasingly high. Therefore, there 
was a recognition within the National Health Service that drug budgets needed better 
management.  
 “The drug budgets [spend on medicines] increasingly grew as new 
medicines came out. So, new medicines, more expensive 
medicines…people knew that pharmacists could help in choosing the 
cheapest drugs that would work in a particular situation.” (P07, 
Pharmacist) 
This study revealed that a number of strategies that supported the development of 
clinical pharmacy were used by hospitals to minimise drug spending. These included 
supporting the development of hospital drug and therapeutics committees and the 
increased participation of pharmacists in purchasing and prescribing decisions of 
medicines.  Hospital drug and therapeutics committees were responsible for preparing 
and maintaining hospital formularies which regulate prescribing and minimise drug 
expenditure. The use of formularies to minimise spending on drugs was supported by 
the Department of Health’s circular on the ‘Way Forward for Hospital Pharmaceutical 
Services’ in 1988 (Department of Health, 1988). Participants perceived that the 
involvement of clinical pharmacists in drug and therapeutic committees and the 
presence of pharmacists on the ward to advise doctors on the cost-effective choice of 
medicines have resulted in cost savings. Some primary care pharmacists interviewed 
noted that primary care pharmacist posts were developed as a result of government 
initiative to ensure adequate management of drug budgets within primary care facilities.  
“Then, because of the financial side, because of the opportunity to 
save money if you manage the medicines more appropriately, people 
began to realise that you could employ a pharmacist to do that…” 
(P05, Pharmacist) 
Therefore some general practices employed pharmacists to work closely with general 
practitioners to manage their prescribing budgets. However such savings in medicine 
costs may not always be the best practice for patient benefit. It could also be a barrier 
to pharmacists’ clinical involvement since much emphasis is likely to be placed in 
minimising prescribing cost with such arrangements. 
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Pharmacists and pharmacy technicians also perceived that asking technicians to do 
some of the roles that were previously undertaken by pharmacists was also a way of 
saving costs on labour because it is cheaper to get the job done with technicians.  A 
pharmacist noted:  
“I think you could argue in the old days that we were paid too much to 
dispense because a technician could dispense, it’s a learning process, 
you don’t need a high level of education to do dispensing.”  (P07, 
Pharmacist) 
Some participants believed that cost saving on healthcare budget was a major driver 
for the promotion of skill mix among pharmacy staff as well as the extension of 
prescribing rights to other healthcare professionals because it will cost more for doctors 
to do the roles that can be handled by other professions. Although some participants 
consider cost saving as an important factor in tasks shifting among healthcare 
professionals including the extension of prescribing rights to non-medical professionals, 
it is usually inconspicuous in policy documents as part of the reasons for role 
extension. 
4.4.3.7 Professional relationship with doctors 
Pharmacists reported that their movement to the wards made them visible in the wards 
and led to the development of a relationship which increased over time with doctors 
and other members of the ward team.  
Pharmacists reported that when they started visiting the wards and attending 
consultant ward rounds, they were visiting wards where the consultants were 
enthusiastic and had good rapport with them.  
“When we started off the ward pharmacy back in the 70s, the wards 
we went into first were the ones that the consultants and the nursing 
staff were very supportive of pharmacy. So we were looking at 
professionals who were supportive of pharmacy, who have had a good 
experience in their dealings with pharmacists.” (P14, Pharmacist) 
A pharmacist who was newly employed in a hospital in the early days of clinical 
pharmacy reported how he was able to do clinical work on the ward as a result of the 
rapport his chief pharmacists had with the medical staff. 
“…XXX who was the chief pharmacist there [name of a hospital] had 
excellent working relationships with the medical staff in the hospital 
and so I routinely spent most of my week working clinically with 
medical consultants…” (P32, Pharmacist) 
 117 
 
Pharmacists felt that over time, these consultants who saw the benefits of the 
pharmacists being on the wards were instrumental in recommending them to their other 
colleagues. 
“…and you know,  incrementally the medical profession started to get 
the message that there was something valuable in having pharmacists 
on wards and supporting ward rounds...” (P04, Pharmacist) 
This study revealed that In the 1970s and 1980s, prescribing to patients on the wards 
was largely done by junior doctors with a varying degree of supervision from their 
senior colleagues. Therefore, pharmacists reported that as they became a credible 
source of information and advice around medicines they were accepted by doctors 
especially the junior doctors who were relying on their expert medicine knowledge and 
advice on the wards.   
“…we will do chart reviews and look for problems with medicines and 
work with junior doctors to formulate solutions around problems found 
with medicines.” (P19, Pharmacist). 
Hospital pharmacists reported that they are now well accepted by medical consultants 
because many consultants now in practice have had positive experience of 
pharmacists’ contribution to patient care when they were junior doctors.  
“…but as the junior doctors are now becoming senior doctors,  they 
were there at the beginning, they have seen us become more clinical 
and we supported them a lot through their training. Now, particularly 
the younger end of the consultants really sees pharmacists as a 
supporting force.” (P27, Pharmacist) 
“Those junior staff [junior doctors] back in the 1980s learn their 
medicine with the pharmacist present on the wards and those junior 
staff are now consultants and senior medical staff and so they expect 
pharmacists to be there because they know what pharmacists can do” 
(P32, Pharmacist) 
In addition, some participants noted that there is now a lot of multidisciplinary work and 
learning involving doctors, pharmacists and other members of the health team going on 
in the country and that has helped to strengthen relationship within the health team. 
“…some of the younger doctors coming along were very used to 
pharmacists being around them and they train with them and they work 
with them. So they don’t really have that culture problem.” (P09, 
Pharmacist) 
Participants also observed that the involvement of the pharmacists in the 
multidisciplinary drug and therapeutics committee led to among other benefits, a better 
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working relationship between doctors and pharmacists. Prior to that, participants 
perceived that doctors saw pharmacists’ roles on the wards as being policing in nature 
and that created a barrier in their relationships.  
“In the old days when I first qualified, I think we were seen a bit like the 
police because we were traditionally trying to save money or to say 
don’t prescribe that because it cost too much” (P27, Pharmacist) 
But as doctors gain more understanding of pharmacists’ contributions to the drugs and 
therapeutics committee, it gave them a different perspective. This understanding has 
also helped hospital pharmacists and doctors to work together towards implementing 
hospitals’ prescribing policies for improved patient care. 
4.4.3.8 Shortage of medical doctors 
Many participants commented on the inability of doctors in the UK to meet the huge 
demand for healthcare due to the growing medical needs of an aging population and 
the impact of chronic diseases on the health system.  
“We also got this massive aging population, they want accessible care 
round the clock and there was a big issue with the number of medics 
available.” (P02, Pharmacy Technician) 
These participants perceived that because doctors were unable to meet up with the 
demand for healthcare provision, certain roles previously undertaken by doctors were 
extended to other healthcare professionals including nurses and pharmacists in order 
to free them up for more specialised tasks.  
“If you look at the increase in patient numbers, you need doctors to do 
what doctors do and you have to free up some of their time…” (P06, 
Pharmacist) 
Furthermore, with the introduction of the European Union (EU) Working Time Directive 
in 1993 which limited doctors working hours (Coucil of the European Commission, 
1993), tasks shifting and role extension to nurses and pharmacists was considered a 
valuable strategy to make up for the time that would be lost as a result of the this EU 
Directive. 
 “So, there were the things like the EU directive saying doctors can’t 
work so many hours. So you got less doctors available to prescribe. 
Suddenly they will need…” (P08, Pharmacist) 
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Hence, some participants perceived that this facilitated role extension to other 
healthcare professionals including the extension of prescribing rights to pharmacists in 
order to maintain service delivery.  
4.4.3.9 The role of leading individuals and professional associations 
Participants described key individuals using various terms including leading individuals, 
forward thinking pharmacists, role models and champions of change who had different 
perspectives of pharmacists’ professional roles. These key individuals were either chief 
pharmacists or other principal pharmacy staff.  They were perceived as having a 
clearer vision of the pharmacists’ clinical role with consequently less dispensary based 
work.  These individuals were able to communicate this vision to pharmacy and 
medical staff to facilitate practice change.  
“XXX hospital has been at the fore front of clinical pharmacy ever since 
it started and that was because of one or two chief pharmacists who 
pushed it forward. So it was individuals really who made the 
difference.” (P07, Pharmacist) 
A number of pharmacists perceived that these leading individuals were influenced by 
the development of clinical pharmacy practice in the US.   
“The chief pharmacist there did a lot of work with the hospitals in 
Chicago US and he kept bringing back ideas from Chicago and they 
were much more dynamic in Chicago with their clinical pharmacy. So 
he was bringing ideas back to England and we were testing things out 
for the first time.” (P19, Pharmacist) 
Some participants interviewed saw themselves as being instrumental in advancing the 
role of pharmacy staff.   
“I was one of the people who helped in my hospital to advance the role 
of the pharmacy technicians. So when I saw a really good pharmacy 
technician who I saw could take on responsibility, we would nurture 
them to take on more management role.” (P17, Pharmacist) 
A participant in this study who was a chief pharmacist described how they came 
together as chief pharmacists in a region and formed various committees with a view to 
developing pharmacists’ clinical roles in the region. 
“I worked with colleagues in the region and set up a committee for 
education and started to organise the education across the whole of 
the region and then everybody took part in the diploma and then we 
looked at how we look forward to more specialist people and we 
developed the doctorate [professional doctorate] programme for a 
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small number of people to then lead clinical work for the future.” (P24, 
Pharmacist) 
Participants also noted that organisations such as the Guild of Hospital Pharmacists, 
the United Kingdom Clinical Pharmacy Association (UKCPA) and the Association of 
Pharmacy Technicians UK (APTUK) were able to influence pharmacy practice.  These 
organisations were instrumental in educating their members on extended roles for 
pharmacy staff, supporting the training pharmacy staff and lobbying the government. 
“Well, I suppose I will have to give it to organisation like that 
Association of Pharmacy Technicians UK. Those pharmacy 
technicians who have been active members of the association have 
lobbied, campaigned, encouraged training and supported pharmacy 
technicians in taking on more extended roles.” (P02, Pharmacy 
Technician) 
“Some key organisations also helped. One of those was the United 
Kingdom Clinical Pharmacy Association and they came together as a 
body within the country as a group of like-minded clinical pharmacists 
who ran conferences. They help to develop clinical pharmacy by 
having an organisation that people can belong to, to share ideas and I 
think that was quite key as well.”  (P17, Pharmacist) 
Some hospital pharmacists observed that there have been some recent national 
drivers from the Royal Pharmaceutical Society. However, they felt that the Royal 
Pharmaceutical Society of Great Britain which was then the professional and regulatory 
body for pharmacists was not proactive toward extended clinical roles for hospital 
pharmacists in the early days.  
“Before as hospital pharmacists, we didn’t feel properly represented by 
the Royal Pharmaceutical Society, we thought they were focussed 
very much on community and we didn’t feel like they understood what 
we did…” (P31, Pharmacist) 
“We had to use UKCPA to do that because at that time the 
Pharmaceutical Society was not engaged with that at all, they were 
more engaged with other aspect of the profession and not in clinical 
practice, they only came to recognise clinical practice much later on.” 
(P32, Pharmacist) 
This may be because at that time there were significantly more community pharmacists 
than were hospital pharmacists. For example in 1985, hospital pharmacists constituted 
about 16% while community pharmacists constituted about 74% of the approximately 
35,000 registered pharmacists in Great Britain (Nuffield Foundation, 1986). The society 
was therefore more likely to be concerned about the development of community 
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pharmacy practice rather than hospital pharmacy practice. However, these participants 
acknowledged that this is no longer the case now and perceived that the separation of 
the regulatory function from the Royal Pharmaceutical Society has enabled the society 
to concentrate on developing pharmacists’ professional roles. For example, a 
participant noted that the Royal pharmaceutical Society Faculty, through its’ advanced 
pharmacy framework, supports professional development by giving its members the 
opportunity to recognise skills that are appropriate to their level of practice. This has 
the potential to make pharmacists more aspirational for advanced practice. 
Theme summary: As reported earlier, this theme has identified nine drivers for 
pharmacy practice change in the UK. These drivers were the need for safe use of 
medicines, government policies and legislations, pharmacists’ education and training, 
specialisation in practice, the role of pharmacy technicians, economic drivers, 
professional relationships with doctors, shortage of medical doctors and the influence 
of leading individuals and professional associations.  These drivers were primarily 
linked to the changes in hospital pharmacy practice in the UK. Overall, the drive from 
government policies and legislations represents a major facilitator and appears to have 
had an effect on other drivers identified. This suggests that nothing could have been 
achieved without government support. In addition, the expansion of the training of 
pharmacy staff including technicians has resulted in developing credible practitioners to 
take on extended clinical roles.  
4.4.4 Barriers to pharmacy practice change 
This theme reported the challenges that pharmacists encountered in achieving 
extended clinical roles in the UK.  According to Birenbaum (1982) the process of 
changing professional roles comes with a number of challenges from both members of 
the professional group and those outside the profession who held  preconceived views 
about the role and social identity of the profession. Therefore, many pharmacists 
interviewed observed that the medical profession as well as pharmacists themselves 
were major barriers to extending their clinical roles. Other sub-themes identified as 
barriers included legal and regulatory constraints, pharmacists’ professional isolation 
and organisational challenges. These barriers are presented below. 
4.4.4.1 The Medical Profession 
Pharmacists commonly reported that there was initial opposition from medical doctors 
(especially the consultants) to the extension of pharmacists’ clinical roles.  They 
reported that in the 1970s, hospital wards were traditionally seen as places in which 
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pharmacists did not have a role. Therefore, their presence on the wards was subject to 
challenge by the medical staff.  Pharmacists also reported that initially, the medical 
profession was uncertain as to the clinical roles of pharmacists and as a result were 
concerned about professional boundary encroachment.   
“One of the common statement when I was a younger pharmacist was 
that you are trying to be a doctor and I maintain right from  the 
beginning that if we work properly, then the doctor makes the 
diagnosis  and the plan, the pharmacist can then deliver the medicine 
and that plan, and how to use the medicine.” .  (P24, Pharmacist) 
However, as pharmacists increased their presence on the wards and made valuable 
contributions to patient care, the medical profession began to appreciate pharmacists’ 
contribution.  
“…incrementally the medical profession started to get the message 
that there was something valuable in having pharmacists on wards and 
supporting ward rounds and doing all these things which traditionally 
had been done badly.’” (P04, Pharmacist) 
Furthermore, pharmacists reported that similar resistance was shown by doctors to 
extension of prescribing rights to pharmacists.  However, they were swift to mention 
that such resistance is rare now in the hospitals because doctors now appreciate the 
benefits of a pharmacist prescriber.  
“The doctors I have worked with were generally pro-pharmacy and 
could see that pharmacists could also do, in some circumstances, the 
routine prescribing and then the doctors can concentrate on more 
complex cases that needed their attention.” (P18, Pharmacist) 
However, some pharmacists mentioned that many doctors are still reluctant to support 
community pharmacists in developing their prescribing role. 
“We have had no difficulties in the hospitals getting a doctor to mentor 
our prescribing students. In the community…, community pharmacists 
have had real difficulties getting independent prescribers to mentor 
them, to supervise them.” (P08, Pharmacist) 
This may be as a result of the poor working relationships between general practitioners 
and community pharmacists.  
4.4.4.2 Professional attitude of pharmacy staff 
Although pharmacists generally reported that many pharmacists were enthusiastic in 
taking up extended clinical roles, some pharmacists observed that there were 
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pharmacists who were reluctant to do so. This was because of the increased 
responsibility and risks associated with it. 
“…some pharmacists may not want to go down this route and don’t 
want to change their role. Some prefer doing the traditional role…” 
(P01, Pharmacist) 
“Pharmacists themselves were part of the barriers and they still are in 
community pharmacy, I would say. Some hospital pharmacists were 
hesitant about becoming clinical, they were scared, they didn’t really 
have confidence and would like the safety of the pharmacy where they 
can dispense.” (P07, Pharmacist) 
Some pharmacy technicians also made similar reports about pharmacy technicians’ 
attitude towards taking up extended roles. 
“… like I said, you get this really highly motivated, ambitious workforce 
but we also have  those people who don’t want to do that but just want 
to deliver the medicines and do that role.” (P03, Pharmacy Technician) 
“When I started in in the 1970s, people that we started at the same 
time as me came into the profession with a different attitude that it was 
perhaps just the job, it was not a career, it was not a profession, it was 
a job and so professionalism isn’t something they were aspiring to.” 
(P22, Pharmacy Technician) 
Many pharmacists and pharmacy technicians reported that some pharmacists felt 
threatened by pharmacy technicians taking on extended roles especially the accuracy 
checking and some managerial roles because of the fear of role erosion.  
“I did hear in several occasions, pharmacists talking or in the 
pharmaceutical journal about pharmacy technicians taking over and 
there won’t be any need for pharmacists because pharmacy 
technicians are taking over.” (P22, Pharmacy Technician) 
“I think sometimes pharmacists are fearful that pharmacy technicians 
are going to take some of the roles that were traditionally pharmacists’. 
But the flip side to that is about pharmacy technicians taking on some 
of these roles to liberate the pharmacists to actually take on more 
clinical role and more patient facing role.” (P21, Pharmacy Technician) 
However, many pharmacy technicians generally reported that they have been well 
supported by pharmacists to develop their roles.  Though, they noted that the fear of 
role erosion is still a problem in community pharmacy. In addition, a pharmacy 
technician alleged that this may account for the reason why community pharmacists 
were reluctant to embrace the role of the accredited checking pharmacy technician.  
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“Community pharmacies adopted that framework little less than 
hospitals. So, they were started to have accuracy checking technicians 
within pharmacies but in terms of the culture and the acceptance of 
having technicians as checkers, it did take in fact 10 years for a degree 
of acceptance.” (P02, Pharmacy Technicians) 
However, community pharmacists’ reluctance to accept the role of the accredited 
checking pharmacy technicians  may have to do with the fear of taking legal 
responsibility in case of  an error made by a technician as further highlighted in section 
4.4.4.3.   
4.4.4.3 Legislative and policy constraints 
Participants including pharmacists and pharmacy technicians mentioned that certain 
policies and regulations were barriers to role extension. Some participants noted that 
the Medicine Act of 1968 which required community pharmacists to be in personal 
control of the pharmacy, supervising every aspect of dispensing might have affected 
community pharmacists’ clinical role development. They reported that it could explain 
why community pharmacists were usually tied to the dispensing bench.  
“Community pharmacists are a little bit restricted in their activity by the 
Medicine Act. For example, they have to be in personal control of the 
pharmacy, supervising dispensing. Within hospital, we were not quite 
subjected to that.” (P32, Pharmacist) 
Also, other participants interviewed associated the delay in the development of clinical 
roles among community pharmacists to the remuneration model (dispensing-based 
remuneration) of community pharmacies which is predominantly linked to supply 
functions.  
“The business model relies on prescription volume, they get paid to 
dispense prescriptions and that is what they concentrate on.” (P19, 
Pharmacist) 
“It is primarily because the remuneration system is wrong. So, you get 
paid for dispensing a prescription, you don’t get paid for talking to a 
patient.” (P07, Pharmacist) 
Because community pharmacy has historically been founded on a business model, it 
was difficult for it to consider developing roles that were non-remunerated or without 
financial incentives.   
On the other hand, hospital pharmacists noted that even when they were contributing 
to prescription writing and in principle writing the prescriptions themselves and asking 
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the doctors to sign, they couldn’t prescribe because the law did not allow them to do 
so. 
“When I used to work in the hospital, we couldn’t prescribe. So we 
would write the prescription and get the doctor to sign it. So, I would 
work out all the doses, write the prescription and then I would put it on 
the doctors’ notes and they would sign it. You know I was doing the 
prescribing but at that point pharmacists couldn’t prescribe which 
wasn’t satisfactory.” (P17, Pharmacist) 
A pharmacy technician also made a similar observation. This technician reported that 
certain policy documents, like the responsible pharmacist regulation which put a limit 
on what other pharmacy staff can do, affects the development of the roles of 
technicians.  
I write the procedures for this department for the Trust, I authorise 
them but in the eyes of the GPhC, I can’t do that because I am not the 
responsible pharmacist.” (P03, Pharmacy Technician) 
Also, some pharmacy technicians perceived that the lack of registration of technicians 
until recently, affected the development of the technician workforce especially in 
community pharmacies. They believed that some pharmacists were reluctant to give 
technicians additional responsibilities because they were not registered and considered 
them not accountable. 
“…pharmacists have been fearful that if they delegate a role, an 
activity to a pharmacy technician and something happens and there is 
an error, the pharmacist will be accountable for it.” (P21, Pharmacy 
Technician) 
Pharmacy technicians reported that being registered with the General Pharmaceutical 
Council made them accountable for their roles and they perceived that pharmacists 
now consider them accountable and responsible for the increased role.  
4.4.4.4 Professional Isolation 
Up to the early 1970s, it was unusual for pharmacists to be present on the hospital 
wards. They were mainly found in the dispensary performing their core functions of 
compounding, dispensing and offering medicine advice to patients and staff. In 
addition, some pharmacists reported that communication between them and ward staff 
including doctors and nurses was poor at that time. This was mostly done on the 
telephone and on most occasions it involved querying a prescription. Thus, hospital 
pharmacists were professionally isolated from other clinical staff. Therefore, those 
outside the pharmacy profession did not understand pharmacists’ professional clinical 
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roles. However, the increased work on wards and the work in medical information units 
have removed hospital pharmacists from being professionally isolated and gave them 
an identity that other professions could see. 
On the other hand, some participants reported that community pharmacists are still 
professionally isolated from other healthcare professions. 
“I found it [community pharmacy practice] quite professionally isolating, 
you didn’t really have much opportunity to speak to GPs. If you did, 
you are just querying a dose of a prescription or just trying to facilitate 
the supply of medication to a patient.” (P28, Pharmacist) 
This is because community pharmacists mostly work in isolation from other healthcare 
professionals. Therefore, it is difficult for them to establish a good working relationship 
with other clinicians including general practitioners who can support their clinical roles. 
“I think secondly, the commercial basis on which community 
pharmacies operate and its relative isolation from GP practices, I know 
in some areas they could be of close location…but in a vast majority, 
there is clear physical separation between GP practices and 
community pharmacies. That doesn’t help in terms of building the 
necessary relationships.” (P04, Pharmacist) 
 Furthermore, some participants noted that pharmacist prescribing is still lagging 
behind in community practice because many community pharmacists don’t have a 
good rapport with general practitioners who will act as their mentors. 
“It is more difficult for community pharmacists because they need to 
get a GP to mentor them but the GP doesn’t directly benefit from it. So, 
you got to have a good relationship with the local GP before he can 
accept to mentor you” (P05, Pharmacist) 
Also, unlike hospital pharmacists who work with other pharmacists in larger 
departments, most community pharmacists work in smaller units and in relative 
isolation. As a result there is little opportunity for interaction with other pharmacist 
colleagues.  
“If you go into hospital practice as a junior pharmacist, you are 
mentored from day one, whereas as a community pharmacist, you are 
generally on your own. So, you don’t get this day to day mentoring.” 
(P05, Pharmacist) 
In addition about a quarter of community pharmacists in Great Britain work as locums 
(Phelps et al., 2014). Such working arrangements do not provide an opportunity for 
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professional mentorship, networking, communication and commitment to 
professionalism.  
However, many hospital pharmacists interviewed observed that they were able to 
embrace and show positive attitudes towards clinical roles because they were working 
alongside other pharmacists who they referred to as role models or champions of 
extended clinical roles. In addition, hospital pharmacists interviewed stated that being 
members of the Guild of Hospital Pharmacists and the United Kingdom Clinical 
Pharmacists Association (also open to community pharmacists) provided them with a 
forum where they networked with other members of the profession across the country 
to promote clinical pharmacy services in their hospitals. 
4.4.4.5 Organisational barriers 
Other barriers mentioned by participants were mainly organisational. One key issue 
that was predominantly mentioned by pharmacists was staffing. Pharmacists pointed 
out that in the early days of ward pharmacy, they couldn’t visit all the wards because 
there were not sufficient numbers of hospital pharmacists to do that. In addition, the 
time they spent on the ward was limited because they had other roles in the dispensary 
which they considered as important.  
 “You still have some pharmacists saying I cannot take on any more 
extended roles because I haven’t got enough time in a day to do what I 
am already doing.” (P06, Pharmacist) 
“So, if all the pharmacists had spent a lot of time on the ward, the 
dispensing wouldn’t have been done.” (P07, Pharmacist) 
Participants noted that even though several measures were taken to resolve the 
increase workload on pharmacists, staffing issues continued to be a barrier to clinical 
role extension. Some hospital pharmacists observed that the shortage of pharmacists 
was still a barrier to being permitted to go on prescribing courses. This is because they 
would need a replacement to take time out of work to do the course. 
“There is still a barrier in getting everybody to be a prescriber because 
6 months of training is a big time commitment and to go to those study 
days, you have to be out of work. So we lose staff, so we can’t let 
everybody go at once.” (P27, Pharmacist). 
Other barriers mentioned by participants included funding issues especially for training 
of staff, remuneration for extended roles, lack of research evidence demonstrating the 
effectiveness of some of the extended roles, and the absence of a national framework 
to support some extended roles. 
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Theme summary: This theme has identified five categories of barriers that impeded on 
the development of clinical pharmacy practice in the UK. These barriers were the 
opposition from the medical profession; professional attitude of pharmacists and 
pharmacy technicians towards extended roles; legislative and policy constraints; 
professional isolation of pharmacists especially community pharmacists; and 
organisational barriers including inadequate number of pharmacy staff which was 
commonly noted by participants. However, many of these barriers were surmounted 
especially within hospital pharmacy practice. For example, hospital pharmacists now 
work closely with their medical colleagues who support their roles. In addition, hospital 
pharmacists now show positive attitudes towards a clinical role and many of them now 
work as clinical pharmacists contributing to patient care.  
4.4.5 Benefits of clinical role extension 
This theme presented the perceived benefits of clinical role extension identified by 
participants. Three categories of benefits were identified: patients’ benefits, pharmacy 
staff benefits and economic benefits. 
4.4.5.1 Benefits to the patients 
Many pharmacists viewed the patients’ benefits as the primary benefits of extended 
clinical roles. They reported that they are now using their knowledge and skills to 
enhance patients experience and care.  
“It has enabled the pharmacists to use their clinical knowledge to the 
benefit of the patients....” (P14, Pharmacist) 
Similarly, some pharmacy technicians also reiterated this view. 
“It is all about improving things for patients and everything we do in 
pharmacy is about improving the patient experience.” (P22, Pharmacy 
Technician) 
Pharmacists reported that as a result of their presence and increase clinical activities 
on the wards, patients get the best use of their medicines and patient safety was 
improved.  Pharmacists described how they were able to advise both doctors and 
patients on appropriate use of medicines and also how their expert knowledge on 
medicines were utilised to avert adverse events of medicines and these have helped to 
improve patient care. 
“A lot of patients ask questions about their medicines, they want to 
know what they've got, they want to know what the drugs you are 
giving them are going to do and specialist pharmacists do know that 
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and are able to interact efficiently and effectively with patients.” (P06, 
Female, Pharmacist, 1980s) 
“… because you are there [on the ward], you are used as an 
information resource to deal with issues that the ward is trying to deal 
with.” (P24, Pharmacist). 
A pharmacist described how he ran an anticoagulant clinic in the early 1980s with the 
agreement of the medical director and hospital management and was able to 
demonstrate that anticoagulant therapy could be made safer by tailoring the drugs to 
individual patients. The pharmacist reported that as a result of this service, the safe use 
of warfarin was improved. 
 “At the time I took over the anticoagulant clinic, I think it was about 
300 patients and by the time I finished with it, we were looking after 
two and a half thousand patients. That was because people could see 
that by managing service as opposed to just prescribing, the patients 
had somebody that they could come to and talk about their medicines 
but also everybody was monitored, everybody was followed up. At the 
end the safety profile of warfarin in particular improved immensely.” 
(P24, Pharmacist). 
Pharmacists also mentioned that taking on extended roles including prescribing, have 
contributed to the seamless services experienced by patients in the hospital.  
Pharmacists who were prescribers talked about how patients need not wait now for 
doctors to adjust doses or add medicines which were missing on their prescriptions in 
areas where there was a pharmacist prescriber. 
“It means that they are now getting their medicine promptly and in a 
correct manner and one would hope less potential for error.”  (P23, 
Pharmacist). 
Pharmacists interviewed also perceived that the incidence of drug related problems 
and hospitalisation due to medication error have reduced due to pharmacists’ 
involvement in the wards and in prescribing.   
4.4.5.2 Benefits to pharmacy staff  
Both pharmacists and pharmacy technicians mentioned a number of benefits that were 
linked to them. Pharmacists now view themselves as an indispensable part of the ward 
team. 
“If I think about where we are now, if pharmacists stop doing what they 
are doing on the ward, then the system would fall down completely but 
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in those days, if we stop what we were doing on the ward, things would 
have probably kept going okay.” (P07, Pharmacist). 
Pharmacists reported that assuming a clinical role has helped them build a good 
working relationship with other members of the health care team including doctors and 
nurses who now appreciate their contributions to patient care. They reported that 
pharmacists and doctors now work together to optimise patient care. 
“We are working more closely with the other healthcare professions in 
a way we didn’t before and in special care as well.” (P01, Pharmacist). 
They acknowledged that the extension of prescribing rights to the pharmacists has 
empowered them to take higher level of responsibility in patient care with enhanced 
status and autonomy. 
“Instead of having to go and see the doctor to get the signature, the 
pharmacist can have responsibility which comes with accountability to 
do those extended roles and I see that as exciting and I see that as 
motivating...” (P23, Pharmacist) 
“A lot of the time going to ask a junior doctor that have been qualified 
for 3 months, who knew a fraction of what you knew about medicines, 
asking them to prescribe and take responsibility doesn’t make sense 
really.” (P18, Pharmacist) 
Participants perceived that using the clinical skills of the pharmacists, especially in 
prescribing, has increased the capacity of the health system by complementing the 
demand for medical care and freeing doctors up to enable them do more specialised 
tasks. 
“If you are in a hospital with high cases of hepatitis or HIV, and you 
have a shortage of medics for example, then a specialised HIV 
pharmacist can do an awful lot work freeing up the medics to do the 
diagnosing.” (P06, Pharmacist) 
Pharmacists and pharmacy technicians admitted that they are now doing more 
interesting and satisfying jobs that are appropriate to their training.  
 “I would have been fed up if I spent a lot of time counting or being in a 
dispensary, that just wouldn’t suit me. So, I feel personally more 
satisfied in my job because I have got this ability to work clinically.” 
(P27, Pharmacist). 
Pharmacists mentioned that they now have a career structure which produces 
practitioners working at a very advanced level and thereby contributing to safe and 
effective management of medicines. Pharmacists pointed out that the clinical career 
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pathway in the hospitals offered clinical pharmacists the opportunity to move to the top 
of the pay scale without moving into the management route.  Similarly, pharmacy 
technician also reiterated that they now have a more satisfying career as a result of the 
various career options now available for them.  
“If they do want to progress, there are other options with lots of 
different career choices now for pharmacy technicians. I often say to 
my students, there’s never been a better time to come into the 
profession because there is so much choice.” (P22, Pharmacy 
Technician). 
“There is so much more diversity in terms of careers that are there for 
us because back in the 70s, 80s, you would have been a dispensary 
technician or an aseptic or technical services technician… whereas 
now, there is a multiple range of pathways that you can follow in terms 
of career.” (P02, Pharmacy Technician) 
Furthermore, many technicians pointed out that they now have an enhanced status and 
are able to take more responsibilities because they are now a regulated profession. 
“When I first started, pharmacy technicians were very much tied to the 
dispensing bench, they didn’t do any kind of specialised roles, they 
didn’t do medicines management and now with the voluntary 
registration and subsequently statutory registration, pharmacy 
technicians have become registered health care professionals 
themselves and have been able to take that kind of responsibility.” 
(P20, Pharmacy Technician) 
These technicians perceived that their registration with the General Pharmaceutical 
Council could be responsible for their increased recognition and involvement in 
medicines management roles and work in specialist clinics. 
4.4.5.3 Economic benefits 
Participants reported that there were economic benefits associated with the pharmacist 
taking on extended clinical roles. Many participants felt that pharmacists’ involvement 
in formulary management through the Drug and Therapeutics Committees had resulted 
in effective management of drug budgets and medicines. 
“….pharmacists have been able in hospitals to save money on drug 
budgets by using drug and therapeutics committees” (P07, 
Pharmacist)  
They observed that pharmacists were able to use their expert knowledge on drugs to 
advise medical prescribers on cost-effective treatments. 
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Some participants perceived that having the pharmacy technicians do the dispensing 
role including final accuracy check (rather than the pharmacists) and the pharmacists 
doing the clinical roles ensures appropriate and cost-effective use of the skill mix within 
pharmacy staff. 
“…but the advantages are job satisfaction, it is cheaper to get the job 
done by pharmacy technicians…” (P02, Pharmacy Technician) 
“If you want to develop your pharmacists’ roles, you either double your 
pharmacists workforce which is going to cost you a fortune or you grow 
around it group of technical staff.” (P03, Pharmacy Technician) 
 “I think you could argue in the old days that we were paid too much to 
dispense because a technician could dispense, it’s a learning process, 
you don’t need a high level of education to do dispensing.” (P07, 
Pharmacist) 
Some participants observed that having the pharmacist perform the core function of 
dispensing medicines did not provide value for money because pharmacy technicians 
who are paid less are able to do this role. 
Theme summary: Of the three categories of benefits identified by this theme, patients’ 
benefits were viewed by participants as the primary benefits of advanced clinical roles. 
They acknowledged the opportunity that extended roles has accorded them to use their 
knowledge and skills to enhance patient care. Also, other benefits such as enhanced: 
responsibility and status, career structure and job satisfaction for pharmacy staff were 
widely appreciated. In addition, the economic benefits associated with pharmacists’ 
involvement in medicines management and the use of pharmacy skill mix was 
highlighted. 
4.4.6 Strategies for achieving pharmacy practice change 
Participants of this study described a number of approaches to achieving practice 
change based on their experience in the UK. These included developing credible 
pharmacy practitioners, freeing-up pharmacists’ time, seizing the opportunity for 
extended roles, developing a relationship with the medical profession and the role of 
leading individuals and professional bodies.  
4.4.6.1 Developing a credible pharmacy practitioner 
Participants stressed that what the UK has done over the past 40 years was to develop 
credible practitioners within the hospitals by providing them with the appropriate 
education and training opportunities for future clinical roles. Hence, they pointed out 
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that any country considering extending the clinical role of its pharmacists must develop 
credible practitioners who are able to take on clinical roles.  
“I think the key was creating practitioners who are credible and who 
had the right skills set and right knowledge set to be able to convince, 
particularly senior doctors, that we could talk to them in the same 
language around prescribing and medicine usage and so on.” (P04, 
Pharmacist) 
“There were changes within the training of pharmacy technicians which 
has enabled a more highly skilled workforce.” (P03, Pharmacist) 
Participants mentioned that developing a credible practitioner is much more dependent 
on the robustness of the training offered to practitioners. They reported that the training 
needs of pharmacists and their support staff must be identified vis-à-vis the future 
clinical roles that are anticipated. Participants also advised that both the basic and on-
going education of pharmacy staff should be considered. 
“I think there is got to be some investment in education because you 
are asking them to take on new skill set.” (P02, Pharmacy Technician) 
“I think it is about thinking wider but making sure that everybody has 
suitable education before they go out and try and do things. So you 
need to have good clinical education before you can go out to provide 
clinical advice.” (P27, Pharmacist)” 
Participants observed that having a structure that allows pharmacists to develop 
clinically and specialise within different clinical areas while progressing up the career 
ladder would help in developing credible practitioners. 
“To really position your country’s pharmacy services if you can get a 
structure in place which really allows everybody to move forward, then 
the benefit to the patient is good but also the credibility of the 
pharmacy services is higher.” (P24, Male, Pharmacist, 1970s) 
Participants maintained that being able to specialise in post-registration training and 
practice would result in the development of competent practitioners.  
4.4.6.2 Freeing-up pharmacists to do extended role 
The development of pharmacy technicians to take on some of the traditional roles of 
pharmacists especially the supply functions emerged as a key strategy in freeing-up 
pharmacists to do extended clinical roles. Many participants I interviewed observed that 
pharmacists cannot extend their clinical roles beyond the dispensary as long as their 
role is mainly linked to supply functions. 
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“…this can’t happen without the development of the technicians…” 
(P07, Pharmacist) 
“You have got to have the means by which you can develop a group of 
support staff like pharmacy technicians who can take responsibilities 
for managing the supply side because none of these is possible while 
pharmacists maintain such a strong responsibility for supply.” (P04, 
Pharmacist) 
Overall, both pharmacists and pharmacy technicians maintained that if pharmacists 
wish to extend their clinical roles, they must be willing to develop the technicians to 
take over their supply roles in order to free them up. 
4.4.6.3 Seizing the opportunity 
A number of participants interviewed reported on how they identified gaps in clinical 
practice that pharmacists or pharmacy technicians could fill and took advantage of that 
opportunity to expand their roles.  For example some pharmacists reported that the 
increased incidence of medication administration errors on the wards provided the 
opportunity to design ward-based prescription charts which facilitated the movement of 
pharmacists onto the wards to monitor those charts. 
A pharmacist stated how they took advantage of the national strike action by pathology 
staff working in the haematology unit to establish one of the first pharmacist-led 
anticoagulant clinics in the UK. 
“So, XXX [pharmacist’s name] and I said to the medical consultant, 
“well, we can help you with that, we can help you look at some of the 
patients for you”. So we had patients coming to us for anticoagulation 
where we had to adjust the doses of warfarin and established what 
was in effect one of the first pharmacist-led anticoagulant clinic in the 
country.” (P32, Pharmacist) 
This participant added that because the clinic they ran was successful, several 
pharmacist-led anticoagulant clinics were established in the country and that became 
an extended services provided by pharmacists. 
Similarly, a pharmacy technician interviewed reported how they intended to take 
advantage of their current training and skills in aseptic services to push for role 
extension in that area. 
“You know we are just in the middle of doing some work in aseptics 
because with aseptic production, only the pharmacist can release the 
product at the end, by law. So, we are starting to push those 
boundaries to say actually if this person has the skills and done the 
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training…, we want to challenge that because the pharmacist costs a 
lot of money.” (P03, Pharmacy Technician) 
Therefore many participants interviewed reported that if pharmacists wish to expand 
their clinical roles, they must identify gaps in clinical practice particularly in the aspect 
of medicine use where they have specialised skills, and take advantage of that to 
develop their practice. 
4.4.6.4 Developing a relationship with the medical profession 
Pharmacists observed that having a good relationship with the medical profession is 
very important for clinical role development. They argue that without the support of the 
medical doctors, it is unlikely that pharmacists could expand their roles clinically.  
“I think you have to establish good working relationship between 
pharmacists and senior clinical staff, divisional directors, clinical 
directors, medical directors.”  (P29, Pharmacist) 
 “…without them [doctors] supporting and saying yes, you won’t get 
anywhere. So, you have to get them on board either generally or as 
individuals, you have to make good relationships with the doctors.” 
(P27, Pharmacist) 
Pharmacists also added that the pharmacy profession also needs to enlighten the 
medical profession to have a better understanding on the roles of a clinical pharmacist, 
and how clinical pharmacists have contributed to patient care in other countries such 
as the UK. 
“One thing that is really helpful is getting the medical profession to 
understand the experience of their medical colleagues in other 
countries that have got clinical pharmacists.” (P29, Pharmacist) 
Some pharmacists stated that the participation of pharmacists in ward activities 
(including ward rounds) and inter-professional education are important ways of building 
credible relationships with the doctors. Pharmacist prescribers acknowledged that the 
relationship they had with the medical doctors while working on wards was instrumental 
in helping them get a medical doctor as a mentor for their training as prescribers and in 
also developing their prescribing role. 
4.4.6.5 Leading individuals and professional associations 
According to Birenbaum (1982) professionalization is led by leading individuals who are 
willing to take risks to bring about the envisioned social and legal support. He referred 
to these leading individuals as elite groups of the profession which could either be 
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leaders of the profession or other influential individuals who are advancing new roles.  
Many participants discussed that it is important to have key individuals who are forward 
thinking and would push for clinical role extension either at the local or national level 
and also engage with people in government. 
“You need some key people who are champions to make that change 
within the particular areas you want to make that change.” (P17, 
Pharmacist) 
“I think having people at the top of the profession who had this vision 
of pharmacists doing more clinical work and less pill counting, that is 
what has pushed it forward.”  (P27, Pharmacist) 
Participants also pointed out the need to have professional associations at the national 
level that will push and lobby for clinical role extension. 
“I think if you wanted to get it quickly changed, I think you need a 
central drive and the best way to do that is through your professional 
organisations and particularly if they could talk to the other professions 
like the medical and the nursing professions…” (P31, Pharmacist) 
“I think you need to engage with the politicians, because they make the 
laws…”  (P06, Pharmacist) 
Participants noted that these leading individuals and professional bodies must engage 
with the legislators and other political office holders because some extended roles 
would require legislation and the intervention of the government.   
Theme summary: The four strategies discussed above were drawn as the lessons 
learnt from the UK experience. Developing credible practitioners was considered an 
important strategy that must be achieved for change to happen. This is dependent on 
the nature and quality of clinical training available to pharmacy practitioners because 
no extended role can be successfully implemented without competent practitioners to 
take on the role. The development of pharmacy technicians to take over some of the 
traditional roles of pharmacists in order to free pharmacists up for advanced roles and 
the support of the medical profession were highly valued among participants 
interviewed. In addition, this theme underscored the importance of having key 
individuals at both local and national level who will lobby and push for change in 
pharmacy practice. 
4.5 Study strengths and limitations 
The strength of this study is in its design, including its methods, data analysis and 
steps taken to ensure rigour. The study only included participants who were in practice 
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when significant changes in pharmacy professional structure were made. Some 
participants in this study were directly linked with the change process and their 
accounts were invaluable in understanding how pharmacists were able to develop their 
clinical roles in the UK. The rigorous application of qualitative methods enables an in-
depth understanding of the barriers and facilitators to pharmacy practice change and 
the use of both face-to-face and telephone interviews enabled the researcher to draw 
from the experience of participants across many settings in the UK. The detailed 
description of context and findings presented in this study will enhance its 
transferability in other contexts. Also, being a non-UK pharmacist and a pragmatic 
researcher, helped to minimise my personal bias in the research.  
Certain limitations were associated with this study. First, being a qualitative study, the 
findings cannot be statistically generalised. However, statistical generalisation is not 
the goal of qualitative research. Transferability and theoretical generalisation have 
been adopted in qualitative research (Seale, 1999). Therefore, certain concepts from 
the findings of this study could be transferable to other contexts including Nigeria. For 
example, the development of pharmacy technicians or other category of pharmacists’ 
support staff, to do some of the traditional roles of pharmacists could be crucial in 
freeing up pharmacists time to do extended clinical roles in many countries including 
Nigeria. Secondly, the snowballing strategy used in the recruitment of participants, was 
unable to recruit participants from Northern Ireland and Wales, which could be a 
limitation to the findings of this study.  In addition, participants were mostly recruited 
from England. Therefore, this report mainly centred on changes in pharmacy practice 
observed in England. Thirdly, it is possible that participants in this study had difficulties 
recalling events that happened in the earlier years of their practice. However, this was 
not explicitly shown. Finally, many of the participants interviewed showed a lack of 
understanding of the structure of pharmacy practice in Nigeria. Therefore, they were 
unable to comment on what lessons that could be learned in Nigeria.  
4.6 Chapter summary 
The present study revealed that hospital pharmacists in the UK have successfully 
redefined their roles and are now working at advanced levels clinically including in 
many cases, a prescribing role. Their current clinical roles have been supported by 
changes that occurred in the structure of pharmacy practice including: a shift in the 
focus of pharmacy training to a patient orientated one; specialisation in practice; the 
development of a career route that recognised advanced pharmacy practitioners; 
enhanced working relationship with doctors and the development of pharmacy 
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technicians to take on some roles previously undertaken by pharmacists in order to 
free-up pharmacists for advanced roles. These changes were driven by an appropriate 
policy environment. However, the development of the clinical roles of community 
pharmacists in the UK have been delayed and this was associated to the remuneration 
model of community pharmacists which is predominantly linked to supply functions; 
inability of community pharmacists to engage in post-registration clinical training, 
although this is no longer the case; legislation; professional isolation and poor 
relationships with general practitioners. 
Many of the drivers identified including government policies, enhanced education, task 
shifting to pharmacists’ support staff, relationship with medical doctors and leadership 
are fairly well known and have been linked to the development of clinical pharmacy 
practice in hospitals in some countries including Australia and China (Penm et al., 
2015a, Penm et al., 2014). The findings of the present study adds to the international 
literature by suggesting that within hospital pharmacy practice, a clinical career 
pathway that allows progression within clinical specialty could sustain and support the 
development of pharmacists’ clinical roles.  This is because a clinical career route has 
the potential to make pharmacists aspirational and motivate them to develop clinical 
competencies that are needed for advanced practice in order to progress up the career 
ladder.  In addition, it also promotes the retention of experienced clinical staff who wish 
to use their expertise to enhance patient care rather than to move into managerial roles 
where their clinical expertise would be untapped.  
Therefore, since changes in the professional structure of pharmacy were linked to the 
development of pharmacists’ clinical roles in the present study, the next study, will 
employ a qualitative design to investigate the professional structure of pharmacy in 
Nigeria with a view of identifying the potential changes that would be required for the 
development of pharmacists’ clinical roles to include prescribing. Hence, the design of 
the next study reported in chapter 5 would be informed by the findings of the present 
study. Furthermore, the implications of the findings of this chapter to the Nigerian 
context are discussed in chapter 7.  
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CHAPTER 5: EXPLORING THE FACILITATORS AND BARRIERS TO 
EXTENDING PHARMACISTS’ CLINICAL ROLES TO INCLUDE 
PRESCRIBING IN NIGERIA 
5.1 Introduction 
This chapter presents the report of the second qualitative study conducted as part of 
the sequential mixed methods research outlined earlier in chapter two. The chapter 
begins with a brief background to the study including the qualitative findings in chapter 
4 that informed this study. It then provides the specific objectives of the study. The 
objectives are then followed by the methods employed to address them including data 
collection methods and analysis. The chapter concludes with a presentation of the 
study findings and the measures taken to ensure ‘trustworthiness’ in the study 
conducted. 
In Nigeria, a shift from the traditional pharmacists’ role of dispensing and compounding 
of medications began in the 1980s with the introduction of drug information services 
and unit dose dispensing systems in some hospitals (Erah, 2003). Following these 
developments, clinical pharmacy courses were made mandatory in the undergraduate 
pharmacy curriculum in 1990 (Brown and Ogun, 1998).  More than two decades after 
this, clinical pharmacy practice is still underdeveloped. In many hospitals and 
community pharmacies, pharmacists’ roles are still limited to dispensing of medications 
and inventory control (Auta et al., 2014b). For example, a questionnaire survey 
conducted among 119 pharmacists including hospital and community pharmacists in a 
Nigerian city that assessed the application of 52 suggested pharmaceutical care 
practice standards, found that only 18.2% of the respondents were applying such 
standards in their practice (Erah and Nwazuoke, 2002). More recently, a questionnaire 
survey conducted among 105 pharmacists including those in hospital and community 
practice in a state in Nigeria revealed that none of the respondents had fully 
implemented the concept of pharmaceutical care into their practice. Of the 47 hospital 
pharmacists that participated in the study; only 2 (4.3%) reported that they participated 
on ward rounds with other members of the healthcare team (Suleiman and Onaneye, 
2011).  
Many empirical studies have identified a number of challenges associated with the 
development of clinical pharmacy practice in Nigeria. These challenges include 
opposition from doctors, inadequate infrastructure, shortage of pharmacy staff, 
inadequate clinical education, and lack of access to patient clinical data (Oqua et al., 
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2013, Oparah and Eferakeya, 2005, Erah and Nwazuoke, 2002). However, these 
studies were quantitative and therefore, do not provide a comprehensive, in-depth 
understanding of the barriers to clinical pharmacy practice in Nigeria.  In addition, the 
findings they presented were from the perspectives of pharmacists only. Therefore, the 
studies did not capture the perspectives of the various stakeholders involved in the 
development of clinical pharmacy practice in Nigeria including doctors and 
policymakers. This necessitated this study to explore the facilitators and barriers to 
extending pharmacists’ clinical roles from the perspectives of various stakeholders. 
The findings of the study reported in chapter 4, revealed that changes in the structure 
of pharmacy practice in the UK including education, career structure and development 
of pharmacy technicians were associated with the development of pharmacists’ roles 
including the potential for pharmacist prescribing. Therefore, these findings informed 
the objectives and design of the present study.  
5.2 Objectives 
This study was designed to investigate the facilitators and barriers to extending the 
clinical role of pharmacists to include prescribing in Nigeria. 
The specific objectives were: 
 To investigate the current structure of pharmacy practice in Nigeria in order to 
identify the potential changes needed for the development of pharmacist 
prescribing. 
 To explore the views of stakeholders involved in prescribing, pharmacy training 
and practice on the facilitators and barriers to making prescribing a part of the 
clinical roles of pharmacists in Nigeria. 
5.3 Methods 
5.3.1 Ethics 
Ethical approval for this study was obtained in two stages.  Initially, the School of 
Healthcare Research Ethics Committee (SHREC) (Ref no: SHREC/RP/436) reviewed 
and granted ethical clearance to the project as a prerequisite for ethics application in 
Nigeria (Appendix 9). Following this approval, an ethics application was tendered in 
Nigeria to the Plateau State Specialist Hospital Health Research Ethics Committee. 
The application received a favourable approval (PSSH/ADM/ETH.CO/2014/0025) and 
permission was given to conduct the study (Appendix 10).  
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As with the previous study conducted in the UK, the main ethical issues associated 
with this research were those of obtaining informed consent from participants, 
anonymity of participants, confidentiality in handling data and data protection. 
Participant information sheets (see Appendix 11) were provided to prospective 
participants to enable them to make an informed decision about participating in the 
study. Participants were also given the opportunity to make further enquiries about the 
research. Those who agreed to participate were sent a written consent form through 
their email addresses and requested to sign and return electronically (Appendix 12). 
Participants who were unable to sign the consent form electronically gave a verbal 
consent and were recorded with an audio-digital recorder. 
Anonymity of the participants was maintained by assigning codes (known only to the 
researcher) to all participants. In addition, all personal identifiable data were excluded 
from interview transcripts and the thesis report. Electronic data, including audio–
records of interviews and transcripts, were kept in a password protected M-drive of the 
University. Hard copies of research documents were kept in locked filling cabinets in 
the post-graduate suite of the School of Healthcare, University of Leeds 
5.3.2 Study setting 
This study was conducted with Nigerian participants. Nigeria has a population of  about 
169 million with a landmass  of 923, 678 square kilometres which is about 4 times the 
size of the UK (World Bank, 2014, NPC and ICF MACRO, 2009). The health system in 
Nigeria is decentralised into 3 levels namely primary, secondary and tertiary levels in 
accordance with the 3 tiered system of government in the country: the federal, state 
and local government (World Bank, 2005). The Federal Government through the 
Federal Ministry of Health (FMoH) is responsible for the management of the tertiary 
level. Policy formulation, planning, and provision of technical assistance to the 
secondary level takes place at the tertiary level (WHO, 2002, FMoH, 2010b). 
Pharmacy practice in Nigeria is regulated by the Pharmacists’ Council of Nigeria 
(PCN). There are about 17,000 fully registered pharmacists representing 10 
pharmacists per 100,000 people in Nigeria (PCN, 2014b), compared to the UK with 
about 49,000 practicing pharmacists (78 per 100,000 people) (OECD, 2013). Data on 
the number of pharmacy technicians in Nigeria is lacking because their registration with 
the Pharmacists’ council has not yet been made mandatory for practice. However, in 
2007, it was estimated that there were about 5,500 pharmacy technicians (AHWO, 
2008). 
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This research was initially designed to involve both telephone and face-to-face 
interviews. Face-to-face interviews were to be conducted with participants identified in 
the cities of Jos and Abuja located in north-central Nigeria while those outside these 
cities were to be interviewed via the telephone. However, because of the heightened 
insecurity in the country including a series of bomb blasts in Jos and Abuja at the 
period of the research (BBC, 2014a, BBC, 2014b, BBC, 2014c); travelling to Nigeria to 
conduct face-to-face interview was considered inappropriate. Following a risk 
assessment with my supervisors, we agreed to only conduct telephone interviews from 
the UK with Nigerian participants. 
5.3.3 Recruitment and sampling strategy  
This research recruited various stakeholders including pharmacists, doctors, pharmacy 
technicians, academics, policymakers at the state and federal ministry of health, and 
patient group representatives. These stakeholders were considered suitable as 
participants for this research because they were associated with pharmacy practice 
and/or prescribing in Nigeria. 
Purposive sampling was carried out aiming for maximum variation in order to obtain a 
range of perspectives (mix of stakeholders, practice and geographical settings). 
Generic recruitment emails were sent to 134 prospective participants. These were 
heads of pharmacy and medical departments in some secondary and tertiary hospitals; 
leaders of professional pharmacy and medical associations including the Nigerian 
Association of Hospital and Administrative Pharmacists, Nigerian Association 
Pharmacist in Academia, Pharmaceutical Society of Nigeria, Association of Community 
Pharmacists of Nigeria, National Association of Pharmaceutical Technologists and 
Pharmacy Technicians of Nigeria, Nigerian Medical Association, Medical and Dental 
Consultants Association of Nigeria, and National Association of Resident Doctors. 
Other prospective participants contacted were directors of pharmaceutical and medical 
departments at the State and Federal Ministry of Health; and representatives of the 
Network of People Living with HIV and AIDS in Nigeria and the Diabetes Association of 
Nigeria. Those that responded to the email and indicated an interest in receiving further 
information about the research were sent the information sheet of the study to help 
them make informed decisions to participate in the research. All those who accepted 
the invitation to participate in the study were contacted and arrangements were made 
for telephone interviews at a time convenient to the participants. A total of 49 
stakeholders participated in the study. 
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5.3.4 Interview guide 
The draft interview guides (Appendix 13) used for this study were developed based on 
the findings of the qualitative study conducted in the UK (reported in chapter 4). The 
findings of the UK study revealed that changes in the professional structure of 
pharmacy were linked to the development of pharmacists’ clinical roles.  Therefore, 
among other things, the interview guide explored stakeholders’ opinions on the 
structure of pharmacy practice in Nigeria in order to identify areas for change.  
Three different interview guides (containing similar items) were used in this study to 
ensure that participants were interviewed in accordance with their experience. These 
guides were designed for pharmacy staff including pharmacists and pharmacy 
technicians; doctors; and policymakers/patient representatives. The interview guide 
developed for each group of participants has two sections. The first section pertains to 
the structure of pharmacy practice in Nigeria, while the second concerns stakeholders’ 
views on granting prescribing rights to pharmacists in Nigeria including potential 
facilitators and barriers.  
5.3.5 Pilot interviews 
Four pilot interviews were conducted to test and refine the draft interview guides. The 
four participants interviewed were two pharmacists, a doctor and policymaker in 
Nigeria. The pilot interviews were conducted over the telephone, audio-recorded and 
transcribed verbatim.  
These pilot interviews were reviewed during a supervision meeting and the following 
observations were made:  
 The pilot interviews conducted with the two pharmacists all lasted beyond an 
hour. It was observed that removal of the question that asked about 
pharmacists’ career progression to date could result in a significant reduction of 
the interview time. This question was therefore removed from the interview 
guide. 
 Some participants considered pharmacist prescribing to include counter 
prescribing of over-the-counter medicines. Therefore it was necessary to 
include an introductory paragraph in the interview guide that explains 
pharmacist prescribing from the perspective of this research. Hence, the 
statement below was included in the interview guide: 
“By prescribing, we mean granting pharmacists the legal right to 
prescribe ‘Prescription Only Medicines’ as currently practised by 
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doctors in Nigerian hospitals. This differs from counter prescribing or 
the supply of over the counter medicines as currently practised by 
community pharmacists in response to patients’ complaints or 
symptoms.” 
 A number of participants were not aware of the different models of pharmacist 
prescribing. Therefore, a working definition of the two broad models of 
pharmacist prescribing i.e. collaborative and independent prescribing were 
included in the interview guide to help participants discuss the type of 
pharmacist prescribing model they would support in Nigeria.  
In collaborative prescribing, the pharmacist prescribes in partnership 
with a doctor where the doctor makes the initial diagnosis and 
treatment decisions, while the pharmacist may continue therapy’ adjust 
doses, change therapy or discontinue a medication within an agreed 
plan. In independent prescribing; the pharmacist is responsible and 
accountable for his or her prescribing decisions including clinical 
assessment, diagnosis (where applicable) and management of the 
patient.  
 The interview guide adequately covered the relevant topic area and participants 
responded appropriately to the questions asked. 
The pilot interviews conducted were included in the study because there were no major 
changes to the structure and content of the interview guide following the pilot.  The final 
interview guide used in the main study is presented in Appendix 14. 
5.3.6 Interview process 
In-depth, semi-structured telephone interviews were conducted with Nigerian 
participants between April to June 2014. 
At the start of each interview, the researcher created a relaxed atmosphere for the 
interview by engaging with the participants in a brief informal discussion. As with the 
previous qualitative interviews conducted in the UK, participants were told the purpose 
of the interview, how long the interview was expected to last, and assured of 
confidential handling of any information obtained from them. Permission was also 
sought from participants to record the interviews. No participant objected to the 
recording of his/her interview. Interviews were recorded using an audio digital recording 
device (Roland R-05 Portable MP3 Recorder) with the help of an Olympus (TP-8) 
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telephone pick-up microphone which helps transmit the conversation from the 
telephone to the recording device. 
 An attempt was made by the researcher to complete all interviews within an hour. 
Where this was exceeded, permission was sought from participants to continue the 
interview and they were allowed to freely accept or decline to continue. In addition, 
apologies were offered for exceeding the agreed duration of the interview. Only two 
interviews in the main study exceeded an hour.  At the end of each interview the 
researcher showed gratitude to participants for participating in the study and for their 
time and contributions. The interviews conducted lasted between 20 minutes to 70 
minutes.  
At the design stage of this research, it was anticipated that about 40 interviews would 
be sufficient to reach data saturation. However, 49 semi-structured interviews were 
conducted in all. Data saturation was achieved when further interviews did not yield 
any new thematic information and this was perceived to be reached at about the 35th 
interview. However, further interviews were carried out with the remaining participants 
as they had previously agreed to be interviewed. Demographic details of the 
participants interviewed are outlined in the results section of this chapter.  
5.3.7 Data analysis 
Interview data obtained were analysed using thematic analysis in the manner outlined 
by Braun and Clarke (2006) and reported in chapter 4 of this thesis. The analysis 
proceeded in iterative stages of data familiarisation, generation of codes, searching, 
reviewing, defining and naming of themes. Data management was aided by the use of 
Nvivo 10 software which facilitated the organisation of the data into codes, categories 
and potential themes. 
As with the previous qualitative study reported in chapter 4, familiarisation with the data 
began at the point of data collection (interview) since all telephone interviews were 
conducted by the researcher.  Transcription of interviews and cross-checking of 
transcripts against audio recordings were also carried out by the researcher. All 
interviews were transcribed verbatim. Immersion into the data was achieved by 
repeated listening to the individual recordings of the interviews, transcribing and re-
reading individual transcripts. In addition, initial ideas including potential codes were 
noted and taken into the analysis. 
Initially, five transcripts were coded. Data coding was both deductive (using codes 
derived from the literature, research objectives and interview guide) and inductive (data 
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driven).  The coding process was also iterative with constant refinement of codes. The 
codes generated from the initial transcripts were applied to other transcripts. Additional 
codes also emerged from the data.  
In the next stage of the analysis, the codes developed were grouped into categories by 
looking at relationships between them and searching for patterns within the data. This 
process was also iterative and led to the development of potential themes. The 
potential themes identified were organised in line with the objectives of the study into 
larger themes with sub-themes (see Table 5-1). The sub-themes identified were 
basically themes within a theme. The identified themes were initially reviewed in 
relation to the research questions and a second review of the identified themes was 
carried out by my supervisors.  
5.4 Results 
5.4.1 Demographics 
The demographics of the stakeholders interviewed showed a mix of participants in 
terms of their professional backgrounds, practice settings and geographical locations. 
The forty nine (49) stakeholders interviewed comprised 20 pharmacists, 9 doctors, 11 
policymakers, 6 pharmacy technicians and 3 patient group representatives. These 
participants were drawn from the six geopolitical regions of Nigeria: north-east (5), 
north-west (6), north-central (29), south-east (1), south-west (5), and south-south (3).  
The 11 policymakers interviewed were from the federal (5) and state (6) level. Four (4) 
of the policymakers interviewed had medical backgrounds while seven (7) had 
pharmacy backgrounds. The 20 pharmacists who participated in this study included 4 
academics, 5 community pharmacists and 11 hospital pharmacists; while the 9 doctors 
were 4 consultants, 3 residents, and 2 general practitioners.  The pharmacists 
interviewed had from 5 to 37 years of experience while the doctors had from 10 to 37 
years of experience. The majority of the health care professionals interviewed including 
doctors, pharmacists and pharmacy technicians worked in secondary and tertiary 
facilities located in urban centres. However, 8 participants were practising in secondary 
hospitals located in rural centres.  
The subsequent sections of the results presents the themes identified from the analysis 
of the data.  
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Table 5-1: Themes and sub-themes identified from analysis 
Research objective Theme Sub-theme 
To investigate the current  structure 
of pharmacy practice in Nigeria 
5.4.2 Pharmacists’ professional identity 5.4.2.1  Pharmacists as underutilised 
professionals 
5.4.2.2  Pharmacists as custodians of medicines  
5.4.2.3 Pharmacists’ as dispensers of medicines 
5.4.2.4  Pharmacists as medicines advisers 
5.4.2.5  Pharmacists as clinical practitioners 
5.4.2.6  The business image of pharmacy 
5.4.3 Pharmacy professional structure 5.4.3.1  Confidence 
5.4.3.2  Specialisation and career structure 
5.4.3.3  Shortage of pharmacy staff 
5.4.3.4  Utilisation of pharmacy technicians 
5.4.3.5  Medical dominance and opposition 
5.4.3.6  Collaboration with doctors 
5.4.3.7 Lack of policies to support clinical 
pharmacy practice 
5.4.3.8  Regulation 
To explore the views of stakeholders 
on the facilitators and barriers to 
pharmacist prescribing 
5.4.4   Views on prescribing 5.4.4.1  Prescribing a logical role for pharmacists 
5.4.4.2  Pharmacist prescribing: a threat to 
doctors’ role 
5.4.4.3  Pharmacists’ competence in prescribing 
5.4.4.4  Collaborative prescribing as an 
appropriate model 
5.4.4.5  Potential benefits of pharmacist 
prescribing 
5.4.4.6  Potential facilitators and barriers to 
pharmacist prescribing 
 
 149 
 
5.4.2 Pharmacists’ professional identity 
This theme relates to how various stakeholders characterised pharmacists in relation to 
who they are and what they do. It also includes pharmacists’ self-perception of who 
they are. Overall, pharmacists’ identities were largely described through the roles they 
took on. Analysis of the interview data revealed six ‘identities’ of pharmacists: 
underutilised professionals, custodians of medicines, dispensers, medicines advisers, 
clinical practitioners and business men.  Many non-pharmacy stakeholders interviewed 
saw pharmacists’ role as mainly supply-based. In addition, community pharmacists’ 
roles were viewed as commercial in nature. However, many pharmacists interviewed 
viewed themselves as clinicians. 
5.4.2.1 Pharmacists as underutilised professionals 
Pharmacists were generally seen by all stakeholders interviewed as highly educated 
professionals whose skills are underutilised within their current scope of practice.  
“I think the pharmacist is one of the most highly trained personnel in 
the health sector but least utilised” P25, Hospital Pharmacist. 
 “They [pharmacists] have not yet optimised their functions in the 
health system.” P30, Policymaker & medical doctor 
“When we were in the medical school, I used to look at pharmacists as 
learned colleagues, but now in practice, their roles are so few.” P34, 
Resident Doctor 
These views were commonly reported by participants because pharmacists’ roles in 
Nigeria are limited to medicine handling and supply as would be seen in subsequent 
subthemes. Therefore, many pharmacists felt overeducated for their present roles. 
They perceived that a role extension would promote the utilisation of their skills as 
would be discussed in section 5.4.4.5. 
“….you have so much knowledge but you find yourself in a situation 
where you are not being able to use it.” P04, Hospital Pharmacist 
“So, what is the difference between a pharmacist and a patent 
medicine vendor in Nigeria? What is the essence of going to the 
University and qualifying as a pharmacist to do the same thing as a 
patent medicine vendor? P07, Community Pharmacist 
The last participants’ comment indicates that community pharmacists also hold the 
same perspective of being overeducated for their present scope of practice. They 
considered their roles not to be too different from those of patent medicine vendors. In 
Nigeria, patent medicine vendors are individuals with no formal pharmacy education 
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who are licenced to sell specific over-the-counter medicines in their original packs in 
order to fill the gap created by inadequately skilled professionals needed for medicine 
supply (PCN, 2013). 
5.4.2.2 Pharmacists as custodians of medicines  
Many participants noted that traditionally, pharmacists’ training has been centred on 
medicines. Therefore, pharmacists were viewed as the professionals responsible for 
keeping and handling of medicines.   
“A pharmacist is the health professional trained to handle and 
dispense drugs.” P02, General Practitioner 
Some pharmacists including those in hospital and community pharmacy practice also 
saw themselves as the experts in the handling of medicines. They referred to 
themselves as ‘custodians of medicines’.  
“The pharmacist being the sole custodian of medicines is an important 
personnel. In fact now in Nigeria, there cannot be any existing hospital 
without a pharmacist in it.” P3, Hospital Pharmacist 
“A pharmacist in Nigeria is a pharmacist like every other one in the 
world.  He is an expert or a custodian of drugs.” P08, Community 
Pharmacist 
Such a label on the pharmacist as custodian of medicines is restrictive in terms of role 
expansion because pharmacists with such views will always see their core roles as 
product orientated. However, many pharmacists reported that their expertise is beyond 
medicine handling and supply. They therefore view themselves as experts in all 
aspects of medicines including its use in patient care.  
 “The doctors have decided not to know what we can contribute in 
patient care, they just look at us as drug experts that are just trained to 
handle drugs like procurement, and dispensing and that is all.” P25, 
Hospital Pharmacist  
Further discussions on pharmacists’ role in patient care are presented in section 
5.4.2.5. 
5.4.2.3 Pharmacists’ as dispensers of medicines 
Community and hospital pharmacists’ description of their day to day job role during the 
interview revealed that they were mainly involved in dispensing of medications.  
What we basically do is prescription screening and dispensing. We do 
counselling as well. P25, Hospital Pharmacist 
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“We dispense medications, we attend to minor complains and where 
we have to do referrals, we do referrals. And of course the business 
side, managing the place, managing the accounts and all that.” P23, 
Community pharmacist  
Hence, many stakeholders interviewed including doctors, patient group representatives 
and policymakers viewed pharmacists as dispensers of medicines.  
“They are the professionals when it comes to drug dispensing.” P28, 
Medical Consultant 
“A pharmacist is a trained professional that deals with the aspect of 
drug dispensing in the hospital but I have also found out that they are 
beginning to counsel patients regarding how the drugs relate to their 
health circumstances.” P38, Patient group representative 
Many doctors believed that dispensing is the core function of pharmacists. Therefore 
they did not see pharmacists’ role beyond the dispensary and as a result considered 
pharmacists’ involvement in clinical activities including participation in ward round with 
doctors as unusual. 
“No, I don’t do ward rounds with pharmacists because it is not in the 
curriculum to do ward rounds with pharmacists but if peradventure in 
the course of the ward rounds, I need to clarify something from the 
pharmacist I will call the pharmacist to come and give his or her own 
input.” P10, Medical Consultant 
Therefore, these doctors would want pharmacists to further develop their roles in 
dispensing and other medicine supply functions rather than extending into clinical roles.  
“I think it is all about improving on the existing roles they have, I don’t 
think they need to add any more roles to what they are already doing.” 
P28, Medical Consultant 
“They should be more involved in compounding a lot of drugs in the 
hospital. They should also do more by educating patients on the 
proper way of taking drugs.” P29, Resident Doctor 
A policymaker with a medical background also held a similar view. 
“Dispensing of drugs is not what everybody can do; you need 
someone who has been trained in that. I want pharmacists to 
concentrate on that area of specialisation to support the doctors in 
their practice.” P33, Policymaker 
This perception held by these doctors showed a great unawareness among doctors of 
pharmacists’ professional roles in patient care.  Pharmacists interviewed observed that 
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doctors’ perception of their roles as being product focussed has been a barrier to them 
extending their clinical roles. 
“This is a bit of a challenge to most of the teaching and specialist 
hospitals in Nigeria because the medical doctors have refused to come 
to terms with the fact that the pharmacist has an input especially as 
regards patients’ therapy in the hospital wards.” P31, Policymaker & 
Pharmacist 
In contrast, a few doctors saw pharmacists’ role beyond dispensing and would like to 
have pharmacists contribute to decision making concerning patients’ therapy and 
influence their prescribing as well. 
“If I want to prescribe say Haloperidol and while trying to reach that 
decision with my resident doctors or other consultants during ward 
rounds, I would also like to have input from the pharmacist saying X, Y, 
Z pharmacokinetics,  why not choose Risperidone,… that kind of 
contribution, not only doctors’ input.” P14, Medical Consultant 
5.4.2.4 Pharmacists as medicines advisers 
Apart from dispensing, a major role played by pharmacists in both community and 
hospital pharmacy is advising patients and healthcare professionals on the use of 
medicines. Generally, participants including non-pharmacists viewed provision of 
medicines information and advice as a preserved area for pharmacists because of 
pharmacists’ knowledge of medicines. 
“…a pharmacist is an authority on drugs; he should give advice on any 
drugs.” P08, Community Pharmacist 
“…you will want to ask questions about patient medications, if there 
are issues and they are the ones [pharmacists] to give you the 
information that you need.” P29, Resident Doctor 
Hospital pharmacists reported that they counsel patients on their medicines and this 
mostly occurs at the point of dispensing of medications to patients. 
“Yes, the pharmacist does the dispensing because it is at that point the 
patient counselling takes place.” P03, Hospital Pharmacist 
“The basic thing we do is dispense drugs to patients, then advise them 
on the use of the drugs.” P11, Hospital Pharmacist 
However, some participants noted that the opportunity to adequately counsel patients 
depends on the time the pharmacist has. They noted that in busy periods, patient 
counselling hardly takes place. 
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“…the waiting time for patients to get their drugs is much, let alone 
pharmacists having time to interact with the patients and counsel 
them.” P14, Medical Consultant 
Many doctors also reported that hospital pharmacists were resourceful in providing 
medicine information and advice to them.   
“They give advice to doctors, sometimes before doctors prescribe and 
sometimes when the patients take their prescriptions to the pharmacy. 
The pharmacist may want to get back to the doctor to review dosages 
or duration of medication that the patient has on the prescription.” P14, 
Medical Consultant 
“Once in a while, when I need certain clarification on a medicine, I also 
do call them.” P28, Medical Consultant 
However, analysis of the interview data showed that the medicine information sought 
by doctors were mainly product-based. They consisted mainly of information related to 
the formulation, strength and dosage of medicines rather than information on the 
clinical application of medicines.  
5.4.2.5 Pharmacists as clinical practitioners 
Not many non-pharmacist participants including doctors identified pharmacists as 
clinical practitioners. Many doctors did not see the pharmacists’ role to directly 
encompass patient care. A medical doctor interviewed considered hospital pharmacy 
practice as a secondary role for pharmacists.  
“I think pharmacists should more or less be in places where they can 
actually produce the drugs. I know those jobs are not available in our 
country probably that is why we find them in the hospitals.” P21. 
Resident Doctor 
Although clinical pharmacy practice is evolving in Nigeria, some pharmacists 
particularly those in tertiary hospitals saw themselves as clinical practitioners. They 
viewed clinical pharmacists’ roles to include direct involvement in patient care. This 
encompasses applying pharmacists’ medicine knowledge to identify medicine therapy 
problems, monitoring patient therapy, participating in prescribing decisions and 
counselling patients.  
“As clinical pharmacists, we go on ward rounds. We have designated 
days for pharmacists’ rounds and ‘grand’ rounds. During these rounds 
we ensure that potential and actual drug therapy problems are 
identified and tackled. We collaborate with the physicians in ensuring 
that patients get the best drugs for their various ailments. We also act 
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as drug information resources for the prescribers.” P03, Hospital 
Pharmacist 
“We in the hospitals are clinicians because we get involved in checking 
prescriptions including drug-drug interactions. We also go on a clinical 
ward rounds to ascertain whether patients are responding to drugs.” 
P05, Hospital Pharmacist 
“What I do during ward round is to determine what medicines will be fit 
for the patient, advise the doctor on what to prescribe, determine any 
drug interactions and try to find out if the patient had been on any 
herbal remedy before coming to the hospital since we are in a rural 
location. I also advise patients on their medicines and what to do when 
they experience any unwanted effect from their medicines.” P04, 
Hospital Pharmacist 
Some community pharmacists interviewed reported that they undertook some clinical 
work in their practice including counselling patients about their medicines, identifying 
drug therapy problems, performing some physical examination and treating minor 
illnesses. Many pharmacists argued that community pharmacists have a better 
environment for clinical pharmacy practice than hospital pharmacists. This is because 
they are independent practices and enjoy some degree of autonomy from those factors 
that pharmacists considered were militating against the development of clinical 
pharmacy in hospital settings including medical opposition. In addition, they reported 
that many patients had confidence in community pharmacists and regularly consulted 
them.  
“In community pharmacies, pharmacists have so many opportunities to 
perform their clinical functions. They don’t have to get permission from 
the physician to go near the patient. Clinical means at the side of the 
patient, the patient doesn’t have to be on the bed but as long as you 
are monitoring the patient therapy you are doing your clinical 
pharmacy function.” P22, Policymaker & Pharmacist  
“Now in Nigeria, some international agencies have advocated and 
succeeded in making community pharmacies centres for HIV testing 
and DOTS [directly observed treatment, short-course] provider in 
tuberculosis management. You know that all these things are clinical 
functions.” P23; Community Pharmacist 
However, participants including community pharmacists noted that effective 
collaboration between doctors and community pharmacists are needed to effectively 
develop pharmacists’ clinical roles. 
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5.4.2.6 The business image of pharmacy 
Participants noted that pharmacy in many contexts is seen as a business rather than a 
profession because medicines are seen by many, including pharmacists, as articles of 
commerce. 
“Well, pharmacy deals with drugs and people look at it as a source of 
commerce. So, the public look at the pharmacist as a health 
professional theoretical but in practice sees pharmacy as a trade.” 
P39, Policymaker 
“…they look at drugs as articles of trade” P16, Academic & Community 
Pharmacist  
“….some people erroneously look at the role of pharmacists in 
community pharmacies to be just buying and selling” P31, Policymaker 
& pharmacist 
Therefore, community pharmacists were seen as business men by some doctors 
interviewed.  
“I would say that pharmacists in Nigeria basically are… they are shop 
sellers of medication basically. A few of them are into academic but 
majority are into opening up of pharmacy outlets and selling 
medications.” P17 Medical doctor 
“It is worst with community pharmacists, like in where I live, when they 
open their pharmacy store, they are just like business owners” P15 
Medical consultant  
This identity tended to influence doctors’ views on the potential for community 
pharmacists to be involved in clinical roles including prescribing. Further views of 
participants on the commercial nature of community pharmacists and the potential 
impact on pharmacist prescribing are presented in 5.4.4.6. However, a general 
practitioner (GP) noted that many community pharmacists lack the clinical knowledge 
and skills to be involved in direct patient care. This GP reported that community 
pharmacists had lost touch with professional pharmacy practice as a result of their long 
term engagement with the business aspect of their practice. Hence, this GP saw this as 
a barrier to clinical role extension 
“The pharmacists that have gone into business, they have forgotten all 
their stuff already, their only concern is how to make money. So that is 
another barrier.” P02, General practitioner  
 156 
 
Even though the business image of pharmacy was strongly linked to community 
pharmacy practice, a comment from a medical doctor suggests an underlying 
commercial interest among some hospital pharmacists.   
 “They [hospital pharmacists] prefer to be at the counter where they 
can give drugs and collect cash, instead of being on the wards where 
they can put in their expertise on the management of patients.” P34, 
medical doctor   
Commercial interest in hospital pharmacy practice is likely in Nigeria. This is because 
many hospital pharmacies are run on drug revolving funds. Drug revolving funds are 
cost recovery schemes intended to ensure a steady supply of essential medicines. 
Based on my experience as a hospital pharmacist in Nigeria, there is a tendency for 
pharmacists to focus on revenue generation and profit making when managing 
medicines under the drug revolving funds scheme. Therefore, it is unsurprising that 
some hospital pharmacists could prioritise revenue generation over clinical practice.  
Theme summary: This theme revealed six major identities of pharmacists in Nigeria. 
Pharmacists were seen as underutilised professionals, custodians of medicines, 
dispensers, medicine advisers, clinical practitioners and business men. Overall, 
stakeholders’ perceptions of pharmacists’ professional identity influenced their views 
on pharmacists’ potential roles. Many doctors viewed hospital and community 
pharmacists’ roles to be product focussed and would like them to develop in that 
direction.  However, some doctors and pharmacists viewed pharmacists’ roles to 
encompass the provision of clinical pharmacy services including participating in 
prescribing decisions. Nevertheless, the business nature of community pharmacy 
practice was considered a barrier to the provision of clinical pharmacy services.   
5.4.3 Pharmacy professional structure 
This theme presents participants views on the current structure of pharmacy practice in 
Nigeria. Eight sub-themes were linked to this theme: pharmacists’ confidence in 
performing clinical roles; specialisation and career structure; shortage of pharmacy 
staff; utilisation of pharmacy technicians; medical dominance and opposition; 
collaboration with doctors; lack of policies to support clinical pharmacy practice and 
regulation.  These sub-themes are presented below.  
5.4.3.1 Confidence 
Pharmacists’ confidence to engage in clinical activities at the ward level emerged as a 
sub-theme. Many participants including doctors and pharmacists observed that a major 
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barrier to pharmacists participating in clinical roles is the lack of confidence in their 
clinical knowledge and the practical application of their knowledge in clinical settings.  
“…some of them [pharmacists] are not confident enough to actually go 
out on rounds with medical doctors.” P09, Hospital Pharmacist 
“Most pharmacists are very timid, they are not feeling confident 
enough to face the ward and to collaborate appropriately with the 
health team.” P22, Policymaker & Pharmacist 
Participants observed that unlike the pharmacists’ traditional role of dispensing, many 
pharmacists feel underprepared for clinical roles and this was associated to 
pharmacists’ training. 
“They [pharmacists] are not confident enough which again I want to 
attribute to the training. I think if the training is adequate in that 
respect, their confidence in participation in such activities like ward 
rounds will also increase.” P14, Medical consultant 
“You know pharmaceutical care is all about collaboration. Many of 
them [pharmacists] are shy; many of them are not yet prepared to face 
the ‘ground round’. They are not prepared to do rounds with resident 
doctors or even house officers.” P16, Pharmacist 
The under-preparedness of pharmacists for clinical roles was also obvious from their 
response to interview questions investigating their clinical involvement in patient care 
“You know, pharmaceutical care services are about sound 
knowledge… We don’t want a situation where we join them [doctors] 
on a ward round and the pharmacists are not well prepared.” P05, 
Hospital Pharmacist in a tertiary facility 
 “…on our own part [pharmacists], we were not so willing to join 
doctors on ward rounds, may be because of the fear of not being able 
to contribute meaningfully when they ask us for contributions.” P11. 
Hospital Pharmacist 
A number of pharmacists argued that even though the curriculum of the Bachelor of 
Pharmacy (B. Pharm) programme run by majority of the universities has been 
expanded with a more clinical component added to it, it does not produce practitioners 
who are confident enough to apply their knowledge in clinical settings. Many 
pharmacists observed that the Doctor of Pharmacy (Pharm D) programme which is 
currently being run by a university in Nigeria produce more confident practitioners who 
are able to apply their knowledge in clinical settings than the B Pharm programme. This 
is because a greater proportion of the time in training is spent in clinical practice 
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settings during the Pharm D training programme which helps to build confidence 
among those enrolled in the programme.  
“Our B. Pharm programme is actually deficient in clinical areas but 
Pharm D addresses those areas. So, all the universities that are 
offering pharmacy courses should embrace the Pharm D programme.” 
P05, Hospital Pharmacist 
 “Apart from those that have gone for Pharm D training or those that 
have obtained fellowship of the West African Postgraduate College of 
Pharmacists in clinical pharmacy, the truth is that pharmacists are not 
confident enough to go into the wards, by that I mean they don’t have 
the clinical knowledge base.” P22, Policymaker & Pharmacist 
The second participant’s quote above also suggests that pharmacists with post 
registration clinical training were confident in clinical settings.  
Participants observed that pharmacists’ confidence in clinical settings can be enhanced 
by making the undergraduate training programme more patient orientated with 
significant experiential learning similar to the medical training.  
“Medical students are trained with patients and they graduate and 
become residents with patients but that is not the case with pharmacy 
students. So, there is a need to correct this anomaly with regards to 
pharmacists’ clinical training.” P16, Academic pharmacist 
Furthermore, a structured practice-based post-registration clinical training programme 
was considered essential to enhance pharmacists’ confidence. 
5.4.3.2 Specialisation and career structure 
 In Nigeria, hospital and community pharmacists are generalists in their practice. 
Specialisation in different clinical areas is lacking. Many participants observed that 
specialisation would result in the development of competent pharmacists. They 
mentioned that it would enable pharmacists to develop more depth in their clinical 
knowledge and skills in specific areas and as a result enhance their contribution in 
patient care.  
 “The problem with pharmacy practice is that pharmacists are jack of 
all trades, master of none. But specialisation creates a niche and you 
become more knowledgeable.” P16, Academic Pharmacist 
“Specialisation makes a whole lot of difference. Like I said, I have 
worked with one that was specially trained in paediatrics; she was able 
to look for proper references for us. But right now, I am working with 
those that are not exactly expert in the field, we do have problems and 
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sometimes we are the ones that have to point out to them the newer 
teachings. You see when you specialise in a certain field; you will be 
able to overcome that gap, especially in terms of knowledge.” P28, 
Medical consultant  
Participants also observed that the present career structure in the country does not 
support the development of competent clinical practitioners. Hospital pharmacists 
reported that their current career structure consists of a single route which increasingly 
becomes managerial in nature as they progressed up the career ladder.  
“…what we are saying is that there should be a two-way approach to 
this. For those who want to rise along the rank and may be become an 
assistant director, there should be that career pathway for them. For 
those who want to specialise in clinical areas, there should be a 
pathway too for them. That is how I feel the structure in the hospital 
should be designed but for now, we don’t have such structure on 
ground.” P05, Hospital Pharmacist 
“The present career pathway leads to a managerial function, it does 
not encourage pharmacists to develop clinically and the promotion 
from one cadre to another is based on the number of years of 
experience and not the specialist skills of the pharmacist.” P03, 
Hospital Pharmacists 
“I am a strong advocate of specialisation and reaching to consultancy 
cadre. I will really want to see a more diverse clinical role for the 
pharmacist rather than just aspiring to be the director of 
pharmaceutical services and end up in administration.” P31, 
Policymaker and Pharmacist 
Furthermore, a participant also reported that clinical mentorship for junior pharmacists 
is a challenge in Nigeria. 
“In addition, there are fewer mentors in clinical pharmacy in Nigeria.” 
P16, Pharmacist 
Therefore, a clinical career pathway could serve as a route for mentoring of junior 
pharmacists who would want to go down the clinical route.  
5.4.3.3 Shortage of pharmacy staff 
The shortage of pharmacy staff particularly pharmacists were commonly mentioned by 
participants. Many participants believed that this had impacted significantly on the 
development of pharmacists’ clinical roles in Nigeria. Overall, all stakeholders 
interviewed including doctors, pharmacists and policymakers reported that there are 
inadequate numbers of pharmacists in the country.  
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“For now, we don't have enough pharmacists, that is one of the biggest 
challenges we are having. In Nigeria we have on record over 12,000 
pharmacists but the question is how many of these are really 
practising.” P32, Policymaker  
“Yes, we have a challenge of staffing. As far as we are concerned, we 
cannot match the population of the patients.” P35, Policymaker 
Participants associated the inadequate number of pharmacists in the country to a 
number of factors. These included inadequate number of pharmacists’ training 
institutions; challenges in recruitment and retention of experienced pharmacists; poor 
remuneration and migration of pharmacists to other countries for better practice 
environment and condition of service.   
“We don't have enough [pharmacists] in the service, we have so many 
to employ but no political will from government.” P32, Policymaker 
“You know there are a lot of opportunities outside the government for 
pharmacists. So, very few pharmacists will want to remain with the 
government like some of us are now. Coupled with the condition of 
service and remuneration in the public sector, most pharmacists will 
prefer to take up non-governmental organisation work and other 
private endeavours.” P35, Policymaker 
Furthermore, a wide geographical gap exists in the distribution of pharmacists across 
the country.  Many pharmacists who work in community and hospital practice prefer to 
work in urban centres. Hence, participants reported that many secondary facilities 
located in semi urban or rural locations have few pharmacists or none in some cases.  
For example, one of the participants I  interviewed who is a medical doctor and works 
in a 100 bed size secondary hospital located in a rural area, reported that in the  
hospital where he practiced, there is no pharmacist available. The pharmacy unit is 
being managed by pharmacy technicians. The shortage of pharmacists was also 
reiterated all through the interviews by pharmacists. 
“Like I told you we have shortage of pharmacists in XXX state. There 
are some rural hospitals that don’t have pharmacists at all, they only 
work with technicians.” P04, Hospital Pharmacist 
Participants observed that the number of pharmacists available in Nigerian hospitals 
could among other things account for the wide variation on the adoption of clinical 
pharmacy services seen across hospitals. In tertiary facilities where the staff strength is 
high, pharmacists have been able to extend their roles beyond the dispensary. 
“But quite a number of teaching hospitals have now imbibed the idea 
of pharmacists being involved in the ward. I think it has helped by the 
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fact that teaching hospitals have more pharmacists available. So, I 
think is the availability of manpower to carry through even the 
traditional pharmacy responsibilities and to also go to the wards.” P26, 
Academic Pharmacist 
Concerns were raised by all stakeholders on the impact of the number of pharmacists 
on pharmacists’ ability to take on extended clinical roles. Stakeholders view the 
shortage of pharmacists as a potential barrier to extending the clinical roles of 
pharmacists to include prescribing.  
“Yes! Manpower is also a barrier, we don’t have enough pharmacists. 
You will see a pharmacist having many patients waiting for him, to add 
another responsibility to him will require more hands.” P02, General 
Practitioner 
“Of course, inadequate staff is one of the barriers. Definitely when you 
have very few pharmacists, they may not have time to do other 
additional roles apart from their dispensing and may be drug 
distribution. But if you want to have pharmacists do additional roles, 
then the issue of staffing should be addressed too.” P05, Hospital 
Pharmacist 
Similarly, some participants also expressed concern on the number of pharmacy 
technicians available in the country. They attributed that to limited training institutions 
and enrolment of trainee technicians. These participants observed that the lack of 
support to increase the number of pharmacy technicians has been aggravated by 
pharmacists’ fear of ‘role erosion’. Many pharmacists believed that training more 
pharmacy technicians would lead to pharmacists’ dispensing role taken over by 
technicians. 
“Even though pharmacy technicians as a cadre exist throughout the 
world as a middle cadre technical assisting group, assisting 
pharmacists, in Nigeria, the pharmacists’ council is restricting the 
numbers that schools are allowed to train.” P22, Policymaker & 
pharmacists 
“Also, the student intake has been small which is an indication that 
they don't like us to be more in the society, probably our profession is a 
threat to pharmacists. That is how I see it.” P44, Pharmacy technician 
Furthermore, participants also reported that because the numbers of pharmacy staff 
are inadequate, many unqualified personnel including patent medicine vendors have 
been integrated into the country’s drug distribution channel. However, this has a great 
consequence on safe supply of medicines.  
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“You know right now in Nigeria, the role the pharmacist should do in 
the society is being played by patent medicine vendors.” P17, General 
Practitioner 
“In the hundreds of health centres that we have, we don’t have 
pharmacists. Now what should make up for that is the pharmacy 
technician but other non-pharmacy related junior cadre workers have 
taken over their functions. P22, Policymaker and Pharmacist 
Many participants observed that the involvement of non-pharmacy trained personnel in 
drug supply in Nigeria is currently a threat to pharmacy practice. Many of these 
personnel are involved in the supply of medicines outside their prescribed jurisdiction 
because of the poor regulatory system in the country.   
 “You see, people open premises, they call it PPMV premises- patent 
and propriety medicines vendors’ premises but they will be selling all 
sorts of medicines. So, you can see that the Nigerian pharmacist 
cannot thrive in such an environment and the government is politically 
weary, they cannot enforce the law.” P12, Community Pharmacist 
Overall, all stakeholders observed that if pharmacists’ roles are to be extended, 
concerns about the inadequate number of pharmacy staff must be handled. 
5.4.3.4 Utilisation of pharmacy technicians 
In order to free up pharmacists’ time to undertake new roles, pharmacy technicians 
would be needed to fulfil some traditional roles of pharmacists. Therefore, the 
interviews conducted explored participants’ views on the current and potential roles for 
pharmacy technicians. The study revealed that there is currently no national framework 
in place to ensure the effective use of the skill mix within pharmacy. While there are 
defined roles for pharmacists which include dispensing and the overall management of 
pharmacy units, the utilisation of pharmacy technicians depended on some factors. 
These include the ratio of pharmacist-to-pharmacy technician within a facility and the 
discretion of their supervising pharmacists.  
“Technicians work directly under the pharmacist and do things that the 
pharmacist feels should be delegated to a junior staff to do. So… like 
ensuring that the out of stock drugs are compiled and when 
prescriptions come, they arrange the drugs and all of that for the 
pharmacists to counsel and dispense.” P03, Hospital Pharmacists 
“Pharmacy technicians work with the pharmacist to do the counting of 
the drugs and they work based on instructions given to them by the 
pharmacist.” P09, Hospital Pharmacist 
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Therefore, in hospitals with many pharmacists like the teaching hospitals, technicians’ 
roles are usually limited.  On the other hand, in facilities where there are insufficient 
numbers of pharmacists, pharmacy technicians are utilised to handle dispensing of 
medicines. They sometimes share responsibilities with the pharmacists by engaging in 
roles that are not formally recognised as theirs such as validating prescriptions and the 
final accuracy checks of dispensed medicines.  
“There are times we have evening shift, we may assign them 
[pharmacy technicians] to the evening shift to be in charge of the 
pharmacy because the patient population is less at that time compared 
to the morning shift.” P01, Hospital Pharmacist 
The senior pharmacy technicians were also involved in the overall management of the 
dispensary in hospital facilities where there are no pharmacists. 
“When there was no pharmacist in the hospital, I was the one 
managing the pharmacy for about 3 years but when we had one, he 
took over from me.” P42, Pharmacy Technician 
However, policymakers reported that technicians are only utilised in such manner in 
order to fill the gap created as a result of inadequate number of pharmacists in the 
country. 
“Yes, for now, most of our hospitals are even engaging the supporting 
staff, the pharmacy technicians, who are greater in number.” P35, 
Policymaker & Pharmacist 
There are a lot of things they [pharmacy technicians] are doing that are 
not supposed to be done by them; it is because of this problem of 
manpower. P36, Policymaker & Medical Doctor 
When pharmacists opinion were sought during the interviews on allowing pharmacy 
technicians to take over some traditional roles of pharmacists including dispensing in 
order to free-up pharmacists time to be involved in other advanced roles, there were 
split of opinions.  Although, all stakeholders interviewed acknowledged that the use of 
pharmacy technicians in dispensing role will free-up pharmacists for extended clinical 
roles and promote optimal use of the pharmacy workforce in Nigeria, some 
pharmacists had reservations regarding engaging technicians as dispensers. Major 
concerns of these pharmacists were that of the competence of technicians to handle 
drug dispensing, safe supply of medicines and pharmacists’ role erosion.  
“The supply process is complicated and the technicians don’t have this 
requisite training that will enable them to handle this complicated 
process.” P03, Hospital Pharmacist 
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“No! You see… like I said earlier, even just to dispense drugs, if you 
just allow less qualified people to do that, there are instances they 
make a lot of mistakes. What I am saying is that if we have more 
pharmacists we can do some of these roles. P27, Policymaker and 
pharmacist 
Many pharmacy technicians interviewed also reported that pharmacists are threatened 
by their involvement in dispensing. 
“Truly speaking, there is always rancour, permit me to use that word. 
Pharmacists are not too comfortable with us… We cannot take over 
their jobs, it is not even possible. Technicians have diploma equivalent 
and pharmacists do a degree which takes 5 years. So I don't see the 
reason why they should be afraid.” P44, Pharmacy Technician 
Some pharmacists in this study viewed the control they have over medicine supply as a 
major reason for their professionalism and fear losing their professional status if 
medicine supply process is being handled by pharmacy technicians.  
By giving them [pharmacy technicians] more rights, you are killing the 
pharmacy profession and bringing them up. P08, Community 
Pharmacist 
Unfortunately, pharmacists are beginning to see them [pharmacy 
technicians] as opponents, which is unfortunate. You know it is not 
everything pharmaceutical you must do. There are some non-technical 
things; you can ask the technicians to handle that. P32, Policymaker 
Pharmacy technicians’ account also confirm the fears held (losing their 
professionalism) by these pharmacists 
“They will hardly allow you manage the dispensary for them to go to 
the wards because they believe that there are certain things that they 
feel they should be the ones to control.” P41, Pharmacy Technician 
“They are afraid that if we are giving the chance to work in this way 
[managing the dispensary], we will overtake their duties as 
pharmacists. I don’t know why they are feeling that we are going to 
compete with them. But we as technicians, we respect them as our 
bosses.” P46 Pharmacy Technician 
Furthermore, a pharmacy technician interviewed believed that pharmacists’ increasing 
involvement in dispensing reduces their professional relevance and status given the 
vast amount of knowledge and skills they have. 
In fact, most pharmacists are seen as not relevant in our hospitals. The 
doctor sees them as just ordinary dispensers. They see them as 
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people that give drugs- take these two tablets three times a day. They 
don’t regard pharmacy as a profession” P42, Pharmacy Technician 
However, a number of pharmacists felt that utilising pharmacy technicians in 
dispensing will free them up for other specialised tasks. 
If these ones [pharmacy technicians] are involved in dispensing, 
bringing the drugs, dispensing while the pharmacist does patient 
counselling, therapeutic drug monitoring and other duties, it will be 
better for pharmacists. P16, Academic Pharmacist  
I believe that dispensing should be things that technicians should be 
doing. I feel the pharmacist should be more involved in direct patient 
care. You know, go to the ward and provide services to patients in the 
ward. But right now pharmacists are involved in the packing of drugs, 
counting of drugs and all that I believe those things should be left for 
the technicians, which will now allow a pharmacist to have more time 
to render pharmaceutical care services to patients. P05, Hospital 
Pharmacist 
Also, many pharmacists interviewed commonly cited competencies issues as reasons 
for non-utilisation of pharmacy technicians. However, this study revealed that there is 
currently no framework for further training of pharmacy technicians to enhance their 
competence.  
“The training we received at the colleges of health technology to some 
extent prepares us for work in the hospital but we are asking that after 
training as technicians, they should allow us to proceed, like to a 
degree level. That will help us so much.” P41, Pharmacy technicians 
“In fact there is no provision for further training. There is a programme 
we learnt they were putting together at XXX. So we have been waiting 
because some of us have the zeal to study.” P44, Pharmacy 
Technicians  
The comments in the last quote showed a willingness, among pharmacy technicians, to 
be further trained. This view was commonly expressed by pharmacy technicians 
interviewed. Therefore having a structure for post-registration training of pharmacy 
technicians would enhance their skills and competencies. Developing pharmacy 
technicians to take on some of the traditional roles of pharmacists would free 
pharmacists up for other specialised roles.  
5.4.3.5 Medical dominance and opposition 
Medical control over the health sector was a prominent theme that emerged from this 
study. Interviews with many stakeholders including doctors, pharmacists, policymakers 
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and patient group representatives revealed that the medical profession in Nigeria has 
had a longstanding control over the health system. Participants spoke of medical 
control over the administrative structures of the health system at the national, state and 
institutional levels. They also spoke of medical control over access to patients in 
hospitals and in determining the roles of other healthcare professionals in patient care.  
Unlike in the UK where the NHS is under general management, in Nigeria, the health 
sector is mainly managed by health professionals.  Participants noted that at the 
national, state and institutional level, the medical profession has enjoyed significant 
control of administrative structures by taken over key positions within health ministries, 
departments and hospitals.   
“They [doctors] feel that they have control over the health sector 
because the minister of health is a medical doctor, minister of state is a 
doctor and permanent secretary a doctor too.” P08, Community 
Pharmacist 
“In Nigeria you know, the medical doctor thinks he is all in all and 
should always be the overall boss. So they see the pharmacist as an 
opponent or an enemy in a supposedly teamwork [laughs].  P12, 
Community Pharmacist 
Participants noted that medical control of key positions in the health sector has resulted 
into professional conflicts between the medical profession and other health 
professionals. This has had negative impact on the relationship between doctors and 
other healthcare professionals in Nigeria. 
“….the area of problem is the leadership tussle, every one of them 
[referring to non-doctors] want to be on the driving seat, which is not 
possible.” P36, Policymaker & Medical doctor 
Participants who were not doctors also felt that medical dominance has been a barrier 
to policy development and implementation In Nigeria. They argued that the medical 
profession has majority of membership in most decision making bodies in the health 
sector. Therefore any policy that does not favour them or tend to challenge their 
existing control of the health sector is usually resisted by doctors.   
“I have had cause to present memoranda during XXX council. I can 
say categorically the attack, if I may use the word, or the response 
from the medical practitioners that form the bulk of the members of the 
council have been bad. Simply because they look at us as trying to go 
into their own ‘preserved area’.” P31, Policymaker & Pharmacist  
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“…lots of things have come up. Memos have been presented at the 
highest level of healthcare decision in Nigeria. I have participated as 
XXX for some few years now. I know that when memos are presented 
on these issues, they are passed and approved; the problem is 
implementation. The policy decision makers at the hospital level are 
mainly doctors. Therefore, they are not willing to implement things that 
they think are threats to their own practice.” P32, Policymaker  
Therefore many pharmacists felt that this will also be a barrier to the introduction of 
pharmacist prescribing in Nigeria, since pharmacist prescribing will challenge the 
existing practice where prescribing is seen as a doctors’ role.  
“If you tell Nigerian doctors to relinquish what they see as their birth 
right to another professional, there will be serious opposition” Hospital 
P03, Pharmacist 
Hospital pharmacists also observed that the participation of pharmacists in patient care 
at the ward level has been resisted by doctors. They reported that doctors believe that 
the care of patients in the hospitals is solely under their responsibility and allowing 
other health professionals to be directly involved in patient care would undermine their 
control over patient care.  
“The products of the West African Postgraduate College of 
Pharmacists are finding it difficult to actually practice because the 
doctors feel that they have gone to read clinical pharmacy to take over 
the clinics; that is their perception which in the real sense is not.” P25, 
Hospital Pharmacist 
“…the doctors are claiming they are the owners of the patients and 
that the pharmacist is an intruder [laughs].” P12, Community 
Pharmacist 
A policymaker with a medical background also pointed this out as a barrier to 
collaborative practice in patient care in Nigeria. 
“You know, the doctor is naturally a selfish person especially when it 
comes to patient care. The doctor wants to take the credit at the end of 
the day, I diagnose it, I treated it, I did this... So, there is this feeling 
that if you work collaboratively, who takes the credit at the end of the 
day?” P34, Policymaker & Medical doctor 
This shows that doctors view collaborative practice as a threat to their dominance in 
patient care and would want to maintain their self-worth even if it is not to the best 
interest of the patient and the health system. 
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“A physician or doctor in Nigeria feels that the way things were in the 
early nineteenth century, they should still remain like that.” P03, 
Hospital Pharmacist 
Overall, many pharmacists maintained that achieving professional autonomy in terms 
of pharmacists’ ability to control its administrative structures, negotiate its roles and 
remuneration is essential for clinical role extension. 
“We are discovering ourselves and taking that full independence from 
the so called domineering forces [referring to doctors] in the health 
profession. So, we have come a long way and I think we had become 
independent and we are trying to discover those things we are 
supposed to do. P32, Pharmacist & Policymaker 
“The actualisation and implementation of clinical pharmacy practice is 
well over due in Nigeria, but we need to be more political as 
pharmacists to be able to penetrate the government and lobby for the 
enabling laws” P07, Community Pharmacist 
“Pharmacists don't have enough political strength to make clinical 
pharmacy practice a reality in Nigeria. I think more pharmacists should 
delve into politics in order for us to canvass for our own rights within 
the health sector.” P13, Hospital Pharmacist 
These participants believed that having more pharmacists in government will facilitate 
pharmacists’ ability to negotiate their roles.  
5.4.3.6 Collaboration with doctors 
This study also revealed that collaborative working relationships between doctors and 
pharmacists in patient care is lacking in many hospitals in Nigeria.  Even though the 
doctors and pharmacists interviewed showed positive views towards collaborative 
practice in patient care as shown in the quotes below, they mainly work autonomously.  
“I can’t do without them [doctors]. Collaboration is the key, not 
competition. I will really love to collaborate with doctors.” P23, 
Community Pharmacist 
“For me, I look forward to the time where my practice will be so holistic 
that even basic day to day clinical decisions about prescribing, 
changing of medication, dosage adjustment would be done in such a 
way that I have useful inputs from pharmacists around me.” P14, 
Medical Consultant 
Participants observed that pharmacists in many hospitals work in isolation from doctors 
and are not integrated into the health team.  
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“…most of the time they [pharmacists] are just far removed in their 
department, no interactions with doctors at all.” P15 Medical 
Consultant 
“Actually, I don’t go on ward rounds with the doctors. The ward rounds 
are like meant for the doctors and the nurses. The pharmacist stays in 
his pharmacy and waits for the patient to come for the dispensing of 
drug. That has been the tradition.” P06, Hospital Pharmacist in a 
secondary facility 
Hence, professional communication between doctors and hospital pharmacists is 
minimal. Communication from doctors to pharmacist is usually through a written 
prescription communicated to the pharmacist for dispensing of patients’ medications. 
Both doctors and pharmacists observed that communication from pharmacists to 
doctors mainly occurs when the pharmacist is either querying or seeking clarification of 
a prescription from the doctor; or when the doctor is requesting information about a 
medicine.  
“Most often it is one way traffic but on few occasions they 
communicate back to you about your prescribing. Sometimes if there is 
any issue, probably with the prescription in terms of dosage or issues 
like that, they can write on the prescription paper and return it to you. I 
think largely, the interaction has been one way.” P15, Medical 
consultant 
“…once they [pharmacists] feel that there is contraindication in a 
prescription, they always communicate either by coming in person or 
giving a phone call. Once in a while, when I need certain clarification, I 
also do call them.” P28, Medical consultant 
Such working relationships as described by these participants, where communication 
between healthcare professionals is minimal, could lead to fragmentation of care. 
Participants noted that the patients are the ones at a disadvantage because they don’t 
get the best form of care. 
“Interdisciplinary collaboration does not exist currently in Nigeria. They 
[referring to doctors and pharmacists] fight for positions instead of 
fighting for excellence in patient care. The patients greatly suffer 
because there is no collaboration in the system.” P30, Policymaker & 
medical doctor 
“In the early days of my practice as a pharmacist, practitioners have 
respect for one another irrespective of their categories because 
everybody had a particular role to play. But now, a lot of ego, people 
are not ready to take correction and learn from one another. That is 
just the problem and the patient suffers for it.” P33, Policymaker 
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Pharmacists argued that medical doctors consider their (the pharmacists) direct 
involvement in patient care as an encroachment into doctors’ territory because doctors’ 
hold stereotype views concerning them. They reported that doctors see pharmacists’ 
roles as mainly supply based. 
“They feel we are over-stepping our boundary, as in, we are trying to 
do their own job. They feel the job of the pharmacist is just to stay in 
the pharmacy and dispense drugs.” P11, Hospital Pharmacist  
Some doctors interviewed confirm doctors’ stereotype views about pharmacists’ role in 
patient care. They reported that they have not been able to work collaboratively with 
pharmacists because they believe that pharmacists’ role should be within the pharmacy 
where they dispense medicines to patients.  
“…because we also feel that they should just be at the pharmacy. So 
we don't work collaboratively together.” P34, Resident Doctor 
However, some participants’ comments revealed that in some teaching hospitals, 
pharmacists were working collaboratively with doctors within multidisciplinary 
healthcare team.  
In my hospital, we go on ward rounds with doctors; we collaborate with 
them in ensuring that patients get the best drugs for their various 
ailments. We also act as drug information resource for the prescribers. 
P03, Hospital Pharmacist 
“In many hospitals, the pharmacist is not part of the clinical team 
except in some very few teaching hospitals.” P06, Hospital Pharmacist 
“If you go to XXX teaching hospital, you will find out that the 
pharmacists are working together with doctors as members of the 
health team. They are playing an active role in patient care. In fact, the 
doctors are relying on them now.” P32, Policymaker  
On the other hand, participants observed that there is currently no collaboration 
between community pharmacists and medical doctors including those working as 
general practitioners at the primary care level.  
“….collaboration is the key, not competition but unfortunately it is 
frustrating working with some of them because they don’t even give 
you that feedback from the referral form sent to them.” P23, 
Community pharmacist 
“We discovered that they have dispensing doctors. So, some 
prescriptions don’t come to the community pharmacy again and so 
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pharmacists have to deploy a survival strategy.” P16, Academic & 
Community Pharmacist 
Hence, from the comments of the participants above, competition rather than 
collaboration exists between many private general practices and community 
pharmacies since both practices were established on a business model. 
Other barriers to effective collaboration between doctors and pharmacists were 
highlighted in the previous subthemes reported. These included pharmacists’ lack of 
confidence to engage in clinical roles, medical dominance and inadequate pharmacy 
staff to engage in roles outside the dispensary as previously reported.  
Overall, patient care in Nigeria was viewed to be fragmented because of the poor 
collaboration among healthcare professionals. Participants made a number of 
suggestions on how collaborative practice between pharmacists and doctors could be 
enhanced including promoting inter-professional learning particularly at the 
undergraduate level; participation in joint events; and having institutional policies that 
foster collaborative working relationship.  
5.4.3.7 Lack of policies to support clinical pharmacy practice 
Analysis of the data generated in this study also revealed that there are no adequate 
policies or legal frameworks to support the development of clinical pharmacy in Nigeria. 
Several pharmacists reported that at present, their involvement in clinical activities 
have no policy backing. 
“I don’t think there are sufficient policies in place if actually there is to 
support the development of clinical pharmacy. I think more should be 
done policy-wise by the federal government.” P06, Hospital Pharmacist 
“The system is also a problem. Supposing there was a policy to say; 
as a pharmacist, your work will cover working in the pharmacy to 
provide drugs to outpatients and also going to the ward to see if there 
are any drug therapy problems. If there was a written policy to that 
effect, that will encourage the pharmacists to do that.” P26, Academic 
Pharmacist 
A pharmacist also noted that even the pharmacists’ license to practice does not provide 
any backing for a clinical role.  
“I feel there are no policies to support us as pharmacists. First of all, 
we are legally licensed to practise as pharmaceutical chemist and the 
license only empowers us to manufacture, sell and distribute 
medicines.” P01, Hospital Pharmacists 
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Comments from some medical doctors also suggested that pharmacists’ involvement in 
direct patient care has no legal backing from the government. 
“I just think there is no legal framework for them to perform their 
functions. So it still goes back to the fact that the government has not 
given them such a backing.” P17, General Practitioner 
“No, I don’t do ward rounds with pharmacists because it is not in the 
curriculum to do ward rounds with pharmacists…” P10, Medical 
consultant 
Many pharmacists including those in policymaking noted that policy barriers are as a 
result of medical dominance in the health policymaking process as earlier mentioned in 
section 5.4.3.5. 
5.4.3.8 Regulation 
Regulation of the handling and sales of medicines in Nigeria was commonly discussed 
by participants. In Nigeria, members of the public have access to some prescription 
only medicines including antibiotics without a doctors’ prescription. Participants 
reported that community pharmacies and patent medicines store were common 
sources for these medicines. Many participants noted that non-prescription access to 
prescription medicines is possible as a result of government’s inability to properly 
regulate the handling of medicines including sale and supply of ‘Prescription Only 
Medicines’ in the private sector. Other factors perceived by participants that could 
account for the poor regulation of the pharmaceutical sector in Nigeria include 
corruption, funding issues, inadequate staffing and infrastructure.  
“The problem we even have is that, if you come to a particular state 
capital, in the ministry of health, we have probably one staff member 
who is a pharmacist posted from the pharmacists’ council of Nigeria to 
regulate the practice of pharmacy. So you can see already that, that 
person cannot do that. So, lack of staff, lack of structures and 
institutions for those who are tasked with the function of regulating 
practice.”  P35, Policymaker  
“The government has put in place the laws but enforcement is not 
there. The people who are supposed to enforce the law are at the 
background [behind the scene] people who are sponsoring the illegal 
drug movement because so much pool of money goes through in drug 
world” P39, Policymaker 
Many pharmacists reported that community pharmacists indulge in the supply of 
‘Prescription Only Medicines’ without prescription in order to ease patients’ burden on 
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seeking for healthcare as a result of the limited medical prescribers and the cost of 
consulting a medical prescriber. 
“Here in Nigeria, pharmacists are doing everything for the sake of the 
patient.” P37, Community Pharmacist 
However, analysis of the interview data revealed that some community pharmacists 
engage in such act as a business survival strategy, thereby re-emphasising the 
commercial nature and interest of pharmacy.  
“Officially, we are not allowed to recommend prescription medicines 
but we are doing that because it is becoming inevitable. We have 
discovered that they have dispensing doctors and some prescriptions 
don’t come to the pharmacy again and so the pharmacist has to deploy 
a survival strategy.” P16, Pharmacist 
Of importance to this research is seeking participants’ opinion as to whether 
pharmacist prescribing would legitimise medicine supply and reduce irrational use of 
medicines. Many stakeholders noted that it could minimise the illegal supply of 
prescription medicines.  
“It will minimise illegal access, because everyone knows that they don't 
need to treat themselves by themselves, they can go to a professional 
who is trained on medicine to help them. So the back door movement 
that happened in Nigeria will not happen anymore.” P38 Patient group 
representative 
However, participants observed that effective regulation and drug distribution system is 
crucial to legitimising medicine supply in Nigeria. 
“It is the government and the regulatory body and the law enforcement 
agents that can curb this illegal drug channel. As long as these things 
exist, you cannot have a credible healthcare system in Nigeria. P12, 
Community Pharmacist 
“Drug distribution channel must be properly handled in Nigeria. The 
laws of the land should be put in place properly and whoever go 
against the laws especially the drug laws should be properly 
sanctioned.” P39, Policymaker 
Furthermore, some participants noted that reclassification of some prescription 
medicines into a category that allow pharmacists to supply them without a prescription 
could also help in legitimising drug supply and reduce medicines harm. 
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“…just like in the US, there should be what they call Pharmacists’ Only 
Medicines, so that pharmacists could be supplying these medicines.” 
P22, Policymaker 
“I think if the government change the status of some of these 
prescription medicines to give only pharmacists the right to supply 
them without prescription, it will help.” P08, Community Pharmacist 
Theme summary: This theme revealed that several barriers were associated with the 
development of pharmacists’ clinical roles in Nigeria including pharmacists’ lack of 
confidence, shortage of pharmacy staff, underutilisation of pharmacy technicians, 
medical dominance, lack of collaboration with doctors and inadequate policies to 
support the development of clinical pharmacy practice. Generally, participants 
observed that pharmacists lack confidence to take on clinical roles and this was 
strongly linked to pharmacists’ education and training. A change in the current structure 
of pharmacy practice including enhanced clinical pharmacy education, specialisation, 
change in career structure, utilisation of pharmacy technicians could benefit the current 
system in Nigeria.  
5.4.4 Views on prescribing 
This theme presents the opinion of participants concerning the granting of prescribing 
rights to pharmacists in Nigeria. Six sub-themes emerged from this theme: prescribing 
as a logical role of pharmacists; pharmacist prescribing- a threat to doctors’ role; 
pharmacists’ competence in prescribing; collaborative prescribing as an appropriate 
model of prescribing; potential benefits of pharmacist prescribing; and potential 
facilitators and barriers to pharmacist prescribing. These sub-themes are discussed 
below.  
5.4.4.1 Prescribing a logical role for pharmacists 
Generally, opinions were split between pharmacists and doctors concerning extending 
the clinical roles of pharmacists to include prescribing. Pharmacists were generally in 
support of a prescribing right for pharmacists in Nigeria. They saw it as a logical role for 
them given their knowledge of medicines.  
“Yes, there is a need; we actually need a law to say that pharmacists 
can prescribe.” P26, Academic Pharmacist 
 “Yes, giving pharmacists a prescribing right will enhance the health 
delivery in Nigeria. A pharmacist is even more knowledgeable in drugs 
than most practitioners and yet he is not allowed to prescribe.” P16, 
Academic and Community Pharmacist 
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“I think we should be allowed to prescribe because we have a very 
good knowledge of medications” P23, Community Pharmacist 
In addition, pharmacists argued that since other healthcare professionals including 
Nurses and Community Health Workers which they perceived to be less qualified than 
them have been given some form of prescribing privileges in Nigeria, pharmacists 
deserve to be giving such role too. 
“…I teach nursing students pharmacology, can you imagine that these 
nurses graduated and started prescribing? If you are saying 
pharmacists should not prescribe, why would you allow nurses, 
midwife, health technologists either at the primary healthcare centres 
or even the general hospitals to prescribe? P08, Community 
Pharmacist 
“Do you know the irony in this country is that pharmacists are not 
allowed to prescribe but community health workers in primary 
healthcare are busy prescribing? Are they better than the 
pharmacists?” P32 Policymaker & Pharmacists 
“But we know when we go to the hospitals, let say a general hospital in 
the rural area, the prescribers really are not doctors, they are either 
senior nursing or community health officers. So why not allow the 
pharmacists to also prescribe, more so that he knows the drugs and 
now with his training he knows some of the diseases with their clinical 
features.” P26, Academic Pharmacist 
Some pharmacists, particularly community pharmacists reported that they are involved 
in prescribing although without official recognition. They reported that they do counter 
prescribing in response to patients’ complaints and therefore saw prescribing as a 
natural progression of their roles. 
“Personally I do that but it is not official. Particularly for some of us in 
the community practice, we do a lot of what I will tag as prescribing.” 
P37, Community Pharmacist 
“I attend to patients. They come with minor ailments and I treat them. 
So, I don’t see prescribing as a difficult thing to do.” P08, Community 
Pharmacist 
The view of prescribing as a logical progression of pharmacists’ role was also 
expressed by a hospital pharmacist who reported that they work collaboratively with 
doctors to influence doctors’ prescribing. 
“Sometimes we suggest to the doctor what to prescribe. So, what is 
stopping us from prescribing? We also feel we are able to prescribe 
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because in most occasions, we are the ones that tell the doctor what to 
do and the drug is our domain.” P18, Hospital Pharmacist 
However, many doctors were non-supportive of a prescribing role for pharmacists.   
On a personal note I think pharmacists should not prescribe. I think it is 
not part of their job, they shouldn’t prescribe. P29, Resident Doctor 
“Ehhh… looking at the Nigerian context, I have a lot of reservations 
about it, pharmacists are clinically not competent.” P14 Medical 
Consultant  
Interviews held with policymakers also reiterated the split of views observed between 
doctors and pharmacists as policymakers views were aligned to their professional 
background.  
“Yes, I think it is all right. When you look at the health team generally, 
pharmacists are the people that have more knowledge about drugs 
than any other health worker. So, in my own opinion, I think they are 
well equipped to be granted the right to prescribe. P27, Policymaker & 
pharmacist 
“No, no, no, no, I don't support that. Any person that should be allowed 
to give a prescription should be a medical doctor but for a pharmacist 
to be a prescriber, I don’t support that. Pharmacists are not trained to 
take good care of patients, theirs’ is to dispense.”  P36, Policymaker & 
medical doctor 
Despite many doctors’ lack of support to pharmacist prescribing, a few of them 
reported that granting some form of prescribing right to pharmacists will be a logical 
thing to do. They noted that medical prescribers are insufficient and a lot of patients in 
the community use the community pharmacies as the first port of call for medical 
attention.  
“Actually, we can’t run away from the fact that a lot of patients must 
have visited one pharmacy shop before coming to the hospital. If you 
can put the pharmacists, give them continuous medical education, I 
think it is a welcome idea for them to prescribe if this can be properly 
done.” P29, Resident Doctor 
“You know, hospital facilities are not everywhere. Given our health 
challenges, there is need to empower pharmacists to be able to do 
more than they are doing at the moment. They should be equipped 
sufficiently with the right amount of knowledge that will enable them to 
discharge some of this everyday health issues that necessarily don’t 
need to be seen by a qualified doctor.” P17, General Practitioner 
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A policymaker who is also a medical doctor reported that he will only support 
pharmacist prescribing in rural areas where there are no doctors. 
“In a situation where you don’t have a doctor for instance especially in 
our rural setting, a pharmacist can prescribe and dispense, similarly a 
doctor who is alone in one village and there is no pharmacy staff, he 
should allowed to carry out some basic lab investigations, prescribe 
the drugs and dispense.” P36, Policymaker 
Patient group representatives interviewed also felt that prescribing would be a 
reasonable role for pharmacists and were supportive of pharmacist prescribing. 
“Why not? I will support the pharmacist to be given a right to prescribe 
because they spend years in schools studying all these things. So they 
have an adequate knowledge of medicines and prescriptions that they 
should be able to prescribe, why not? Even nurses who do not have 
the amount of knowledge that pharmacists have on drugs, prescribe. 
So why can’t the pharmacist prescribe?” P38, Patient group 
representative 
5.4.4.2 Pharmacist prescribing: a threat to doctors’ role  
While many participants particularly pharmacists saw the granting of prescribing 
authority to pharmacists as beneficial; others perceived it as a threat. Some 
participants particularly doctors viewed the extension of prescribing authority to 
pharmacists as an encroachment into doctors’ professional boundary as prescribing 
has always been the doctors’ role in Nigeria. Therefore, doctors responded in such a 
way to preserve this boundary.  
“No, I will not support pharmacists prescribing. They should do their 
own work. Prescription is under the boundary of the medical doctors. I 
mean it is one of the main things we have as doctors, by the time 
every other person prescribes, then what does the doctor really do? 
So, that will be like taking our jobs from us.” P33, Policymaker and 
Medical Doctor 
The comment above also shows that this participant viewed prescribing as what 
defines and gives doctors their professional status and power. 
Furthermore, pharmacists felt that if pharmacists are allowed to prescribe, it will lead to 
a professional conflict between pharmacists and doctors. 
“Hmm…, it will cause wahala [problem] because even without the 
prescribing right we are still at loggerheads.” P23, Community 
Pharmacist 
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“There will always be a very serious clash of interest with the doctors 
because of the traditional thing of doctors being the only prescriber. So 
if any other person comes in to start prescribing especially in the 
hospital setting, it is going to be a serious problem.” P06, Hospital 
Pharmacist 
On the other hand, some pharmacists were cautious to support pharmacists 
prescribing because they were concerned that it might result in the possible erosion of 
the pharmacists’ dispensing role. They feared that doctors are likely to seek for some 
dispensing rights if pharmacists are allowed to prescribe or the dispensing role of the 
pharmacists would have to be handed over to pharmacy technicians in order to free 
pharmacist up for prescribing.  
“Ehhhhh… for now, I don’t think we are mature enough for that role. 
Not just the pharmacists alone but even the prescribers because if we 
pursue that objective, the doctors too may want to say let us too have 
some dispensing role which is traditionally the function of the 
pharmacists. except we get to the level of the other countries where 
they understand some basic things about healthcare, I think until then, 
I will not want us to delve into prescribing right.” P03, Hospital 
Pharmacist 
The concern about pharmacists’ dispensing role erosion as a result of pharmacist 
prescribing were strongly expressed by pharmacists who considered dispensing as a 
key role that maintains pharmacists’ professional status as earlier reported in section 
5.4.3.4. 
5.4.4.3 Pharmacists’ competence in prescribing 
Some participants including doctors, pharmacists, policymakers and patient group 
representatives expressed concern over pharmacists’ knowledge and skills to 
prescribe. 
Many pharmacists interviewed commonly maintained that pharmacists are 
knowledgeable about medicines which in their opinion could be a facilitator to 
pharmacist prescribing. However, many of the doctors maintained that prescribing of 
medicines is a complex process that goes beyond being knowledgeable about 
medicines. They particularly noted that appropriate diagnosis is crucial to prescription 
writing. Therefore, they observed that if pharmacists are allowed to prescribe, they may 
not be able to make appropriate prescribing decisions because of their inadequate 
skills in diagnosis. 
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 “Yeah, the concern about pharmacist prescribing will arise basically 
from the fact that the competence to be able to make accurate 
diagnosis is critical in therapy. We know very well that symptoms are 
complex and interrelated. So many symptoms are generated by 
different disease entities and until you have the pre-requisite 
experience, most of the time your therapy will just be trial and error” 
P17, Medical doctor 
 “I may not see it as their role from my own opinion. I think from the 
way we have been trained, I think prescription goes beyond being able 
to issue a drug. I must be able to know what is wrong with the patient 
and I am not sure if the training of the pharmacist would be deep 
enough for him to be able to do that.” P21, Medical doctor   
A patient group representative also expressed similar fears reporting that pharmacists 
may not be able to make appropriate diagnosis especially in complex cases. 
“The problem is… pharmacists do not have access to running clinics 
like doctors do and their training from how I understand it does not 
comprise of them being able to find out what is wrong with the patient. 
I am sure they will only depend on what symptoms the patient have 
and thus suspect what is wrong with the patient.” P38 
However, if pharmacists are to prescribe in collaboration with doctors as discussed in 
section 5.4.4.4, the concern of pharmacists’ inadequate skills in diagnosis would be 
taken care of.  
In this study, doctors interviewed were asked if pharmacists could play a role in repeat 
prescribing for chronic conditions as being practiced in some developed countries.  
Many doctors were unsupportive and reported that pharmacists were unlikely to 
recognise some insidious underlying complications in chronic conditions.  
“If you allow the pharmacist to manage patients on long term 
conditions on repeat prescribing. Some of the complications patient 
present with are subtle, the pharmacist may not be able to know them 
because he is not a specialist. So the patient is a lot safer if he is with 
somebody that is more trained to pick the complications.” P20, medical 
doctor 
“There are salient clinical features that you may not be able to pick 
until certain examinations have been done on the patient and if they 
are not picked on time, they can now result to some complications. 
Otherwise as community physicians, we advocate for tasks shifting. 
P21, Medical doctor 
Some pharmacists including those who are policymakers also expressed concern on 
pharmacists’ competence in prescribing.  
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“To be honest, if you look at it objectively, the role of a doctor is not 
just to prescribe. He has a more in-depth role vis –a vis the condition 
of a patient, he goes through so much to arrive at the prescription. A 
pharmacist doesn’t have an in-depth training as a doctor. I think even if 
he is allowed to prescribe, it should be limited” P39, Policymaker 
Yes, I will be very happy if Nigerian pharmacists are given some 
leverage or prescription right as well but before we do that; there 
should be a change in curriculum. Our curriculum should reflect patient 
care practice because the clinical component of the present curriculum 
we are using in this country is highly deficient in clinical areas.” P05, 
Hospital Pharmacist 
5.4.4.4 Collaborative prescribing as an appropriate model 
Given pharmacists inadequate skills in diagnosis as observed above, many participants 
noted that collaborative prescribing which entails working in partnership with doctors 
would be an appropriate model to implement within the Nigerian context.  Participants 
noted that this form of prescribing would overcome the problem of pharmacists’ 
inadequate skills in diagnoses and ensures patient safety. 
“I think in Nigeria the best way for now is to do it in collaboration with a 
doctor because they are trained to diagnose. So when the doctor 
diagnoses and may be initiate therapy, the pharmacists can now 
monitor but the initial diagnosis should be done by a doctor.” P11, 
Hospital Pharmacist 
 “I am of the opinion that pharmacists should prescribe in collaboration 
with doctors. Let the doctors be involved in the diagnosis because they 
are trained for that. If you say the pharmacists should independently 
manage a patient, I think it is not too right. I don’t think the pharmacist 
is trained in diagnosis.” P32, Policymaker & Pharmacist 
“Yes, the pharmacists should work with doctors. The doctors should 
serve as the mentors to the pharmacists in this process. The 
pharmacist will need a lot of capacity building and on the job 
mentorship. Sometimes, it is not all about drugs, there could be some 
other things that are needed.” P24, Patient Group Representative 
Despite the unwillingness of many medical doctors to support pharmacist prescribing, a 
few doctors interviewed found collaborative prescribing appealing to them since they 
will maintain the overall management of the patient. 
“If I am sure I have a resident doctor or a pharmacist, somebody who 
we can share care with, why not?” P14, Medical doctor 
“Having pharmacists prescribe alongside doctors will be feasible but it 
will be guided by the doctors. Where the pharmacist has a problem, he 
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should always seek consent of the doctor before taking any decision.” 
P10, Medical doctor 
Furthermore, participants observed that collaborative prescribing would only be 
practicable in hospital settings where doctors and pharmacists work together in patient 
care. They reported that this is unlikely in community pharmacy settings given that 
there is currently no structure in place that allows community pharmacists to work in 
partnership with doctors. In addition, some participants noted that access to patients’ 
data by community pharmacists will also be a challenge if collaborative prescribing is to 
be implemented.  
“The problem is hospitals may not like to share their patients’ record 
with community pharmacists.” P11, Hospital Pharmacist 
“The absence of patient records will be the challenge in the community 
pharmacy.” P23, Community Pharmacist 
Some participants therefore suggested that if community pharmacists were allowed to 
prescribe, they should do so independently in very limited areas or for minor conditions.  
On the other hand a number of participants considered implementing both models to 
be appropriate in Nigeria depending on the context.  
“Like I said earlier on, for certain diseases or ailments, the pharmacist 
can manage them from the beginning to the end independently. But 
there are other situations that they will require a joint management 
between the doctor and the pharmacists and there could be a work out 
plan that can be set up for the management of the patient. In that case, 
of course we are now looking at very chronic diseases. The pharmacist 
can monitor the patient really and of course in consultation from time to 
time as the disease process evolved with the doctor.” P17 General 
Practitioner 
 “The collaborative model appears to be more professionally 
appropriate because it will now bring the doctor and the pharmacist to 
work together which is what we are advocating for. But in the rural 
areas where doctors are lacking, a collaborative model will not be 
feasible. I will advocate the amalgamate of the two depending on the 
practice setting.” P31, Policymaker & Pharmacist  
Overall, participants seem to prefer collaborative prescribing to independent 
prescribing because of pharmacists’ inadequate skills in diagnosis.  
5.4.4.5 Potential benefits of pharmacist prescribing 
Participants interviewed outlined a number of benefits that could be associated with 
pharmacist prescribing in Nigeria. These benefits were identified by all participants 
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including those who were not supportive of pharmacist prescribing.  Generally, there 
was a perception among many stakeholders that allowing pharmacists to prescribe 
could improve patients’ access to treatment. Participants noted that having pharmacists 
as prescribers could provide quicker access to treatment and reduce patients’ waiting 
time.  
“You will see a doctor consulting like 100 clients in a day and that is 
killing you know.  You see some facilities there are no doctors at all. 
Allowing pharmacists to prescribe will go a long way.” P24, Patient 
group representative 
“The patient time will be saved because the patient will not have to 
wait all day waiting for a doctor’s’ prescription” P2, General Practitioner 
A participant also noted that it will increase the options in which patients have to seek 
treatment from different professionals, thereby empowering the patient. 
“You will have more experts prescribing the drugs to the patients rather 
than just the doctor.” P27, Policymaker & Pharmacist 
There was a perception particularly among pharmacists that pharmacist prescribing 
could promote safe prescribing of medicines because of pharmacists’ knowledge in 
medicines and skills in resolving drug therapy problems.  
“Pharmacists are more likely to prescribe the right medication in terms 
of patients not experiencing adverse drug reactions or side effects of 
those drugs.” P05, Hospital Pharmacist   
“You know by our training, we are trained to identify drug therapy 
problems and some of these problems could be life threatening. If we 
are giving the right to prescribe, it will free us to save lives of people 
who could have been exposed to fatal doses of certain drugs.” P26, 
Academic Pharmacist 
However, some medical doctors raised concern about patient safety and the quality of 
care the patient would receive if pharmacists are prescribing.  
“Since they know more about the drugs, their prescribing is likely to be 
safe for the patients but because their ability to make appropriate 
diagnosis is deficient, it may be counterproductive.” P29, Resident 
Doctor  
Participants, particularly pharmacists observed that introducing pharmacist prescribing 
in Nigeria could result in certain benefits for pharmacists and the pharmacy profession. 
They reported that it will promote the utilisation of pharmacists’ skills and make 
pharmacists job more satisfying.  
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 “It will enhance job satisfaction to the pharmacists” P26, Academic 
Pharmacist 
“Definitely, there will be job satisfaction on the part of the pharmacists. 
I am very, very satisfied doing clinical work. Each time I go into the 
ward, review patient medications, identify drug therapy problem and 
resolve them, I feel fulfilled at the end of the day rather than doing the 
traditional role.” P05, Hospital Pharmacist  
A pharmacist also added that pharmacist prescribing could promote staff retention. 
“…because most pharmacists that are graduating in Nigeria go out of 
the country for better working conditions. So, by adding this aspect of 
practice [prescribing], it may retain some of them.” P16, Pharmacist  
Participants also noted that allowing pharmacists to prescribe will grant pharmacists 
more responsibility in patient care and enhance their professional status.  
“Yes, the professional image of pharmacists will definitely improve. 
People will begin to perceive pharmacists in a different light, they will 
not look at the pharmacist as that professional that gives the drug 
across the counter.” P05, Hospital Pharmacist 
“It will boost our morale and our role will be seen as important. It will 
also give us more professional status and people will know that the 
pharmacist is not just a dispenser.” P37, Community Pharmacist   
A medical doctor also expressed similar view on the potential benefit to the pharmacy 
profession. 
“I think it will be a lot of fun for them. Pharmacists will be able to have 
patients that they treat from beginning to the end of the disease 
process all on their own and that will be quite an exciting experience 
and might inspire them to be even more professional about their 
practice and of course the satisfaction they will derive from all of that I 
think all will add up to improving perhaps the practice so to say of the 
pharmacist in the public eye.” P17, General Practitioner 
There was a general view among all stakeholders that pharmacist prescribing in 
Nigeria could reduce doctors’ workload and free them up to concentrate on other 
specialised tasks 
 “It will take the pressure off the general practitioner which means that 
the doctors will now concentrate on more delicate issues of diagnosis 
instead of having to be battling with minor illness.” P31, Policymaker & 
Pharmacist 
The first advantage is that it will relieve the doctor of his workload and 
help him to better manage the patient. As I told you, by the time you 
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have so many patients to attend to and if you have a helping hand, it 
will help you to better manage the patient and the patient will be the 
one to have the benefit at the end of day. P10, Medical Consultant 
In addition, a participant noted that collaborative prescribing could promote teamwork 
and professional relationships between doctors and pharmacists. 
“The collaborative model appears to be more professionally 
appropriate because it will now bring the doctor and the pharmacist to 
work together which is what we are advocating for.” P31, Policymaker 
Generally the benefits of pharmacist prescribing were underscored by all stakeholders 
interviewed including those not in support of granting pharmacists prescribing authority. 
5.4.4.6 Potential facilitators and barriers to pharmacist prescribing 
Participants identified a number of factors that could facilitate or hinder the introduction 
of pharmacist prescribing in Nigeria. Many pharmacists reported that pharmacists’ 
undergraduate training has evolved over time to be more diseases and patient 
orientated. They saw this as a potential facilitator to pharmacist prescribing.  
“Pharmacists’ training over the years has moved from only drug focus 
to also patient focus. In the training, more knowledge has been 
impacted clinically. I think pharmacists can also add this responsibility 
of drug prescription because we have added more knowledge.” P16, 
Pharmacist 
“By our training now, we are trained also in knowing disease 
conditions. As I told you earlier on, I teach pathology so that students 
are exposed to what kind of diseases there are and how they can be 
treated.” P26, Pharmacist 
Furthermore, many pharmacists are currently undergoing postgraduate training in 
clinical pharmacy with the West African Postgraduate College of Pharmacists. Many 
participants felt that the ‘products’ of this college are better positioned for prescribing 
roles.  
 “Many pharmacists now are specialising through the fellowship 
programme of the West African Postgraduate College of Pharmacy. 
Those that have this training should be allowed to prescribe 
prescription only medicines.” P16, Pharmacist 
However, as pointed out in previous theme, many doctors argued that appropriate 
diagnosis is crucial in prescribing and the present pharmacists’ training does not 
incorporate that.  
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It is not all about knowing the drugs but how do you come out with a 
diagnosis?  How do you ascertain the extent of the disease? P02, 
Medical doctor 
Therefore, many participants including pharmacists felt that pharmacists’ inadequate 
skills in clinical diagnosis could be a potential barrier to pharmacist prescribing.  
“We have a very good understanding of medications but when it 
comes to diagnosis we may not be so good at that.” P23, Pharmacist 
“You have to have a working diagnosis for you to prescribe and I don’t 
think pharmacists’ present training involves diagnosis. Their ability to 
make diagnosis is deficient.” P29 Medical doctor 
Also, increasing patient access to treatment was also considered a potential facilitator. 
Participants reported that patients have difficulty getting access to doctors because of 
the high patient to doctor ratio in Nigeria. This often results in long waiting times in 
hospitals.  
“…patients will stay very long hours in a queue waiting for very few 
medical doctors to come and examine them. If pharmacists are 
allowed to prescribe, I think it will go a long way in reducing the burden 
on the patients and waiting time in the clinic.” P24, Patient group 
representative 
Therefore, participants felt that pharmacist prescribing could promote access to 
treatment by increasing the number of providers. In addition, they stated that 
pharmacist prescribing also has the potential of reducing doctors’ workload. This is 
because many patients present to doctors with conditions which participants felt could 
be handled by other healthcare professionals including pharmacists and nurses. 
Hence, reducing doctors’ workload and freeing them up to concentrate on more 
specialised tasks were viewed as potential facilitators.  
 “As I said, our health centres are heavily congested. You know, some 
of the patients come to the hospital and they spend the whole day 
waiting, those with minor conditions can be sorted out early and get 
their prescriptions from a pharmacist. P02, medical doctor 
“It will take the pressure off the general practitioner which means that 
the doctors will now concentrate on more delicate issues of diagnosis 
instead of having to be battling with minor illness.” P31, Pharmacist & 
Policymaker 
Unlike hospitals, community pharmacies are accessible to patients in many locations.   
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“We know that we can easily go to the pharmacists because there are 
community pharmacies on every street, not every street literally but 
there are more pharmacies available and close to the community than 
you have hospitals.” P38, Patient group representative 
“We are the closest health facility to the community, the first port of call 
for every form of ailment.” P07, Community pharmacist 
Therefore, community pharmacists reported that they are usually the first point of call 
for many patients in Nigeria. They noted that there is a great reliance and confidence 
on them by members of the public.  
“From what we see happening these days, more and more people are 
beginning to rely on the community pharmacists for their health needs. 
The community pharmacists have become the first port of call for many 
cases even the major ones that will eventually get to the teaching 
hospital would have passed through the community pharmacist.” P23, 
Community pharmacist 
Therefore, community pharmacists felt that such reliance and confidence by members 
of the public on them could indicate potential acceptance by patients for pharmacist 
prescribing. Some doctors interviewed also felt that patients’ acceptance of prescribing 
by community pharmacists would not be a problem given that Nigerian patients consult 
other less qualified personnel for their health needs.  
“I think the Nigerian patients wouldn’t have issues. Very large numbers 
of patients are consulting even people who are far less qualified than 
pharmacists. They consult herbalists, those who run patent medicine 
stores and so many unqualified people compared to the pharmacists, I 
don’t think that will be an issue.” P14, Medical doctor 
Hence, many participants including pharmacists and patient group representatives 
argued that prescribing by community pharmacists could improve access to treatment 
and consequently reduce the number of patients that would require doctors’ care.  
“So if it becomes legalised, then we all know that we necessarily do 
not have to queue for a doctor for every kind of conditions that 
pharmacists [community pharmacists] will be allowed to take care of. 
So it will give you access to your drugs and healthcare needs than it is 
now.” P38, Patient group representative 
However, prescribing by community pharmacists as envisaged by these participants is 
associated with a number of challenges. These challenges include lack of collaborative 
working relationship with doctors including those in primary care; and lack of access to 
patients’ records because hospitals do not share patients’ information with community 
pharmacists.  
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“The way things are, it might not be too feasible because we don’t 
have access to the patient records, we might not know what else is 
wrong with the patient and what the patient can use and may not use.” 
P07, Community Pharmacist 
Therefore, these problems could lead to fragmentation of care.  
Furthermore, some participants expressed concern that community pharmacists may 
have conflict of interest in their prescribing since many community pharmacies were 
established on a business model. 
“If the pharmacist is allowed to prescribe in his community pharmacy, 
there will be a lot of problems because the pharmacist will only be 
interested in the patient buying his drugs and this can bias his 
prescription.” P06, Pharmacist 
 “So, if community pharmacists are going to be engaged more actively 
in patient care the way you are envisaging, then certainly the 
commercial aspect of pharmacy has to shift”. P17 General Practitioner  
“They [community pharmacists] may have commercial interest in their 
prescribing because at the moment they are more used to the 
commercial aspect of dealing with drugs. So they will certainly need 
some reorientation around drugs and the need to put patient health 
needs first.” P38, Patient group representative 
However, some pharmacists interviewed viewed the concern for a conflict of interest in 
prescribing by community pharmacists differently. They noted that community 
pharmacists have no commercial interest. They believed that involving them in 
prescribing will ensure cost-effective prescribing because they will utilise their 
knowledge of medicine prices to provide cost effective treatment.  
“A community pharmacist has no commercial interest. Pharmacists are 
wonderful people” P22, Policymaker & pharmacist 
“It will help to save cost for the patient because we will know the cost 
effective medicines that should be given to the patient.” P37, 
Community Pharmacist   
Also, some participants mentioned that community pharmacists may not have 
adequate facilities to support their prescribing practice.  
“I will prefer to see a doctor in a situation where I know it is complex 
because he has access to all the other facilities for testing, he can ask 
for scans and whatever for me which a community pharmacist cannot.” 
P38, Patient group representative 
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“I guess the setting in the community pharmacy now has to change 
because there should be a proper room where you can sit with the 
patient and communicate properly.” P23, Pharmacists 
In contrast, participants reported that in some tertiary hospitals, pharmacists are now 
working in partnership with doctors and other healthcare professions. Therefore, this 
could potentially facilitate collaborative prescribing.   
“We go on ward rounds with doctors and we make a contribution 
during ward rounds. In our hospital, we have been able to build that 
kind of good relationship with our doctors. They hardly go on ward 
rounds without inviting us because overtime they have been able to 
see the contribution of pharmacists to patient care.” P18, Pharmacist 
There were also reports that pharmacist’s attitude in taking up extended clinical roles 
could be a possible barrier to pharmacist prescribing as mentioned by a participant 
below. 
“Pharmacists’ attitude is usually a big barrier. Some pharmacists are 
very comfortable with those traditional roles, they don’t want to acquire 
new skills, and they don’t want to move into different areas where 
pharmacists are needed in clinical practice and all that.” P05, 
Pharmacists 
However, the popular view held by many pharmacists indicated that majority of 
pharmacists in Nigeria are dissatisfied with their current roles and are willing to expand 
their roles clinically. Such willingness for role expansion could be a driver to pharmacist 
prescribing.  
“…you have so much knowledge but you find yourself not being able to 
use that.” P04, Pharmacist 
“Yes, the younger pharmacists are willing to expand their roles 
clinically, even some older ones too. The younger pharmacists 
because of their mode of training they see themselves as being under-
utilised and that is why they are jumping at any opportunity to practice 
abroad where things are better.” P16, Pharmacist 
Also, some pharmacists maintained that some key pharmacy leaders and the 
Pharmaceutical Society of Nigeria would be willing to push for pharmacist prescribing 
in Nigeria.    
“We have a few key leaders who can fight for pharmacist prescribing.  
The PSN is also interested in the pharmacist extending their roles but I 
don’t know if part of what they are currently advocating for includes 
prescribing.” P11, Hospital Pharmacist 
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Generally, resistance from the medical profession was cited as a fundamental barrier to 
pharmacist prescribing in Nigeria. Participants felt that such resistance is expected 
because doctors would react in such a way to protect their territory.  
“If you tell Nigerian doctors to relinquish what they see as their birth 
right to another professional, there will be serious opposition” P03, 
Pharmacist 
“I think the main barrier will be the doctors. I believe they see 
prescribing as one of their primary roles or duties. So asking 
pharmacists to prescribe will be like taking their baby from them.” P38, 
Patient group representative 
Many pharmacists felt that medical resistance is likely to occur at policy level because 
of the overriding dominance of doctors in the leadership structure of health sector as 
previously reported in section 5.4.3.5. 
“If you look at the federal and state ministry of health, the top 
hierarchies are occupied by doctors. So, policy wise there is also a 
barrier.” P32, Policymaker 
Another major barrier mentioned was the inadequate number of pharmacists in many 
hospitals as previously reported in section 5.4.3.3.  
“I think there are not enough pharmacists to do that really. If you go to 
most facilities, you will see so many patients, the waiting time for 
patients to get their drugs is much, let alone pharmacists having time 
to interact with the patients and counsel them. The same problem the 
doctor is facing, the pharmacist is also facing too.” P14, Medical doctor 
“…lack of enough pharmacists to cater for the traditional pharmacy 
responsibilities and for them to go into the wards. So, hospital 
pharmacists are overwhelmed by the traditional pharmacy 
responsibilities of dispensing medications and procuring drugs.  So, 
they may not have the time to do an additional role but if they are more 
in number that will be facilitated.” P26, Pharmacist 
However, if pharmacy technicians are developed to handle some of the traditional roles 
of pharmacists, that will help in releasing pharmacists for advanced roles. But having 
pharmacy technicians do some of the traditional roles of pharmacists is not without 
resistance from some pharmacists as previously reported. 
Theme summary: There was a split of opinion between doctors and pharmacists on 
granting pharmacists prescribing authority. Many pharmacists were in support of 
pharmacist prescribing and saw prescribing as a logical role for them while many 
doctors were unsupportive. These doctors expressed concern about pharmacists’ skills 
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in diagnosis which they considered crucial in prescribing. However, collaborative 
prescribing which participants considered appropriate for the Nigerian context would 
take care of pharmacists’ inadequate skills in diagnosis. Overall, participants 
acknowledged many potential benefits of pharmacist prescribing in Nigeria. These 
benefits included the potential to improve patient access to care, promote the utilisation 
of pharmacists’ skills and reduce the workload on doctors. Furthermore, several 
potential barriers and facilitators to pharmacist prescribing were identified including 
current training provisions for pharmacists, ease of access to community pharmacists, 
inadequate pharmacy staff, and resistance from the medical profession.  
5.5 Ensuring rigour in this study 
As we saw in the last chapter, rigour in qualitative research is demonstrated in these 
four criteria: credibility, transferability, dependability and confirmability (Lincoln and 
Guba, 1985).   
Several steps were taken to build credibility into the study. The use of a digital 
recording device to record all interviews, and the transcription and cross checking of 
transcripts against their recordings by the researcher ensured accurate representation 
of participants’ views. The triangulation of data sources which enhances credibility was 
also employed in this study (Miles et al., 2014). This was done by recruiting participants 
to reflect the diversity of stakeholders concerned with clinical pharmacy practice in 
Nigeria. Therefore, doctors, pharmacists, pharmacy technicians, policymakers and 
patient group representatives were included in the study. Furthermore, the themes in 
this study were generated from coded data and illustrative quotes were used to 
sufficiently support the themes reported. In addition, contrasting views of participants 
were also represented. The reviewing of the themes and their interpretations by my 
supervisors also adds to the credibility of this study. 
Transferability which is similar to generalizability in quantitative research (Lincoln and 
Guba, 1985), was achieved through a detailed account of the study including its 
research setting, methods, process of interviews and data analysis to enable other 
readers to ascertain the transferability of the findings to other contexts. In addition, 
reaching saturation in the themes generated could imply that the findings could be 
generalised to the study population. Similarly, a detailed account of the research 
method including procedures involved and decisions made also contributes to the 
study dependability. Finally, confirmability was achieved through the detailed 
description of the findings of this study and the use of supporting quotes from 
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participants. These would enable the readers of this report to ascertain whether the 
account presented reflected participants’ views. 
5.6 Strengths and limitations of the study 
This is the first study in Nigeria that explored stakeholders’ views on the extension of 
pharmacists’ clinical roles to include prescribing in Nigeria. Using qualitative semi-
structured interviews in this research enabled an in-depth exploration and 
understanding of the issues related to clinical pharmacy practice and the granting of 
prescribing authority to pharmacists in Nigeria. The additional strength of this research 
is in the mix and backgrounds of stakeholders interviewed including doctors, 
pharmacists, pharmacy technicians, patient group representatives and policymakers 
across many locations in Nigeria.  
Even though this study was initially designed to involve both face-to-face and 
telephone interviews, the researcher was unable to travel to Nigeria to conduct face-to-
face interviews due to security challenges in Nigeria at the time of this research as 
earlier reported. As a result, some prospective participants couldn’t be reached from 
the UK. For example only two patient groups: the network of people living with HIV/AID 
and the diabetes association of Nigeria were contacted because the other groups 
couldn’t be reached via email. However, the quality and depth of data obtained was not 
compromised (except for non-verbal response which was difficult to obtain) since the 
researcher was experienced in telephone interviews. In addition, data collection 
continued until saturation was reached. 
As mentioned in the last chapter, qualitative studies are subject to certain limitations 
including lack of statistical generalisation but statistical generalisation was not the aim 
of this study. However, this study was followed-up with a quantitative survey reported in 
the next chapter to test the generalisability of the findings of this study. 
5.7 Chapter summary 
This study revealed how different stakeholders socially perceive and construct the role 
of pharmacists in Nigeria. Pharmacists were viewed as underutilised professionals, 
custodians of medicines, dispensers, medicines advisers, clinicians and in the case of 
community pharmacists, business people. The findings of this study are similar to other 
studies investigating community and hospital pharmacists’ identities (Elvey et al., 2013, 
Pottie et al., 2009, Varnish, 1998). Elvey et al. (2013) Identified nine identities: the 
scientist, the medicines adviser, the clinical practitioner, the social carer, the medicine 
maker, the medicine supplier, the manager, the business person and the unremarkable 
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character. These researchers presented a comprehensive list of pharmacists’ identities 
than those found in this study. This is because their study from its design set out to 
investigate pharmacists’ professional identities. However in this study, pharmacists’ 
professional identity emerged as a finding. In addition, the context (the UK) in which 
their study was carried out is different from that of this study (Nigeria). This could 
account for the difference in the list of pharmacists’ identities that emerged in both 
studies. But this assertion is not conclusive as other Nigerian pharmacists’ identities 
are likely to be identified with a study whose primary aim is to explore pharmacists’ 
professional identity. Nevertheless, the current study adds to the body of evidence of 
the professional identities of pharmacists. 
The present study also revealed that clinical pharmacy practice is still underdeveloped 
in Nigeria and many factors were responsible for this. These factors were 
predominantly linked to the structure of pharmacy. They include limited clinical 
education and training; lack of specialisation in practice; a career structure that does 
not support clinical development; poor relationships with medical doctors and medical 
dominance; inadequate pharmacy staff; underutilisation of pharmacy technicians and 
inadequate policies to support the development of clinical pharmacy practice. The 
findings of the present study indicated that a change in the existing structure of 
pharmacy in Nigeria could be beneficial in developing clinical pharmacy practice. 
There were splits of opinions between participants who were medical doctors and 
those who were not doctors regarding pharmacist prescribing in Nigeria. While many 
non-medical stakeholders interviewed including pharmacists and patient group 
representatives supported an extended role for pharmacists in prescribing, many 
medical doctors including those in policy making were reluctant to do so. Many 
pharmacists interviewed including those who are policymakers considered prescribing 
a logical role for pharmacists considering pharmacists’ knowledge in therapeutics 
which they considered essential for prescribing. In addition, they also argued that they 
are more knowledgeable in clinical pharmacology and pathology of diseases than 
nurses and community health workers who are currently allowed to prescribe 
medicines for certain conditions in facilities where there are no doctors. However, many 
medical doctors interviewed commonly cited pharmacists’ inadequate skills in clinical 
examination and diagnosis as their reason for non-support. In addition, these doctors 
also perceived pharmacist prescribing as an encroachment into their professional 
boundary domain that could undermine their authority over prescribing.  However, a 
few doctors were supportive of collaborative prescribing since they would still maintain 
the overall management of the patient. In addition, many non-doctors stakeholders 
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interviewed preferred collaborative prescribing over independent prescribing because it 
will complement pharmacists’ inadequate skills in diagnosis. It will also foster 
collaboration between doctors and pharmacists which has been identified as lacking in 
many practice settings in Nigeria.  
The results of this study provide insightful ideas to the facilitators and barriers to 
developing Nigerian pharmacists’ clinical roles including prescribing. The perceived 
benefits associated with pharmacist prescribing were commonly seen by participants 
as potential facilitators to pharmacist prescribing in Nigeria. These potential benefits 
include increasing access to patient treatment, better utilisation of pharmacists’ skills, 
reduction in doctors’ workload and the potential to legitimise prescription medicine 
supply. Other potential facilitators to pharmacists prescribing identified included: 
pharmacists’ positive attitude towards extended clinical role; the existing working 
relationship among doctors and pharmacists in some tertiary hospitals; community 
pharmacists’ accessibility and patients’ reliance on them.  On the other hand, notable 
barriers identified included shortage of pharmacists; pharmacists’ inadequate skills in 
diagnosis as mentioned earlier; medical opposition and lack of government support. 
The implications of the views on pharmacist prescribing including potential facilitators 
and barriers expressed by Nigerian stakeholders interviewed are further explored in the 
integrated discussion chapter (chapter 7) of this thesis. 
In the next phase of this project, the key findings of this study were further examined in 
a quantitative survey to test, compare and generalise the views expressed by 
participants. The design and content of the survey was primarily informed by the 
findings of this qualitative study. Details of the survey conducted including objectives, 
questionnaire design and results are presented in the next chapter.  
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Chapter 6: Nigerian survey 
Phase Method Product 
 
Qualitative 
Phase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quantitative 
Phase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 semi-structured 
interviews with UK 
pharmacy staff 
 
 
 
 Thematic analysis 
 
 
 
 
 
 Developing 
interview questions 
 
 
 
 
49 semi-structured 
interviews with 
purposively sampled 
stakeholders  
 
 
 Thematic analysis 
 
 
 
 
 
 
 Developing 
research objective 
 Developing 
survey items 
 
 
 
 
 
 Cross-sectional 
web survey 
 
 
 
 Univariate and 
multivariate 
analysis 
 
  
 
 Interpretation and 
explanations of 
qualitative and 
quantitative results 
 
 
 
 
 Textual data 
(interview 
transcripts) 
 
 
 
 Themes related to 
UK’s pharmacy 
structure 
 
 
 
 Interview guide for 
qualitative study 2 
 
 
 
 
 Textual data 
(interview 
transcripts) 
 
 
 
 Themes related to 
barriers & facilitator 
to clinical role 
extension 
 
 
 
 Research 
objectives 
 Questionnaire 
 
 
 
 
 
 
 Numeric data 
 
 
 
 
 Descriptive and 
inferential 
statistics 
 
 
 
 
 Discussions 
 Implications for 
practice & policy 
 Future research 
 
Qualitative Data 
collection 1 
 
Qualitative data 
analysis 1 
Qualitative Data 
collection 2 
 
Qualitative data 
analysis 2 
Quantitative 
data analysis  
Quantitative 
Data collection  
 
Connecting 
qualitative 
study 1 &2 
Connecting 
qualitative & 
quantitative 
phases 
Integrating 
qualitative & 
quantitative 
results 
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CHAPTER 6: A CROSS-SECTIONAL SURVEY OF PHARMACISTS’ VIEWS 
ON THE FACILITATORS AND BARRIERS TO EXTENDING THEIR 
CLINICAL ROLES TO INCLUDE PRESCRIBING IN NIGERIA 
6.1 Introduction 
This chapter presents the quantitative component of the exploratory sequential mixed 
methods design. The quantitative component was an online cross-sectional survey 
conducted as a follow-up to the qualitative findings reported in chapter 5. The current 
chapter begins by presenting key findings of the qualitative study in chapter 5 that 
informed the design of the present quantitative study. This leads to the objectives of the 
study. The objectives are then followed with the description of the research methods 
employed including study design, data collection methods and analysis. The section 
following the methods presents the results of the study and this is followed by a 
discussion on the strengths and limitations of the study.  
6.2 Key qualitative findings informing the present study 
As mentioned in the last chapter, this study was intended to test, compare and 
statistically generalise the qualitative findings reported in chapter 5. The semi-
structured interviews held with Nigerian stakeholders including doctors, pharmacists 
and policymakers identified key potential areas for change in the professional structure 
of pharmacy in Nigeria. The key areas were in pharmacists’ professional identity, 
pharmacists’ training, specialisation in practice, career structure, collaboration in 
practice and utilisation of pharmacy technicians. This study sought Nigerian 
pharmacists’ views on these key areas.  
Furthermore, the qualitative findings revealed a strong support for pharmacist 
prescribing by pharmacists including those in policymaking; this study aims to confirm 
this. The stakeholders interviewed in the last chapter identified a number of potential 
benefits that could be associated with pharmacist prescribing in Nigeria including 
increasing patients’ access to treatment, legitimising medicine supply and better 
utilisation of pharmacists’ skills. They perceived that these benefits in addition to recent 
changes in pharmacists’ training could potentially facilitate pharmacist prescribing. This 
study will assess the prevalence of these views among pharmacists. Also, a number of 
potential barriers were also reported in the last chapter. These barriers include 
opposition from the medical doctors; pharmacists’ limited skills in clinical assessment 
and diagnosis; lack of government support and shortage of pharmacy staff among 
others.  There was also a strong argument by stakeholders for collaborative prescribing 
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as the appropriate model for pharmacist prescribing in Nigeria. The current study 
therefore intends to investigate and confirm or refute all these issues. In addition, it 
intends to identify any demographic association or predictor of views held by 
participants with respect to extending the clinical roles of pharmacists to include 
prescribing in Nigeria. 
6.3 Objectives 
The objectives of this study were:  
1. To explore the views of pharmacists on clinical pharmacy practice in Nigeria in 
order to identify the potential changes needed for extended clinical role. 
2. To explore the views of pharmacists in Nigeria on the extension of prescribing 
authority to them and determine their willingness to be prescribers. 
3. To determine the demographic factors associated with pharmacists’ support for 
pharmacist prescribing in Nigeria. 
4. To identify the potential facilitators and barriers to introducing pharmacist 
prescribing in Nigeria 
6.4 Methods 
6.4.1 Ethics 
As with the study reported in the last chapter, ethical approval for this study was 
granted by the School of Healthcare Research Ethics Committee (SHREC) (Ref no: 
SHREC/RP/436) and the Plateau State Specialist Hospital Health Research Ethics 
Committee (PSSH/ADM/ETH.CO/2014/0025).  
Ethical issues associated with this research were the same as those identified in 
previous studies including informed consent, anonymity of participants, confidentiality 
in handling of data and data protection. Prospective participants were provided with 
information on the study and the implications of participating in the study on the 
introductory page of the online survey (Appendix 15). This is to enable them make 
informed decisions to participate in the study. Prospective participants were given the 
opportunity to make further enquiries about the research and were allowed to make a 
free, independent and voluntary informed choice to participate in the study or withdraw. 
Submission of the online questionnaire was taken to indicate that respondents had 
given their consent for their responses to be collated and analysed. Respondents were 
duly informed about this before accepting to participate in the study (Appendix 15). 
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Anonymity of the respondents was achieved by making the questionnaire anonymous. 
In addition, it was not possible for the researcher to link completed surveys to any 
individual contacted for the survey. The choice of the Bristol Online Survey (BOS), a 
UK-based survey system that allows researchers to create and run online surveys, 
ensures that data entered into the system by respondents were secured according to 
the UK data protection act. The password protected login to the survey ensures that 
only the researcher had access to the results. At the completion of the survey, all data 
entered by respondents were directly imported from the survey system (using a 
university computer) into my password protected space of the M-drive of the University.  
6.4.2 Recruitment of participants 
The initial design of the project was to recruit participants who were representatives of 
the pharmacists’ population in Nigeria in order to ensure statistical generalisation of the 
study findings. Hence, I initially intended to use the list of all pharmacists on the 
Pharmacists’ Council of Nigeria (PCN) register (about 16,000 pharmacists as at April 
2014) as the sampling frame. However, on contacting the PCN, I was told that it was 
not possible to get the emails of all the registered pharmacists on the council list as 
many pharmacists do not have their emails on the councils’ database. Therefore, it was 
not possible to recruit participants through the council for the online survey. The 
Facebook group of the Pharmaceutical Society of Nigeria (PSN) was considered as an 
alternative. PSN is the professional body for pharmacists in Nigeria. PSN’s Facebook 
group had 5,214 members at the time of this survey and it was used as the sampling 
frame to recruit participants for the survey. However, this sampling frame is biased as it 
excludes pharmacists who are non-members of this group. This is discussed as a 
limitation to this study in section 6.6.  
6.4.3 Sample size  
There are various methods of sample size determination including the use of formulae, 
web-based and computer programs (Eng, 2003). The sample size of a study depends 
on the type of study being conducted i.e. whether comparative or descriptive and the 
nature of the primary variables to be measured in the research, whether the variables 
are continuous or categorical (Eng, 2003, Kotrlik and Higgins, 2001).  Since this survey 
was descriptive, the calculation of sample size was based on the sample size 
calculation formula for  descriptive studies (Eng, 2003). 
𝑁 =  
4(𝑍𝑐𝑟𝑖𝑡)
2𝑝(1 − 𝑝)
𝐷2
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Where N is the sample size; Zcrit is the standard normal deviate corresponding to the 
selected significance criteria and confidence interval (CI) given in statistical table. For 
this survey, a Zcrit value of 1.960 determined at 95% CI was used. P is the pre-study 
estimate of the proportion to be measured. For this research, a P value of 90% (0.9) 
was estimated based on other research in Nigeria which indicated that about 90% of 
pharmacists will support an extended clinical role (Auta et al., 2014a, Oparah and 
Eferakeya, 2005).  D is the total width of the expected CI and an assumption of 5% 
(0.05) was made.  
Therefore,      
𝑁 =  
4(1.960)20.9(1−0.9)
0.052
  = 553 
Since online surveys are usually associated with low response rates (Bryman, 2012), 
40% of the sample size was added to the pre-determined sample size to yield the final 
sample size of 775. Therefore, 775 pharmacists were selected from the 5214 members 
of the Pharmaceutical Society of Nigeria Facebook group. Selecting 775 prospective 
respondents and sending private messages to them rather than sending a message to 
all the 5214 members of the group was considered because, on Facebook, group 
messages sent to members are seen by all. Therefore, this will breach confidentiality. 
In addition, sending more than 5,000 messages would have been an enormous task 
and I stood the danger of my account being blocked due to the volume of activity it 
would have involved.  
The sample size determined was tested for its appropriateness for the statistical tests 
to be conducted in this study including regression analysis. Kotrlik and Higgins (2001)  
and Miller and Kunce (1973) suggested that a minimum ratio of ten observations per 
independent variable is needed for regression analysis. Since the number of 
independent variables considered during the design of this study was below 10, the 
sample size estimated was considered appropriate.  
6.4.4 Sampling 
This survey was intended to employ a stratified random sampling technique to ensure 
proportional representation of pharmacists from the six regions of Nigeria. However, 
stratification of prospective participants according to their demographic details prior to 
sampling was not possible because the list of the members of the Pharmaceutical 
Society of Nigeria Facebook group does not contain comprehensive demographic 
details of members. Therefore, the survey employed a simple random sampling 
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technique.  Random sampling was achieved with the use of Microsoft Excel 2010 to 
generate a list of 775 random non-repeated numbers. Following approval by the 
administrator of the PSN Facebook group, a list of the members of the group was 
retrieved in alphabetical order. This list was then numbered serially and pharmacists 
with corresponding numbers on the list of random numbers generated were recruited 
for the survey. Figure 6-1 below shows the relationship between the target population 
of this study (all registered pharmacists in Nigeria) and the final participants recruited.  
 
 
Target population 
 
 
 
 
 
 
 
Source population 
 
 
 
 
 
 
 Sample 
 
 
 
 
 
 
Final survey 
Respondents 
 
Figure 6-1: Relationship between target population and study participants 
6.4.5 Questionnaire development 
The development of the questionnaire used in this study followed the basic principles of 
questionnaire design. These principles included: (i) careful selection of the wordings of 
each question to avoid ambiguity; (ii) avoiding multifaceted or double-negative 
questions; (iii) not including leading questions to avoid response bias; (iv) making each 
question brief and specific; (v) organising questions in a sequential and logical manner; 
(vi) choosing a user friendly layout; and (vii) keeping the questionnaire length brief to 
maximise response rate (Oppenheim, 2003, Peterson, 2000, Parfitt, 1997). 
All registered 
pharmacists in 
Nigeria  
(About 16,000) 
 
Members of PSN’s 
Facebook group 
(n=5214) 
 
775 Pharmacists drawn 
from members of PSN’s 
Facebook group 
 
315  
Pharmacists  
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The questionnaire developed was informed by the findings of the qualitative study 
conducted with Nigerian stakeholders and a review of other studies investigating the 
extension of prescribing authority to pharmacists including Hoti et al. (2014), Hoti et al. 
(2010) and Child et al. (1998). Themes that emerged from the findings of the semi-
structured interviews including pharmacists’ professional identity; pharmacists’ 
confidence in clinical roles; collaborative working relationship with doctors; potential 
changes needed in training and practice; and perceived benefits, facilitators and 
barriers to granting prescribing authority to pharmacists were used to develop the 
objectives of this study and the initial draft of the questionnaire. Table 6-1 
demonstrates how the qualitative findings were transformed into survey items.  
Table 6-1: How survey items were generated from qualitative data 
Qualitative theme Qualitative data Survey Item 
The business image of 
pharmacy 
“…once they graduate, the next 
thing is that they desire to make 
the quickest money within the 
shortest possible time. So any 
activity that will not be profiteering 
to them in terms of cash, they will 
not want to engage on.” 
Pharmacists are more 
interested in the 
business aspect of their 
practice than clinical 
pharmacy practice. 
Confidence “They [pharmacists] are not 
confident enough which again I 
want to attribute to the training. I 
think if the training is adequate in 
that respect, their confidence in 
participation in such activities like 
ward rounds will also increase.” 
The current 
undergraduate 
pharmacy curriculum 
does not produce 
confident pharmacists 
able to apply their 
knowledge in clinical 
settings 
Prescribing a logical 
role for pharmacists 
“Yes, there is a need; we actually 
need a law to say that pharmacists 
can prescribe.” 
Pharmacists in Nigeria 
should be given the 
right to prescribe 
Facilitators and barriers 
to pharmacist 
prescribing 
“If you tell Nigerian doctors to 
relinquish what they see as their 
birth right to another professional, 
there will be serious opposition” 
There will be resistance 
to pharmacist 
prescribing by the 
medical doctors 
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The initial version of the questionnaire had 87 items intended to measure participants’ 
views on a 5 point Likert scale: strongly agree, agree, unsure, disagree and strongly 
disagree. This version of the questionnaire was divided into 7 sections: demography, 
clinical pharmacy practice in Nigeria, collaborative practice, views on pharmacist 
prescribing, barriers to pharmacist prescribing in Nigeria, training need and perceived 
benefits. All questions in this questionnaire were closed questions. This initial version 
was reviewed by my supervisors who have extensive experience in pharmacy practice 
research and questionnaire design. A number of issues were identified with the draft 
and several suggestions were made to improve on the first draft. These suggestions 
include the inclusion of an introductory statement in each section to say why 
participants should answer each question and how it fit to the overall objectives of the 
study; the use of logic to guide respondents once they have stated the group they 
belong to; and the need to include an open ended question at the end of each section 
where participants can freely make comments.  
The draft of the questionnaire was reviewed  in conjunction with my supervisors until a 
final version was produced. The final version of the questionnaire (Appendix 15) had 3 
sections and contained 50 items consisting of both close and open ended questions. 
The first section of the questionnaire had 8 items and sought to obtain anonymous 
demographic details of respondents including gender, years of experience, area and 
place of practice. These data are needed to enable the statistical classification of 
respondents’ views and test for relationship between participants’ demographics and 
views. The second section sought participants’ views on clinical pharmacy practice in 
Nigeria in order to identify the potential changes needed to develop clinical pharmacy 
practice. It had 9 items including an open ended question. All the closed questions 
asked in this section were measured on a five point Likert scale: strongly agree, agree, 
unsure, disagree and strongly disagree. The 9 items in the second section explored 
participants views on changes needed in pharmacists’ training, career structure and 
practice. Participants were asked at the end of this section to freely give any other 
relevant comments on clinical pharmacy practice in Nigeria.  
The third section of the questionnaire was developed based on the views of 
stakeholders on granting pharmacists prescribing authority in Nigeria. It contained 33 
items comprising: (i) Six (6) items (on a 5 point Likert scale) measuring participants’ 
views on pharmacist prescribing in Nigeria including their preferred model; (ii) Twenty 
five (25) items (on a 5 point Likert scale) measuring participants’ views on potential 
facilitators and barriers to introducing pharmacist prescribing in Nigeria; (iii) One (1) 
item with 13 sub-items measuring participants’ willingness to be a prescriber and their 
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perceived areas of training needs. This item was developed based on the qualitative 
findings and the study by Hoti et al. (2014); and (iv) An open ended item seeking 
participants’ opinions on the facilitators and barriers to pharmacist prescribing in 
Nigeria. All the 5 point Likert scale items in this section were measured on strongly 
agree, agree, unsure, disagree and strongly disagree.   
6.4.6 Validity and reliability 
According to Hammersley (1992 p.69) "an account is valid or true if it represents 
accurately those features of the phenomena that it is intended to describe, explain or 
theorize". Therefore, the validity of an instrument refers to the degree to which the 
instrument measures what it is designed to measure (Peterson, 2000, Coolican, 2004). 
The questionnaire developed was evaluated for content validity by my supervisors 
through an iterative review process. In addition, two pharmacy practice researchers in 
Nigeria were asked to assess the ability of the questionnaire to answer the research 
question, and its coverage on all relevant aspect of the research objectives as 
suggested by Polgar and Thomas (2008). The two researchers considered the content 
of the questionnaire to have met the objectives of the study. The only issue raised by 
one of the researchers was on the location of the section containing the demographic 
details of participants. The researcher considered putting it at the end of the 
questionnaire to be better as some participants may be put-off or become uninterested 
with surveys beginning with demographic details. However, this advantage was 
discussed in a supervisory meeting and it was considered worthwhile to leave the 
demographics at the initial section of the questionnaire. This is because demographic 
data are easy to respond to and will smoothly usher the responder into the main survey 
without any difficulty. However, it was agreed that if such issue comes up during the 
pilot study, a review of the order of the sections of the questionnaire would be 
necessary.  
The reliability of a questionnaire is the extent to which the results obtained through the 
use of the questionnaire can be replicated under the same or similar conditions 
(Peterson, 2000, Parfitt, 1997). Various measures including internal consistency test, 
inter-rater reliability and test-retest reliability are used to evaluate the reliability of an 
instrument (Roberts et al., 2006, Peterson, 2000). Inter-rater reliability evaluates the 
extent to which the research instrument produces consistent results when used by 
different individuals while test-retest reliability is concerned with how consistent the 
results are when the research instrument is used at two or more points in time (Roberts 
et al., 2006, Peterson, 2000). Inter-rater reliability test was considered not applicable to 
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this study while test-re-test reliability was not carried out because in this form of 
reliability assessment, time is critical and it was considered not feasible within the 
entire timing of the PhD programme to re-test the survey instrument. However, the 
internal consistency test was carried out in this research. This form of reliability test, 
measures the extent to which different items measuring the same construct are 
correlated (Roberts et al., 2006, Peterson, 2000). The internal consistency of questions 
measuring the same construct is determine statistically using Cronbach’s alpha (α) 
coefficient (Roberts et al., 2006, Peterson, 2000, Cronbach, 1951). The Cronbach’s 
alpha coefficient of the 5 point Likert scale items measuring the facilitators and barriers 
to pharmacist prescribing in Nigeria was determined. The result is reported in section 
6.4.7.3. The internal consistency of the item measuring participants’ perceived training 
needs for pharmacist prescribing was also determined. This aspect of the 
questionnaire asked respondents to indicate their perceived areas of training need. 
Therefore, each of the areas of training need was treated as a binary variable 
consisting of a ‘No’ and ‘Yes’ response and coded ‘0’ and ‘1’ respectively. In calculating 
the internal consistency of items in binary responses measuring a particular construct, 
the Kuder-Richardson reliability coefficients (KR-20) which is also a measure of internal 
consistency is preferred over Cronbach’s  alpha as Cronbach’s is more appropriate for 
items with a range of multiple responses (Şeref, 2009, Feldt, 1969). However, in 
practice, the KR-20 and Cronbach alpha could yield similar results when applied to 
binary variables (Feldt, 1969). Therefore the KR-20 of the 13 items measuring 
perceived areas of training needs of respondents in the pilot study was determined to 
assess their internal consistency. The KR-20 value obtained is reported in section 
6.4.7.3. 
6.4.7 Pilot survey 
Pilot surveys are small-scale studies essentially designed to pre-test a survey 
instrument (Peterson, 2000). They also provide additional information including 
potential response rate; cost and feasibility of the main study; and data used to 
determine sample size for the main study in areas where there are no available 
information to inform sample size determination (Thabane et al., 2010, Peterson, 
2000). A pilot survey was therefore undertaken in this research to pre-test the 
developed questionnaire including its layout; questions sequence and clarity; and 
determine the internal consistency of the items measuring specific constructs in the 
questionnaire. The pilot survey also provided the opportunity to test the possibility of 
using the online survey software (Bristol Online Survey) to conduct a survey with 
Nigerian participants. 
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6.4.7.1 Pilot sample 
Even though what constitute an appropriate sample size for pilot studies is subject to 
debate, participants in pilot studies should be representatives of the study target 
population (Thabane et al., 2010, Peterson, 2000). Therefore they should be included 
in the pilot study using similar inclusion criteria that would be employed in the main 
study (Thabane et al., 2010, Peterson, 2000). There are several suggestions in the 
literature regarding the sample size of pilot studies in quantitative research. According 
to Peterson (2000), a sample size of at least 60 individuals are needed in piloting a 
survey questionnaire while Polgar and Thomas (2008) suggested that pilot survey 
should be conducted in about 10% of the study population. This study therefore works 
with the suggestion of Polgar and Thomas (2008) and recruited 80 participants for the 
pilot survey. The participants were pharmacists who were members of the PSN’s 
Facebook group identified through a simple random technicque by generating a list of 
80 random numbers using Microsoft Excel. Members of  the Facebook group whose 
serial number on the Facebook group list correspond with the numbers generated were 
contacted for the pilot survey. 
6.4.7.2 Pilot data collection 
 An online pilot survey was conducted in August 2014 using the Bristol Online Survey. 
The online survey was created by the researcher and then previewed together with one 
of  my supervisors for face value and any spelling errors before it was launched online.   
Pharmacists selected from the PSN’s Facebook group list were sent a message 
through Facebook inviting them to participate in the pilot survey. The message sent to 
them contained the link to the online pilot survey. Participants were asked to provide 
feedbacks to the researcher on any question they considered ambiguous or any other 
issue they identify with the questionnaire including style, length, access to the online 
questionnaire and difficulty faced when completing the online survey. A follow-up 
message was sent after two weeks thanking those who have completed the survey and 
requesting those who were yet to participate to do so.  
6.4.7.3 Pilot results 
Of the 80 pharmacists that were contacted for the pilot survey, 48 participants 
attempted to complete the survey but only 41 were completely filled. This represents a 
response rate of 51.3%. This response rate was considered good for an online survey 
since they are associated with low response rate (Bryman, 2012). No report was 
received from any participant indicating that any of the questions asked was confusing 
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or difficult to answer.  In addition, analysis of the uncompleted surveys showed that the 
missing response per items (with the exception of the open ended questions) were less 
than 10%. This further indicates that respondents had clear understanding of questions 
asked and were able to respond to them. Almost a third (n=12) of the respondents 
responded to the open ended questions. This was not considered a major concern as 
non-response rate as high as 76% have been reported for open ended question in 
many surveys (Andrews, 2005). In addition, the open ended questions asked were 
optional in the main survey. They were expected to generate narrative data that were 
not intended for statistical generalisation.  
Reliability testing of the questionnaire was carried out using Chronbach’s alpha (α). 
The internal consistency of the 25 items measuring the facilitators and barriers to 
granting prescribing rights to pharmacists in Nigeria was determined using SPSS and 
that gave an α value of 0.745. In social research including pharmacy practice research, 
an α value of 0.7 is usually considered acceptable (George and Mallery, 2003). 
Therefore the internal consistency of the items included in the questionnaire to 
measure the facilitators and barriers to pharmacist prescribing in Nigeria was 
considered appropriate. The KR-20 of the 13 items measuring respondents’ perceived 
areas of training need for pharmacist prescribing was 0.892. Similar to Cronbach’s 
alpha, the KR-20 range from 0-1 and the value obtained from the pilot was considered 
good. Overall, the researcher and the supervisory team thought there was no need for 
any modification of the questions asked. 
Nevertheless, other issues related to the administration of the questionnaire were 
identified by respondents including non-inclusion of a progress bar and having many 
questions on a single page as indicated by respondents’ comments below. 
“Include a progress bar and take out the page numbers. It didn't help 
me to know I was on page 2 of 6, I just wanted to know if I was nearly 
done or how much longer I had to go.” 
“I think people might be more inclined to go to the end of the survey if 
the questions are spread over more pages rather than have so many 
on one page. I know you have split them in to sections which cover 
particular topics but for the respondents, it is easier to click on next 
rather than keep scrolling down.” 
These comments were considered and it was observed that unlike other online survey 
systems, the Bristol Online Survey do not have a progress bar where it indicates the 
percentage of the survey covered. It only indicates progress made based on the 
number of pages covered as used in the pilot. Also, having the online survey into many 
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pages as suggested was also considered. However, the supervisory team consider it 
worthwhile to keep the number of pages of the survey to a minimum. This is because 
internet connection in Nigeria may not be as good to allow respondents navigate 
through so many pages without much difficulty or being disconnected. Therefore, the 
fewer the pages, the easier it is for respondents to navigate through the questionnaire. 
6.4.7.4 Modifications based on pilot findings 
Given the findings of the pilot survey, no major modification was considered necessary 
to the content and layout of the piloted online survey. The only modification made to 
the survey was to make responding to all the closed ended questions compulsory in 
order to minimise the number of missing response in the survey. However, the open 
ended questions were optional. 
Since no major changes were made to the questionnaire following the pilot study, the 
data collected were included in the overall results of this study. However, some 
researchers have expressed concern over the inclusion of pilot results in the main 
study in quantitative research. They argue that this is likely to lead to data 
contamination (van Teijlingen and Hundley, 2002). This was not considered to be the 
case in this study.  Data contamination was unlikely because pilot participants were 
drawn from the same target population used for the main study. In addition, they were 
included in the study based on the same inclusion criteria and sampling technique used 
for the main study. Furthermore, the pilot participants were not recruited into the main 
study. Therefore no new or additional data were collected from them.  
6.4.8 Main study 
A cross-sectional survey was conducted from September to October 2014 among 
pharmacists in Nigeria using an online self-completion questionnaire as the data 
collection instrument. A simple random sample of 695 pharmacists who were members 
of the Facebook group of the PSN were invited to participate in the online survey. They 
were invited through a generic recruitment mail (see Appendix 16) sent to their 
Facebook inbox. The mail contained a link to the online survey.   
The first page (see Appendix 15) of the online survey contained an introductory 
statement relating to the study. In addition, it contained information on consent and 
implication for participating in the study.  Those who accepted to continue with the 
survey moved unto the next page of the survey which contained the survey questions. 
The survey consisted of 50 items which were divided into 3 sections as described in 
section 6.4.5 above. 
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Reminders were sent to research participants, 2 weeks after they received the initial 
invitation mail. Since the link sent to participants for the survey was generic, it was not 
possible to track those that had responded to the survey. Therefore, reminders were 
sent to all those recruited in the survey, thanking those that have completed the survey 
and urging those that have not to please do so. An additional 3 weeks was allowed to 
collect responses following the reminder. The survey was closed at the end of October 
2014.  
6.4.9 Data Analysis 
The data collected in this study were imported from the BOS system into the IBM 
SPSS version 22 for data management and analysis. The analysis of the data 
proceeded as described below. 
6.4.9.1 Descriptive analysis 
Descriptive statistics are methods used in describing the basic feature of a sample 
(Mann, 2007). Descriptive statistics includes among others frequencies, mean, median, 
standard deviation and variance (Marsh and Elliott, 2008).  In this study, frequencies 
and percentages generated using SPSS were used to describe the demographic 
characteristic of respondents including respondents’ gender, academic qualifications, 
years of experience and area of practice. Respondents’ views were also summarised in 
frequencies and percentages. In some occasions, these views were presented in bar or 
pie charts to enhance understanding of the data. 
6.4.9.2 Bivariate relationships 
The data collected in this research were mainly categorical. Therefore, relationships 
between two (bivariate relationships) variables for example respondents’ practice 
setting and views on granting pharmacists prescribing authority were evaluated using 
chi-square test. In testing for associations between variables, respondents’ views were 
rescaled into three categories (strongly agree/agree, unsure and disagree/strongly 
disagree) instead of the five point Likert scale (strongly agree, agree, unsure, disagree 
and strongly disagree) which the data was collected. This rescaling was done because 
of the small sample size of the study. In addition, re-categorising respondents’ view into 
three (as opposed to 5) in chi-square analysis will minimise the probability of making 
type 2 error (failing to reject the null hypothesis even though there is a difference 
between the groups in the population) which is usually manifested when the sample 
size is small or when considering a small sub-group within a large survey (Marsh and 
Elliott, 2008). Furthermore, Fisher’s exact test was used to determine statistical 
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difference between groups in instances where the groups were small, particularly when 
the numbers of counts per cell in the contingency table were less than 5 in more than 
20% of the cells (Field, 2009). In all the Chi-square and Fisher’s exact tests conducted, 
a p-value of less than 0.05 was considered statistically significant. 
6.4.9.3 Logistic regression 
A binary logistic regression was conducted to determine the independent predictors of 
support for pharmacist prescribing. The dependent variable which was a dichotomous 
variable was coded as 0 and 1 for responses not supporting pharmacist prescribing 
and those supporting it, respectively. The demographic characteristics of respondents 
including gender, years of experience and area of practice were used as the 
independent or predictor variables.  
6.4.9.4 Analysis of textual data 
Two questions in the survey sought textual responses from respondents. In one of the 
questions, respondents were asked to comment freely on clinical pharmacy practice in 
Nigeria. In the second question, they were asked to comment on any additional 
information that the researcher could consider as potential barriers and facilitators to 
granting prescribing rights to pharmacists in Nigeria. The textual data obtained from 
participants were extracted from the BOS system and imported into Nvivo software 
version 10 for data management.    
The data were analysed using thematic analysis and proceeded in a similar fashion as 
previously reported in the preceding chapters. The transcripts generated were read 
repeatedly to familiarise the researcher with the data. These data were then coded 
inductively as the researcher read through the transcripts to generate codes.  Coded 
data were thoroughly examined and links were established between codes to develop 
categories and potential themes. These themes were then reviewed in relation to the 
coded data and the objectives of this study.  
6.5 Results 
6.5.1 Response rate 
Of the 695 pharmacists contacted for the main survey (which excluded the 80 already 
included in the pilot), 316 attempted to complete the survey but only 274 surveys were 
completely filled while the remaining 42 were uncompleted. The 42 uncompleted 
surveys were unusable and therefore excluded from the study.  Hence, the response 
rate for the main study was 39.4% (n=274/695). Adding the pilot surveys [pilot 
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response rate of 51.3% (n=41/80)] to those obtained in the main study yielded an 
overall response rate of 40.6% (n=315/775).  
This is one of the first online pharmacy practice surveys in Nigeria. Therefore, there is 
no available data for comparison in terms of response rate. However, the response rate 
(40.6%) of this study is small compared to other pharmacy practice surveys where 
questionnaires were administered face-to-face to pharmacists in their practice settings 
in Nigeria. For example, Erah and Nwazuoke (2002) and Oparah and Eferakeya (2005) 
obtained a response rate of 79% and 67% respectively, in their survey. Nevertheless, 
online surveys including those of pharmacy practice are generally associated with low 
response rate (Bryman, 2012, Pedersen et al., 2011). For example, Pedersen et al. 
(2011)  reported a response rate of 28.8% in a national survey of hospital pharmacy 
practice in the US. Therefore, the response rate of the present study was considered 
good.  
6.5.2 Demographic details of respondents 
Table 6-2 presents a summary of the demographic characteristics of respondents. 
Majority of respondents were male (n=197; 62.5%). About half of the respondents were 
between 31-40 years old and have between 0-10 years of experience as pharmacists. 
The Bachelor of Pharmacy degree was the most common basic pharmacy qualification 
held by respondents (n=294; 93.3%). Twenty eight (8.9%) respondents hold a 
postgraduate clinical pharmacy qualification. Many respondents were working as 
hospital pharmacists (n=190; 60.3%). Hospital pharmacists included those working in 
primary (n=10; 3.2%), secondary (n=68; 21.6%) and tertiary care (n=112; 35.6%). 
Many of those that responded to the online questionnaire were located in the north-
central (n=88; 27.9%) and south-west (n=80; 25.4%) geopolitical zone of Nigeria.   
 210 
 
Table 6-2: Demographic characteristics of respondents 
Demographic  Number of 
respondents 
Percentage 
(%) 
Gender 
Male 
Female 
 
197 
118 
 
62.5 
37.5 
Age group (years) 
21-30  
31-40  
41-50  
> 50  
 
73 
148 
84 
10 
 
23.2 
47.0 
26.7 
3.2 
Years of experience 
0-5 
6-10 
11-15 
16-20 
> 20 
 
92 
105 
60 
32 
26 
 
29.2 
33.3 
19.0 
10.2 
8.3 
Type of undergraduate pharmacy degree 
Bachelor of Pharmacy  
Pharm D  
Bachelor of Pharmacy and Pharm D. 
 
294 
11 
10 
 
93.3 
3.5 
3.2 
Hold a postgraduate clinical pharmacy 
qualification 
Yes 
No 
 
 
28 
287 
 
 
8.9 
91.1 
Hold the Fellowship of the West African 
College of Pharmacy 
Yes 
No 
 
 
37 
278 
 
 
11.7 
88.3 
Primary area of practice 
Hospital 
Community  
Industry 
Academic 
Administrative 
Others 
 
190 
44 
23 
28 
13 
17 
 
60.3 
14.0 
7.3 
8.9 
4.1 
5.4 
Geopolitical zone  
North-west 
North-east 
North-central 
South-west 
South-east 
South-south 
 
47 
39 
88 
80 
28 
33 
 
14.9 
12.4 
27.9 
25.4 
8.9 
10.5 
N=315 
Recent data on the demographic distribution of pharmacists in Nigeria is lacking. 
However, available data as at December 2007 showed that 30.5% of the 13,199 
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pharmacists in the country were females (AHWO, 2008). Majority of pharmacists in the 
country as at then were located in South-west (44%) and North-central (20%) region of 
Nigeria (AHWO, 2008). However, precise data on the practice settings of these 
pharmacists were lacking (AHWO, 2008). Even though 37.7% of respondents in this 
study were female and the majority of respondents resided in North-central and South-
west region, the statistical representation of these data is unlikely. This is because the 
current demographic distribution of pharmacists in Nigeria is likely to be different from 
the 2007 data. Furthermore, the population (PSN’s Facebook group) to which the 
sample of this study was drawn was a biased one. 
6.5.3 Views on clinical pharmacy practice in Nigeria 
This study explored the views of Nigerian pharmacists on key aspect of clinical 
pharmacy including education, specialisation in practice, career pathway and the 
development of pharmacy technicians. Respondents reported that specialisation in 
practice (n=320; 98.4%) and a clinical career pathway for pharmacists (n=320; 98.4%) 
would be needed for the development of clinical pharmacy practice in Nigeria (Table 
6-3). These views were commonly held by all categories of respondents as it was not 
associated (p > 0.05) with any demographic characteristics of respondents. About two-
thirds of the respondents (n=220; 69.8%) agreed that the present undergraduate 
pharmacy curriculum does not produce confident pharmacists able to apply their 
knowledge in clinical settings. This view was found to be associated with hospital 
pharmacists (p < 0.05). A higher proportion of pharmacists in tertiary (n=85; 75.9%) 
and secondary (n=41; 60.3%) hospitals compared to those in primary (n=5; 50.0%) 
hospitals reported that the current undergraduate curriculum is not sufficient for 
practice in clinical settings.  
Many respondents (n= 256; 81.3%) reported that the current separation of prescribing 
as doctors’ role and dispensing as pharmacists’ role in Nigeria is not in the best interest 
of the patient. This view was commonly held by all categories of respondents as it was 
not associated (p > 0.05) with any of respondents’ demography. 
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Table 6-3: Views of respondents on clinical pharmacy practice in Nigeria 
Statements SA/A 
n (%) 
Unsure 
n (%) 
D/SD 
n (%) 
Demographic factor 
associated with 
Pharmacist specialisation in different clinical sub-specialties would 
promote the development of clinical pharmacy practice in Nigeria 
310 (98.4) 3 (1.0) 2 (0.6) None 
A clinical career pathway should be created for pharmacists who want 
to be clinical pharmacists.  
310 (98.4) 1 (0.3) 4 (1.3) None 
The current undergraduate pharmacy curriculum does not produce 
confident pharmacists able to apply their knowledge in clinical setting  
220 (69.8) 17 (5.4) 78 (24.8) Hospital pharmacists 
(p=0.033) 
Collaborative practice between doctors and pharmacists in patient 
care is needed for the development of clinical pharmacy practice 
303 (96.2) 5 (1.6) 
 
7 (2.2) None 
Pharmacy technicians should  be further trained to do some of the 
traditional medicine supply functions of pharmacists 
152 (48.3) 47 (14.9) 116 (36.8) Postgraduate clinical 
qualification (p=0.010) 
There are policies in place in the country that support the development 
of clinical pharmacy practice. 
47 (14.9) 134 (42.5) 134 (42.5) None 
The current separation of prescribing as doctors’ role and dispensing 
as pharmacists’ role in Nigeria is in the best interest of the patient.  
39 (12.4) 20 (6.3) 256 (81.3) None 
Pharmacists are more interested in the business aspect of their 
practice than clinical pharmacy practice. 
131 (41.6) 21 (6.7) 163 (51.7) None 
N= 315; SA/A: Strongly agree/Agree; D/SD: Disagree/Strongly disagree
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As seen in the table above, many respondents were either unsure (42.5%) or 
disagreed (42.5%) that there are policies in the countries that support the development 
of clinical pharmacy practice. Also, over a third of respondents (41.6%) reported that 
pharmacists are more interested in the business aspect of their practice than clinical 
pharmacists practice. This result further confirms the claim in chapter 5 of the 
commercial interest of community pharmacists. 
Furthermore, about a half (n= 152; 48.3%) of the respondents were in support of 
further training of pharmacy technicians to enable them do some traditional medicine 
supply roles of pharmacists. This view was found to be associated (p < 0.05) with 
having a postgraduate qualification in clinical pharmacy. Seventy five percent (n=21) of 
those with a postgraduate qualification in clinical pharmacy compared to 45.6% 
(n=131) of those without a postgraduate clinical pharmacy qualification held this view 
(see Figure 6-2).  
 
Figure 6-2 : Relationship between postgraduate clinical qualification and 
respondents’ agreement on further training of pharmacy technicians to do some 
pharmacists’ traditional medicine supply roles 
Also, just over half of the respondents (n=163; 51.7%) were not in agreement that 
pharmacists are more interested in the business aspect of their practice than clinical 
pharmacy practice. 
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 214 
 
6.5.4 Views on pharmacist prescribing 
The results of this study revealed an enormous support for an extended role in 
prescribing for pharmacists in Nigeria. Three hundred and six (97.1%) respondents 
agreed that pharmacists should be given the authority to prescribe medicines. Of these 
306 respondents, 295 (96.4%) were willing to be prescribers. Analysis of the data 
showed no significant difference (p < 0.05) between hospital and community 
pharmacists in their willingness to be prescribers as 95.8% and 97.7% of hospital and 
community pharmacists respectively, were willing to be prescribers.  
Of the 295 respondents who were willing to be prescribers, 148 (50.2%) would prefer to 
prescribe in collaboration with medical doctors where the doctor makes the diagnosis 
while 31 (10.5 %) preferred independent prescribing. Just over one-third of these 
respondents (n=111; 37.6%) would prefer a combination of collaborative and 
independent prescribing. Prescribing from a limited drug formulary was the least 
preferred model of prescribing among respondents as seen in Figure 6-3.  
 
Figure 6-3: Respondents’ preferred model of prescribing 
The chi-square tests performed showed no significant difference (p > 0.05) between 
hospital and community pharmacists in their preference for any of the prescribing 
models as seen in Table 6-4.  
 
 
Collaborative 
prescribing alone, 
148 (50.2%) 
Independent 
prescribing alone, 
31 (10.5%) 
Colaborative and 
Independent 
prescribing,        
111 (37.6%) 
Limited formulary 
prescribing alone, 
5 (1.7%) 
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Table 6-4: Relationship between respondents’ area of practice and preferred 
prescribing model 
Areas of practice N Col. alone  
n (%) 
Ind. alone 
n (%) 
Both 
n (%) 
Hospital 182 93 (51.1) 21 (11.5) 65 (35.7) 
Community 43 18 (41.9) 4 (9.3) 19 (44.2) 
Others 70 37 (52.8) 6 (8.6) 27 (38.6) 
N=295; Col. Alone= Collaborative prescribing alone; Ind. Alone= Independent prescribing alone 
The majority of respondents (n= 234; 79.3%) who were willing to be prescribers 
strongly agreed or agreed that prescribing should be reserved for experienced 
pharmacists who are able to demonstrate certain competences. This view was 
commonly held by all categories of respondents as it was not significantly associated 
(p > 0.05) with any demographic variable. 
Furthermore, the majority of respondents (n=285; 96.6%) who were willing to be 
prescribers reported that they will need additional training in order to become 
prescribers. In addition, all of these respondents strongly agreed or agreed that 
postgraduate clinical courses should be developed to prepare pharmacists for 
prescribing. The most perceived areas of training need were in the principles of 
differential diagnosis (81.4%), pathophysiology of diseases (74.0%) and interpreting 
laboratory results (68.1%). Medication adherence (25.6%) and communication skills 
(35.1%) were reported as areas of least training need as shown in Figure 6-4. 
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Figure 6-4: Areas of training need identified by respondents 
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6.5.5 Independent predictors of support for pharmacist prescribing  
Binary logistic regression was performed to determine the independent demographic 
predictors of support for pharmacist prescribing. The model included gender, holding a 
postgraduate qualification in clinical pharmacy, years of experience and respondents’ 
practice setting as covariates. The predictive accuracy of the logistic regression model 
was high (97.1%). However, the results showed that none of the demographic 
variables was a predictor of the support for pharmacist prescribing among respondents. 
The final regression model produced did not differ significantly from the initial model 
containing only the constant (Chi-square=10.409; p-value = 0.494).  
6.5.6 Potential facilitators and barriers to pharmacist prescribing 
This section presents the potential facilitators and barriers to granting prescribing 
authority to pharmacists in Nigeria. All respondents (n= 315) completed the facilitators 
and barriers scales. Table 6-5 shows the items linked to the potential facilitators and 
barriers to pharmacist prescribing in Nigeria. The table is presented in such a way that 
the items with a high proportion of strongly agree/agree responses appear at the top 
rows.  Respondents identified increasing patients’ access to care (n=308; 97.8%) and 
better utilisation of pharmacists’ skills (n=307; 97.5%) as the most likely facilitators. On 
the other hand, resistance from the medical doctors (n=299; 94.9%) and pharmacists’ 
inadequate skills in diagnosis (n=255; 81.0%) were perceived as the most likely 
barriers. Other factors identified by respondents that could facilitate pharmacist 
prescribing were ensuring effective use of the limited human resources for health 
(n=290; 92.1%), reducing doctors’ workload (n=273; 86.7%), cost-savings on 
healthcare budgets (n=271; 86.0%) and legitimising prescription medicine supply 
(n=246; 78.1%).  
Similarly, other barriers identified by respondents were shortage of pharmacists 
(n=220; 69.8%), pharmacists’ lack of time (n=165, 52.4%), lack of access to patients’ 
clinical data (n=208; 66.0%), pharmacists’ limited training in clinical assessment 
(n=192; 61.0%) and poor working relationships with medical doctors (n=199; 63.2%). 
Lack of government’s support also emerged as a barrier to pharmacist prescribing in 
Nigeria. Many respondents were either uncertain (n=127; 40.3%) or disagreed (n=143; 
45.5%) that the government is interested in developing pharmacists’ clinical roles. 
Furthermore, many respondents perceived that reduction in quality of care (n=286; 
90.8%), the potential for prescribing errors (n=257; 81.6%) and conflict of interest 
(n=167; 53.0%) in prescribing will not be barriers to pharmacist prescribing in Nigeria.  
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Table 6-5: Perceived facilitators and barriers to pharmacist prescribing 
Statements SA/A 
n (%) 
Unsure 
n (%) 
D/SD 
n (%) 
Pharmacist prescribing will increase patients’ access to care 308 (97.8) 2 (0.6) 5 (1.6) 
Pharmacist prescribing will enable better use of pharmacists’ professional skills 307 (97.5) 3 (1.0) 5 (1.6) 
There will be resistance to pharmacist prescribing by the medical doctors 299 (94.9) 4 (1.3) 12 (3.8) 
Pharmacist prescribing will ensure effective use of the limited human resources in the health sector 290 (92.1)  13 (4.1) 12 (3.8) 
Pharmacist prescribing will reduce doctors’ workload 273 (86.7) 20 (6.3) 22 (7.0) 
Pharmacist prescribing will save healthcare cost for the government. 271 (86.0) 32 (10.2) 12 (3.8) 
Pharmacists’ skills in making diagnoses are limited 255 (81.0) 17 (5.4) 43 (13.7) 
Pharmacist prescribing will minimise the current illegal supply of ‘Prescription Only Medicines’ 
without a prescription in Nigeria 
246 (78.1) 51 (16.2) 18 (5.7) 
There are inadequate number of pharmacists in the country to do additional roles 220 (69.8) 20 (6.3) 75 (23.8) 
 Pharmacists lack access to patients’ clinical data 208 (66.0) 21 (6.7) 86 (27.3) 
Pharmacists’ training in clinical assessment is limited 192 (61.0) 26 (8.3) 97 (30.8) 
Pharmacists lack time to take on additional roles 165 (52.4) 20 (6.3) 130 (41.3) 
Pharmacists lack confidence to take on clinical roles 141 (44.8)  23 (7.3) 151 (47.9) 
There are inadequate facilities within community pharmacist to allow pharmacist prescribing 115 (36.5) 31 (9.8) 169 (53.7) 
Pharmacist prescribing will only happen if technicians are further trained to take on some of the 
supply roles of pharmacists 
108 (34.3) 51 (16.2) 156 (49.5) 
Pharmacists have negative attitude toward taking up clinical roles 106 (33.7) 34 (10.8) 175 (55.6) 
Pharmacists have a close working relationship with doctors in patient care 89 (28.3) 32 (10.2) 194 (61.6) 
Pharmacists will have commercial interest in prescribing 79 (25.1) 69 (21.9) 167 (53.0) 
There will be conflict of interest with pharmacists acting as both prescribers and dispensers 61 (19.4) 55 (17.5) 199 (63.2) 
The government is interested in developing pharmacists’ clinical roles 45 (14.3) 127 (40.3) 143 (45.4) 
Pharmacist prescribing will create confusion among the public as to the role of doctors and 
pharmacists 
33 (10.5) 38 (12.1) 244 (77.5) 
Pharmacist prescribing will increase the likelihood for prescribing errors 27 (8.6) 31 (9.8) 257 (81.6) 
Pharmacist prescribing will reduce the quality of care the patient receives 20 (6.3) 9 (2.9) 286 (90.8) 
Pharmacist prescribing will not be accepted by patients 7 (2.2) 11 (3.5) 297 (94.3) 
Pharmacist prescribing will be more expensive for the patient 6 (1.9) 14 (4.4) 295 (93.7) 
N=315; SA/A: Strongly agree/Agree; D/SD: Disagree/Strongly disagree 
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6.5.7 Analysis of textual data 
Two optional open ended questions (question 17 and 50 in Appendix 15) were asked in 
this study. Respondents made comments on clinical pharmacy practice and the 
facilitators and barriers to extending pharmacists’ clinical roles to include prescribing in 
Nigeria.  
Generally, 151 (47.9%) respondents responded to ‘Question 17’ while 69 (21.9%) 
responded to ‘Question 50’.  The comments were short responses with an average 
word length of 36. The responses from both questions were collectively analysed.  
Analysis of the comments showed similar findings with that of the interviews held with 
Nigerian stakeholders in chapter 5, thereby confirming the qualitative findings. 
Overall, respondents’ comments revealed that clinical pharmacy practice in Nigeria is 
still in its infancy stage. Many respondents viewed it as an evolving practice whose 
development has been slow due to the lack of an enabling practice and policy 
environment.   
“Clinical pharmacy practice in Nigeria is at a low ebb probably because 
the environment is not enabling”. R69, Community Pharmacist 
“The systems and structures in place in Nigeria had not given 
adequate room for clinical pharmacy practice”. R152, Hospital 
Pharmacist  
Respondents reported that in many hospital facilities, pharmacists’ roles have been 
limited to dispensing and counselling of patients on their medicines. Many respondents 
viewed this as an underutilisation of their skills.  
“What we find pharmacists do is what we call 'two 3 times daily' which 
even an illiterate can do if shown how to do it.” R55, Hospital 
Pharmacist 
“Pharmacists in hospitals simply count drugs and do nothing more at 
the hospitals, their brains just waste away without proper use of it.” 
R36, Public Health Pharmacist 
Respondents in their comments associated the underdevelopment of clinical pharmacy 
practice to a number of challenges. These challenges could be classified into internal 
factors which are pharmacy related including limited clinical education and 
pharmacists’ attitude to clinical roles; and factors which are external to the pharmacy 
profession including opposition from the medical profession and policy barriers. 
Respondents perceived that these challenges could potentially serve as barriers to 
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granting prescribing authority to pharmacists in Nigeria. The themes that emerged from 
respondents’ comments are presented in Table 6-6. 
Table 6-6: Themes and supporting quotes identified from the analysis of textual 
data 
Theme Description Supporting quotes 
Limited clinical education 
(109 comments) 
The current undergraduate 
training curriculum was viewed 
by many respondents as 
deficient in clinical component. 
According to respondents, this 
has resulted in the lack of 
confidence demonstrated by 
pharmacists in clinical settings. 
In addition, respondents 
reported that post-registration 
training with specialisation is 
needed to enhance clinical 
pharmacy practice.   
Respondents also noted that if 
pharmacists’ roles are to be 
extended to include prescribing, 
additional training would be 
necessary. 
“The pharmacy curriculum does not give 
the pharmacist the opportunity to develop 
confidence to practice as a clinical 
pharmacist. Therefore there is need to 
review the curriculum.” R190, Hospital 
Pharmacist 
“Sadly, the training provided is not geared 
towards making pharmacists confident and 
competent in carrying out these clinical 
duties.” R21, Academic Pharmacist 
“Clinical pharmacy practice in Nigeria can 
be improved through the review of 
curriculum, introduction of residencies 
program for pharmacists which will allow 
for various specialisation” P187, Academic 
Pharmacist 
Pharmacists’ attitudes  
(21 comments) 
Respondents mentioned that 
many pharmacists prefer to 
carry on with their existing role 
in dispensing rather than take on 
additional clinical roles. 
Respondents also mentioned 
that a number of pharmacists 
are only interested in the 
business aspect of pharmacy 
practice. Furthermore, younger 
pharmacists cited lack of 
support/mentorship from their 
older colleagues as possible 
barriers. 
“Many pharmacists are not ready for 
change. Hence, changing their routine 
practice is very difficult.” R28, Hospital 
Pharmacists 
 “The younger pharmacist are more patient 
oriented while the older ones are more 
business oriented on their practice”. R12, 
Community Pharmacist 
“There is need for older colleagues to 
show more interest in mentoring younger 
colleagues”. R115,Hospital Pharmacist 
Inadequate numbers of 
pharmacists (10 
comments) 
Respondents reported that 
pharmacists are inadequate in 
number. As a result, they are 
unable to perform additional 
roles other than their traditional 
role of dispensing. They 
reported that this has slowed the 
development of pharmacists’ 
role outside of the dispensary.  
“One major problem is inadequate staffing. 
A general hospital having between 10-12 
doctors has probably 2 or 3 pharmacists. 
Therefore many pharmacists are not able 
to attend to in-patients.” R301, Hospital 
pharmacist 
“The number of pharmacists in the nation 
does not support additional role to be 
assigned to pharmacists because we are 
still battling to cope with dispensing and 
patient counselling. R288, Hospital 
Pharmacist 
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Table 6-6: Themes and supporting quotes identified from the analysis of textual 
data continued. 
Theme Description Supporting quotes 
Policy (37 comments) Lack of appropriate policies to 
support the development of 
clinical pharmacy practice was 
commonly reported by 
respondents. Respondents felt 
that the current policy 
documents including the 
national drug policy and the 
pharmacists’ license to practice, 
recognised pharmacists’ roles 
as being product-based.  
“There are no government policies to 
encourage the clinical pharmacy 
practice.” R173, Hospital Pharmacist 
“There is no government framework on 
the practice of clinical pharmacy 
especially at the primary and secondary 
levels of health care.” R248, Hospital 
Pharmacist 
“The license to practice is more 
commercial than clinical, We are 
licensed to import, export, sell and 
distribute drugs. The only clinical aspect 
that has been introduced recently is ‘to 
counsel patients’." R134, Academic 
Pharmacist 
Medical dominance  
(49 comments) 
Medical doctors’ control and 
influence on health policies, 
administrative structure of the 
health system and roles of other 
healthcare professionals were 
commonly reported. 
Respondents also commented 
on lack of collaboration between 
doctors and pharmacists in 
Nigeria and viewed this as a 
challenge to clinical pharmacy 
development. Overall, 
respondents reported that any 
role extension including 
pharmacist prescribing that 
would potentially challenge 
medical control would be 
resisted by medical doctors.  
 
“The doctors hold the political power as 
far as the health sector is concerned in 
Nigeria. The physicians have always 
antagonised all policies that tend to 
promote the growth of pharmacy 
profession.” R290, Hospital Pharmacist 
“The obstacles to clinical pharmacy 
practice are largely due to lack of 
legislative backing and outright 
resistance (from doctors) to the changing 
roles of the clinical pharmacist from 
traditional dispensing to collaborative 
patient care.” R67, Hospital Pharmacist 
“Medical doctors will do anything in their 
power to stop pharmacist prescribing so 
that they can maintain their control over 
us.” R64, Hospital Pharmacist 
 
6.6 Study strengths and limitations 
This is the first national survey that investigated pharmacists’ views on the extension of 
their clinical roles to include prescribing in Nigeria. As mentioned earlier, the population 
in which the respondents of this survey were drawn was a biased one. Only members 
of the Facebook group of PSN were recruited which excluded Nigerian pharmacists 
who were not members of the group. This makes the findings of this study unlikely to 
be generalised. Despite this limitation, this study triangulated the qualitative findings in 
chapter 5. In addition, it provides valuable insight into the facilitators and barriers to 
developing pharmacists’ clinical roles to include prescribing in Nigeria.  
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About 60% of those contacted for this survey did not participate in the study. This is 
likely to introduce a non-response bias in the findings of the survey. However, with 
respect to views on pharmacist prescribing,  non-response bias is unlikely because of 
the highly supportive views for pharmacist prescribing recorded in this study (Hoti et al., 
2010). This implies that a significant difference in the results obtained is unlikely. 
6.7 Chapter summary 
This study was intended to further explore and confirm the qualitative findings reported 
in chapter 5. Overall, the findings of this survey confirm the results of the qualitative 
study in the last chapter thereby enhancing its validity.  
The findings on clinical pharmacy practice in Nigeria revealed that the present 
undergraduate pharmacy curriculum does not produce confident pharmacists who are 
able to apply their knowledge in clinical settings. Also, the survey identified the need for 
a clinical career pathway for pharmacists, pharmacists’ specialisation in practice, 
collaboration with medical doctors in practice, utilisation of pharmacy technicians in 
some traditional pharmacists’ roles and adequate polices to support the development 
of clinical pharmacy practice. These findings reflect some of the key potential areas for 
change.  
Generally, pharmacists showed a positive attitude towards pharmacist prescribing as 
the majority of them supported it and were willing to be prescribers. Many of those who 
were willing to be prescribers would prefer to prescribe in collaboration with doctors. 
However, many of these pharmacists who were willing to prescribers noted that they 
will need additional training in order to be prescribers. The training areas particularly 
identified were in the aspects of principles of differential diagnosis, pathophysiology of 
diseases and interpreting of laboratory results. These knowledge and skill gaps could 
be handled by training including  mentorship  under a medical prescriber as currently 
being practiced in the UK and New Zealand. 
The major facilitators to pharmacist prescribing identified in this survey were linked to 
the potential benefits of pharmacist prescribing. These facilitators are increasing 
patients’ access to care, better utilisation of pharmacists’ skills, effective use of the 
limited human resources for health, reducing doctors’ workload, cost-savings on 
healthcare budgets and legitimising prescription medicine supply. However, a number 
of barriers were identified. The commonly reported barriers were the resistance from 
medical doctors and pharmacists’ inadequate skills in diagnosis. Other potential 
barriers also identified were shortage of pharmacists, pharmacists’ lack of time, lack of 
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access to patients’ clinical data, pharmacists’ limited training in clinical assessment, 
poor working relationships with medical doctors and lack of government support. The 
narrative data from survey respondents also confirm these findings.  
Therefore, in the next chapter, an integrated discussion will be carried out on the major 
findings of the three studies conducted in the entire research project. This discussion 
will form the basis of the overall conclusion and recommendations of the entire project 
work. 
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Chapter 7: Discussion and conclusion 
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CHAPTER 7: DISCUSSION AND CONCLUSION 
7.1 Introduction  
This final chapter presents an integrated discussion of the key findings of the three 
studies conducted as part of the mixed methods research presented in this thesis. The 
discussion will provide the basis for the conclusion and recommendations of this thesis. 
The present chapter begins with a synopsis of the aim, objectives and key findings of 
this thesis. This is then followed by an integrated discussion of the key findings and the 
implications of the findings on the extension of pharmacists’ clinical roles to include 
prescribing in Nigeria. The integrated discussion is structured around two broad 
headings: development of clinical pharmacy practice and the potential for pharmacist 
prescribing in Nigeria. Under each heading, discussions are made around key themes 
(see Figure 7-1 on page 227) that emerged from the empirical studies. For examples, 
in the heading considering the ‘development of clinical pharmacy practice’ key themes 
discussed were: government support through appropriate legislation and policies; 
education and training; pharmacy workforce shortages and utilisation of pharmacy 
technicians; career structure and specialisation and medical dominance and 
professional relationship with doctors. The discussion on pharmacist prescribing in 
Nigeria was organised into: views on pharmacist prescribing and facilitators and 
barriers to pharmacist prescribing. 
The discussions on the above mentioned themes are then followed by the section on 
the strengths and limitations of the exploratory sequential mixed methods design used 
in this research.  Furthermore, this chapter presents a conclusion and then makes 
policy, practice and research recommendations which addresses the final objective of 
this thesis:   
 To make practice and policy recommendations for pharmacist prescribing in 
Nigeria. 
7.2 Overview of thesis aim, objectives and key findings 
The aim of this research is to investigate the facilitators and barriers to extending 
pharmacists’ clinical roles to include prescribing in Nigeria. This aim was addressed 
through theoretical and empirical investigations. The theoretical component of the 
thesis was intended to: 
 Review the barriers and facilitators to pharmacist prescribing in the UK  
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This was achieved through a scoping review of the literature. The detailed findings 
were presented in chapter 2. However, the review revealed that the available evidence 
on pharmacist prescribing is predominantly based on stakeholders’ perceptions 
including patients, doctors and pharmacists. The key facilitators to pharmacist 
prescribing identified in the scoping review were legislation, pharmacists’ education 
and training, pharmacists’ clinical experience including specialisation in a clinical area 
prior to prescribing, pharmacists’ willingness/motivation to be prescribers, relationship 
with the medical doctors, patients’ acceptance, access to support from  organisations,  
peers and medical mentors and team approach to prescribing. The scoping review also 
revealed that the shortage of medical doctors and community pharmacists’ accessibility 
(even though there aren’t many community pharmacists as prescribers) also facilitated 
the extension of prescribing authority to pharmacists in the UK.  The barriers to 
pharmacist prescribing identified were often converse. Medical resistance to 
pharmacist prescribing was commonly reported, however, many of the barriers to 
pharmacist prescribing identified were mainly organisational including lack of 
organisational strategy for nonmedical prescribing, lack of funding and shortage of 
pharmacy staff.   
The empirical component of the research employed a sequential mixed methods 
approach to:  
 Investigate the changes in the structure of pharmacy practice in the UK prior to 
the introduction of pharmacist prescribing in order to identify lessons that might 
assist in the potential changes needed in Nigeria.  
 Explore the views of stakeholders involved in prescribing and pharmacy 
practice about the barriers and facilitators to the extension of a prescribing role 
to pharmacists in Nigeria. 
 Identify the potential changes that would be required in the structure of 
pharmacy practice for the development of pharmacist prescribing in Nigeria.  
The findings of the three studies that comprised the mixed methods research have 
been described in detail in chapters 4, 5 and 6. Figure 7-1 overleaf represents the key 
issues that emerged from the research.  
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Figure 7-1: Key issues that emerged from empirical research  
 
Themes identified in the UK and Nigerian studies 
 
 
 
 
 
 
 
 
 
 
 
Critical for clinical 
pharmacy practice  
Pharmacist 
prescribing  
Facilitators in Nigeria 
- Pharmacists’ knowledge of 
medicines  
- Increasing patients access to 
medicines 
- Pharmacists’ accessibility 
- Patients’ support 
- Pharmacists’ positive attitude  
- Relationship with doctors in 
teaching hospitals 
Barriers in Nigeria 
- Lack of government support 
- Medical opposition 
- Shortage of pharmacists 
- Inadequate skills in diagnosis 
- Pharmacists’ lack of confidence in 
clinical settings 
- Poor relationship with doctors 
 
Pre-registration  
- Undergraduate 
education 
- Recruitment 
including Intake 
of trainee 
technicians  
Post-registration 
- Post-registration training  
- Pharmacy workforce and 
utilisation of skill mix 
- Staff retention 
- Career structure 
- Specialisation 
- Medical support 
 
 228 
 
The findings in chapter 4 linked the development of pharmacists’ clinical roles 
including prescribing, to changes in the structure of pharmacy. Chapter 4 identified a 
shift in the focus of pharmacy training from purely scientific to a patient orientated one; 
positive attitudes of pharmacists towards extended clinical roles; specialisation in 
practice; a career route that recognised advanced pharmacy practitioners; enhanced 
working relationships with doctors; the development of pharmacy technicians to do 
some roles previously undertaken by pharmacists and supportive government policy 
environment as key factors that enabled change particularly in hospital pharmacy 
practice in the UK. Chapter 4 concluded by suggesting that changes in the traditional 
structure of pharmacy practice could benefit the development of pharmacists’ clinical 
roles in Nigeria.  
Hence, the qualitative interviews with Nigerian stakeholders reported in chapter 5, 
explored their views on the current structure of pharmacy practice and on making 
prescribing a part of the pharmacists’ role in Nigeria. The results in chapter 5 revealed 
an ongoing struggle by Nigerian pharmacists to establish their clinical identities as 
many non-pharmacy stakeholders viewed pharmacists’ roles to be mainly supply-
based. Barriers to the development of clinical pharmacy practice in Nigerian hospitals 
identified included pharmacists’ lack of confidence, shortage of pharmacy staff, 
underutilisation of pharmacy technicians, lack of specialisation and clinical career 
structure for pharmacists, poor relationship with doctors, medical dominance and 
opposition, and lack of policies that support clinical pharmacy practice.  
On the other hand, there were differences of opinions concerning pharmacist 
prescribing among Nigerian stakeholders interviewed. While many non-medical 
stakeholders including pharmacists and patient group representatives supported 
pharmacists prescribing in Nigeria, many medical doctors including those in 
policymaking positions were reluctant to do so. However, ‘collaborative’ prescribing 
where the doctor sets the limits and remains in overall charge of the patient was 
identified by many stakeholders including some doctors as an appropriate model for 
pharmacist prescribing in Nigeria. Many stakeholders considered the potential benefits 
associated with pharmacist prescribing, especially in increasing patients’ access to 
medicines as a key facilitator to pharmacist prescribing in Nigeria. Other factors which 
stakeholders considered could facilitate pharmacist prescribing were pharmacist expert 
knowledge of medicines, pharmacists’ positive attitude towards clinical roles, the 
current working relationship between doctors and pharmacists in some teaching 
hospitals and community pharmacists’ accessibility and patients’ reliance on them.  
Many potential barriers to pharmacist prescribing were identified. Notable among them 
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were medical resistance and pharmacists’ inadequate skills in diagnosis. Other key 
barriers mentioned by stakeholders were shortage of pharmacists, lack of collaboration 
between doctors and pharmacists and lack of access to patients’ medical records by 
community pharmacists.  
The research then continued with chapter 6, which reported a cross-sectional survey 
of Nigerian pharmacists’ views intended to confirm the findings of the qualitative 
interviews in chapter 5. Overall, the findings of the survey confirm the findings of the 
qualitative interviews. Similar to the Nigerian stakeholders’ interviews, the pharmacists’ 
survey identified the need for collaborative practice, specialisation in practice, a career 
pathway for clinical pharmacists, a change in pharmacy training to reflect a more 
patient orientated approach, and better utilisation of pharmacy technicians in Nigeria. 
The majority of pharmacists in the survey reported that the current separation of 
prescribing as the doctors’ role and dispensing as the pharmacists’ role in Nigeria is not 
in the best interest of the patient. Therefore, these pharmacists showed a positive 
attitude towards pharmacist prescribing and were willing to be prescribers. However, 
they indicated that they would need additional training particularly in the aspects of the 
principles of differential diagnosis, pathophysiology of diseases and interpretation of 
laboratory results in order to be prescribers. Similar to the findings of the qualitative 
interviews, collaborative prescribing was preferred over independent prescribing in the 
survey. 
Furthermore, the results of the survey also revealed that the potential benefits 
associated with pharmacist prescribing including increasing patients’ access to 
treatment and better utilisation of pharmacists’ skills could facilitate pharmacist 
prescribing in Nigeria. Also resistance from the medical doctors and pharmacists’ 
inadequate skills in diagnosis were perceived as the most likely barriers to be 
encountered and would need to be overcome. Other barriers reported in the survey 
also confirm those identified in the interviews including shortage of pharmacists and 
lack of government support. 
7.3 Development of clinical pharmacy practice 
7.3.1 Government support 
The interviews conducted in chapter 4 with pharmacists and pharmacy technicians in 
the UK indicated that government support through appropriate legislations and policies 
were instrumental in the development of pharmacists’ clinical roles. As mentioned in 
previous chapters, pharmacists in the UK were able to take on a prescribing role as a 
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result of the legislative change contained in the Health and Social Care Act 2001.  
Other research reports including Penm et al. (2015a) and Gastelurrutia et al. (2009) 
have identified support from government or healthcare authorities as a key facilitator to 
the development of clinical pharmacy practice in hospital and community pharmacies.  
In China for instance, recent reports have shown that the development of hospital 
pharmacists’ clinical roles have been supported by the new policies made by the 
Ministry of Health (Penm et al., 2015a, Penm et al., 2014). These policies included 
those relating to the establishment of a drugs and therapeutics committee and the 
employment of clinical pharmacists in hospitals (Penm et al., 2014).   
Although, the Nigerian Drug Policy states that the government shall promote the 
practice and development of clinical pharmacy in hospitals in order to enhance patient 
care (FMoH and WHO, 2005), there has been no strategic follow-up by government to 
this commitment. The findings from the interviews and survey conducted with Nigerian 
participants in chapters 5 and 6 indicated that government support towards the 
development of clinical pharmacy practice is lacking.  In the cross-sectional survey 
conducted, the majority (85.0%) of pharmacists who participated were either unsure or 
disagreed that there were policies in place in Nigeria that support the development of 
clinical pharmacy practice. This was because the available policy documents including 
the National Drug Policy recognised pharmacists’ role to be mainly supply-based 
(FMoH and WHO, 2005). In addition, the Nigerian government has been slow to 
implement changes that would enhance the development of clinical pharmacy practice. 
For example, despite government’s assurance in 2005 to reclassify the medicines in 
Nigeria into three categories: prescription only, pharmacy only and general sale 
medicines to enable pharmacists supply the ‘Pharmacy only’ medicines without a 
prescription(FMoH and WHO, 2005), this is yet to be actualised.  
In the UK, a number of factors facilitated government support for extended clinical roles 
including improving patients’ access to medicines, utilisation of pharmacists’ skills, cost 
saving on medicines budgets and cost effective use of available human resources 
(Department of Health, 1999). Therefore these drivers could be used by pharmacists in 
Nigeria to advocate for government support for extended roles.  
7.3.2 Education and training 
Research evidence from chapter 4 suggested that the development of credible 
practitioners was essential to achieve change in pharmacy practice. This depends on 
the robustness of training received by pharmacists. Pharmacy training particularly at 
undergraduate level is evolving to meet the challenges of healthcare provision in 
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hospital and community pharmacy settings. Even in countries where pharmacists’ roles 
have been expanded considerably, the undergraduate curriculum is constantly being 
reviewed in order to prepare pharmacists for future roles (Smith and Darracott, 2011, 
Canadian Pharmacists Association, 2011). For example, in the UK, the undergraduate 
pharmacy curriculum has been restructured to include more clinical components and 
practice-based learning. Procedures are on the way to integrate more fully the pre-
registration year into the undergraduate programme (Smith and Darracott, 2011). The 
reasoning behind this is to produce more competent pharmacists able to apply their 
knowledge and skills in clinical settings upon graduation.  
The research evidence from the Nigerian studies reported in Chapters 5 and 6 
indicated that the present undergraduate pharmacy programme in Nigeria does not 
produce confident pharmacists who are able to apply their knowledge in clinical 
settings. Even though the curriculum of the undergraduate pharmacy programme in 
Nigeria has changed significantly (Udeogaranya et al., 2009, Alo, 2006), the clinical 
components of the present curriculum in many pharmacy institutions is insufficient for 
clinical pharmacy practice.  In addition, experiential learning through clinical rotations 
which will potentially enhance pharmacists’ clinical skills and confidence in clinical 
settings is inadequate (Udeogaranya et al., 2009). In the undergraduate training 
curriculum of many pharmacy institutions in Nigeria, clinical pharmacy rotations are 
usually carried out in the final year of the undergraduate programme. These clinical 
rotations only account for about 10% of the final year curriculum (NUC, 2007).  
Furthermore,  when students are involved in clinical rotations, they are usually 
conducted in settings where clinical pharmacy services are yet  to be fully developed, 
which limits students’ practice-based learning experience (Udeogaranya et al., 2009). 
Therefore, to enhance pharmacists’ confidence, the current training curriculum needs 
to incorporate more clinical contents with practice based learning conducted at sites 
where clinical pharmacy services are offered. However, finding appropriate training 
sites will continue to be a challenge as long as pharmacists’ roles in many hospital 
settings remain underdeveloped.  
Another factor that could account for the lack of confidence seen among pharmacists in 
clinical settings in Nigeria could be the absence of a national framework to evaluate the 
skills and competencies of those entering into the profession. Unlike the UK, there is 
currently no pre-registration assessment for pharmacists (PCN, 2014a). New graduates 
enter into the profession after a year of pre-registration training in an accredited centre. 
At the end of the training programme, these graduates are issued a ‘certificate of 
experience’ as evidence of experience with a registered pharmacist which is a pre-
 232 
 
requisite for application to register as a pharmacist in Nigeria (PCN, 2014a). Even 
though the pre-registration training centres are accredited by the PCN, the potential for 
variation in training among the various training centres is high. Therefore a national 
pre-registration assessment is essential to ensure that pharmacists achieve minimum 
competences standard before entering into the profession. 
Furthermore, the research evidence from chapter 4 showed that practice-based 
postgraduate clinical pharmacy programmes are essential in enhancing pharmacists’ 
clinical skills and confidence in clinical settings. Many researchers have argued that 
these programmes provide a specialised level of training that cannot be achieved 
within the undergraduate pharmacy programme (Jungnickel et al., 2009, Leiker et al., 
2009, Murphy et al., 2006). This is because the undergraduate pharmacy programme 
prepares pharmacists for practice in diverse kind of settings including the industry. 
Therefore, it cannot achieve the level of depth needed for independent practice in 
patient care settings (Jungnickel et al., 2009). Hence many countries including the UK 
and US have taken up post-registration clinical pharmacy training in order to prepare 
pharmacists’ for specialised roles in clinical settings (Leiker et al., 2009). In addition, 
post-registration clinical training is increasingly becoming a pre-requisite for advanced 
clinical practice in hospitals in many countries, including the UK, Portugal and Spain 
(Van Mil and Schulz, 2006). 
In Nigeria, masters of clinical pharmacy programmes are available in some Universities 
(Ogaji and Ojabo, 2014). However, these programmes are largely theoretical with little 
practice based learning. More recently, the West African Postgraduate College of 
Pharmacists (WAPCP) has played a significant role in the postgraduate training of 
pharmacists in clinical pharmacy. WAPCP was established by the West African 
Pharmaceutical Federation in 1991 to prepare pharmacists in the West African region 
including Nigeria for expanded roles (WAPCP, 2013). The clinical pharmacy 
programme of the WAPCP is a distance learning programme of 4 years duration 
incorporating two cycles of update lectures annually (WAPCP, 2012b).  Since its 
inception, at least 300 Nigerian pharmacists have completed the WAPCP clinical 
pharmacy programme (WAPCP, 2012a). In 2014, a residency component was 
introduced into the programme with some of the graduates of the programme serving 
as preceptors at practice site (WAPCP, 2014). However, the effectiveness of the 
residency programme would largely depend on the development of clinical pharmacy 
services at the selected practice sites of the residents. Nevertheless, pharmacists’ 
accounts in the qualitative interviews in chapter 5 indicated that the WAPCP 
programme is a key driver in the development of pharmacists’ clinical skills in Nigeria. 
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Many pharmacists argued that the graduates of this college are better positioned for 
extended clinical roles. In addition, the WAPCP programme appears to be more 
popular among pharmacists than university-based postgraduate programmes because 
of its flexibility. Pharmacists are able to participate in this programme from their 
practice settings. Overall, this programme appears to have more potential than the 
present university-based masters’ programmes in preparing hospital and community 
pharmacists for potential clinical roles in Nigeria.  However, further evaluation of this 
programme is necessary to confirm this claim and to investigate how the present 
WAPCP programme is meeting the training needs of pharmacists in patient care 
settings.   
Similarly, the present training curriculum for pharmacy technicians outlined by the 
Pharmacists’ Council of Nigeria (PCN, 2004), seems sufficient to enable them carry out 
routine manual tasks associated with dispensing including selection, assembling and 
labelling of medicines as would be discussed in  section 7.3.3. However, additional 
post-registration training would be needed to enable technicians to take on other 
advanced roles including accuracy checking.  
7.3.3 Pharmacy workforce shortages and utilisation of pharmacy technicians 
An important barrier to the development of clinical pharmacy practice in Nigeria is the 
shortage of pharmacists. This was identified in the two studies conducted with Nigerian 
participants. For instance, in the cross-sectional survey conducted, about 70% of 
respondents reported that there are inadequate numbers of pharmacists in the country 
to take on additional clinical roles. In addition, slightly more than half of the 
respondents reported that pharmacists lacked time to take on additional roles. Other 
research reports from Nigeria have also highlighted the shortage of pharmacists as a 
barrier to providing pharmaceutical care (Oparah and Eferakeya, 2005, Erah and 
Nwazuoke, 2002). This is unsurprising considering the ratio of pharmacists to the 
population of Nigeria. As mentioned earlier in chapter 5, there are about 17,000 
pharmacists in Nigeria which represents about 10 pharmacists to 100,000 people 
(PCN, 2014b), compared to the UK with about 49,000 practising pharmacists (78 per 
100,000 people) (OECD, 2013). Besides, the pharmacists currently practising in 
Nigeria are far less than this quoted figure. This is because the 17,000 available 
pharmacists include non-practising pharmacists and those who have migrated. For 
instance, only 7,584 pharmacists have applied for and were licensed to practice in 
2014 by the Pharmacists Council of Nigeria (PCN, 2014c).  Since adequate pharmacy 
staffing has been identified as a facilitator to the development of clinical pharmacy 
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practice (Penm et al., 2015b, Bond et al., 2004, Bond et al., 1999), this shortage of 
pharmacists is a barrier to the delivery of clinical pharmacy services in Nigeria and 
must be addressed.  
Key factors responsible for pharmacists’ shortage in Nigeria are: insufficient supply of 
pharmacists by training institutions; movement of pharmacists into other sectors such 
as marketing and non-governmental organisations where remuneration and conditions 
of service are better; and migration of pharmacists to other countries (Ubaka et al., 
2013, Federal Republic of Nigeria, 2007). There are currently 16 accredited pharmacy 
training institutions in Nigeria (PCN, 2012). These institutions are unable to meet the 
supply demand for pharmacists. The expansion of the current training institutions has 
been hindered by inadequate facilities and academic staff to train pharmacists among 
other things. Therefore, this acute shortage of pharmacists is likely to continue unless 
the issues highlighted above are addressed.  
The classical response to pharmacists shortages is to increase the production of new 
pharmacists by increasing the number of pharmacists training institutions or student 
intake; or to increase the utilisation of pharmacists’ support staff in order to free up 
pharmacists for advanced roles (Cooksey et al., 2002). Both strategies have been 
recommended and implemented in response to pharmacists shortages in many 
advanced countries including Australia, UK and the USA (Anderson et al., 2009).  
However, increasing the production of new pharmacists does not present a short term 
feasible option for Nigeria in view of the constraints discussed. In addition, it will take a 
minimum of five years (following initial plan to increase pharmacists’ numbers) to 
produce new pharmacy graduates since pharmacy programmes last for a minimum of 
5 years in Nigeria. Therefore, increasing the utilisation of the current pharmacy 
technicians’ workforce represents an immediate solution with long term benefits for 
Nigeria.  
As revealed in the UK study reported in chapter 4, utilising trained pharmacy 
technicians in the dispensing process including accuracy checks of dispensed items 
could do a lot in freeing up pharmacists for extended clinical roles. Furthermore, 
available international evidence supports the pharmacy technicians’ role in dispensing. 
A prospective study conducted in three large hospitals in Washington State shows no 
difference between pharmacists’ and trained pharmacy technicians’ accuracy checks of 
dispensed medicines  (Ness et al., 1994).  
However, the interviews held with Nigerian stakeholders reported in Chapter 6 reveals 
that there are no clear job descriptions for pharmacy technicians. Therefore, their 
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utilisation in many Nigerian hospitals is dependent on the availability of pharmacists 
and the discretion of their supervising pharmacists. For example, in teaching hospitals 
where there are relatively adequate numbers of pharmacists, they serve as ‘assistants’ 
providing support to pharmacists. Their role could range from arranging medicines on 
shelves to counting or packaging of medicines for dispensing. The interviews with 
Nigerian stakeholders suggest that in many cases, the physical aspects of dispensing 
including selection, assembling and labelling of medicines are typically done by 
pharmacists in these hospitals.  
Generally, dispensing of medicines in many Nigerian hospitals usually consists of a 
series of steps. This process begins with validation of prescriber’s and patient’s 
information following the receipt of a prescription. After which, the prescription is 
clinically validated. This is then followed by the selection, assembling and labelling and 
entering of labelled medicine items into a register. The final phase of the dispensing 
process involves accuracy checking, packaging and delivery of the medicines to 
patients. Patient counselling is usually done at the point of the delivery.  
The active involvement of pharmacists in all of these stages account for why they are 
usually tied to the dispensary. Thus, utilising pharmacy technicians in the physical 
aspects of dispensing following the clinical check of prescription including selection, 
assembling, labelling and accuracy checks of final dispensed medicines would free 
pharmacists’ up to do more clinical role in Nigeria.  
However, for technicians’ roles to be considerably expanded to include accuracy 
checks of final dispensed medicines, additional training and accreditation as currently 
done in the UK would be needed. The interviews held with Nigerian pharmacy 
technicians indicated that many pharmacy technicians were happy to be further trained 
to enable them take on some of the traditional roles of pharmacists including 
dispensing. Therefore, such positive attitude shown by technicians presents an 
opportunity to take advantage of in order to enhance clinical pharmacy practice in 
Nigeria.  
Nevertheless, some participants in the qualitative interviews in chapter 5 reported that 
there are inadequate pharmacy technicians in Nigeria. As mentioned earlier, reliable 
data on the number of pharmacy technicians in Nigeria is lacking because their 
registration with the Pharmacists’ council has not yet been made mandatory for 
practice. Some Nigerian participants in the qualitative interviews attributed the current 
shortage of pharmacy technicians to restrictions by the Pharmacists’ council on the 
intake of trainee pharmacy technicians. There are at least 27 pharmacy technicians’ 
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training institutions in Nigeria (PCN, 2004). The Pharmacists’ council has restricted the 
number of trainee intake in each institution to 15 annually (PCN, 2004). Anecdotal 
evidence has shown that this number is below the training capacity of many of these 
institutions. Therefore, this restriction could be an attempt by pharmacists to maintain 
their dominance over the ‘pharmacy territory’ by maintaining a specific ratio of 
pharmacists to pharmacy technicians. But as seen in the UK study, pharmacy 
technicians are needed to release pharmacists for extended roles. Therefore, not 
having sufficient pharmacy support staff could impede pharmacists’ role extension.  
7.3.4 Career structure and specialisation 
The findings from the UK study conducted revealed that the opportunity to specialise 
and move up the career ladder through a clinical career pathway rather than 
management were significant drivers to the changes in hospital pharmacy practice.  
These findings necessitated the investigation of the present career structure of hospital 
pharmacists in Nigeria. The interviews with Nigerian stakeholders revealed that the 
present career structure consist of a single career route for pharmacists which 
becomes increasingly managerial as one progresses up the career ladder. In addition, 
progression across the career ladder is largely based on practitioners’ years of practice 
rather than competencies developed.  Therefore, many Nigerian stakeholders 
appreciated the inability of this career structure to support the development of clinical 
pharmacy practice. This is because experienced clinical pharmacists are often lost to 
management posts as they move up the career ladder. Therefore almost all (98.4%) 
pharmacists who participated in the cross-sectional survey in chapter 6 indicated that a 
clinical career structure should be created for clinical pharmacists. As in the UK, this 
will make pharmacists aspirational and motivate them to develop clinical competencies 
that are appropriate for advanced practice. In addition, it also promotes the retention of 
experienced clinical staff who desire to use their expertise to enhance patient care 
rather than move into managerial roles where their clinical expertise would be 
untapped. 
The UK study in chapter 4 and others including Marriott et al. (2008)  suggest that 
specialisation is supported by a clinical career route. For instance, Marriott et al. (2008) 
reported that the introduction of the senior clinical positions in hospital pharmacy 
practice in Australia resulted in the development of more specialised clinical practice. 
Specialist as opposed to generalist practice is essential to enhance pharmacists’ 
contribution to patient care considering that pharmacists will have to work with other 
specialists in multidisciplinary teams. In addition, the complex nature of diseases and 
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medicines makes it increasingly difficult for a pharmacist to expertly address all 
medication related issues in all categories of patients in all care settings including 
community, hospital and mental health settings (Jungnickel et al., 2009). This makes 
specialisation imperative in order to enhance patient care. Other disciplines such as 
medicine and nursing have in time past realised this (Storey et al., 2011). However, in 
pharmacy, specialisation is yet to be widely adopted in many countries. 
Although studies comparing the relative impact of specialist and non-specialist 
pharmacists in patient care are lacking, a systematic review conducted to assess the 
impact of care provided to cancer patients by specialists and non-specialist clinicians 
showed that the patients receiving specialists’ care had better health outcomes 
including reduced mortality rate than those receiving care from non-specialists (Grilli et 
al., 1998). Hence, pharmacists’ specialisation is likely to have a similar impact on 
patient care. A few studies including Leape et al. (Leape et al., 1999) have revealed 
that pharmacists’ contribution in patient care including drug therapy interventions is 
enhanced when an experienced pharmacist specifically works with a specialist team as 
opposed to a generalist. 
The need for pharmacists’ specialisation in Nigeria was underscored by many 
participants including pharmacists and doctors in the qualitative interviews conducted 
with Nigerian stakeholders. In addition, nearly all pharmacists in the Nigerian survey 
supported pharmacists’ specialisation in different clinical areas. Specialisation in 
practice is easily achievable if practice-based post-registration trainings such as 
residency training programmes are available (Storey et al., 2011, Bright et al., 2010, 
Jungnickel et al., 2009). This will enable pharmacists to develop specialised skills in 
specific clinical areas. The residency components of the WAPCP programme 
mentioned earlier can be used to facilitate specialisation within clinical areas. However, 
the specialisation of pharmacists’ into different clinical areas would take pharmacists 
away from general functions. This would potentially impact negatively on the number of 
pharmacists that are available for generalist roles and worsen the present shortage of 
pharmacists in Nigerian hospitals. Therefore, a more flexible and practical approach to 
specialisation is needed in Nigeria. In the interim, the training of advanced generalist 
practitioners with additional specialist skills should be explored. This would allow 
pharmacists to be useful in both generalist and specialist areas of their interest.  
Therefore, this thesis proposes the Pharmacist with Special Interests (PhwSIs) model 
that is similar to that of the UK, as an interim route to pharmacists’ specialisation in 
Nigeria.  In the UK, PhwSIs are generalist pharmacist practitioners who supplement 
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their core generalist role by delivering additional specialist role (Department of Health, 
2006a). Their accreditation is based on a number of competency clusters including 
expert skills and knowledge in a defined specialist area (Department of Health, 2006a).  
Although, PhwSI work in primary care settings in the UK, this can be adopted in 
Nigerian hospitals. Post-registration training incorporating both theoretical and practical 
components can be designed for pharmacists entering into hospital practice to enable 
them to develop core advanced generalist and specialist skills in a defined clinical area. 
This training programme should be designed based on a specific competency 
framework that would be used to assess practitioners at the end of the training.  
7.3.5 Medical dominance and professional relationship with doctors 
Medical dominance and poor professional relationships with doctors were commonly 
reported by Nigerian stakeholders including doctors and pharmacists as barriers to the 
development of clinical pharmacy practice in Nigeria. In Nigerian hospitals, doctors 
control the boundaries of the professional work of other healthcare professionals 
because they are perceived to have the prime responsibility of patient care. Therefore, 
they define the role played by other healthcare professionals in patient care. Hence, 
pharmacists’ direct involvement in patient care has always been viewed by Nigerian 
doctors as an encroachment into their professional boundary and has often times been 
resisted (Erah, 2003).  
Chapter 4 revealed that establishing professional relationships with doctors led to 
doctors’ support for clinical pharmacy practice in the UK. For instance, the UK 
interviews revealed that doctors who had good rapport with pharmacists were 
instrumental in recommending pharmacists to their colleagues. On the contrary, the 
two Nigerian studies conducted revealed a poor professional working relationship 
between doctors and pharmacists in many practice settings. In the survey conducted, 
less than a third (28.3%) of respondents agreed that a close professional relationship 
existed between pharmacists and doctors in Nigeria, while the remaining were either 
unsure (10.2%) or disagreed (61.6%). This poor professional relationship may account 
for lack of doctors’ support for clinical pharmacy practice. Hence, collaborative working 
relationships between doctors and pharmacists are needed for the development of 
clinical pharmacy practice including prescribing in Nigeria.  This view was supported by 
nearly all (96.2%) of the pharmacists who participated in the survey.  
Zillich et al. (2004) suggested that collaborative working relationship with doctors can 
be initiated by establishing communication with doctors through the development of 
services that improve doctors’ care of the patient (Zillich et al., 2004). This will involve 
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identifying a gap in doctors’ practice where pharmacists can fill in positively. For 
example, the development of drug information services by UK pharmacists in the late 
1960s and later ward pharmacy services following the increasing number of medicines 
available in clinical practice, established communication between doctors and 
pharmacists. Doctors were relying on pharmacists for medicines information in order to 
be up-to-date with new medicines and minimise prescribing errors. This service added 
value to doctors’ roles by enhancing their care of the patient and established a 
collaborative working relationship.    
Furthermore, many authors have argued that doctors with positive experience of 
clinical pharmacists are usually supportive of clinical pharmacy practice (Adamcik et 
al., 1986, Ritchey and Raney, 1981). As seen in chapter 4, doctors’ trust and 
commitment to work with pharmacists further developed in the UK as pharmacists 
established themselves as reliable practitioners through the demonstration of their 
knowledge, clinical skills and contribution to patient care. Therefore, Nigerian 
pharmacists must seek to identify areas where they can make positive contributions 
that will enhance doctors’ care of the patient and ultimately result in better 
communication and closer working relationship between them and doctors.  
Working in collaboration with other healthcare professionals requires the knowledge of 
each other’s roles (Jungnickel et al., 2009). Many authors have argued that 
collaboration between healthcare professionals increases as they become aware of 
each other’s knowledge and skills (Zwarenstein et al., 2009, O’Daniel and Rosenstein, 
2008).  Therefore, inter-professional education has been suggested as a means of 
promoting inter-professional understanding among healthcare professionals 
(Zwarenstein et al., 2009). In Nigeria, pharmacy and medical students are trained in 
isolation from one another (uni-professional education) as it is largely done in the UK.  
This form of learning may account for the stereotype views held by doctors concerning 
pharmacists’ role in patient care during the qualitative interviews conducted with 
Nigerian stakeholders. Therefore, joint learning sessions within undergraduate 
programmes would help to promote understanding of the roles of both professionals in 
patient care. Learning sessions such as joint therapeutics teaching sessions between 
medical and pharmacy students as reported by  Greene et al. (1996) could be 
beneficial.  For instance, the Kings College, London has developed a number of inter-
professional training opportunities for undergraduate students of medicine and other 
health sciences to enhance inter-professional collaboration in practice (Kings College, 
2015). For example, the ‘Keeping Patients Safe from Medication Errors’ workshop of 
the university gives final year students of medicine, nursing, midwifery and pharmacy 
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the opportunity to learn medication management together and that could enhance 
collaborative practice in medication management in practice.     
Other measures that could foster inter-professional relationships between pharmacists 
and doctors include providing opportunities for pre-registration pharmacists to work 
with doctors during internship training; organising joint continuing education events or 
clinical meetings; and having policies/legislations that would enhance collaborative 
practice (Van et al., 2012). For example, in Ontario, Canada, a legislative amendment, 
the Regulated Health Professions Statute Law Amendment Act, 2009 was introduced 
to support inter-professional collaborations between healthcare professionals 
(Government of Ontario, 2009). This legislation mandated regulatory colleges to work 
collaboratively with each other to foster collaborative practice (Government of Ontario, 
2009).  This form of legislation could be beneficial in Nigeria. 
Also, the relative isolation of many hospital and community pharmacists from other 
healthcare professionals as revealed in the qualitative interviews in chapter 5 also 
contributes to their poor professional relationships with doctors. However, participants 
in the Nigerian qualitative interviews noted that in some teaching hospitals where 
pharmacists have expanded their roles beyond the dispensary, a good professional 
relationship exists between pharmacists and doctors.  
7.4 The potential for pharmacist prescribing in Nigeria 
7.4.1 Views on pharmacist prescribing 
Interviews with Nigerian stakeholders showed a split of opinion between participants 
who were medical doctors and others. While many non-medical stakeholders 
interviewed including pharmacists and patient group representatives supported an 
extended role for pharmacists in prescribing, many medical doctors including those in 
policy making were reluctant to do so.  
Many medical doctors in the qualitative interviews conducted were unsupportive of 
pharmacist prescribing because prescribing in Nigeria is mainly under their jurisdiction. 
Therefore many doctors viewed pharmacist prescribing as an encroachment into 
medical territory and a challenge to medical dominance. This finding is unsurprising 
because similar attitudes were shown by medical doctors in other countries including 
South Africa and Canada where pharmacists have attempted to expand their roles to 
include prescribing (Kondro, 2007, Gilbert, 1998). Doctors in these countries 
responded in such a way to protect their professional territory from encroachment 
(Kondro, 2007, Gilbert, 1998). The general behaviour of medical doctors could be 
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explained by the sociological theory that posit that prescribing is a core role that 
confers clinical autonomy to medical doctors and also grants them control over the role 
of other healthcare professionals (Britten, 2001, Eaton and Webb, 1979). For example, 
a pharmacist’s role of dispensing is dependent on an instruction (prescription) from a 
doctor. This therefore puts the medical doctor in control of the work sphere of the 
pharmacist (Eaton and Webb, 1979). Hence, the fear of the loss of this control could 
account for doctors’ non-support for pharmacist prescribing.  
On the other hand, many Nigerian pharmacists’ interviewed supported pharmacist 
prescribing. Pharmacist support was further demonstrated in the survey conducted 
where 97.1% of the 315 Nigerian pharmacists who participated reported that they 
should be given the authority to prescribe medicines. In addition, nearly all (96.4%) 
those who supported pharmacist prescribing were willing to be prescribers. These 
findings are similar to those reported by Hoti et al. (2010), where 83.9% of the 2592 
Australian pharmacists who participated in a survey were in favour of a prescribing 
authority being extended to them. The strong support for pharmacist prescribing is 
unsurprising in view of pharmacists’ aspirations for better utilisation of their skills and 
enhanced clinical autonomy in their practice (Buckley et al., 2006). These desires are 
believed to be achievable within the scope of practice of the pharmacist prescriber 
(McCann et al., 2011, Stewart et al., 2009a). Therefore, such perception would have 
influenced pharmacists’ support for prescribing. 
Furthermore, many pharmacists interviewed including those who are policymakers 
considered prescribing to be a logical role for pharmacists considering pharmacists’ 
knowledge in therapeutics which they considered essential for prescribing. In addition, 
they also argued that pharmacists are more knowledgeable in clinical pharmacology 
and pathology of diseases than nurses and community health workers who are 
currently allowed to prescribe medicines for certain conditions in facilities where there 
are no doctors. However, prescribing is a complex process that encompasses 
identifying patients’ problems, specifying treatment objectives, determining the safe 
and cost-effective treatment and instituting and monitoring of patients’ therapy (De 
Vries et al., 1994). These processes involve the use of the prescribers’ knowledge and 
skills in diagnosis and therapeutics to make informed clinical decisions concerning 
patients’ therapy (Nissen, 2011). Unlike the medical practitioners’ training, pharmacists’ 
basic training is limited in clinical assessment and diagnosis. Therefore, many 
participants identified pharmacists’ limited skills in diagnosis as a potential barrier to 
pharmacist prescribing in Nigeria. However, in many countries where pharmacists are 
legally allowed to prescribe including the UK and New Zealand additional training is 
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provided to prepare pharmacists for prescribing (Stewart et al., 2012, Nissen, 2011). 
The training incorporates applied therapeutics and differential diagnosis; and a period 
of learning in practice under a medical mentor (Stewart et al., 2012).  In addition, these 
countries implemented collaborative or supplementary forms of prescribing initially 
which do not require the pharmacist to make diagnostic decisions. Therefore, a 
collaborative form of prescribing as suggested by Nigerian participants (in both the 
interviews and survey) would be good for initial implementation in Nigeria. This form of 
prescribing would appeal to doctors as the  diagnosis and initial treatment decisions 
remain with the medical prescriber (Nissen, 2011). Also, certain benefits are likely to be 
associated with a collaborative prescribing in Nigeria. It will foster collaboration 
between doctors and pharmacists and provide the prescribing pharmacist with the 
opportunity to learn from the medical prescriber, especially in the aspects of diagnosis. 
The experience gained could be instrumental if independent prescribing is 
subsequently implemented. In addition, collaborative prescribing will overcome the 
problem of pharmacists’ access to patient clinical records which was viewed by 66% of 
the survey respondents as a potential barrier to pharmacist prescribing. 
However, collaborative prescribing is more likely to be successful within hospital 
settings in the Nigerian context. Unlike hospital pharmacists, there is currently no 
system in place to foster collaborative working relationships between doctors and 
community pharmacists. In addition, community pharmacists have no access to 
patients’ medical records maintained by hospitals. As a result, these factors are likely 
to present a challenge to community pharmacist collaborative prescribing.  
Therefore, a model likely to be successful in Nigerian community pharmacies is a 
limited form of independent prescribing using approved formularies or standard 
treatment guidelines for minor conditions. This was the type of prescribing model 
community pharmacists were authorised to do in South Africa (Ward et al., 2014). As 
mentioned earlier in chapter 2, these pharmacists were licensed to independently 
diagnose and prescribe for disease conditions listed in the South Africa’s Primary 
Health Care Essential Medicine List and Standard Treatment Guidelines (SAPC, 2011). 
Community pharmacists are found in many communities including those underserved 
with health facilities in Nigeria (Auta et al., 2014b). Previous studies in Nigeria have 
advocated policy change to allow community pharmacists to treat minor disease 
conditions in Nigeria (Auta et al., 2014b, Oparah and Arigbe-Osula, 2002). Hence, 
utilising community pharmacists to provide primary healthcare in a similar manner to 
South Africa, offers an opportunity to increase patients access to care particularly in 
communities underserved by primary health centres. It also offers the opportunity to 
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revitalise the current primary health care system in Nigeria which has been described 
as ineffective, and could serve as an incentive for community pharmacies presence in 
rural areas (WHO, 2015, Ward et al., 2014). Nevertheless, additional training would be 
needed to prepare community pharmacists to independently diagnose and treat 
disease conditions using standard treatment guidelines at the primary healthcare level.  
Furthermore, almost all pharmacists (96.6%) who reported that they were willing to be 
prescribers in the survey stated that they will need additional training to be prescribers. 
The perceived areas of most training needs were in the principles of differential 
diagnosis, pathophysiology of diseases and interpretation of laboratory results, 
although much of these could be included on the undergraduate courses. These 
findings further confirm respondents’ concerns of pharmacists’ inadequate skills in 
diagnosis and clinical assessment as potential barriers to pharmacist prescribing in 
Nigeria. In addition, the findings of this study were similar to those of Hoti et al. (2014) 
where Australian pharmacists identified the pathophysiology of diseases, principles of 
diagnosis and patient assessment and monitoring as their most preferred areas of 
training needs. As mentioned previously, pharmacists intending to be prescribers in 
many countries are required to undergo additional training to enhance their 
competence in prescribing. Although training requirements vary across countries, the 
UK training model appears to be better established than others and has been 
evaluated for its appropriateness in meeting the training needs of prescribers. Many 
supplementary and independent pharmacist prescribers in the UK have reported that 
the prescribing courses they attended provided them with relevant knowledge and skills 
for their roles. In addition, the period of learning and practice under a medical 
prescriber was highly appreciated (Latter et al., 2010, Cooper et al., 2008d). The UK 
training curriculum for non-medical prescribers is based on the National Prescribing 
Centre’s (NPC) prescribing competencies framework (Brown, 2014, NPC, 2012). This 
is a single framework that ensures that all prescribers irrespective of their professional 
background develop comparable set of competencies (NPC, 2012). A similar 
competencies framework has been developed for Australian prescribers (NPS, 2012). 
Developing similar competencies framework and using it to inform the training of 
prescribers in Nigeria would be beneficial.  Such competencies framework would 
ensure that all prescribers in Nigeria attain a minimum level of competency in which 
they can safely and competently prescribe medicines within their jurisdiction.  
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7.4.2 Potential facilitators and barriers to pharmacist prescribing 
As mentioned earlier in section 7.2 many potential facilitators and barriers to 
pharmacist prescribing were identified in the two studies conducted with Nigerian 
participants. The potential facilitators mentioned earlier were the potential benefits 
associated with pharmacist prescribing especially in increasing access to treatment, 
the perceived pharmacists’ expert knowledge of medicines, pharmacists’ willingness to 
be prescribers, the current working relationship between doctors and pharmacists in 
some teaching hospitals and community pharmacists’ accessibility and patients’ 
reliance on them. The potential barriers to pharmacist prescribing identified were 
medical resistance, pharmacists’ inadequate skills in diagnosis, shortage of 
pharmacists, lack of collaboration between doctors and pharmacists, lack of access to 
patients’ medical records by community pharmacists and a perceived lack of political 
will from government to drive the pharmacist prescribing agenda. These facilitators and 
barriers are similar to those identified in other countries including the UK as 
demonstrated in the review chapter of this thesis.  
Many of the Nigerian stakeholders interviewed perceived that the potential benefits 
associated with pharmacist prescribing could facilitate it happening in Nigeria.  Patient 
group representatives were very supportive of a prescribing authority for pharmacists 
because they perceived it would promote quick and convenient access to treatment. 
Other stakeholders including medical doctors and policymakers also acknowledged 
that pharmacist prescribing could potentially increase patients’ access to treatment in 
Nigeria. Furthermore, nearly all the survey respondents (97.8%) acknowledged this 
benefit. Increasing patients’ access to medicines while maintaining patient safety has 
primarily been one of the key policy objectives of non-medical prescribing including 
pharmacist prescribing in countries where it has been introduced including the UK and 
Canada (Alberta College of Pharmacists, 2007a, Department of Health, 2005b). As 
pointed out in chapter 2, patients in some studies in the UK have reported an increase 
in patients’ access to care including perceived reduction in appointment delays as a 
result of non-medical prescribing (Courtenay et al., 2011b, Stewart et al., 2009a). This 
would be of great benefit to patients in Nigeria. For example, about 110 million malaria 
cases are clinically diagnosed annually in Nigeria and uncomplicated malaria accounts 
for about two-thirds of outpatient visits in hospitals (NPC and ICF MACRO, 2009). As 
mentioned in chapter one, more than 50% of out-patients wait for between one to three 
hours to see a doctor as a result of the shortage of medical prescribers (Ogunfowokan 
and Mora, 2012, Umar et al., 2011, Ajayi, 2002). Therefore, authorizing pharmacists to 
prescribe for these uncomplicated cases of malaria could provide prompt access to 
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malaria treatment. In addition, it could potentially reduce doctors’ workload even though 
research evidence demonstrating this claim is still lacking as identified in chapter 2. 
However, it is logical to assert that an extra pair of hands would be of immense help to 
an already overburdened medical practitioner particularly in relieving the medical 
practitioner to concentrate on other, more complex tasks. 
Historically, role extensions in healthcare including the extension of prescribing 
authority have also been centred on increasing the utilisation of the skills of healthcare 
professionals (Bright et al., 2010). In many occasions, healthcare professionals 
advocate for role extension following the acquisition of additional skills (PCNZ, 2007). 
Therefore, it is unsurprising that many pharmacists in both the qualitative interviews 
and survey conducted, considered promoting the utilisation of their skills as a potential 
driver for pharmacist prescribing in Nigeria. This is particularly important given recent 
advances in pharmacists’ education and training such as the clinical pharmacy 
programme of the WAPCP whose goal is to prepare pharmacists for future roles. 
Notwithstanding, many pharmacists in the qualitative interviews and comments offered 
in the survey questionnaire acknowledged the need for additional training as a 
perquisite for prescribing. 
Other potential benefits of pharmacist prescribing which Nigerian participants thought 
could facilitate the extension of prescribing authority to pharmacists were its likelihood 
to legitimise the supply of medicines and reduce harm associated with access to 
prescription medicines without a prescription, and save government’s cost on 
healthcare. However, this problem of non-prescription access to prescription-only 
medicines in Nigeria is as a result of the poor regulation of the pharmaceutical sector 
and the porous drug distribution channels (Auta et al., 2012). Therefore, this problem is 
likely to continue unless the issues with the drug distribution routes are addressed and 
the pharmaceutical sector is well regulated with appropriate sanctions applied to 
offenders.  
On the other hand, contrasting views exist in the qualitative literature regarding the 
potential for non-medical prescribing to save government’s healthcare cost (Pojskic et 
al., 2014, Cooper et al., 2008a). While some individuals argued that it could save salary 
cost by utilising healthcare professionals who are paid less compared to doctors, 
others maintained that the overall cost of providing healthcare would be unaffected 
because of the small proportion of non-medical prescribers (Blenkinsopp et al., 2008, 
Cooper et al., 2008a). In addition, some individuals believed that other indirect costs 
associated with non-medical prescribing including training costs, and the increase in 
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the utilisation of prescribing services could increase government spending (Pojskic et 
al., 2014, Cooper et al., 2008a).  Furthermore, economic evaluations of non-medical 
prescribing are lacking. Available research evidence is weak in methodologies. For 
example, Dole et al. (2007) evaluated a pain clinic managed by a pharmacist prescriber 
in the US. They reported that pharmacist prescribing in non-cancer related pain led to 
annual savings of $450,000. However, this was a single site study that was not 
randomised or controlled. Therefore, the economic impact of pharmacist prescribing is 
still unknown. Notwithstanding, savings on healthcare cost could potentially facilitate 
pharmacist prescribing in Nigeria since historically many governments including those 
in advanced countries have used financial savings on healthcare spending as one of 
the reasons for role extension or substitution. 
In the Nigerian interviews conducted, many community pharmacists interviewed felt 
well placed for prescribing considering their accessibility and the reliance on them by 
members of the public. In addition, many pharmacists and patient group 
representatives felt that allowing community pharmacists to prescribe would legitimise 
their current practice of recommending medicines to patients in response to patients’ 
symptoms. Legalising this practice could potentially drive pharmacist prescribing. For 
example, in the Netherlands, representatives of the Nurses’ organisations interviewed 
in a qualitative study investigating Nurse prescribing reported that prescribing authority 
was extended to nurses in order to legitimise their practice of prescribing (Kroezen et 
al., 2013). This was because nurses in the Netherlands were prescribing without legal 
backing  prior to extension of prescribing authority to them (Kroezen et al., 2013). 
Hence, the current counter prescribing practice of community pharmacists in Nigeria 
and the reliance on them by members of the public for their treatment needs could be a 
potential facilitator to pharmacist prescribing. However, introducing prescribing in 
community pharmacies in Nigeria is subject to a number of challenges. These 
challenges as reported earlier include lack of collaboration between community 
pharmacists and doctors; and lack of access to patients’ clinical records since there is 
no structure in place that would facilitate exchange of patients’ clinical data between 
community pharmacies and hospitals. In addition, some Nigerian participants including 
pharmacists and patients felt that the commercial interests of community pharmacists 
would be a potential barrier to prescribing authorisation.  
Medical resistance was a key barrier that emerged from the Nigerian stakeholder 
interviews.  It was also perceived by the majority of survey respondents (94.9%) as the 
most likely barrier to pharmacist prescribing. This finding is consistent with the 
experience of other countries including the UK, US, Canada and South Africa as 
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reports from these countries have shown fierce resistance from the medical profession 
on the extension of prescribing authority to pharmacists (Glatter, 2012, Kondro, 2007, 
Moss, 2005, Gilbert, 1998). For example, Gilbert (1998 p.155) described the opposition 
from the medical profession in South Africa as “a fierce and organised resistance”.  
Also, in the UK, the Department of Health’s plan to introduce independent nurse and 
pharmacist prescribing was described by leaders of the British Medical Association as 
“an irresponsible and dangerous move” (Moss, 2005). Medical resistance in Nigeria is 
likely to be minimal if pharmacists are to prescribe in collaboration with doctors since 
doctors would still maintain the overall control of the prescribing process. In addition, 
the doctor in collaborative prescribing sees the pharmacist as someone who enhances 
or complements the doctors’ role and not doctors’ substitute.  However, independent 
prescribing is viewed by doctors as substitutive of their role in patient care and 
therefore attracts much resistance from doctors (Kondro, 2007, Hadley, 1989). 
Furthermore, one of the ways of overcoming medical control over a task domain such 
as prescribing is through the intervention of the state by making legislation that would 
grant prescribing authority to other healthcare professionals (Gilbert, 1998). The 
unsupportive views for pharmacist prescribing expressed by many doctors including 
those in policymaking in the interviews conducted seem to suggest that a government 
intervention would be necessary for pharmacist prescribing to become a reality in 
Nigeria. However, pharmacists’ comments in both the interviews and survey conducted 
showed that the government has not played an active role in driving the ‘pharmacy 
agenda’ and this could be a barrier to pharmacist prescribing. In addition, health 
policies in Nigeria are predominantly informed by the decisions of the National Council 
on Health (Senate, 2008). The National Council of Health is the highest health 
policymaking body in Nigeria and advises the government on healthcare delivery 
(Senate, 2008). Healthcare professionals other than doctors including pharmacists 
have described this council as being medically dominated in terms of its membership 
and decisions (Muanya, 2014). This could have a serious policy implication for 
pharmacist prescribing. However, this trend is likely to change with the recent signing 
of the National Health bill in Nigeria which among other things, granted more powers to 
healthcare professionals other than doctors in the health policy structure of the country 
(Muanya, 2014). This was revealed in the comments made below by the president of 
the Pharmaceutical Society of Nigeria following the signing of the bill into law.  
“Historically, the harmonised version of the National Health Bill 
signifies the first time the borders of restriction in healthcare was 
opened as major Health Professional Associations and Trade Unions 
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are represented in key structures of the new Health Act.” (Muanya, 
2014)  
Therefore, if this bill is implemented, it would significantly impact on the health 
policymaking process in Nigeria.  
Pharmacists’ inadequate skills in diagnosis and limited training in clinical assessments 
were also identified as potential barriers in the Nigerian studies conducted. In the 
survey, 81.0% and 61.0% of respondents noted that pharmacists’ inadequate skills in 
diagnosis and limited training in clinical assessments respectively, were potential 
barriers. These results explain why 81.4% and 58.9% respectively of those who were 
willing to be prescribers reported that they will need additional training in the principles 
of differential diagnosis and patient assessment.  These barriers could be resolved with 
additional training. Furthermore, as mentioned earlier, prescribing in collaboration with 
doctors will complement pharmacists’ inadequate skills in diagnosis as the diagnosis of 
the disease condition would rest on the doctor.  
Other barriers to pharmacist prescribing identified in the Nigerian studies conducted 
were organisational. These barriers included shortage of pharmacists and pharmacists’ 
lack of time to take on additional role. These issues were discussed earlier on in 
section 7.3.3. Section 7.3.3 identified that increasing the utilisation of pharmacy 
technicians in Nigeria represents a feasible immediate option to address pharmacists’ 
shortage and lack of time to do extended clinical roles. It identified that adequately 
trained pharmacy technicians could do a lot in freeing up pharmacists’ time. 
Furthermore, in order for pharmacists to expand their scope of practice, there must be 
an internal drive for change from pharmacists themselves. Although, pharmacists’ 
negative attitudes towards clinical roles were reported as potential barriers to role 
extension, analysis of the quantitative and qualitative survey responses revealed that 
this attitude does not cut across all groups of pharmacists. The qualitative data showed 
that many young pharmacists were interested in taking on clinical roles. In addition, the 
high level of pharmacists’ willingness to be prescribers recorded in the survey negates 
the perception that pharmacists are unwilling to take on clinical roles. Similarly, the 
interviews conducted with UK participants and other research reports have emphasised 
the importance of having leading individuals who will push for  change in pharmacy 
practice at both local and national levels (Roberts et al., 2003, Tsuyuki and Schindel, 
2008). Some Nigerian pharmacists interviewed showed confidence in the ability of the 
Pharmaceutical Society of Nigeria to push for change in pharmacy practice. The recent 
advances by the society including the call for the transition from the Bachelor of 
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Pharmacy (B. Pharm) to the Doctor of Pharmacy (Pharm D) as pharmacists’ entry level 
qualification to practice (PSN, 2014), represent a positive move for practice change 
that would subsequently support pharmacist prescribing in Nigeria.  
7.5 Strengths and limitations of the exploratory sequential mixed methods 
design 
The strength and limitations of the individual studies conducted in this research have 
been discussed in the individual chapters. This section discusses the strength and 
limitations of the overall exploratory sequential mixed methods design employed in the 
research contained in this thesis.  
As identified in chapter 3, one of the advantages of mixed methods research is its 
ability to offset the weaknesses associated with mono-methods by drawing on the 
strengths of the combination of qualitative and quantitative studies (Teddlie and 
Tashakkori, 2008, Johnson and Onwuegbuzie, 2004). In this research, a limitation of 
the qualitative studies conducted was their lack of generalisability to a larger 
population. For example, the views on pharmacist prescribing expressed by 
pharmacists in the Nigerian stakeholders’ interviews could not be generalised to the 
Nigerian pharmacists’ population because it was only possible to interview a few 
purposeful samples. However, with the cross-sectional study conducted, a larger 
population of randomly sampled Nigerian pharmacists participated in the survey. 
Despite the limitations associated with the survey as outlined in chapter 6, the highly 
supportive view for pharmacist prescribing reported from this larger sample of 
pharmacists is indicative of the views of the Nigerian pharmacists’ population. 
Therefore, the survey was useful in offsetting the potential weakness associated with 
the qualitative interviews. The interviews were also useful in providing rich and 
insightful data that would be unlikely to be generated by a survey.  
Although, the quantitative component (survey) of the exploratory sequential mixed 
methods design plays a supplementary function as priority was given to the qualitative 
phase, the survey conducted, which triangulates the qualitative findings, would make 
the findings of this thesis acceptable to quantitative-biased audiences (Creswell and 
Plano-Clark, 2011). Also, the sequential nature of the exploratory mixed methods 
design makes it easier for the entire project to be described, implemented and reported 
in this thesis. Likewise, this design has resulted in the development of a new 
instrument (the questionnaire used in the survey) which can be adopted by other 
researchers to measure pharmacists’ views on extended clinical roles including 
prescribing in similar context. Another key strength of the overall research is in the 
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range of stakeholders that participated in the studies conducted. This enabled the use 
of multiple perspectives to triangulate research evidence.  
However, certain limitations were associated with the mixed methods design employed 
in this thesis. Firstly, the sequential nature of the design makes it time consuming as 
the first study would have to be concluded before the second could be implemented 
and so on. Secondly, it was not possible to apply for ethical approval at the beginning 
of the study since one study is informing the other. Therefore, the direction of the next 
study is largely unknown until the findings of the study before it are obtained. This 
makes it difficult to satisfy the ethics committee in the University of Leeds for a single 
approval for the study.  Also, because the studies were conducted in both the UK and 
Nigeria, ethics approval was obtained in both countries which required a considerable 
amount of time.  
Furthermore, as a result of the time constraint associated with this design, only a single 
reliable test, the internal consistency test was carried out on the questionnaire 
developed. Other confirmatory tests such as the test-re-test reliability and factor 
analysis which measures items correlations were not done. This is worthy of 
investigation in further research.  
7.6 Research dissemination 
A part of this research has already been disseminated in some peer-reviewed journals 
and conferences listed below. 
1. Auta A, Maz J, Strickland-Hodge B. Perceived facilitators to change in hospital 
pharmacy practice in England. International Journal of Clinical Pharmacy. 
DOI:10.1007/s11096-015-0153-9 (online first article) 
2. Auta A, Strickland-Hodge B, Maz J, Alldred DP. Pharmacist prescribing in the 
United Kingdom and the implication for the Nigerian context.  West African 
Journal of Pharmacy. 2015; 26(1): 54-61 
3. Auta A, Maz J, Strickland-Hodge B. Clinical pharmacy practice in Nigerian 
hospitals: flourishing or floundering? Poster presentation at the 75th 
International Pharmaceutical Federation (FIP) World Congress of Pharmacy 
and Pharmaceutical Sciences. Düsseldorf, Germany. 29 September - 3 October 
2015 
4. Auta A, Maz J, Strickland-Hodge B. Pharmacists’ willingness to be prescribers 
in Nigeria: a cross-sectional survey. Poster presentation at the 75th 
International Pharmaceutical Federation (FIP) World Congress of Pharmacy 
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and Pharmaceutical Sciences. Düsseldorf, Germany. 29 September - 3 October 
2015 
5. Auta A, Strickland-Hodge B, Maz J. Exploring pharmacy staff perception on the 
facilitators to change in hospital pharmacy practice in the United Kingdom. Oral 
presentation at the Postgraduate Research Student Conference of the School 
of Healthcare, University of Leeds. 24th October 2014. 
6. Auta A, Strickland-Hodge B, Maz J. Pharmacist Prescribers – would it work in 
Nigeria? Exploring the barriers and facilitators. Poster presentation at the 
Postgraduate Research Student Conference of the Faculty of Medicine and 
Health, University of Leeds. 8th July 2013 
Further dissemination will include presenting the summary of the key findings and 
recommendations of this research to the Federal Ministry of Health, Pharmacists’ 
Council of Nigeria and Pharmaceutical Society of Nigeria. In addition, other aspects of 
the research will be published in peer-reviewed journals.  
7.7 Conclusion 
This research was designed to investigate the facilitators and barriers to extending 
pharmacists’ clinical roles to include prescribing in Nigeria. An audit trail of the key 
findings and conclusions of the chapters reporting the individual studies conducted in 
this thesis showed that this thesis has accomplished its aim.  
The UK study reported in chapter 4 identified many barriers and facilitators that were 
associated with the development of clinical pharmacy practice in the UK. However, 
many of the facilitators identified were linked to the changes in the professional 
structure of pharmacy including changes in pharmacy education and training; 
specialisation in practice; a career route that recognised advanced pharmacy 
practitioners; enhanced working relationships with doctors and the development of 
pharmacy technicians to do some roles previously undertaken by pharmacists. Hence, 
the UK study suggests that changes in the traditional structure of pharmacy could 
benefit the development of pharmacists’ clinical roles in Nigeria.  
The findings of the Nigerian studies reported in chapters 5 and 6 revealed that 
pharmacy practice in Nigeria is characterised by limited roles with dispensing 
medicines as the core function of pharmacists; a generalist approach to practice; 
limited post-registration education and training to enhance pharmacists clinical skills;  
shortage of pharmacists; limited roles for pharmacy technicians; a single career 
pathway that is increasingly managerial as pharmacists progress through their career; 
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professional isolation of pharmacists from other members of the healthcare team, 
medical opposition to clinical pharmacy practice  and inadequate policies to support the 
development of clinical pharmacy practice. According to Rogers (2003), the structure of 
a social system can facilitate or hinder the adoption of an innovation. This assertion is 
consistent with the findings of the UK study in this thesis where a change in structure of 
pharmacy resulted in enhanced clinical roles for pharmacists. Therefore, this thesis 
concludes that the existing structure in Nigeria does not support the development of 
clinical pharmacy practice.   
In relation to pharmacist prescribing, the Nigerian studies indicated that it would be well 
supported in Nigeria by many stakeholders including pharmacists and patient group 
representatives.  Pharmacist prescribing represents an opportunity to promote patients’ 
access to treatment and the utilisation of pharmacists’ skills in Nigeria. Important 
factors that could facilitate pharmacist prescribing included the pharmacists’ expert 
knowledge of medicines; potential benefits associated with pharmacist prescribing; 
positive attitude of pharmacists towards extended clinical roles including prescribing; 
community pharmacists’ accessibility and the existing working relationship of 
pharmacists with doctors in some teaching hospitals. On the other hand, several 
barriers to pharmacist prescribing were identified. These barriers included pharmacists’ 
inadequate skills in clinical assessment and diagnosis as earlier mentioned, 
pharmacists’ lack of confidence to do clinical roles, shortage of pharmacists, poor 
working relationships with medical doctors, lack of medical and government’s support. 
In view of these barriers, pharmacist prescribing is likely to be unsuccessful in the 
current structure of pharmacy practice in Nigeria. Therefore, this thesis suggests that a 
change in the current structure of pharmacy is needed to enhance pharmacists’ clinical 
roles including prescribing. The key areas for change are contained in the 
recommendations made below. 
7.8 Recommendations 
The following recommendations are made based on the findings of this thesis.  
7.8.1 Recommendations for policy 
 Government should make policies that would support the development of 
clinical pharmacy practice in all hospitals in Nigeria. These policies should 
include those relating to the recruitment and retention of clinical pharmacists. 
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 A clinical career structure should be created for hospital pharmacists. This will 
allow hospital clinical pharmacists to progress in rank and status without moving 
into managerial roles and remain active clinically.  
 Professional working relationships between doctors and pharmacists should be 
encouraged. This can be initiated locally in hospitals by developing policies that 
promote multidisciplinary working relationships among members of the 
healthcare team. 
 The government should develop and define pharmacy technicians’ roles and 
responsibilities in all practice settings.  
 Pharmacist prescribing presents an opportunity to improve patients’ access to 
treatment and utilisation of pharmacists’ skills. Therefore, in the future, 
government should consider the extension of prescribing authority to 
pharmacists in Nigeria. 
 The Pharmaceutical Society of Nigeria and other pharmacy groups including 
the Nigerian Association of Hospital and Administrative Pharmacists should 
provide leadership, serve as change agents and advocate for extended clinical 
roles for pharmacists. They should lobby the government to develop policies 
that will support the development of clinical pharmacy practice in Nigeria. 
7.8.2 Recommendations for practice 
 Pharmacists have valuable roles to play in patient care. Therefore, they should 
be integrated within healthcare teams in hospitals. 
 Pharmacists should perform roles that are commensurate to their level of 
training. Therefore, their roles should move beyond dispensing. Ward pharmacy 
should be practised in all hospitals. 
 Specialisation in different clinical areas should be encouraged in order to 
enhance the contribution of pharmacists to patient care.  
 In view of the pharmacists’ shortage, the PhwSIs model of practice should be 
considered as an interim route to pharmacists’ specialisation. 
 Some traditional roles of pharmacists including dispensing should be handled 
by pharmacy technicians in order to free up pharmacist time for clinical roles. 
 Collaborative practice between doctors and pharmacists is needed for the 
development of clinical pharmacy. This will enhance patient care and prevent 
fragmentation of care. In addition, professional relationships between GPs and 
community pharmacists should be encouraged. Therefore, the Pharmaceutical 
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Society of Nigeria and the Nigerian Medical Association should work together 
towards ensuring this. 
 Community pharmacists should be trained and licensed to treat minor diseases 
using standard treatment guidelines and formularies.  
7.8.3 Recommendations for education 
 More clinical pharmacy components should be included in the undergraduate 
curriculum. Also, more time should be spent on experiential learning at sites 
where clinical pharmacy services are offered in order to enhance pharmacists’ 
confidence in clinical settings.   
 Practitioners should be involved in the undergraduate training as this would 
help in bridging the gap between training and practice.  
 There should be clearly defined competencies to be attained by entry level 
pharmacists following pre-registration training. Also, as in the UK, there should 
be a competence-based test at the end of the pre-registration year in order to 
ensure that all pharmacists entering into the profession in Nigeria attain a 
minimum level of skills.  
 Post-registration practice based clinical programmes/trainings should be 
established in order to prepare pharmacists for advanced clinical roles. These 
programmes should enable pharmacists to develop specialist skills in specific 
clinical areas. 
 Professional development frameworks should be established for both early 
career and senior pharmacists in order to ensure that pharmacists are 
developing according to the stage of their career. 
 Post-registration training programmes for pharmacist technicians should be 
developed in order to prepare them for future advanced roles including 
accuracy checking and medication history taking. 
 A postgraduate programme specifically designed to prepare pharmacists for 
prescribing would be needed prior to the introduction of pharmacist prescribing 
in Nigeria.  
 In view of the shortage of pharmacists in Nigeria, government in the long term 
should consider expanding the current pharmacists’ training institutions in order 
to increase the number of pharmacists produced in the country.   
 The Pharmacists’ Council of Nigeria should increase the number of trainee 
pharmacy technicians that technicians’ training institutions are allowed to admit 
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into their programmes since the training institutions have the capacity to admit 
more than the 15 students they are currently allowed to take annually.  
7.8.4 Recommendations for research 
In the UK: 
 More research is needed to explore what stakeholders including pharmacists 
and policymakers are doing to resolve the barriers associated with the 
implementation of pharmacist prescribing in practice settings including 
hospitals, GP practices and community pharmacies. 
 There is also the need for research to explore pharmacists’ views on the current 
consultant pharmacist role in hospitals including barriers to implementation and 
the impact on their practice.   
In Nigeria: 
 A cross-sectional survey of doctors’ views on pharmacist prescribing in Nigeria 
is necessary as a follow-up to the qualitative interviews conducted with doctors 
in this thesis. This will enable the views of doctors to be generalised and 
quantitative comparisons can be made with the views of pharmacists obtained 
in the survey conducted in this thesis. 
 There is a need to investigate how well the current post-registration training 
programmes in Nigeria (including that of the WAPCP) is preparing pharmacists 
for advanced roles in patient care settings. 
 Further research is needed to determine how best the post-registration training 
of pharmacists in Nigeria should be organised. 
 There is a need for empirical research to investigate prescribing by nurses and 
community health workers in Nigeria in order to identify potential barriers and 
facilitators. 
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Appendices 
Appendix 1: Literature Search Strategy 
Example of the literature search strategies used 
Database: Embase Clasic + Embase 1947 to 2015 
Updated: 10 April 2015 
# Searches Results 
1 Pharmac*.mp. [mp=title, abstract, subject headings, heading 
word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
1106357 
2 Pharmacist* Prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
295 
3 Supplementary Prescrib*.mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
201 
4 Dependent Prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
11 
5 Independent Prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
182 
6 Non medical prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
166 
7 Collaborative prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
14 
8 Prescribing right*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
88 
9 prescribing authority.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
86 
10 (Extend* adj2 role*).mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
1553 
11 (advanced adj2 role*).mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
1131 
12 Prescription adaptation*.mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
 
7 
13 (Expand* adj2 role*).mp. [mp=title, abstract, subject headings, 4433 
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heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
14 Nurse* Prescrib*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
607 
15 prescribing privilege*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
69 
16 Collaborative pract*.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
1057 
17 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 
15 or 16 
9334 
18 1 and 17 1576 
19 United Kingdom.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
467243 
20 Britain.mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
24291 
21 Northern Ireland.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
4912 
22 Scotland.mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
16406 
23 Wales.mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
22465 
24 England.mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
76932 
25 19 or 20 or 21 or 22 or 23 or 24 534803 
26 18 and 25 334 
27 limit 26 to yr="1990 -Current" 332 
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Appendix 2: Included studies 
Authors, year* Research aim/objective Study design, participants and settings Key findings 
Blenkinsopp et al. 
(2008)
[1] 
To explore general practitioner (GP) perceptions of 
the advantages and disadvantages of pharmacist 
supplementary prescribing. 
Focus group discussions with 13 GPs from 3 
medical practices in the Midlands region of 
England. 
GPs reported that prescribing pharmacists in their practices 
have negotiated new areas of work. However, GPs maintained 
control over pharmacists’ prescribing practice. 
Buckley et al. 
(2006)
[2] 
To investigate the factors that will enable or inhibit 
the implementation of non-medical prescribing. 
Semi-structured interviews with 15 stakeholders 
including doctors and pharmacists in a 
secondary care trust in the West Midlands, 
England. 
Stakeholders supported non-medical prescribing within the 
trust although medical staff had reservations and disagreed 
with independent prescribing. Pharmacists were 
acknowledged as experts in drug therapy but lacking 
diagnostic skills and knowledge of patients. 
Cooper et al. 
(2008a)
[3] 
To explore the views of stakeholders involved in 
SP policy, training and practice, focusing upon 
issues such as SP beneﬁts, facilitators, 
challenges, safety and costs, thereby informing 
future practice and policy. 
Semi-structured interviews with 43 UK 
stakeholders, including pharmacist and nurse 
supplementary prescribers, doctors, patient 
group representatives and policymakers.  
SP was perceived positively by stakeholders acknowledging its 
benefits to include improved access to medicines. A numbers 
of facilitators and barriers to implementation of non-medical 
prescribing were identified including prescribers’ enthusiasm, 
support networks and awareness of non-medical prescribing. 
Cooper et al. 
(2012)
[4] 
To explore whether the introduction of 
supplementary prescribing in the UK represent a 
challenge to medical authority. 
Qualitative case study involving 77 observations 
of SP consultations and interviews with 28 
patients and 11 doctors at Ten case study sites 
including primary care and hospital settings in 
England. 
Supplementary prescribing was viewed positively by all 
participants but many doctors and patients appeared to lack 
awareness and understanding of supplementary prescribing.  
Doctors maintained control over supplementary prescribing.  
Courtenay et al. 
(2011a)
[5] 
To explore the role of the organisational NMP lead 
across a range of practice settings within one 
Strategic Health Authority (SHA) and consider the 
development of NMP from a multi-organisational 
perspective. 
Semi-structured interviews with 28 NMP leads 
across one SHA  
Identified factors impeding the development of NMP including 
lack of clarity about the NMP lead role and responsibilities, 
strategic support and a lack of protected time 
Courtenay et al. 
(2012)
[6] 
To provide an overview of NMP across one SHA. An on-line questionnaire survey involving 1,585 
NMPs including pharmacist prescribers across 
one SHA. However, 883 (55.7%) completed the 
survey.  
About a third of pharmacist prescribers, allied health 
professionals, and community practitioner prescribers did not 
prescribe. Organisational policy and support were identified as 
factors affecting prescribing practice.  
Dawoud et al. 
(2011)
[7] 
To investigate pharmacist prescribers’ views and 
experiences of the early stages of SP 
implementation. 
Qualitative longitudinal study involving semi-
structured interviews with 16 pharmacist 
supplementary prescribers, trained in Southern 
England. Participants were interviewed at 3 and 
6 months after registering as prescribers. 
Three types of pharmacists’ experiences were identiﬁed: ‘‘a 
blind alley’’, ‘‘a stepping stone’’ and ‘‘a good ﬁt’’. Some 
participants felt that SP implementation was bureaucratic and 
limited pharmacists’ freedom in their decision making. 
*Reference number of articles indicated in square brackets  
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Authors, year* Research aim/objective Study design, participants and settings Key findings 
George et al. 
(2006a)
[8] 
To explore SP pharmacists’ early experiences of 
prescribing and their perceptions of the prescribing 
course. 
Postal questionnaire survey involving 518 
supplementary prescribers in Great Britain. 
Response rate was 82.2%.  
Many respondents (71%) identified better patient management as 
the main benefit of SP while inadequate funding (36.4%) and lack 
of organizational recognition (18%) were reported as barriers to 
SP.  
George et al. 
(2006b)
[9] 
To investigate community pharmacists’ aware- 
ness, views and attitudes to independent 
prescribing and their perceptions of competence 
and training needs for the management of some 
common conditions. 
Postal questionnaire survey involving 500 
Community pharmacists in Scotland. Response 
rate was 43.4%. 
Respondents showed high confidence in their ability to be 
independent prescribers and felt competent in diagnosing and 
treating the common conditions considered including 
uncomplicated urinary tract infection in women. However, 97.7% of 
respondents identified training need in diagnosis. 
George et al. 
(2007a)
[10] 
To evaluate the views and experiences of SP 
pharmacists and DMPs regarding the PLP and 
identify their perceived support needs during the 
PLP. 
Postal questionnaire survey involving 242 
pharmacists and their DMPs (n = 232) in 
Scotland. However, 186 (76.9%) pharmacists 
and 144 (62.1%) DMPs completed the survey. 
Just over half of the pharmacists knew what was expected of them 
and their DMPs during the PLP. Opportunities for professional 
development and teamwork were regarded as major positive 
experiences while organizational, attitudinal, and time barriers 
were reported as negatives. 
George et al. 
(2007b)
[11] 
To investigate the challenges experienced by 
pharmacists in delivering SP services, to explore 
their perceptions of benefits of SP and to obtain 
feedback on both SP training and implementation. 
Postal questionnaire survey involving 488 SP 
pharmacists in Great Britain. A total of 401 
(82.2%) completed the survey. 
About half of respondents (n=195; 48.6%) had started practising 
SP. Better patient management (n = 58; 29.7%) was identified as 
the main benefit of SP and inadequate funding (n = 27; 13.8%) as 
the biggest challenge in delivering SP service. 
George et al. 
(2008)
[12] 
To explore the views and experiences of 
pharmacists and their DMPs about the PLP as part 
of SP training. 
Focus groups discussion with 12 pharmacists 
and semi-structured interviews with 13 DMPs in 
Scotland. 
Planning the PLP in consultation with the DMP was found to be 
crucial for an optimal learning experience. Pharmacists who did 
not have a close working relationship with the medical team had 
difﬁculties in identifying a DMP and organising their PLP. 
Hobson and Sewell 
(2006)
[13] 
To investigate the implementation of 
supplementary pharmacist prescribing within 
primary (PCTs) and secondary care trusts (SCTs) 
in England. 
Questionnaire survey involving pharmacists from 
SCTs (n=143) and PCTs (271) in England who 
would oversee the implementation of 
supplementary prescribing by pharmacists. The 
response rate was 68% for both surveys 
Majority of pharmacists (67%) in SCTs did not believe that it would 
be difficult to recruit DMP while many PCTs pharmacists (47%) 
considered recruiting DMP as a challenge. The total number of 
pharmacists employed by PCTs was significantly associated with 
the intention to implement supplementary pre- scribing by 
pharmacists. 
Hobson et al. 
(2010)
[14] 
To explore the opinions of patients on the 
development of NMP. 
Semi-structured interviews with 18 patients in 
four primary and secondary care trusts in 
England. 
Participants acknowledged the expert drug knowledge of 
pharmacists and their accessibility. However, they expressed 
concerns about clinical governance, privacy and facilities to 
provide the service in community pharmacies.  
*Reference number of articles indicated in square brackets  
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Authors, year* Research aim/objective Study design, participants and settings Key findings 
Hughes and 
McCann (2003)
[15] 
To explore barriers between GPs and community 
pharmacists in relation to closer inter-professional 
working and the extension of prescribing rights to 
pharmacists. 
Focus groups with 22 GPs and 31 pharmacists 
in Northern Ireland.  
The ‘shopkeeper’ image of community pharmacy emerged as 
a major theme. Many GPs saw community pharmacists as 
business people and felt that their commercial interest would 
represent a conflict of interest in pharmacist prescribing. 
Lim et al. (2013)
[16] To explore the role of NMP leads in organisations 
across one SHA and to inform future planning. 
Semi-structured interviews with 27 NMP leads 
across one SHA 
The processes used to appoint NMP leads lacked clarity and 
varied between trusts. Many NMP leads did not have a 
designated time for their role. Factors that supported the role 
included organisational support and dedicated time. 
Lloyd and Hughes 
(2007)
[17] 
Explored the views and professional context of 
pharmacists and DMPs prior to the start of 
supplementary prescribing training. 
Semi-structured interviews with pharmacists 
(n=63) from the first four cohorts enrolled for 
supplementary prescribing training in Northern 
Ireland and focus groups with their DMPs (n=54) 
Supplementary prescribing was generally welcomed by 
pharmacists and their DMPs. However, there were concerns 
about loss of diversity, deskilling of junior doctors, safety and 
professional encroachment. 
Lloyd et al. 
(2010)
[18] 
Explored the context and experiences, in relation 
to the practice of supplementary prescribing, of 
pharmacists and DMPs at least 12 months after 
pharmacists had qualified as supplementary 
prescribers. 
Focus groups with pharmacists (n=40) and semi-
structured interviews with their DMPs (n=31) in 
primary and secondary care stings in Northern 
Ireland 
Three-quarters of pharmacists qualified to practise as 
supplementary prescribers were not actively prescribing. This 
was largely due to logistical and organisational barriers rather 
than inter-professional tensions.  
MacLure et al. 
(2013)
[19] 
To explore the views of the Scottish general public 
on non-medical prescribing. 
Postal questionnaire survey involving 5,000 
members of the general public in Scotland. The 
response rate was 37.1%. 
Respondents generally showed a lack of understanding of 
NMP and expressed concern on access to patients’ medical 
records prior to prescribing.  
McCann et al. 
(2011)
[20] 
To capture information on pharmacist prescribing 
in Northern Ireland 
Questionnaire survey involving 100 pharmacists 
who were identiﬁed as qualiﬁed prescribers in 
Northern Ireland. Response rate was 76%. 
About half (46.1%) of the respondents had never prescribed 
since qualifying as prescribers. Barriers to pharmacist 
prescribing reported included inadequate funding and lack of 
access to patients records.  
McCann et al. 
(2012)
[21] 
To provide an in-depth understanding of 
pharmacist prescribing from the perspective of 
pharmacist prescribers, medical colleagues and 
key stakeholders in Northern Ireland. 
Semi-structured interviews with 32 participants 
including 11 pharmacists, 8 mentors and 13 key 
stakeholders in Northern Ireland. 
Three major themes emerged: the effect on patient care; 
challenges facing pharmacist prescribers and the importance 
of the inter-professional team. The challenges identified 
included lack of support by some doctors and pharmacists’ 
competence in dealing with complex cases.  
McCann et al. 
(2015)
[22] 
To explore patients’ perspectives of pharmacists 
as prescribers. 
Focus groups with 34 patients of three 
independent pharmacist prescribers in primary 
and secondary care settings in Northern Ireland. 
This study is part of a larger case study 
conducted at three sites linked to these 
prescribers.  
Team approach to patient care emerged as an overarching 
team. There was an overwhelming lack of awareness of 
pharmacist prescribing by patients prior to attending 
pharmacist prescribers’ clinic. 
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Authors, year* Research aim/objective Study design, participants and settings Key findings 
Smalley (2006)
[23] To evaluate patients’ experience of a pharmacist-
led supplementary prescribing hypertension clinic. 
Postal questionnaire survey involving 127 patients 
attending a pharmacist-led supplementary 
prescribing clinic in Derby, England. The response 
rate was 73%.  
Eighty-nine respondents (83%) at tended the first clinic.. Of 
these, 91% continue to attend, 8% no longer attend and 1% 
decided against participating in the clinic. Preference to continue 
with GP or nurse care was given as the reason for not continuing 
with the pharmacist prescriber. 
Stewart et al. 
(2007)
[24] 
To investigate in Great Britain pharmacists, who 
have not yet applied for a SP course, their planned 
participation in training, and attitudes towards 
pharmacist SP. 
Postal questionnaire survey involving 4300 
pharmacists. The response rate was 55.1% 
(2371/4300).  
Of the 1707 with patient contact, almost all (1668, 97.7%) were 
aware of pharmacist SP.  Some predictors of prescribing training 
actions identified were: awareness of local networks for SP; 
receptivity to change; know ledge of colleagues who had 
undertaken or were currently undertaking SP training and 
postgraduate qualifications. 
Stewart et al. 
(2008)
[25] 
To explore patients’ perspectives and experiences 
of pharmacist SP in Scotland. 
A questionnaire survey involving 180 patients of 
nine supplementary prescribers in primary and 
secondary care settings in Scotland.  Response 
rate was 57.2%.  
Most patients were positive in their attitudes, agreeing that they 
would recommend a pharmacist prescriber to others. However, 
65% would prefer to consult a doctor. 
Stewart et al. 
(2009a)
[26] 
To explore the perspectives of pharmacist 
supplementary prescribers, their linked 
independent prescribers and patients, across a 
range of settings, in Scotland, towards pharmacist 
prescribing. 
Semi-structured interviews with 9 pharmacist 
prescribers, 8 linked independent prescribers 
(doctors) and 18 patients in primary and secondary 
care settings in Scotland. 
All stakeholders were supportive of pharmacists as 
supplementary prescribers. Patients had little idea of what to 
expect on their first visit. Pharmacists and doctors expressed 
concerns around a potential lack of funding, inadequate support 
networks and continuing professional development. 
Stewart et al. 
(2009b)
[27] 
To determine the awareness of, views on, and 
attitudes of Scottish general public toward 
nonmedical prescribing, with an emphasis on 
pharmacist prescribing. 
Postal questionnaire survey involving 5,000 
members of the general public in Scotland. The 
response rate was 37.1%. 
Many respondents (56.6%) were aware of NMP and supported 
the pharmacist having a prescribing role. However, there were 
concerns about lack of privacy in a community pharmacy. 
Stewart et al. 
(2011)
[28] 
To evaluate the views of patients across primary 
care settings in Great Britain who had experienced 
pharmacist prescribing. 
Questionnaire survey involving 143 patients of 
pharmacist prescribers in Great Britain. Patients 
were largely recruited from general practices or 
community pharmacies. Response rate was 73.4%  
Respondents were positive towards pharmacist prescribing and 
most would recommend consulting a pharmacist prescriber. 
However, 69.6% of respondents would prefer to consult their GP 
if they thought their condition was getting worse. 
Tann et al. 
(2008)
[29] 
Explored GP and pharmacist perceptions of the 
introduction of pharmacist supplementary 
prescribing, focusing on the consequences for 
professional boundaries, power relations and 
knowledge 
Semi-structured interviews with 7 pharmacist 
supplementary prescribers (PSPs) and focus 
groups with PSPs and 7 GPs in two PCTs in the 
Midlands, England. 
GPs have delegated some routine work in specific chronic 
conditions, and a limited amount of decision making, to 
pharmacists. However, they maintain the overall control in the 
prescribing process. 
*Reference number of articles indicated in square bracket  
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Authors, year* Research aim/objective Study design, participants and settings Key findings 
Tonna et al. 
(2010)
[30] 
To explore pharmacists’ perceptions of the 
feasibility and value of pharmacist prescribing of 
antimicrobials in secondary care in Scotland. 
Six focus groups with 37 pharmacists from 5 
Scottish regions.  
Pharmacists’ identiﬁed potential roles and opportunities for 
pharmacist prescribing of antimicrobials. However, they 
perceived that it is unlikely for the medical profession to readily 
accept pharmacist prescribing unless a prior diagnosis has 
been made by the medical clinician. 
Tully et al. 
(2007)
[31] 
To investigate the views and experiences of 
pharmacists in England before and after they 
registered as supplementary prescribers. 
Semi-structured interviews with 8 pharmacists in 
England. Interviews were held during their 
training and when they qualify as supplementary 
prescribers. 
Participants anticipated that training would legitimise their 
current ‘informal’ prescribing practices, but experienced many 
procedural delays in implementing their new role including 
delays associated with registering as a prescriber. 
Warchal et al. 
(2006)
[32] 
To ascertain whether successfully completing a 
supplementary prescribing (SP) course can 
empower pharmacists in terms of their extended 
roles 
Postal questionnaire survey involving 38 
pharmacist supplementary prescribers in the UK. 
This was followed with 10 telephone interviews 
with respondents in the survey who agreed to be 
interviewed.  
Participants were confident to begin their new roles; however, 
they experienced a number of barriers particularly among 
community pharmacists where time and access to patients’ 
medical records were a problem.  These challenges were less 
likely with hospital pharmacist prescribers. 
Weiss and Sutton 
(2009)
[33] 
Investigated the potential threat to medical 
dominance posed by the addition of pharmacists 
as prescribers in the UK. 
Semi-structured interviews with 23 pharmacist 
supplementary prescribers in Great Britain.  
Pharmacist prescribing has been aided by: (1) blurred 
deﬁnitions of prescribing; (2) the emphasis on new prescribers’ 
competence urging pharmacist prescribers to limit their areas 
of clinical practice; and (3) a team approach to patient 
management. 
McIntosh et al. 
(2012a)
[34] 
To investigate newly registered pharmacists’ 
awareness of pharmacist prescribing and views on 
potential future roles as prescribers. 
Postal questionnaire survey involving 1658 
pharmacists joining the Pharmacist Register of 
the RPSGB in 2009. Response rate was 25.2% 
(n = 418)  
Majority (79.5%) of respondents were aware of non-medical 
prescribing. Most (86.4%) expressed interest in prescribing 
training. The results revealed access to patient information as 
a barrier to pharmacist prescribing implementation. 
Baqir et al. 
(2010)
[35] 
To evaluate pharmacist prescribing including 
barriers to implementation across the north east of 
England. 
Mixed methods: Questionnaire survey involving 
179 pharmacists who had completed a 
prescribing course in the University of 
Sunderland. This was followed by a focus group 
discussions with 6 of the pharmacists involved in 
the survey. 
97 responded to the survey. Of these 84 had registered as 
prescribers but 37 were currently not prescribing including 
those who had never prescriber (n=24). Barriers identified 
included change of job and lack of organisational support. 
Pharmacists’ relationship with their medical colleagues was 
noted as a facilitator. 
*Reference number of articles indicated in square brackets 
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Adigwe (2012)
[36] To develop new theory regarding the experience 
of nurses and pharmacists who qualify as 
prescribers and to explain the barriers and 
facilitators they encounter when prescribing for 
chronic pain. 
Mixed methods: qualitative component involves 
interviews with 22 non-medical prescribers and 
12 patients, while the quantitative component 
survey 545 non-medical prescribers in Yorkshire 
and Humber region, England. Survey response 
rate was 33% (n=180). 
Maintaining relationships with colleagues, managers and 
patients influenced how prescribers perceived safety and 
support in NMP. Pharmacists were seen as more knowledgeable 
in relation to medicines but were limited by a lack of experience 
with chronic pain patients, access to CPD and concerns around 
‘second checking’. 
Candlish et al. 
(2006)
[37] 
To follow up pharmacists who have successfully 
completed their SP course, with particular interest 
in those who are prescribing and the barriers 
encountered. 
Postal questionnaire survey involving 107 
pharmacists who had successfully completed 
their SP course at the University of Sunderland, 
England. Response rate was 50.5%.  
50% (n=27) of respondents were had started prescribing. Those 
not prescribing commonly reported change of job (22.2%), no SP 
role available (33.3%), (18.5%) await prescription pads (18.5%), 
and reported insufficient time (11.1%) as barriers. 
Dapar (2012)
[38] To investigate the structures and processes of 
pharmacist prescribing in Great Britain, focusing 
on primary care settings. 
Mixed methods: The quantitative component 
was a postal questionnaire survey among 1654 
pharmacist prescribers in Great Britain. 
Response rate was 42.3% (n=695). The 
qualitative component was semi-structured 
interviews with 34 pharmacist prescribers.  
Prescribers in hospitals of general medical practices were more 
likely to have prescribed than those in community practice. 
Professional isolation, lack of access to patient medical records 
and administrative support were hindering prescribing in 
community practice.  However,  lack of clarity and definition of 
the pharmacist prescribing role was hindering 
Pharmacist prescribing in all settings. 
Latter et al. 
(2010)
[39] 
To evaluate nurse and pharmacist independent 
prescribing in order to inform planning for current 
and future prescribers. 
Multi-study design involving surveys, case 
studies and stakeholders workshop.  
Between 2% and 3% of both the nursing and pharmacist 
workforce are qualiﬁed to prescribe medicines independently. 
93% of nurse prescribers and 80% of pharmacist prescribers 
had used their independent prescribing qualiﬁcation. NMP has 
been largely driven by individual practitioners and only about 
50% of Trusts had a strategy or written plan for the development 
of NMP. 
Jones and Western 
(2009)
[40] 
To investigate the views of healthcare 
professionals (HCPs) on the service provided by 
the SP pharmacists within a mental health 
outpatient setting. 
Semi-structured interviews with 12 HCPs (7 
doctors, 3 nurses and 2 social workers) who 
work in collaboration with SP mental health 
pharmacists in 3 outpatient clinics in Wales.  
Participants were supportive of pharmacist prescribing within 
their work environment, acknowledging that pharmacists have 
extensive knowledge of the medication they prescribe. However, 
there was a lack of awareness within the services of the 
pharmacists’ role 
Lloyd et al. 
(2005a)
[41] 
To explore the views and opinions of junior house 
officers (JHOs) and senior house officers (SHOs) 
on the introduction of hospital pharmacist 
supplementary prescribing in Northern Ireland. 
Questionnaire survey among 516 JHOs and 
SHOs in 11 hospitals in Northern Ireland. 
Response rate was  22.3% (n=115) 
Majority of doctors (84.4%) felt they currently had a good 
working relationship with pharmacists. However, 68.1% were 
unaware of the role of a supplementary prescribing pharmacist. 
*Reference number of articles indicated in square brackets  
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Cope (2013)
[42] To identify the likely predictors of successful NMP 
in a community pharmacy setting, what barriers 
were required to be overcome and how these were 
overcome in order to achieve success. 
Semi-structured interviews with 18 pharmacist 
prescribers in England , Wales and Scotland  
All participants were positive towards developing NMP.  
Pharmacists in England and Wales, where central funding was 
not available, described accessing funding as being a key 
issue. Pharmacists in Scotland, where central funding was 
available, cited continuity of funding as being of greater 
importance. 
Lloyd et al. 
(2005b)
[43] 
To explore the views and opinions of nurses 
towards the introduction of hospital pharmacist 
supplementary prescribing in Northern Ireland. 
Questionnaire survey among 820 nurses in 11 
hospitals in Northern Ireland. Response rate was  
25% (n=205) 
The majority of nurses (79%) felt they currently had a good 
working relationship with pharmacists but only 20% were 
aware of the role of a pharmacist supplementary prescriber. 
MacLure et al. 
(2011)
[44] 
To explore how pharmacist prescribers view their 
transition from supplementary to independent 
prescribing with particular focus on potential 
facilitators and barriers affecting service 
development 
Semi-structured interviews with 22 pharmacist 
prescribers who had completed, or were on their 
conversion course at Robert Gordon University, 
Scotland.  
The most cited facilitators were supportive professional 
relationships, training courses and prior prescribing 
experience. Barriers to the transition included time, resource 
and funding constraints and the perceived need for a national 
strategy supported by local Health Boards. 
McIntosh et al. 
(2012b)
[45] 
To determine the current views and attitudes 
towards, and uptake of prescribing training 
programmes among pharmacists in Great Britain. 
Postal questionnaire survey involving 4000 non-
prescribing pharmacists on the practising 
Register of the RPSGB. Response rate was 
32.7%. 
95.9% (n = 1254) were aware of pharmacist prescribing. Most 
(65.9%, n = 862) had never thought about training as 
prescribers or had thought about it but had not explored it 
further. Some barriers were reported including lack of 
organisational and financial support for pharmacist prescribing. 
Mulholland 
(2013)
[46] 
To determine how far pharmacist prescribing has 
developed in Neonatal Intensive Care Units 
(NICU), what beneﬁts are perceived and what 
barriers have been encountered. 
A survey involving Neonatal and Paediatric 
Pharmacists Group members working in NICU. 
Total numbers of questionnaire distributed was 
not indicated but 45 responses were received. 
Also, the research setting was also not indicated. 
Just under half (47%) were prescribers, with 40% being 
independent prescribers. Lack of funding and time to 
undertake prescribing course and the potential need for a 
second pharmacist to clinically check what a pharmacist has 
prescribed were reported as barriers. 
Sutton et al. 
(2010)
[47] 
To explore pharmacist prescribing in clozapine 
clinics. 
Case study methodology incorporating 
quantitative (patient surveys) and qualitative 
(semi-structured interviews with staff and 
patients) methods in 7 sites.  
Pharmacist independent prescribers (PIPs) were leading 3 of 
the clozapine clinics, while the remaining 4 were run by 
nurses. However, these pharmacists were working as 
supplementary prescribers. Reasons for this included lack of 
support from colleagues and ‘the system’ and being wary of 
taking responsibility for the prescribing of clozapine. 
*Reference number of articles indicated in square brackets
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Authors, year* Research aim/objective Study design, participants and settings Key findings 
Alaeddine et al. 
(2014)
[48] 
To identify how pharmacist independent 
prescribers use their prescribing skills in Imperial 
College Hospital NHS Trust (ICHT). 
Questionnaire survey involving 19 Pharmacist 
independent prescribers at ICHT, London. 
Response rate was 68% (13/19) 
77% of PIPs report prescribing only for inpatients, 15% solely 
in outpatient clinics and 8% in both. Some reasons given by 
prescribers for not prescribing frequently were: do not wish to 
de-skill medical staff, lack of time, excess workload, asking 
doctors is faster, not seeing patients independently, and not 
having the opportunity to attend ward rounds. 
Rees (2013)
[49] To evaluate pharmacist independent prescribing in 
Wales 
Questionnaire survey involving 128 pharmacists 
who qualified as independent prescribers in 
Wales. Response rate was 59% (n=75) 
About two-thirds (64%, n=48) have used their qualification. 
Factors that enabled this included support from colleagues 
(n=28), clinical knowledge and experience (n=8), time (n=7) 
and funding (n=3). Reasons given for not prescribing were lack 
of time (n=10) and funding (n=9).  
Park et al. (2013)
[50] To investigate patient opinion on pharmacist 
prescribing during their inpatient stay on an 
elective orthopaedic ward. 
A questionnaire was distributed to all (58) 
patients admitted to an elective orthopaedic 
ward. 
Most patients (65.5%) felt that pharmacists were appropriately 
qualified to prescribe their medicines during their inpatient 
stay. However, 58.6% were not aware that pharmacists were 
able to prescribe. 
Phelps et al. 
(2014)
[51] 
To improve GPhC’s understanding of the 
registrants’ work, training and professional 
practice. 
Online and postal survey involving 3040 
registered pharmacists including pharmacist 
prescribers (n=1914) in Great Britain.  21,672 
registered pharmacy technicians were also 
surveyed. Response rate for pharmacists was 
50.8%.  
Three quarters (74%) of prescribers had prescribed at some 
point since they qualified. However, only 61% of all prescribers 
had prescribed in the last 12 months of the survey. The 
reasons giving for not prescribing were categorised into lack of 
opportunities (such as commissioning environment), changed 
circumstances (such as moving into a management role) and 
personal reasons such as retirement and maternity leave 
Jones (2006)
[52] To conduct research on the training, 
implementation and development of pharmacist 
supplementary prescribing in wales. 
Case study approach which included semi-
structured interviews with 7 pharmacists during 
and after training, and non-participant 
observation of pharmacist supplementary 
prescribers’ consultations.  Follow-up semi-
structured interviews were held with pharmacist 
prescribers (3), DMP (1) and patients (2). 
Participants were supportive of pharmacist prescribing. 
Pharmacist supplementary prescribing was perceived to 
benefit patient care, utilise skills and a ‘stepping stone’ to 
independent prescribing. Barriers to implementation were 
identified including funding, time and access to patient medical 
records. 
*Reference number of articles indicated in square brackets
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Shrestha et al. 
(2011)
[53] 
To assess the views and experiences of nurse and 
pharmacist prescribers and the attitudes of doctors 
and non-prescribing pharmacists regarding the 
role of a non-medical prescriber in a secondary 
care setting 
Questionnaire survey administered to 
pharmacist prescribers, non-prescribing 
pharmacists, nurse prescribers and doctors in 
Whipps Cross University Hospital NHS Trust, 
London, England. The response rates were 
100% (6/6), 93% (14/15), 35% (7/20) and 20% 
(12/60), respectively. 
All the non-medical prescriber respondents were independent 
prescribers. All respondents viewed NMP positively. However, 
42% (5) of doctors showed concerns for the boundary 
encroachments of NMP and 67% (9) of them agreed there was a 
lack of diagnostic skill among non-medical prescribers to prescribe 
independently. 83 % (5) of pharmacist prescribers showed 
concerns regarding their lack of diagnostic skills. 
While et al. 
(2004)
[54] 
To investigate community pharmacists’ views 
regarding supplementary prescribing. 
Postal questionnaire survey involving 238 
community pharmacists from 7 primary care 
trusts in England. Response rate was 53.4% 
(n=127). 
Respondents expressed concerns regarding supplementary 
prescribing to include lack of time for consultation (25.2%) and 
access to patient records (20.5%). Pharmacists with postgraduate 
qualifications more positive on their views on supplementary 
prescribing. 
Ziegler et al. 
(2014)
[55] 
To explore the barriers to becoming a qualiﬁed 
pharmacist prescriber, investigate pharmacist pre- 
scribers’ experiences of the transition from 
qualifying as a prescriber to prescribing in a 
palliative care context and identify any continuing 
professional development needs. 
Questionnaire survey among 180 members of 
the National Palliative Care Pharmacy Network. 
The response rate was 38.9% (n=70).  
All pharmacists reported that a pharmacist prescribing qualiﬁcation 
would be relevant to their current role. Only 20% (14) were 
currently prescribing as Pharmacist Independent Prescriber. They 
prescribe a wide range of medicines in patients with complex 
comorbid conditions. This complexity presented some unmet 
training needs. 
Child et al. 
(1998)
[56] 
To identify attitudes towards pharmacist-written 
prescriptions and pharmacist prescribing. 
Questionnaire survey among 19 doctors, 200 
nurses and 87 hospital pharmacists in 
Birmingham, England. The response rate was 
57.5% 
Support for pharmacist-written prescriptions and pharmacist 
prescribing ranged from 43.6 per cent to 94 per cent, depending 
on the scenario described and the profession of the responder.  
95.5% of pharmacists were willing to prescribe. Barriers to 
pharmacist prescribing identified included, education/training, 
access to patient data, lack of time and shortage of pharmacists. 
Department of 
Health (1999)
[57] 
To develop a framework to determine in what 
circumstances health professionals might 
undertake new roles with regard to the prescribing, 
supply and administration of medicines. 
Consultations and group meetings with key 
stakeholders. Over 750 submissions were 
received.  
The report identified facilitators for change to the arrangement of 
prescribing, supply and administration of medicines. These 
included changes in patients’ expectations, professional 
relationships and education/training of healthcare professionals 
Winstanley 
(2009)
[58] 
To explore the continuing professional 
development (CPD) needs of  pharmacist 
prescribers  
Cross-sectional survey involving 971 pharmacist 
prescribers in Great Britain.  The response rate 
was 30% (n=294).  
Almost half of the respondents were currently prescribing. Most 
pharmacists wanted  to extend their scope of practice and to have 
access to appropriate resource for CPD.  
McIntosh et al. 
(2015) 
To describe and understand reasons for non-
prescribing  
Semi-structured interviews with 7 pharmacists 
and 6 nurses who qualified as prescribers but 
were not prescribing in Scotland.  
Reasons for not prescribing identified were Lack of organisational 
support to implement and develop NMP and lack of access to 
patients’ medical records by community pharmacists.  
*Reference number of articles indicated in square brackets
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Appendix 3: Comparisons of common paradigms used in social and behavioural 
sciences 
Paradigm Positivism Postpositivism Pragmatism Constructivism 
Methods Quantitative Primarily 
quantitative 
Quantitative and 
qualitative 
Qualitative 
Logic Deductive Primarily 
deductive 
Deductive and 
inductive 
Inductive 
Epistemology Objective point 
of view. Knower 
and the known 
are dualism  
Modified dualism. 
Findings 
probably 
objectively “true” 
Both objective 
and subjective 
point of view 
Subjective point 
of view. Knower 
and the known 
are insuperable. 
Axiology Inquiry is value 
free 
Inquiry involves 
values, but they 
may be 
controlled 
Values play a 
large role 
interpreting 
results 
Inquiry is value-
bound 
Ontology Naïve realism Critical or 
transcendental 
realism 
Accept external 
reality. Choose 
explanations 
that best 
produce desired 
outcomes 
relativism 
Causal linkages Real causes 
temporally 
precedent to or 
simultaneous 
with effects 
There are some 
lawful, 
reasonably 
stable 
relationships 
among social 
phenomenon. 
These may be 
known 
imperfectly. 
Causes are 
identifiable in a 
probabilistic 
sense that 
changes over 
time 
There may be 
causal 
relationships, 
but we will never 
be able to pin 
them down. 
All entities 
simultaneously 
shaping each 
other. It’s 
impossible to 
distinguish 
causes from 
effects 
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Appendix 4: Ethical approval letter for the UK study 
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Appendix 5: Participant Information Sheet (UK study) 
 
 
INVESTIGATING THE CHANGES IN THE PROFESSIONAL STRUCTURE OF 
PHARMACY IN THE UNITED KINGDOM: LESSONS FOR THE NIGERIAN 
CONTEXT 
You are being invited to take part in the above named study but before you decide, 
please read the following information.   
What is the purpose of this study? 
This study is the first part of a larger study aimed at identifying the barriers and 
facilitators to extending prescribing roles to pharmacists in Nigeria.  Findings from this 
study are expected to inform the next phase of study in Nigeria. 
There is evidence from the literature that the current roles of pharmacists in the UK 
including prescribing are supported by the changes that occurred in the professional 
structure of pharmacy following the implementation of the recommendations of the 
Noel Hall Report (1970) and the Nuffield Report (1986). 
This study will investigate the changes in the professional structure of pharmacy in the 
UK prior to the introduction of pharmacist prescribing in order to learn lessons from the 
UK experience that might assist in the potential changes needed in Nigeria.  
Who is doing the study?  
This study is being undertaken by Mr Asa Auta as part of his PhD studies at the School 
of Healthcare, University of Leeds. Dr Barry Strickland-Hodge, Dr David Alldred and Dr 
Julia Maz from the School of Healthcare, University of Leeds are supervising this 
research.   
Why have I been asked to participate? 
You have been invited to participate in this study because you were practising as a 
pharmacist or pharmacy technician in the UK between the 1970s and 1990s and have 
witnessed the changes that occurred in hospital and community pharmacy practice 
within this period. We are inviting about 30 participants in total to take part in this study.  
What will be involved if I take part in this study? 
If you choose to participate in the study, you will be invited to a single interview which 
will last approximately one hour and will be audio-recorded. The interview will take 
place at a time and location convenient to you. If you live outside the Yorkshire region, 
the interview will be by telephone. You will need to give us a contact phone number of 
your choice, which will be used for the telephone interview. 
What are the advantages and disadvantages of taking part? 
There is no direct benefit to you for taking part in this study, but your views will help us 
understand the issues that are important in changes in professional structure and role 
 292 
 
expansion; and will assist us in determining the potential changes that will be needed in 
the Nigerian context.  
Do I have to take part ? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. 
Can I withdraw from the study at any time?  
You are free to withdraw at any time before or during the interview without giving a 
reason and up to two weeks after the interview has taken place. Once this period has 
expired, the information obtained from you will be analysed and cannot be withdrawn. 
Will the information obtained in the study be confidential?  
All information obtained from you will be kept strictly confidential. Your name will be 
removed from the interview transcription, which means only Asa will know what you 
have said.  Asa’s supervisors: Dr Barry Strickland-Hodge, Dr David Alldred and Dr Julia 
Maz may have access to the audio interview and transcripts for the purpose of 
verification of transcription and analysis. However, all your personal identifiable details 
will be removed before granting them access to your data. The digitalised record of 
your interview will be deleted after transcription and the transcript held in a password 
protected secure network of the University of Leeds for a period of five years, after 
which, it will be securely and irreversibly deleted from the device on which it is stored. 
What will happen to the results of the study? 
Your responses and that of other participants will be analysed. Some quotes will be 
used from all participants’ responses to illustrate the views of participants. However, 
these quotes will not be associated with your name. The results of this study will form 
part of Asa’s PhD thesis and will also be published in a scientific journal and be 
presented at a conference.  
Who has reviewed this study? 
Ethical approval has been granted by the School of Healthcare Research Ethics 
Committee (Ref no: SHREC/RP/344 of 20 June 2013). 
 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact 
Asa Auta 
PhD Student, 
School of Healthcare, 
Baines Wing, 
University of Leeds, 
LS2 9UT, Leeds, UK. 
Tel: 0113 3437185 or email: hs09aa@leeds.ac.uk 
 
Thank you for taking the time to read this information sheet. 
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Appendix 6: Consent form (UK study) 
 
 
PARTICIPANT CONSENT FORM 
INVESTIGATING THE CHANGES IN THE PROFESSIONAL STRUCTURE OF 
PHARMACY IN THE UNITED KINGDOM: LESSONS FOR THE NIGERIAN 
CONTEXT 
Please confirm agreement to the following statements by putting a tick in the box below: 
I have read and understood the participant information sheet  
I am aware that I can ask questions about the research and receive 
satisfactory answers 
 
I have received enough information about the study  
I understand that I am free to withdraw from the study at any time 
without giving a reason before or during the interview and for up to two 
weeks after the interview has taken place and that all information 
obtained from me will not be included in the study following my 
withdrawal. 
 
 
 
I understand that that once the information obtained from me has been 
analysed, it cannot be withdrawn. 
 
I understand that my interview will be audio-recorded  
I understand that any information I provide, including personal details, 
will be kept confidential, stored securely and only accessed by those 
carrying out the study 
 
I understand that any information I give may be included in published 
documents but all information will be anonymised. 
 
I agree to take part in this study 
 
 
Participant Signature …………………………                      Date                       
Name of Participant:  
Researcher Signature ……………………….                       Date  
Name of Researcher:  
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Appendix 7:  Final interview guide used in the UK study 
INVESTIGATING CHANGES IN THE PROFESSIONAL STRUCTURE OF 
PHARMACY IN THE UNITED KINGDOM: LESSONS FOR THE NIGERIAN 
CONTEXT 
Preamble: 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the changes in the professional structure of pharmacy in the UK prior to the 
introduction of pharmacist prescribing. This interview is expected to last about an hour, 
and you are free to stop from participating in the interview at any point in time. All 
information obtained from you will be kept confidential.  
Are you happy for me to record the interview? 
Key Interview Questions 
1. May I ask how long you have been a practising pharmacist? 
o This will help me decide which changes they may have seen introduced 
2. What is your current main practice setting as a pharmacist/pharmacy 
technician? 
3. What is your current role in your practice setting? 
o If a prescriber, note the type of prescriber (SP or IP) and should later in 
the interview find out from the participant how the changes that occurred 
in pharmacy structure are related to or currently supporting his/her 
present role 
4. Can you tell me something about the roles you have had in your career and 
how these roles have evolved over time? 
o If in senior management  at a point, they may have been responsible for 
change and know what it was like prior to the change 
o Probe to know what factors were responsible for changes in roles of 
participant if necessary. 
 
5. In your opinion, what changes have occurred in the structure of pharmacy in the 
UK since you registered?   
If prompting is needed, mention changes following Noel Hall & Nuffield Reports 
o Career structure 
o Roles of supporting staff 
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o Roles of pharmacist (may mention some of the extended roles such as 
prescribing at this stage) 
o Salaries 
o Training 
o Others 
Prompt 2: Do you have an idea on what made pharmacists to move into the 
ward in the first instance?   
6. How have these changes affected pharmacy staff roles (expansion or erosion)? 
o Need to ensure the word roles is stressed but may also want to consider 
activities of the different staff groups 
7. What do you think were the facilitators for change?  
o May need to explain what facilitators mean at this stage and keep this 
definition the same for all interviews. May need some examples as 
prompts such as influential individuals, need for change, need to keep 
professionals interested, patient expectations,  educational 
programmes, specialisation, legislation 
8. Were there any barriers to the change process? If they were, how were they 
overcome? 
o What were the barriers to developing clinical roles 
o May need to have some examples ready such as money, other 
professional groups, other pharmacists or pharmacy technicians. 
9. What advantages and disadvantages do you think are associated with these 
changes?  
o This should help consider barriers and facilitators and if the interviewee 
is in favour of change or not. 
10. In your opinion, what lessons do you think are there for other countries to learn 
from the UK experience? 
11. Do you have any other comment that you think might be helpful to this 
research? 
Thank you for taking part in this interview 
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Appendix 8: Mind mapping of potential ideas during thematic analysis 
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Appendix 9: SHREC’s Ethics approval letter for the Nigerian study 
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Appendix 10: Nigerian ethics approval letter 
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Appendix 11: Participant Information Sheet (Nigerian study) 
 
 
FACILITATORS AND BARRIERS TO EXTENDING PHARMACISTS’ 
CLINICAL ROLE TO INCLUDE PRESCRIBING  
You are being invited to take part in the above named study but before you decide, 
please read the following information.   
What is the purpose of this study? 
Prescribing to patients has been the exclusive role of doctors and dentists until the 
introduction of non-medical prescribing in some countries which allowed other health 
professionals including nurses and pharmacists to prescribe medicines. 
In Nigeria, only medical doctors and dentists have the legal right to prescribe 
medicines. However, a nurse or a community health worker can be designated by the 
government to prescribe medicines in a primary healthcare facility without a doctor.  
Access to medicines in Nigeria can be seriously affected by the shortage of medical 
prescribers, long waiting times in hospitals and poor geographical access to 
physicians. 
Pharmacists in Nigeria are highly educated professionals with expertise in medicines 
management. Despite the cost and high level of training of Nigerian pharmacists, their 
expertise is not utilised effectively. They mainly perform the traditional role of 
dispensing, which could be handled by suitably trained pharmacy technicians as in 
other countries such as the UK.  
This study will therefore investigate the facilitators and barriers to extending the clinical 
role of pharmacists to include prescribing in Nigeria. 
Who is doing the study?  
This study is being undertaken by Mr Asa Auta as part of his PhD studies at the School 
of Healthcare, University of Leeds. Dr Barry Strickland-Hodge and Dr Julia Maz from 
the School of Healthcare, University of Leeds are supervising this research.   
Why have I been asked to participate? 
You have been invited to participate in this study because you have been identified as 
a stakeholder who has been involved in prescribing, pharmacy practice or training in 
Nigeria. We are inviting about 40 participants in total to take part in this study.  
What will be involved if I take part in this study? 
If you choose to participate in the study, you will be invited to a single telephone 
interview which will last about 30 minutes and will be audio-recorded. The interview will 
take place at a time convenient to you. You will need to give us a contact phone 
number of your choice, which will be used for the telephone interview. 
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What are the advantages and disadvantages of taking part? 
There is no direct benefit to you for taking part in this study, but your views will help us 
understand the issues that are important in clinical role extension for pharmacists in 
Nigeria and assist in determining the potential changes needed in pharmacy practice, 
training and policy.   
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. 
Can I withdraw from the study at any time?  
You are free to withdraw at any time before or during the interview without giving a 
reason and up to two weeks after the interview has taken place. Once this period has 
expired, the information obtained from you will be analysed and cannot be withdrawn. 
Will the information obtained in the study be confidential?  
All information obtained from you will be kept strictly confidential. Your name will be 
removed from the interview transcription, which means only Asa will know what you 
have said.  Asa’s supervisors: Dr Barry Strickland-Hodge and Dr Julia Maz may have 
access to the audio interview and transcripts for the purpose of verification of 
transcription and analysis. However, all your personal identifiable details will be 
removed before granting them access to your data. The digitalised record of your 
interview will be deleted after transcription and the transcript held in a password 
protected secure network of the University of Leeds for a period of five years, after 
which, it will be securely and irreversibly deleted from the device on which it is stored. 
What will happen to the results of the study? 
Your responses and that of other participants will be analysed. Some quotes will be 
used from all participants’ responses to illustrate the views of participants. However, 
these quotes will not be associated with your name. The results of this study will form 
part of Asa’s PhD thesis and will also be published in a scientific journal and be 
presented at a conference.  
Who has reviewed this study? 
Ethical approval has been granted by the School of Healthcare Research Ethics 
Committee (Ref no: SHREC/RP/436) and the Plateau State Specialist Hospital Health 
Research Ethics Committee (Ref no: PSSH/ADM/ETH.CO/2014/025). 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact 
Asa Auta 
School of Healthcare, 
University of Leeds, 
LS2 9UT, Leeds, UK. 
Tel: +447448486187 or email: hs09aa@leeds.ac.uk 
Thank you for taking the time to read this information sheet. 
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Appendix 12: Consent form (Nigerian study) 
 
 
PARTICIPANT CONSENT FORM 
FACILITATORS AND BARRIERS TO EXTENDING PHARMACISTS’ 
CLINICAL ROLE TO INCLUDE PRESCRIBING 
Please confirm agreement to the following statements by putting a tick in the box 
below: 
I have read and understood the participant information sheet  
I am aware that I can ask questions about the research and receive 
satisfactory answers 
 
I have received enough information about the study  
I understand that I am free to withdraw from the study at any time 
without giving a reason before or during the interview and for up 
to two weeks after the interview has taken place and that all 
information obtained from me will not be included in the study 
following my withdrawal. 
 
 
 
I understand that that once the information obtained from me has 
been analysed, it cannot be withdrawn. 
 
I understand that my interview will be audio-recorded  
I understand that any information I provide, including personal 
details, will be kept confidential, stored securely and only accessed 
by those carrying out the study 
 
I understand that any information I give may be included in 
published documents but all information will be anonymised. 
 
I agree to take part in this study 
 
 
Participant Signature …………………………                      Date                       
Name of Participant:  
Researcher Signature ……………………….                       Date  
Name of Researcher:  
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Appendix 13: Draft interview guides for the Nigerian study 
Pharmacists and pharmacy technicians 
Preamble: 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the barriers and facilitators to extending the clinical role of pharmacists to 
include prescribing in Nigeria. This interview is expected to last about an hour, and you 
are free to stop from participating in the interview at any point. All information obtained 
from you will be kept confidential.  
Are you happy for me to record the interview? 
Demography and investigating pharmacy professional structure 
 When did you qualify as a pharmacist or pharmacy technician? 
 What is your current practice setting? 
 Can you tell me something about your career to date including the previous jobs 
you have had and your current role? 
 What factors influenced the choice of your present job? 
 What career structure is available for pharmacy staff in your institution? Are 
there provisions for a clinical career pathway?  
 What is your general view of pharmacists and pharmacy technicians, what they 
do and what they’re like? 
 Describe a typical role of pharmacy staff in your organisation? 
 What is your opinion on the level of pharmacists’ clinical involvement and 
contribution to a multidisciplinary health team? 
 What kind of roles will you want to see pharmacy staff do? 
 What educational and training provisions are available for pharmacy staff in 
your institution? 
Views on pharmacist prescribing 
 Are you aware that pharmacists are prescribing in some countries? 
 Do you think pharmacists should be given the right to prescribe medicines in 
Nigeria? 
 How do you think patients will feel about the pharmacists prescribing their 
medicines? 
 Do you have any reservations concerning extending prescribing rights to 
pharmacists? 
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 What are the constraints or barriers to having the pharmacists prescribe 
medicines in Nigeria? 
 How do you think doctors will react about pharmacist prescribing, will they be 
ready to support the pharmacists develop role in prescribing? 
 What factors will enable the pharmacists develop a role in prescribing in 
Nigeria? 
 In your opinion, what are the potential areas for pharmacist prescribing in 
Nigeria? 
 What changes to the structure of pharmacy in your place of work would be 
needed to develop prescribing by pharmacists? 
 What benefits do you think are there in having the pharmacists prescribe 
medicines? 
 Do you have any question or comment on issues that you think have not been 
covered by this interview? 
 
Thank you for taking part in this interview 
 
Doctors 
Preamble: 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the barriers and facilitators to extending the clinical role of pharmacists to 
include prescribing in Nigeria. This interview is expected to last about an hour, and you 
are free to stop from participating in the interview at any point. All information obtained 
from you will be kept confidential.  
Are you happy for me to record the interview? 
Demography and investigating pharmacy professional structure 
 How long you have been a practising doctor? 
 What is your current role and specialty? 
 What is your general view of pharmacists, what they do and what they’re like? 
 What experience have you had with pharmacists in your institution? 
 What is your opinion on the level of pharmacists’ clinical involvement and 
contribution to a multidisciplinary health team? 
 What kind of roles will you want to see pharmacists do? 
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Views on pharmacist prescribing 
 Are you aware that pharmacists are prescribing in some countries? 
 Do you think pharmacists should be given the right to prescribe medicines in 
Nigeria? 
 How do you think patients will feel about the pharmacists prescribing their 
medicines? 
 Do you have any reservations concerning extending prescribing rights to 
pharmacists? 
 What are the constraints or barriers to having the pharmacists prescribe 
medicines in Nigeria? 
 Will you be willing to support the pharmacists develop a role in prescribing? 
 What factors will enable the pharmacists develop a role in prescribing in 
Nigeria? 
 In your opinion, what are the potential areas for pharmacist prescribing in 
Nigeria? 
 What benefits do you think are there in having the pharmacists prescribe 
medicines? 
 Do you have any question or comment on issues that you think have not been 
covered by this interview? 
 
Thank you for taking part in this interview 
 
Policymakers and other stakeholders 
Preamble: 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the barriers and facilitators to extending the clinical role of pharmacists to 
include prescribing in Nigeria. This interview is expected to last about an hour, and you 
are free to stop from participating in the interview at any point. All information obtained 
from you will be kept confidential.  
Are you happy for me to record the interview? 
Demography and investigating pharmacy professional structure 
 Can you tell me a bit about your current role? 
 Do you have an idea on the career structure available for pharmacy staff?  
 305 
 
 What is your general view of pharmacists, what they do and what they’re like? 
 What is your opinion on the level of pharmacists’ clinical involvement and 
contribution to multidisciplinary health team? 
 What kind of roles will you want to see pharmacy staff do? 
 What educational and training provisions are available for pharmacy staff? 
Views on pharmacist prescribing 
 Are you aware that pharmacists are prescribing in some countries? 
 Do you think pharmacists should be given the right to prescribe medicines in 
Nigeria? 
 How do you think patients will feel about the pharmacists prescribing their 
medicines? 
 Do you have any reservations concerning extending prescribing rights to 
pharmacists? 
 What are the constraints or barriers to having the pharmacists prescribe 
medicines in Nigeria? 
 How do you think doctors will react about pharmacist prescribing, will they be 
ready to support the pharmacists develop role in prescribing? 
 What factors will enable the pharmacists develop a role in prescribing in 
Nigeria? 
 In your opinion, what are the potential areas for pharmacist prescribing in 
Nigeria? 
 What benefits do you think are there in having the pharmacists prescribe 
medicines? 
 Do you have any question or comment on issues that you think have not been 
covered by this interview? 
Thank you for taking part in this interview    
NB: Interviews were tailored towards the experience of each stakeholder 
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Appendix 14: Final interview guide used in interviewing Nigerian pharmacists 
and pharmacy technicians 
 
Areas covered by the interview 
Preamble 
Thank you for agreeing to take part in this interview. The purpose of this interview is to 
investigate the barriers and facilitators to extending the clinical role of pharmacists to 
include prescribing in Nigeria. By prescribing, we mean granting pharmacists the legal 
right to prescribe ‘Prescription Only Medicines’ as currently practised by doctors in 
Nigerian hospitals. This differs from counter prescribing or the supply of over the 
counter medicines as currently practised by community pharmacists in response to 
patients’ complaints or symptoms.  
This interview is expected to last about an hour, and you are free to stop from 
participating in the interview at any point. All information obtained from you will be kept 
confidential.  
Are you happy for me to record the interview? 
Demography and investigating pharmacy professional structure 
 When did you qualify as a pharmacist or pharmacy technician? 
 What is your current role? 
 What career structure is available for pharmacy staff in your institution? Are 
there provisions for a clinical career pathway?  
 What is your general view of pharmacists and pharmacy technicians, who they 
are and what they do? 
 What experience have you had with doctors in your workplace? What kind of 
professional relationship exists between doctors and pharmacists in your 
workplace? 
 What kind of clinical roles do you do in your practice? 
Prompt: 
o Level of pharmacists’ clinical involvement  
o Contribution to a multidisciplinary health team? 
 What kind of clinical roles will you want to do or see pharmacists do in Nigeria? 
Prompt: 
o Why? 
o What are the barriers to attaining such roles 
 What educational and training provisions are available for pharmacy staff in 
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your institution? 
Views on pharmacist prescribing 
 Are you aware that pharmacists are prescribing in some countries? 
 Do you think pharmacists in Nigeria should be granted the right to prescribe 
prescription only medicines? Why? 
 Do you have any reservation concerning extending prescribing rights to 
pharmacists? 
 What are the constraints or barriers to having the pharmacist prescribe 
medicines in Nigeria? 
 How do you think pharmacists could be introduced to prescribing in the future? 
 Prompts 
o Potential areas 
o Models: Collaborative/independent 
In collaborative prescribing, the pharmacist prescribes in partnership 
with a doctor where the doctor makes initial diagnosis and treatment 
decisions, while the pharmacist may continue therapy, adjust doses, 
change therapy or discontinue a medication within an agreed plan. In 
independent prescribing; the pharmacist is responsible and accountable 
for his or her prescribing decisions including clinical assessment, 
diagnosis (where applicable) and management of the patient.  
o Limited prescribing? 
 What factors will enable the pharmacists develop a role in prescribing in 
Nigeria? 
 What changes to the structure of pharmacy in your place of work would be 
needed to develop prescribing by pharmacists? 
 What benefits do you think are there in having the pharmacists prescribe 
medicines? 
o Will it promote safe supply of medicines or minimise medicine related 
harm? 
 Do you have any question or comment on issues that you think have not been 
covered by this interview? 
Thank you for taking part in this interview 
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Appendix 15: Online Survey Questionnaire 
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Appendix 16: Online survey recruitment letter 
 
 
Dear Pharmacist, 
I am a PhD student at the School of Healthcare, University of Leeds, United Kingdom. I 
got your details from the PSN’s Facebook group. I write to invite you to participate in 
the online survey I am carrying out to investigate the facilitators and barriers to 
extending pharmacists’ clinical role to include prescribing in Nigeria. In the UK and to a 
lesser degree in other countries, pharmacists have prescribing rights. I am interested in 
finding out if such rights would be possible in Nigeria. Your opinion as a pharmacist 
working in Nigeria is essential to my research. 
 
Please find below the link to the survey for further information. 
https://www.survey.leeds.ac.uk/pharmnigeria/ 
 
Kind regards 
 
Asa Auta 
 
